This is the multi-page printable view of this section. Click here to print.
Gene Ontology (GO)
- 1: ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose [GO_0004135]
- 2: (2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK) [GO_0004001]
- 3: (d)ADP + ADP <=> (d)AMP + ATP (AK1) [GO_0004017]
- 4: (d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1) [GO_0050145]
- 5: (d)GMP + ATP <=> (d)GDP + ADP (GUK1) [GO_0004385]
- 6: (d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3) [GO_0004550]
- 7: (S)-2-hydroxy-acid oxidase activity [GO_0003973]
- 8: 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] [GO_0004144]
- 9: 1,4-alpha-glucan branching enzyme activity [GO_0003844]
- 10: 1,4-alpha-oligoglucan phosphorylase activity [GO_0004645]
- 11: 1-acyl LPE is acylated to PE by LPEAT [GO_0003841]
- 12: 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C [GO_0004622]
- 13: 1-acylglycerophosphocholine O-acyltransferase activity [GO_0047184]
- 14: 1-phosphatidylinositol 4-kinase activator activity [GO_0098744]
- 15: 1-phosphatidylinositol binding [GO_0005545]
- 16: 1-phosphatidylinositol-3-kinase regulator activity [GO_0046935]
- 17: 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO_0016309]
- 18: 1-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by IP6K1/3 in the cytosol [GO_0000829]
- 19: 1/3 PP-IP5 is dephosphorylated to IP6 by NUDT(1) in the cytosol [GO_0052842]
- 20: 14-3-3 protein binding [GO_0071889]
- 21: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO_0044594]
- 22: 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0072582]
- 23: 17-beta-ketosteroid reductase activity [GO_0072555]
- 24: 2 H2O2 => O2 + 2 H2O [GO_0004096]
- 25: 2 iron, 2 sulfur cluster binding [GO_0051537]
- 26: 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO_0090560]
- 27: 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity [GO_0106360]
- 28: 2-hydroxyacyl-CoA lyase activity [GO_0106359]
- 29: 2-hydroxyphytanoyl-CoA => pristanal + formyl-CoA [GO_0016830]
- 30: 2-iminobutanoate deaminase activity [GO_0120242]
- 31: 2-iminobutanoate/2-iminopropanoate deaminase [GO_0120241]
- 32: 2-MAG and DAG are transacylated to TAG by PNPLA2/3 [GO_0016411]
- 33: 2-oxoglutarate + NADPH + H+ => (R)-2-hydroxyglutarate + NADP+ [mutant IDH1] [GO_0051990]
- 34: 2-oxoglutarate-dependent dioxygenase activity [GO_0016706]
- 35: 2-Phospho-D-glycerate <=> 3-Phospho-D-glycerate [GO_0004619]
- 36: 2-Phospho-D-glycerate <=> Phosphoenolpyruvate + H2O [GO_0004634]
- 37: 2xENPP1 hydrolyzes FAD to FMN [GO_0004551]
- 38: 2xPDKX:2xZn2+ phosphorylates PDX [GO_0008478]
- 39: 2xPNPO:2xFMN oxidizes PXAP to PXLP [GO_0004733]
- 40: 2xPPCS ligates PPanK with Cys [GO_0004632]
- 41: 2xTRAP hydrolyzes FMN to RIB [GO_0003993]
- 42: 3 iron, 4 sulfur cluster binding [GO_0051538]
- 43: 3',2'-cyclic GMP-AMP synthase activity [GO_0140700]
- 44: 3'-5' DNA/RNA helicase activity [GO_0033679]
- 45: 3'-5' exonuclease activity [GO_0008408]
- 46: 3'-5' RNA helicase activity [GO_0034458]
- 47: 3-dehydrosphinganine reductase activity [GO_0047560]
- 48: 3-hydroxyacyl-CoA dehydratase activity [GO_0018812]
- 49: 3-ketohexacosanoyl-CoA + CoASH => tetracosanoyl-CoA + acetyl-CoA [GO_0003988]
- 50: 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO_0003863]
- 51: 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO_0004315]
- 52: 4 iron, 4 sulfur cluster binding [GO_0051539]
- 53: 4-hydroxyphenylpyruvate dioxygenase activity [GO_0003868]
- 54: 4-methylcholesta-8(9),24-dien-3-one is reduced to 4-methylcholesta-8(9),24-dien-3beta-ol [GO_0000253]
- 55: 4-methylcholesta-8(9),24-dien-3beta-ol is oxidized to 4-carboxycholesta-8(9),24-dien-3beta-ol [GO_0000254]
- 56: 4a-hydroxytetrahydrobiopterin => q-dihydrobiopterin + H2O [GO_0008124]
- 57: 4xPALM-C-p-2S-ABCA1 tetramer transports PL from transport vesicle membrane to plasma membrane [GO_0005548]
- 58: 5'-3' exodeoxyribonuclease activity [GO_0035312]
- 59: 5'-3' exoribonuclease activity [GO_0004534]
- 60: 5'-3' RNA polymerase activity [GO_0034062]
- 61: 5'-deoxynucleotidase activity [GO_0002953]
- 62: 5'-nucleotidase activity [GO_0008253]
- 63: 5,6-dihydrothymine + H2O => beta-ureidoisobutyrate [GO_0004157]
- 64: 5-hydroxy-L-tryptophan decarboxylase activity [GO_0036467]
- 65: 5-Phosphoribosylamine + Glycine + ATP => GAR + ADP + Pi [GO_0004637]
- 66: 5beta-cholestan-7alpha,27-diol-3-one is reduced to 5beta-cholestan-3alpha,7alpha,27-triol [GO_0004033]
- 67: 5S rRNA binding [GO_0008097]
- 68: 5S rRNA primary transcript binding [GO_0008098]
- 69: 6-phosphofructokinase activity [GO_0003872]
- 70: 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0047022]
- 71: 7S RNA binding [GO_0008312]
- 72: [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO_0008467]
- 73: [heparan sulfate]-glucosamine N-sulfotransferase activity [GO_0015016]
- 74: A-type (transient outward) potassium channel activity [GO_0005250]
- 75: abacavir monophosphate + H2O => carbovir monophosphate + cyclopropylamine [GO_0004000]
- 76: ABC-type fatty-acyl-CoA transporter activity [GO_0015607]
- 77: ABC-type polyamine transporter activity [GO_0015417]
- 78: ABC-type transporter activity [GO_0140359]
- 79: ABC-type xenobiotic transporter activity [GO_0008559]
- 80: ABC7, mABC1 and mABC2 mediate heme transport [GO_0015439]
- 81: ABCC4 accumulation of dense granule contents [GO_0015662]
- 82: AcCho is hydrolyzed to Cho and acetate by ACHE [GO_0003990]
- 83: ACE hydrolyzes Angiotensin-(1-9) to Angiotensin-(1-7) [GO_0070573]
- 84: ACE2 hydrolyzes Angiotensin-(1-8) to Angiotensin-(1-7) [GO_0004181]
- 85: acetaldehyde dehydrogenase (acetylating) activity [GO_0008774]
- 86: acetate CoA-transferase activity [GO_0008775]
- 87: acetate ester transmembrane transporter activity [GO_1901375]
- 88: acetate ester transport [GO_1901374]
- 89: acetate-CoA ligase activity [GO_0003987]
- 90: acetoacetyl-CoA reductase activity [GO_0018454]
- 91: acetoacetyl-CoA+acetyl-CoA => HMG-CoA + CoASH [GO_0004421]
- 92: acetyl-CoA + 7 malonyl-CoA + 14 NADHP + 14 H+ => palmitate + 7 CO2 + 14 NADP+ + 8 CoASH + 6 H2O [GO_0004312]
- 93: Acetyl-CoA + H2O + Oxaloacetate => Citrate + CoA [GO_0004108]
- 94: acetyl-CoA binding [GO_1905502]
- 95: acetyl-CoA C-acetyltransferase activity [GO_0003985]
- 96: acetylation-dependent protein binding [GO_0140033]
- 97: acetylcholine binding [GO_0042166]
- 98: acetylcholine receptor activator activity [GO_0030549]
- 99: acetylcholine receptor activity [GO_0015464]
- 100: acetylcholine receptor inhibitor activity [GO_0030550]
- 101: acetylcholine receptor regulator activity [GO_0030548]
- 102: acetylcholine receptor signaling pathway [GO_0095500]
- 103: acetylcholine secretion [GO_0061526]
- 104: acetylcholine secretion, neurotransmission [GO_0014055]
- 105: acetylcholine transport [GO_0015870]
- 106: acetylcholine-gated cation-selective channel activity [GO_0022848]
- 107: acetylesterase activity [GO_0008126]
- 108: acetylpyruvate hydrolase activity [GO_0018773]
- 109: acetyltransferase activator activity [GO_0010698]
- 110: acid secretion [GO_0046717]
- 111: acid sphingomyelin phosphodiesterase activity [GO_0061750]
- 112: acid-amino acid ligase activity [GO_0016881]
- 113: acid-ammonia (or amide) ligase activity [GO_0016880]
- 114: acid-sensing ion channel activity [GO_0044736]
- 115: acid-thiol ligase activity [GO_0016878]
- 116: acidic amino acid transmembrane transporter activity [GO_0015172]
- 117: acidic amino acid transport [GO_0015800]
- 118: Acidification of Tf:TfR1 containing endosome [GO_0015078]
- 119: acinar cell differentiation [GO_0090425]
- 120: acinar cell proliferation [GO_1990863]
- 121: acireductone dioxygenase [iron(II)-requiring] activity [GO_0010309]
- 122: ACP phosphopantetheine attachment site binding [GO_0044620]
- 123: Acrosin Cleavage [GO_0002020]
- 124: ACSBG1,2 ligates CoA-SH to VLCFA, forming VLCFA-CoA [GO_0031957]
- 125: ACSL3,4 ligates coenzyme A (CoA-SH) to palmitate yielding palmitoyl-coenzyme A in the pancreatic beta cell [GO_0090433]
- 126: actin binding [GO_0003779]
- 127: actin cytoskeleton [GO_0015629]
- 128: actin cytoskeleton organization [GO_0030036]
- 129: actin filament [GO_0005884]
- 130: actin filament binding [GO_0051015]
- 131: actin filament bundle [GO_0032432]
- 132: actin filament bundle assembly [GO_0051017]
- 133: actin filament bundle organization [GO_0061572]
- 134: actin filament organization [GO_0007015]
- 135: actin filament-based movement [GO_0030048]
- 136: actin filament-based process [GO_0030029]
- 137: actin filament-based transport [GO_0099515]
- 138: actin monomer binding [GO_0003785]
- 139: actin-based cell projection [GO_0098858]
- 140: actinin binding [GO_0042805]
- 141: action potential [GO_0001508]
- 142: Activated Adenylyl cyclase synthesizes cyclic AMP [GO_0004016]
- 143: Activated ERK1/2 threonine-phosphorylates FGFR4-associated FRS2. [GO_0004707]
- 144: Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3 [GO_0004708]
- 145: Activated JNK phosphorylates c-JUN [GO_0004705]
- 146: Activated MAP2Ks phosphorylate MAPKs downstream of inactive BRAF mutants [GO_0004712]
- 147: Activated type I receptor phosphorylates R-Smad1/5/8 directly [GO_0004675]
- 148: activation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0006919]
- 149: Activation of highly calcium permeable postsynaptic nicotinic acetylcholine receptors [GO_0015276]
- 150: Activation of NLK [GO_0004674]
- 151: Activation of TWIK-related K+ channel (TREK) [GO_0005267]
- 152: active ion transmembrane transporter activity [GO_0022853]
- 153: Active PKA, CaMK IV do not phosphorylate MECP2 mutants R306C,(R306H) at T308 [GO_0010857]
- 154: Active PLCG1 hydrolyses PIP2 [GO_0004435]
- 155: active transmembrane transporter activity [GO_0022804]
- 156: activin binding [GO_0048185]
- 157: activin receptor activity [GO_0017002]
- 158: activin receptor activity, type I [GO_0016361]
- 159: activin receptor activity, type II [GO_0016362]
- 160: activin receptor binding [GO_0070697]
- 161: activin receptor signaling pathway [GO_0032924]
- 162: actomyosin [GO_0042641]
- 163: actomyosin structure organization [GO_0031032]
- 164: acyl binding [GO_0000035]
- 165: acyl carnitine transmembrane transport [GO_1902616]
- 166: acyl carnitine transmembrane transporter activity [GO_0015227]
- 167: acyl carnitine transport [GO_0006844]
- 168: acyl carrier activity [GO_0000036]
- 169: acyl-CoA binding [GO_0120227]
- 170: acyl-CoA desaturase activity [GO_0016215]
- 171: acyl-CoA hydrolase activity [GO_0047617]
- 172: acylglycerol biosynthetic process [GO_0046463]
- 173: acylglycerol metabolic process [GO_0006639]
- 174: acylphosphatase activity [GO_0003998]
- 175: acyltransferase activity, acyl groups converted into alkyl on transfer [GO_0046912]
- 176: acyltransferase activity, transferring groups other than amino-acyl groups [GO_0016747]
- 177: ADAM10:Zn2+:TSPANs cleaves APP(18-770) [GO_1902945]
- 178: ADAT1 deaminates adenosine-37 in tRNA(Ala) [GO_0008251]
- 179: Addition of GlcNAc to the glycan on the A arm [GO_0003827]
- 180: Addition of GlcNAc to the Tn antigen forms a Core 3 glycoprotein [GO_0008499]
- 181: Addition of isopentenyl pyrophosphate to DMAPP [GO_0004161]
- 182: adenine nucleotide transmembrane transporter activity [GO_0000295]
- 183: adenine nucleotide transport [GO_0051503]
- 184: adenosine 3',5'-bisphosphate transmembrane transport [GO_0071106]
- 185: adenosine 3',5'-bisphosphate transmembrane transporter activity [GO_0071077]
- 186: adenosine 5'-monophosphoramidase activity [GO_0043530]
- 187: adenosine-phosphate deaminase activity [GO_0047623]
- 188: adenosylmethionine decarboxylase activity [GO_0004014]
- 189: adenyl nucleotide binding [GO_0030554]
- 190: adenyl ribonucleotide binding [GO_0032559]
- 191: adenylate cyclase activator activity [GO_0010856]
- 192: adenylate cyclase binding [GO_0008179]
- 193: adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO_0001640]
- 194: adenylate cyclase inhibitor activity [GO_0010855]
- 195: adenylate cyclase regulator activity [GO_0010854]
- 196: adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO_0007196]
- 197: adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO_0007193]
- 198: adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO_0007188]
- 199: adenylosuccinate synthase activity [GO_0004019]
- 200: adenylyltransferase activity [GO_0070566]
- 201: ADH5 oxidises S-HMGSH to S-FGSH [GO_0051903]
- 202: adipokinetic hormone binding [GO_0097004]
- 203: adipokinetic hormone receptor activity [GO_0097003]
- 204: adipokinetic hormone receptor binding [GO_0097005]
- 205: adiponectin binding [GO_0055100]
- 206: adipose tissue development [GO_0060612]
- 207: ADP binding [GO_0043531]
- 208: ADP metabolic process [GO_0046031]
- 209: ADP phosphatase activity [GO_0043262]
- 210: ADP transmembrane transporter activity [GO_0015217]
- 211: ADP transport [GO_0015866]
- 212: ADP-ribose diphosphatase activity [GO_0047631]
- 213: ADP-ribosylglutamate hydrolase activity [GO_0140293]
- 214: adrenergic receptor activity [GO_0004935]
- 215: adrenergic receptor signaling pathway [GO_0071875]
- 216: adult behavior [GO_0030534]
- 217: adult feeding behavior [GO_0008343]
- 218: adult locomotory behavior [GO_0008344]
- 219: adult walking behavior [GO_0007628]
- 220: aerobic respiration [GO_0009060]
- 221: aggressive behavior [GO_0002118]
- 222: aging [GO_0007568]
- 223: alanine-glyoxylate transaminase activity [GO_0008453]
- 224: alanine-oxo-acid transaminase activity [GO_0047635]
- 225: ALAS condenses SUCC-CoA and Gly to form dALA [GO_0003870]
- 226: alcohol binding [GO_0043178]
- 227: alcohol dehydrogenase (NAD+) activity [GO_0004022]
- 228: alcohol dehydrogenase (NADP+) activity [GO_0008106]
- 229: alcohol dehydrogenase [NAD(P)+] activity [GO_0018455]
- 230: alcohol dehydrogenase activity, zinc-dependent [GO_0004024]
- 231: alcohol metabolic process [GO_0006066]
- 232: ALD3A1 oxidises 4HPCP to CXPA [GO_0004030]
- 233: aldehyde biosynthetic process [GO_0046184]
- 234: aldehyde decarbonylase activity [GO_0071771]
- 235: aldehyde dehydrogenase (NAD+) activity [GO_0004029]
- 236: aldehyde dehydrogenase (NAD+) inhibitor activity [GO_0140631]
- 237: aldehyde oxidase activity [GO_0004031]
- 238: aldehyde-lyase activity [GO_0016832]
- 239: ALDH4A1 oxidises L-GluSS to Glu [GO_0003842]
- 240: alditol:NADP+ 1-oxidoreductase activity [GO_0004032]
- 241: aldose 1-epimerase activity [GO_0004034]
- 242: alkali metal ion binding [GO_0031420]
- 243: alkaloid biosynthetic process [GO_0009821]
- 244: alkaloid catabolic process [GO_0009822]
- 245: alkaloid metabolic process [GO_0009820]
- 246: alkane 1-monooxygenase activity [GO_0018685]
- 247: alkanesulfonate transmembrane transporter activity [GO_0042959]
- 248: alkanesulfonate transport [GO_0042918]
- 249: allantois development [GO_1905069]
- 250: allatostatin receptor activity [GO_0008261]
- 251: alpha,alpha-trehalase activity [GO_0004555]
- 252: alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO_0003825]
- 253: alpha-1,3-glucosidase activity [GO_0090600]
- 254: alpha-actinin binding [GO_0051393]
- 255: alpha-amino acid biosynthetic process [GO_1901607]
- 256: alpha-amino acid catabolic process [GO_1901606]
- 257: alpha-amino acid metabolic process [GO_1901605]
- 258: alpha-aminoadipate + alpha-ketoglutarate <=> alpha-ketoadipate + glutamate [GO_0047536]
- 259: alpha-catenin binding [GO_0045294]
- 260: alpha-D-glucose 6-phosphate + NADP+ => D-glucono-1,5-lactone 6-phosphate + NADPH + H+ [GO_0004345]
- 261: alpha-galactosidase activity [GO_0004557]
- 262: alpha-glucosidase activity [GO_0090599]
- 263: alpha-ketoglutarate transmembrane transporter activity [GO_0015139]
- 264: alpha-ketoglutarate transport [GO_0015742]
- 265: alpha-tubulin binding [GO_0043014]
- 266: ALPI dimer hydrolyses phosphate monoesters [GO_0004035]
- 267: AMDHD2 hydrolyses GlcNGc-6-P to GlcN6P and CCA [GO_0008448]
- 268: ameboidal-type cell migration [GO_0001667]
- 269: amide binding [GO_0033218]
- 270: amide biosynthetic process [GO_0043604]
- 271: amide transmembrane transporter activity [GO_0042887]
- 272: amide transport [GO_0042886]
- 273: amidine-lyase activity [GO_0016842]
- 274: amidophosphoribosyltransferase activity [GO_0004044]
- 275: amine binding [GO_0043176]
- 276: amine biosynthetic process [GO_0009309]
- 277: amine catabolic process [GO_0009310]
- 278: amine metabolic process [GO_0009308]
- 279: amine transmembrane transporter activity [GO_0005275]
- 280: amine transport [GO_0015837]
- 281: amine-lyase activity [GO_0016843]
- 282: amino acid binding [GO_0016597]
- 283: amino acid homeostasis [GO_0080144]
- 284: amino acid kinase activity [GO_0019202]
- 285: amino acid transmembrane transport [GO_0003333]
- 286: amino acid transport [GO_0006865]
- 287: amino acid:cation symporter activity [GO_0005416]
- 288: amino acid:sodium symporter activity [GO_0005283]
- 289: amino-acid racemase activity [GO_0047661]
- 290: aminoacyl-tRNA editing activity [GO_0002161]
- 291: aminoacyl-tRNA hydrolase activity [GO_0004045]
- 292: aminoacyl-tRNA ligase activity [GO_0004812]
- 293: aminoacyl-tRNA metabolism involved in translational fidelity [GO_0106074]
- 294: aminoacylase activity [GO_0004046]
- 295: aminoacyltransferase activity [GO_0016755]
- 296: aminoglycan biosynthetic process [GO_0006023]
- 297: aminoglycan catabolic process [GO_0006026]
- 298: aminoglycan metabolic process [GO_0006022]
- 299: ammonia ligase activity [GO_0016211]
- 300: ammonia-lyase activity [GO_0016841]
- 301: ammonium excretion [GO_0140734]
- 302: ammonium homeostasis [GO_0097272]
- 303: ammonium ion binding [GO_0070405]
- 304: ammonium ion metabolic process [GO_0097164]
- 305: ammonium transmembrane transport [GO_0072488]
- 306: ammonium transport [GO_0015696]
- 307: AMP binding [GO_0016208]
- 308: AMP biosynthetic process [GO_0006167]
- 309: AMP deaminase activity [GO_0003876]
- 310: AMP metabolic process [GO_0046033]
- 311: AMP transmembrane transporter activity [GO_0080122]
- 312: AMP transport [GO_0080121]
- 313: AMT transfers NH2CH2 from GCSH:SAMDLL to THF [GO_0004047]
- 314: amylase activity [GO_0016160]
- 315: amyloid precursor protein catabolic process [GO_0042987]
- 316: amyloid precursor protein metabolic process [GO_0042982]
- 317: amyloid-beta binding [GO_0001540]
- 318: An unknown carrier transports mitochondrial glyoxylate to the cytosol [GO_0022857]
- 319: An unknown oxidase oxidises D-UBGN to UBN [GO_0016627]
- 320: anaphase-promoting complex binding [GO_0010997]
- 321: anatomical structure development [GO_0048856]
- 322: anatomical structure formation involved in morphogenesis [GO_0048646]
- 323: anatomical structure homeostasis [GO_0060249]
- 324: anatomical structure maturation [GO_0071695]
- 325: anatomical structure morphogenesis [GO_0009653]
- 326: anchoring junction [GO_0070161]
- 327: androgen secretion [GO_0035935]
- 328: anesthesia-resistant memory [GO_0007615]
- 329: angioblast cell differentiation [GO_0035779]
- 330: angiogenesis [GO_0001525]
- 331: angiogenesis involved in coronary vascular morphogenesis [GO_0060978]
- 332: animal organ development [GO_0048513]
- 333: animal organ formation [GO_0048645]
- 334: animal organ maturation [GO_0048799]
- 335: animal organ morphogenesis [GO_0009887]
- 336: anion binding [GO_0043168]
- 337: anion channel activity [GO_0005253]
- 338: anion homeostasis [GO_0055081]
- 339: anion transmembrane transport [GO_0098656]
- 340: anion transmembrane transporter activity [GO_0008509]
- 341: anion transport [GO_0006820]
- 342: anion:cation symporter activity [GO_0015296]
- 343: anion:sodium symporter activity [GO_0015373]
- 344: ankyrin binding [GO_0030506]
- 345: annealing activity [GO_0140666]
- 346: anterior/posterior pattern specification [GO_0009952]
- 347: anterograde trans-synaptic signaling [GO_0098916]
- 348: Anthrax lef cleaves target cell MAP2K7 (MEK7) [GO_0008237]
- 349: antigen binding [GO_0003823]
- 350: antioxidant activity [GO_0016209]
- 351: aorta development [GO_0035904]
- 352: aorta morphogenesis [GO_0035909]
- 353: aorta smooth muscle tissue morphogenesis [GO_0060414]
- 354: aortic smooth muscle cell differentiation [GO_0035887]
- 355: AP-1 adaptor complex binding [GO_0035650]
- 356: AP-2 adaptor complex binding [GO_0035612]
- 357: apical ectodermal ridge formation [GO_1905139]
- 358: apolipoprotein binding [GO_0034185]
- 359: apoptotic chromosome condensation [GO_0030263]
- 360: apoptotic nuclear changes [GO_0030262]
- 361: apoptotic process [GO_0006915]
- 362: apoptotic process involved in blood vessel morphogenesis [GO_1902262]
- 363: apoptotic process involved in development [GO_1902742]
- 364: apoptotic process involved in endocardial cushion morphogenesis [GO_0003277]
- 365: apoptotic process involved in heart morphogenesis [GO_0003278]
- 366: apoptotic process involved in morphogenesis [GO_0060561]
- 367: apoptotic process involved in outflow tract morphogenesis [GO_0003275]
- 368: apoptotic process involved in tube lumen cavitation [GO_0060609]
- 369: apoptotic signaling pathway [GO_0097190]
- 370: appendage development [GO_0048736]
- 371: appendage morphogenesis [GO_0035107]
- 372: arginine kinase activity [GO_0004054]
- 373: arginine N-methyltransferase activity [GO_0016273]
- 374: arginine-tRNA ligase activity [GO_0004814]
- 375: argininosuccinate lyase activity [GO_0004056]
- 376: argininosuccinate synthase activity [GO_0004055]
- 377: arginyltransferase activity [GO_0004057]
- 378: ARHGAP35 stimulates RHOA GTPase activity [GO_0003924]
- 379: aromatic amino acid transmembrane transporter activity [GO_0015173]
- 380: aromatic amino acid transport [GO_0015801]
- 381: aromatic compound biosynthetic process [GO_0019438]
- 382: aromatic compound catabolic process [GO_0019439]
- 383: aromatic-L-amino-acid decarboxylase activity [GO_0004058]
- 384: Arp2/3 complex binding [GO_0071933]
- 385: arterial endothelial cell differentiation [GO_0060842]
- 386: artery development [GO_0060840]
- 387: artery morphogenesis [GO_0048844]
- 388: ARV1 transports CHOL from ER membrane to plasma membrane [GO_0015248]
- 389: arylamine N-acetyltransferase activity [GO_0004060]
- 390: arylesterase activity [GO_0004064]
- 391: ascending aorta development [GO_0035905]
- 392: ascending aorta morphogenesis [GO_0035910]
- 393: asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO_0046988]
- 394: asparagine-tRNA ligase activity [GO_0004816]
- 395: aspartate + glutamine + ATP <=> asparagine + glutamate + AMP + pyrophosphate [ASNS] [GO_0004066]
- 396: aspartate + tRNA(Asp) + ATP => Asp-tRNA(Asp) + AMP + pyrophosphate [GO_0004815]
- 397: aspartate 1-decarboxylase activity [GO_0004068]
- 398: aspartate transmembrane transport [GO_0015810]
- 399: aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902944]
- 400: aspartic-type endopeptidase inhibitor activity [GO_0019828]
- 401: aspartic-type peptidase activity [GO_0070001]
- 402: ASPG hydrolyses L-Asn to L-Asp [GO_0004067]
- 403: Association of GABA B receptor with G protein beta-gamma subunits [GO_0004965]
- 404: associative learning [GO_0008306]
- 405: asymmetric cell division [GO_0008356]
- 406: asymmetric neuroblast division [GO_0055059]
- 407: asymmetric stem cell division [GO_0098722]
- 408: ATG3 transfers LC3 from ATG7 to ATG3 [GO_0019776]
- 409: Atg8-specific peptidase activity [GO_0019786]
- 410: ATP + 3-Phospho-D-glycerate <=> ADP + 1,3-bisphospho-D-glycerate [GO_0004618]
- 411: ATP biosynthetic process [GO_0006754]
- 412: ATP citrate synthase activity [GO_0003878]
- 413: ATP generation from ADP [GO_0006757]
- 414: ATP metabolic process [GO_0046034]
- 415: ATP transmembrane transporter activity [GO_0005347]
- 416: ATP transport [GO_0015867]
- 417: ATP-dependent activity [GO_0140657]
- 418: ATP-dependent activity, acting on DNA [GO_0008094]
- 419: ATP-dependent activity, acting on RNA [GO_0008186]
- 420: ATP-dependent chromatin remodeler activity [GO_0140658]
- 421: ATP-dependent DNA damage sensor activity [GO_0140664]
- 422: ATP-dependent FeS chaperone activity [GO_0140663]
- 423: ATP-dependent H2AZ histone chaperone activity [GO_0140849]
- 424: ATP-dependent histone chaperone activity [GO_0140674]
- 425: ATP-dependent protein binding [GO_0043008]
- 426: ATP-dependent protein folding chaperone [GO_0140662]
- 427: ATP2C1/2:Mg2+ transport cytosolic Ca2+ to Golgi lumen [GO_0005388]
- 428: ATP:ADP antiporter activity [GO_0005471]
- 429: ATPase activator activity [GO_0001671]
- 430: ATPase activity, coupled to transmembrane movement of ions, rotational mechanism [GO_0044769]
- 431: ATPase binding [GO_0051117]
- 432: ATPase coupled ion transmembrane transporter activity involved in regulation of postsynaptic membrane potential [GO_0099581]
- 433: ATPase inhibitor activity [GO_0042030]
- 434: ATPase regulator activity [GO_0060590]
- 435: ATPase-coupled cation transmembrane transporter activity [GO_0019829]
- 436: ATPase-coupled inorganic anion transmembrane transporter activity [GO_0043225]
- 437: ATPase-coupled ion transmembrane transporter activity [GO_0042625]
- 438: ATPase-coupled lipid transmembrane transporter activity [GO_0034040]
- 439: atrial cardiac muscle tissue development [GO_0003228]
- 440: atrial cardiac muscle tissue morphogenesis [GO_0055009]
- 441: atrial septum development [GO_0003283]
- 442: atrial septum morphogenesis [GO_0060413]
- 443: atrioventricular node cell development [GO_0060928]
- 444: atrioventricular node cell differentiation [GO_0060922]
- 445: atrioventricular node development [GO_0003162]
- 446: Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 [GO_0008349]
- 447: Autoglucosylation of GYG1 complexed with GYS1-a [GO_0008466]
- 448: autonomic nervous system development [GO_0048483]
- 449: Autophosphorylation of LYN kinase [GO_0004713]
- 450: AV node cell action potential [GO_0086016]
- 451: AV node cell to bundle of His cell communication [GO_0086067]
- 452: AV node cell to bundle of His cell signaling [GO_0086027]
- 453: axial mesoderm development [GO_0048318]
- 454: axial mesoderm formation [GO_0048320]
- 455: axial mesoderm morphogenesis [GO_0048319]
- 456: axis specification [GO_0009798]
- 457: axo-dendritic protein transport [GO_0099640]
- 458: axo-dendritic transport [GO_0008088]
- 459: axon [GO_0030424]
- 460: axon cytoplasm [GO_1904115]
- 461: axon development [GO_0061564]
- 462: axon guidance [GO_0007411]
- 463: axon guidance receptor activity [GO_0008046]
- 464: axonal dopamine secretion [GO_0099124]
- 465: axonemal microtubule [GO_0005879]
- 466: axonemal microtubule depolymerization [GO_0060404]
- 467: axoneme [GO_0005930]
- 468: axoneme assembly [GO_0035082]
- 469: axonogenesis [GO_0007409]
- 470: azole transmembrane transport [GO_0045117]
- 471: azole transmembrane transporter activity [GO_1901474]
- 472: B3GALTL transfers glucose to O-fucosyl-proteins [GO_0016757]
- 473: B4GALNT2 transfers GalNAc to Type 2 MSGG to form Sda [GO_0008376]
- 474: backward locomotion [GO_0043057]
- 475: Bacterial GUSB hydrolyses BDG to BIL [GO_0004553]
- 476: banded collagen fibril [GO_0098643]
- 477: basal RNA polymerase II transcription machinery binding [GO_0001099]
- 478: basal transcription machinery binding [GO_0001098]
- 479: basement membrane [GO_0005604]
- 480: basement membrane assembly [GO_0070831]
- 481: basement membrane collagen trimer [GO_0098651]
- 482: basement membrane disassembly [GO_0034769]
- 483: basement membrane organization [GO_0071711]
- 484: basic amino acid transmembrane transport [GO_1990822]
- 485: basic amino acid transport [GO_0015802]
- 486: BBOX1:AscH-:Fe2+ dimer dioxygenates TEABT and 2OG to form CAR and SUCCA [GO_0008336]
- 487: BCAP Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3 [GO_0035004]
- 488: behavior [GO_0007610]
- 489: behavioral response to nutrient [GO_0051780]
- 490: behavioral response to pain [GO_0048266]
- 491: behavioral response to starvation [GO_0042595]
- 492: benzene-containing compound metabolic process [GO_0042537]
- 493: beta-1,3-galactosyltransferase activity [GO_0048531]
- 494: beta-1,4-mannosyltransferase activity [GO_0019187]
- 495: beta-alanyl-dopamine hydrolase activity [GO_0003832]
- 496: beta-alanyl-histamine hydrolase activity [GO_0031964]
- 497: beta-catenin binding [GO_0008013]
- 498: beta-catenin destruction complex binding [GO_1904713]
- 499: beta-galactosidase activity [GO_0004565]
- 500: beta-glucosidase activity [GO_0008422]
- 501: beta-hydroxyisobutyryl-CoA + H2O => beta-hydroxyisobutyrate + CoA [GO_0003860]
- 502: beta-mannosidase activity [GO_0004567]
- 503: beta-N-acetylglucosaminidase activity [GO_0016231]
- 504: beta-tubulin binding [GO_0048487]
- 505: beta-ureidoisobutyrate + H2O => 3-aminoisobutyrate + NH4+ + CO2 [GO_0003837]
- 506: bHLH transcription factor binding [GO_0043425]
- 507: bicarbonate transmembrane transporter activity [GO_0015106]
- 508: bicarbonate transport [GO_0015701]
- 509: bidentate ribonuclease III activity [GO_0016443]
- 510: bile acid and bile salt transport [GO_0015721]
- 511: bile acid biosynthetic process [GO_0006699]
- 512: bile acid catabolic process [GO_0030573]
- 513: bile acid metabolic process [GO_0008206]
- 514: bile acid secretion [GO_0032782]
- 515: bilirubin transmembrane transporter activity [GO_0015127]
- 516: bilirubin transport [GO_0015723]
- 517: biliverdin reductase (NAD(P)+) activity [GO_0004074]
- 518: binding [GO_0005488]
- 519: biological adhesion [GO_0022610]
- 520: biological phase [GO_0044848]
- 521: biological process involved in interspecies interaction between organisms [GO_0044419]
- 522: biological regulation [GO_0065007]
- 523: biological_process [GO_0008150]
- 524: biosynthetic process [GO_0009058]
- 525: BIR domain binding [GO_1990525]
- 526: bis(5'-adenosyl)-hexaphosphatase activity [GO_0034431]
- 527: bis(5'-adenosyl)-pentaphosphatase activity [GO_0034432]
- 528: bisphosphoglycerate 3-phosphatase activity [GO_0034417]
- 529: bisphosphoglycerate phosphatase activity [GO_0034416]
- 530: blastocyst development [GO_0001824]
- 531: blastocyst formation [GO_0001825]
- 532: blastocyst growth [GO_0001832]
- 533: bleb [GO_0032059]
- 534: bleb assembly [GO_0032060]
- 535: blood circulation [GO_0008015]
- 536: blood vessel development [GO_0001568]
- 537: blood vessel endothelial cell differentiation [GO_0060837]
- 538: blood vessel maturation [GO_0001955]
- 539: blood vessel morphogenesis [GO_0048514]
- 540: blue light photoreceptor activity [GO_0009882]
- 541: blue light signaling pathway [GO_0009785]
- 542: BMP binding [GO_0036122]
- 543: BMP receptor activity [GO_0098821]
- 544: BMP receptor binding [GO_0070700]
- 545: BMP signaling pathway [GO_0030509]
- 546: body fluid secretion [GO_0007589]
- 547: body morphogenesis [GO_0010171]
- 548: bone cell development [GO_0098751]
- 549: bone development [GO_0060348]
- 550: bone growth [GO_0098868]
- 551: bone marrow development [GO_0048539]
- 552: bone maturation [GO_0070977]
- 553: bone morphogenesis [GO_0060349]
- 554: bounding membrane of organelle [GO_0098588]
- 555: box H/ACA snoRNA binding [GO_0034513]
- 556: brain development [GO_0007420]
- 557: brain morphogenesis [GO_0048854]
- 558: brainstem development [GO_0003360]
- 559: branched-chain amino acid transmembrane transporter activity [GO_0015658]
- 560: branched-chain amino acid transport [GO_0015803]
- 561: branched-chain-amino-acid transaminase activity [GO_0004084]
- 562: branching involved in blood vessel morphogenesis [GO_0001569]
- 563: branching involved in labyrinthine layer morphogenesis [GO_0060670]
- 564: branching involved in pancreas morphogenesis [GO_0061114]
- 565: branching morphogenesis of a nerve [GO_0048755]
- 566: branching morphogenesis of an epithelial tube [GO_0048754]
- 567: bronchiole development [GO_0060435]
- 568: bronchiole morphogenesis [GO_0060436]
- 569: bronchus cartilage development [GO_0060532]
- 570: bronchus cartilage morphogenesis [GO_0060533]
- 571: bronchus development [GO_0060433]
- 572: bronchus morphogenesis [GO_0060434]
- 573: Btn-ACACA:2Mn2+ polymer carboxylates Ac-CoA to form Mal-CoA [GO_0003989]
- 574: Butyrylcholinesterase hydrolyzes acyl Ghrelin [GO_0016788]
- 575: C-acetyltransferase activity [GO_0016453]
- 576: C-acyltransferase activity [GO_0016408]
- 577: C-palmitoyltransferase activity [GO_0016454]
- 578: C4-dicarboxylate transmembrane transporter activity [GO_0015556]
- 579: C4-dicarboxylate transport [GO_0015740]
- 580: Ca2+ influx into the post-synaptic cell [GO_0005231]
- 581: CAAX-protein geranylgeranyltransferase activity [GO_0004662]
- 582: cadherin binding [GO_0045296]
- 583: cadherin binding involved in cell-cell adhesion [GO_0098641]
- 584: cadmium ion transmembrane transport [GO_0070574]
- 585: cadmium ion transmembrane transporter activity [GO_0015086]
- 586: cadmium ion transport [GO_0015691]
- 587: CAIR + Aspartate + ATP => SAICAR + ADP + Pi [GO_0004639]
- 588: calcitonin binding [GO_0032841]
- 589: calcitonin family binding [GO_0097644]
- 590: calcitonin family receptor activity [GO_0097642]
- 591: calcitonin receptor activity [GO_0004948]
- 592: calcium activated cation channel activity [GO_0005227]
- 593: calcium channel inhibitor activity [GO_0019855]
- 594: calcium channel regulator activity [GO_0005246]
- 595: Calcium Influx through Voltage-gated Calcium Channels [GO_0005245]
- 596: calcium ion binding [GO_0005509]
- 597: calcium ion homeostasis [GO_0055074]
- 598: calcium ion transmembrane import into cytosol [GO_0097553]
- 599: calcium ion transmembrane transport [GO_0070588]
- 600: calcium ion transmembrane transporter activity [GO_0015085]
- 601: calcium ion transport [GO_0006816]
- 602: calcium sensitive guanylate cyclase activator activity [GO_0008048]
- 603: calcium- and calmodulin-responsive adenylate cyclase activity [GO_0008294]
- 604: calcium-activated potassium channel activity [GO_0015269]
- 605: calcium-dependent ATPase activity [GO_0030899]
- 606: calcium-dependent phospholipase A2 activity [GO_0047498]
- 607: calcium-dependent phospholipid binding [GO_0005544]
- 608: calcium-dependent protein binding [GO_0048306]
- 609: calcium-dependent protein kinase inhibitor activity [GO_0008427]
- 610: calcium-dependent protein kinase regulator activity [GO_0010858]
- 611: calcium-dependent protein serine/threonine kinase activity [GO_0009931]
- 612: calcium-dependent protein serine/threonine phosphatase activity [GO_0004723]
- 613: calcium-dependent protein serine/threonine phosphatase regulator activity [GO_0008597]
- 614: calcium-induced calcium release activity [GO_0048763]
- 615: calcium-mediated signaling [GO_0019722]
- 616: calcium-release channel activity [GO_0015278]
- 617: calmodulin binding [GO_0005516]
- 618: calmodulin dependent kinase signaling pathway [GO_0099004]
- 619: calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO_0048101]
- 620: calmodulin-dependent protein phosphatase activity [GO_0033192]
- 621: Calpain cleaves p35 to p25 [GO_0004198]
- 622: camera-type eye development [GO_0043010]
- 623: camera-type eye morphogenesis [GO_0048593]
- 624: camera-type eye photoreceptor cell differentiation [GO_0060219]
- 625: CaMKK phosphorylates CAMK4 [GO_0004683]
- 626: cAMP binding [GO_0030552]
- 627: cAMP response element binding [GO_0035497]
- 628: cAMP response element binding protein binding [GO_0008140]
- 629: cAMP-dependent protein kinase activity [GO_0004691]
- 630: cAMP-dependent protein kinase regulator activity [GO_0008603]
- 631: cAMP-mediated signaling [GO_0019933]
- 632: Cap-bound mRNA is activated by helicases [GO_0003724]
- 633: carbohydrate binding [GO_0030246]
- 634: carbohydrate biosynthetic process [GO_0016051]
- 635: carbohydrate catabolic process [GO_0016052]
- 636: carbohydrate derivative binding [GO_0097367]
- 637: carbohydrate derivative biosynthetic process [GO_1901137]
- 638: carbohydrate derivative catabolic process [GO_1901136]
- 639: carbohydrate derivative metabolic process [GO_1901135]
- 640: carbohydrate derivative transmembrane transporter activity [GO_1901505]
- 641: carbohydrate derivative transport [GO_1901264]
- 642: carbohydrate homeostasis [GO_0033500]
- 643: carbohydrate kinase activity [GO_0019200]
- 644: carbohydrate metabolic process [GO_0005975]
- 645: carbohydrate phosphorylation [GO_0046835]
- 646: carbohydrate transmembrane transport [GO_0034219]
- 647: carbohydrate transmembrane transporter activity [GO_0015144]
- 648: carbohydrate transport [GO_0008643]
- 649: carbohydrate:cation symporter activity [GO_0005402]
- 650: carbohydrate:proton symporter activity [GO_0005351]
- 651: carbon-halide lyase activity [GO_0016848]
- 652: carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO_0016884]
- 653: carbon-nitrogen lyase activity [GO_0016840]
- 654: carbon-oxygen lyase activity [GO_0016835]
- 655: carbon-oxygen lyase activity, acting on phosphates [GO_0016838]
- 656: carbon-sulfur lyase activity [GO_0016846]
- 657: Carbonic anhydrase dehydrates bicarbonate (cytosol) [GO_0004089]
- 658: carbonyl reductase (NADPH) activity [GO_0004090]
- 659: carboxyl-O-methyltransferase activity [GO_0010340]
- 660: carboxylic acid binding [GO_0031406]
- 661: carboxylic acid biosynthetic process [GO_0046394]
- 662: carboxylic acid catabolic process [GO_0046395]
- 663: carboxylic acid metabolic process [GO_0019752]
- 664: carboxylic acid transmembrane transport [GO_1905039]
- 665: carboxylic acid transmembrane transporter activity [GO_0046943]
- 666: carboxylic acid transport [GO_0046942]
- 667: carcinine transmembrane transporter activity [GO_1905131]
- 668: CARD domain binding [GO_0050700]
- 669: cardiac atrium development [GO_0003230]
- 670: cardiac atrium formation [GO_0003210]
- 671: cardiac atrium morphogenesis [GO_0003209]
- 672: cardiac blood vessel endothelial cell differentiation [GO_0060946]
- 673: cardiac cell development [GO_0055006]
- 674: cardiac chamber development [GO_0003205]
- 675: cardiac chamber formation [GO_0003207]
- 676: cardiac chamber morphogenesis [GO_0003206]
- 677: cardiac conduction [GO_0061337]
- 678: cardiac conduction system development [GO_0003161]
- 679: cardiac endothelial cell differentiation [GO_0003348]
- 680: cardiac fibroblast cell development [GO_0060936]
- 681: cardiac fibroblast cell differentiation [GO_0060935]
- 682: cardiac glial cell development [GO_0060952]
- 683: cardiac glial cell differentiation [GO_0060950]
- 684: cardiac left atrium formation [GO_0003216]
- 685: cardiac left atrium morphogenesis [GO_0003212]
- 686: cardiac left ventricle formation [GO_0003218]
- 687: cardiac left ventricle morphogenesis [GO_0003214]
- 688: cardiac muscle adaptation [GO_0014887]
- 689: cardiac muscle cell action potential [GO_0086001]
- 690: cardiac muscle cell apoptotic process [GO_0010659]
- 691: cardiac muscle cell development [GO_0055013]
- 692: cardiac muscle cell differentiation [GO_0055007]
- 693: cardiac muscle cell myoblast differentiation [GO_0060379]
- 694: cardiac muscle cell proliferation [GO_0060038]
- 695: cardiac muscle contraction [GO_0060048]
- 696: cardiac muscle hypertrophy [GO_0003300]
- 697: cardiac muscle myoblast proliferation [GO_0110021]
- 698: cardiac muscle tissue development [GO_0048738]
- 699: cardiac muscle tissue growth [GO_0055017]
- 700: cardiac muscle tissue growth involved in heart morphogenesis [GO_0003245]
- 701: cardiac muscle tissue morphogenesis [GO_0055008]
- 702: cardiac myofibril [GO_0097512]
- 703: cardiac myofibril assembly [GO_0055003]
- 704: cardiac neural crest cell development involved in heart development [GO_0061308]
- 705: cardiac neural crest cell development involved in outflow tract morphogenesis [GO_0061309]
- 706: cardiac neural crest cell differentiation involved in heart development [GO_0061307]
- 707: cardiac neuron development [GO_0060959]
- 708: cardiac neuron differentiation [GO_0060945]
- 709: cardiac pacemaker cell development [GO_0060926]
- 710: cardiac pacemaker cell differentiation [GO_0060920]
- 711: cardiac right atrium formation [GO_0003217]
- 712: cardiac right atrium morphogenesis [GO_0003213]
- 713: cardiac right ventricle formation [GO_0003219]
- 714: cardiac right ventricle morphogenesis [GO_0003215]
- 715: cardiac septum cell differentiation [GO_0003292]
- 716: cardiac septum development [GO_0003279]
- 717: cardiac septum morphogenesis [GO_0060411]
- 718: cardiac skeleton development [GO_0003204]
- 719: cardiac ventricle development [GO_0003231]
- 720: cardiac ventricle formation [GO_0003211]
- 721: cardiac ventricle morphogenesis [GO_0003208]
- 722: cardioblast differentiation [GO_0010002]
- 723: cardiocyte differentiation [GO_0035051]
- 724: cardiogenic plate morphogenesis [GO_0003142]
- 725: cargo adaptor activity [GO_0140312]
- 726: carnitine O-acetyltransferase activity [GO_0004092]
- 727: carnitine O-acyltransferase activity [GO_0016406]
- 728: cartilage development [GO_0051216]
- 729: cartilage development involved in endochondral bone morphogenesis [GO_0060351]
- 730: cartilage morphogenesis [GO_0060536]
- 731: caspase binding [GO_0089720]
- 732: catabolic process [GO_0009056]
- 733: catalytic activity [GO_0003824]
- 734: catalytic activity, acting on a glycoprotein [GO_0140103]
- 735: catalytic activity, acting on a nucleic acid [GO_0140640]
- 736: catalytic activity, acting on a protein [GO_0140096]
- 737: catalytic activity, acting on a rRNA [GO_0140102]
- 738: catalytic activity, acting on a tRNA [GO_0140101]
- 739: catalytic activity, acting on DNA [GO_0140097]
- 740: catalytic activity, acting on RNA [GO_0140098]
- 741: catalytic complex [GO_1902494]
- 742: catechol oxidase activity [GO_0004097]
- 743: catechol-containing compound biosynthetic process [GO_0009713]
- 744: catechol-containing compound catabolic process [GO_0019614]
- 745: catechol-containing compound metabolic process [GO_0009712]
- 746: catecholamine binding [GO_1901338]
- 747: catecholamine biosynthetic process [GO_0042423]
- 748: catecholamine catabolic process [GO_0042424]
- 749: catecholamine metabolic process [GO_0006584]
- 750: catecholamine secretion [GO_0050432]
- 751: catecholamine secretion, neurotransmission [GO_0160043]
- 752: catecholamine transport [GO_0051937]
- 753: catecholamine uptake [GO_0090493]
- 754: cation binding [GO_0043169]
- 755: cation efflux transmembrane transporter activity [GO_0046583]
- 756: cation homeostasis [GO_0055080]
- 757: cation transmembrane transport [GO_0098655]
- 758: cation transmembrane transporter activity [GO_0008324]
- 759: cation transport [GO_0006812]
- 760: cation:chloride symporter activity [GO_0015377]
- 761: CCR4-NOT complex binding [GO_1905762]
- 762: CD27 receptor binding [GO_0005175]
- 763: CD320 transports extracellular TCII:Cbl to endosome [GO_0038024]
- 764: CD38 hydrolyses NAD+ to NAM and ADP-ribose [GO_0003953]
- 765: CD4 biosynthetic process [GO_0045222]
- 766: CDK12 phosphorylates RNA Pol II CTD at DNA repair genes [GO_0004693]
- 767: CDP-alcohol phosphatidyltransferase activity [GO_0017169]
- 768: CDP-choline pathway [GO_0006657]
- 769: CDP-DAG is converted to PI by CDIPT [GO_0003881]
- 770: cell adhesion [GO_0007155]
- 771: cell adhesion involved in heart morphogenesis [GO_0061343]
- 772: cell adhesion mediator activity [GO_0098631]
- 773: cell adhesion molecule binding [GO_0050839]
- 774: cell adhesion receptor activity [GO_0004895]
- 775: cell body [GO_0044297]
- 776: cell chemotaxis [GO_0060326]
- 777: cell communication [GO_0007154]
- 778: cell communication involved in cardiac conduction [GO_0086065]
- 779: cell cortex [GO_0005938]
- 780: cell cortex region [GO_0099738]
- 781: cell cycle [GO_0007049]
- 782: cell cycle DNA replication [GO_0044786]
- 783: cell cycle DNA replication DNA unwinding [GO_1902297]
- 784: cell cycle phase [GO_0022403]
- 785: cell cycle process [GO_0022402]
- 786: cell death [GO_0008219]
- 787: cell development [GO_0048468]
- 788: cell differentiation [GO_0030154]
- 789: cell differentiation in hindbrain [GO_0021533]
- 790: cell differentiation in spinal cord [GO_0021515]
- 791: cell differentiation involved in embryonic placenta development [GO_0060706]
- 792: cell division [GO_0051301]
- 793: cell fate commitment [GO_0045165]
- 794: cell fate commitment involved in formation of primary germ layer [GO_0060795]
- 795: cell fate commitment involved in pattern specification [GO_0060581]
- 796: cell growth [GO_0016049]
- 797: cell growth involved in cardiac muscle cell development [GO_0061049]
- 798: cell junction [GO_0030054]
- 799: cell junction assembly [GO_0034329]
- 800: cell junction disassembly [GO_0150146]
- 801: cell junction maintenance [GO_0034331]
- 802: cell junction organization [GO_0034330]
- 803: cell leading edge [GO_0031252]
- 804: cell leading edge cell cortex [GO_1904269]
- 805: cell maturation [GO_0048469]
- 806: cell migration [GO_0016477]
- 807: cell migration in hindbrain [GO_0021535]
- 808: cell migration involved in coronary angiogenesis [GO_0060981]
- 809: cell migration involved in coronary vasculogenesis [GO_0060980]
- 810: cell migration involved in endocardial cushion formation [GO_0003273]
- 811: cell migration involved in gastrulation [GO_0042074]
- 812: cell migration involved in heart development [GO_0060973]
- 813: cell migration involved in heart formation [GO_0060974]
- 814: cell migration involved in vasculogenesis [GO_0035441]
- 815: cell morphogenesis [GO_0000902]
- 816: cell morphogenesis involved in differentiation [GO_0000904]
- 817: cell morphogenesis involved in neuron differentiation [GO_0048667]
- 818: cell motility [GO_0048870]
- 819: cell motility involved in camera-type eye morphogenesis [GO_0003411]
- 820: cell part morphogenesis [GO_0032990]
- 821: cell periphery [GO_0071944]
- 822: cell population proliferation [GO_0008283]
- 823: cell projection [GO_0042995]
- 824: cell projection assembly [GO_0030031]
- 825: cell projection membrane [GO_0031253]
- 826: cell projection morphogenesis [GO_0048858]
- 827: cell projection organization [GO_0030030]
- 828: cell proliferation in hindbrain [GO_0021534]
- 829: cell proliferation in midbrain [GO_0033278]
- 830: cell proliferation involved in compound eye morphogenesis [GO_0035736]
- 831: cell proliferation involved in embryonic placenta development [GO_0060722]
- 832: cell proliferation involved in endocardial cushion morphogenesis [GO_1905315]
- 833: cell proliferation involved in heart morphogenesis [GO_0061323]
- 834: cell proliferation involved in outflow tract morphogenesis [GO_0061325]
- 835: cell surface receptor signaling pathway [GO_0007166]
- 836: cell surface receptor signaling pathway involved in cell-cell signaling [GO_1905114]
- 837: cell-cell adhesion [GO_0098609]
- 838: cell-cell adhesion mediator activity [GO_0098632]
- 839: cell-cell fusion [GO_0140253]
- 840: cell-cell junction [GO_0005911]
- 841: cell-cell junction assembly [GO_0007043]
- 842: cell-cell junction disassembly [GO_0150147]
- 843: cell-cell junction organization [GO_0045216]
- 844: cell-cell signaling [GO_0007267]
- 845: cell-cell signaling by wnt [GO_0198738]
- 846: cell-cell signaling involved in cardiac conduction [GO_0086019]
- 847: cell-cell signaling involved in cell fate commitment [GO_0045168]
- 848: cell-cell signaling involved in lung development [GO_0060495]
- 849: cell-cell signaling involved in placenta development [GO_0060673]
- 850: cell-cell signaling via exosome [GO_0099156]
- 851: cellular aldehyde metabolic process [GO_0006081]
- 852: cellular amide metabolic process [GO_0043603]
- 853: cellular amine metabolic process [GO_0044106]
- 854: cellular amino acid biosynthetic process [GO_0008652]
- 855: cellular amino acid catabolic process [GO_0009063]
- 856: cellular amino acid metabolic process [GO_0006520]
- 857: cellular ammonium homeostasis [GO_0097275]
- 858: cellular anatomical entity [GO_0110165]
- 859: cellular anion homeostasis [GO_0030002]
- 860: cellular aromatic compound metabolic process [GO_0006725]
- 861: cellular biogenic amine biosynthetic process [GO_0042401]
- 862: cellular biogenic amine catabolic process [GO_0042402]
- 863: cellular biogenic amine metabolic process [GO_0006576]
- 864: cellular biosynthetic process [GO_0044249]
- 865: cellular calcium ion homeostasis [GO_0006874]
- 866: cellular carbohydrate biosynthetic process [GO_0034637]
- 867: cellular carbohydrate catabolic process [GO_0044275]
- 868: cellular carbohydrate metabolic process [GO_0044262]
- 869: cellular catabolic process [GO_0044248]
- 870: cellular cation homeostasis [GO_0030003]
- 871: cellular chemical homeostasis [GO_0055082]
- 872: cellular component assembly [GO_0022607]
- 873: cellular component assembly involved in morphogenesis [GO_0010927]
- 874: cellular component biogenesis [GO_0044085]
- 875: cellular component disassembly [GO_0022411]
- 876: cellular component disassembly involved in execution phase of apoptosis [GO_0006921]
- 877: cellular component maintenance [GO_0043954]
- 878: cellular component morphogenesis [GO_0032989]
- 879: cellular component organization [GO_0016043]
- 880: cellular component organization or biogenesis [GO_0071840]
- 881: cellular detoxification [GO_1990748]
- 882: cellular developmental process [GO_0048869]
- 883: cellular divalent inorganic anion homeostasis [GO_0072501]
- 884: cellular divalent inorganic cation homeostasis [GO_0072503]
- 885: cellular glucan metabolic process [GO_0006073]
- 886: cellular glucose homeostasis [GO_0001678]
- 887: cellular homeostasis [GO_0019725]
- 888: cellular ion homeostasis [GO_0006873]
- 889: cellular ketone metabolic process [GO_0042180]
- 890: cellular lipid metabolic process [GO_0044255]
- 891: cellular localization [GO_0051641]
- 892: cellular macromolecule biosynthetic process [GO_0034645]
- 893: cellular macromolecule catabolic process [GO_0044265]
- 894: cellular macromolecule localization [GO_0070727]
- 895: cellular macromolecule metabolic process [GO_0044260]
- 896: cellular metabolic process [GO_0044237]
- 897: cellular metal ion homeostasis [GO_0006875]
- 898: cellular modified amino acid biosynthetic process [GO_0042398]
- 899: cellular modified amino acid metabolic process [GO_0006575]
- 900: cellular monovalent inorganic anion homeostasis [GO_0030320]
- 901: cellular monovalent inorganic cation homeostasis [GO_0030004]
- 902: cellular nitrogen compound biosynthetic process [GO_0044271]
- 903: cellular nitrogen compound catabolic process [GO_0044270]
- 904: cellular nitrogen compound metabolic process [GO_0034641]
- 905: cellular oxidant detoxification [GO_0098869]
- 906: cellular phosphate ion homeostasis [GO_0030643]
- 907: cellular pigmentation [GO_0033059]
- 908: cellular polysaccharide biosynthetic process [GO_0033692]
- 909: cellular polysaccharide catabolic process [GO_0044247]
- 910: cellular polysaccharide metabolic process [GO_0044264]
- 911: cellular process [GO_0009987]
- 912: cellular process involved in reproduction in multicellular organism [GO_0022412]
- 913: cellular protein localization [GO_0034613]
- 914: cellular protein metabolic process [GO_0044267]
- 915: cellular protein modification process [GO_0006464]
- 916: cellular respiration [GO_0045333]
- 917: cellular response to abiotic stimulus [GO_0071214]
- 918: cellular response to acetylcholine [GO_1905145]
- 919: cellular response to alcohol [GO_0097306]
- 920: cellular response to alkaloid [GO_0071312]
- 921: cellular response to antibiotic [GO_0071236]
- 922: cellular response to biotic stimulus [GO_0071216]
- 923: cellular response to blue light [GO_0071483]
- 924: cellular response to BMP stimulus [GO_0071773]
- 925: cellular response to caffeine [GO_0071313]
- 926: cellular response to catecholamine stimulus [GO_0071870]
- 927: cellular response to chemical stimulus [GO_0070887]
- 928: cellular response to chemical stress [GO_0062197]
- 929: cellular response to cytokine stimulus [GO_0071345]
- 930: cellular response to DNA damage stimulus [GO_0006974]
- 931: cellular response to dopamine [GO_1903351]
- 932: cellular response to endogenous stimulus [GO_0071495]
- 933: cellular response to environmental stimulus [GO_0104004]
- 934: cellular response to farnesol [GO_0097308]
- 935: cellular response to fibroblast growth factor stimulus [GO_0044344]
- 936: cellular response to growth factor stimulus [GO_0071363]
- 937: cellular response to hormone stimulus [GO_0032870]
- 938: cellular response to insulin stimulus [GO_0032869]
- 939: cellular response to light stimulus [GO_0071482]
- 940: cellular response to lipid [GO_0071396]
- 941: cellular response to lipopolysaccharide [GO_0071222]
- 942: cellular response to molecule of bacterial origin [GO_0071219]
- 943: cellular response to monoamine stimulus [GO_0071868]
- 944: cellular response to nitrogen compound [GO_1901699]
- 945: cellular response to organic cyclic compound [GO_0071407]
- 946: cellular response to organic substance [GO_0071310]
- 947: cellular response to organonitrogen compound [GO_0071417]
- 948: cellular response to oxidative stress [GO_0034599]
- 949: cellular response to oxygen radical [GO_0071450]
- 950: cellular response to oxygen-containing compound [GO_1901701]
- 951: cellular response to peptide [GO_1901653]
- 952: cellular response to peptide hormone stimulus [GO_0071375]
- 953: cellular response to purine-containing compound [GO_0071415]
- 954: cellular response to radiation [GO_0071478]
- 955: cellular response to reactive oxygen species [GO_0034614]
- 956: cellular response to steroid hormone stimulus [GO_0071383]
- 957: cellular response to stimulus [GO_0051716]
- 958: cellular response to stress [GO_0033554]
- 959: cellular response to superoxide [GO_0071451]
- 960: cellular response to toxic substance [GO_0097237]
- 961: cellular response to xenobiotic stimulus [GO_0071466]
- 962: cellular sodium ion homeostasis [GO_0006883]
- 963: cellular sulfate ion homeostasis [GO_0030642]
- 964: cellular trivalent inorganic anion homeostasis [GO_0072502]
- 965: cellular_component [GO_0005575]
- 966: central nervous system development [GO_0007417]
- 967: central nervous system formation [GO_0021556]
- 968: central nervous system maturation [GO_0021626]
- 969: central nervous system morphogenesis [GO_0021551]
- 970: central nervous system neuron development [GO_0021954]
- 971: central nervous system neuron differentiation [GO_0021953]
- 972: central nervous system vasculogenesis [GO_0022009]
- 973: ceramide + H2O <=> stearate + sphingosine [endoplasmic reticulum] [GO_0017040]
- 974: ceramide 1-phosphate binding [GO_1902387]
- 975: ceramide 1-phosphate transfer activity [GO_1902388]
- 976: ceramide 1-phosphate transport [GO_1902389]
- 977: ceramide binding [GO_0097001]
- 978: Ceramide glucosyltransferase (UGCG) catalyses the transfer of glucose to ceramide [GO_0008120]
- 979: ceramide phosphoethanolamine synthase activity [GO_0002950]
- 980: ceramide transfer activity [GO_0120017]
- 981: ceramide transport [GO_0035627]
- 982: CERK phosphorylates CERA to form C1P [GO_0001729]
- 983: CES1trimer hydrolyses ACEI pro-drugs to ACEIs [GO_0052689]
- 984: CFTR F508del is degraded by the 26S proteasome [GO_0004175]
- 985: cGAS produces cyclic GMP-AMP [GO_0061501]
- 986: cGMP binding [GO_0030553]
- 987: cGMP biosynthetic process [GO_0006182]
- 988: cGMP metabolic process [GO_0046068]
- 989: cGMP:CNG transports Na+ and Ca2+ into the rod outer segment [GO_0005221]
- 990: channel activator activity [GO_0099103]
- 991: channel inhibitor activity [GO_0016248]
- 992: channel regulator activity [GO_0016247]
- 993: chaperone binding [GO_0051087]
- 994: chemical homeostasis [GO_0048878]
- 995: chemical homeostasis within a tissue [GO_0048875]
- 996: chemical synaptic transmission [GO_0007268]
- 997: chemical synaptic transmission, postsynaptic [GO_0099565]
- 998: chemoattractant activity [GO_0042056]
- 999: chemoattractant activity involved in axon guidance [GO_1902379]
- 1000: chemoattraction of axon [GO_0061642]
- 1001: chemokine activity [GO_0008009]
- 1002: chemokine receptor binding [GO_0042379]
- 1003: chemorepellent activity [GO_0045499]
- 1004: chemorepulsion of axon [GO_0061643]
- 1005: chemosensory behavior [GO_0007635]
- 1006: chemotaxis [GO_0006935]
- 1007: chitin binding [GO_0008061]
- 1008: chitin deacetylase activity [GO_0004099]
- 1009: chitin synthase activity [GO_0004100]
- 1010: chitinase activity [GO_0004568]
- 1011: chloride channel inhibitor activity [GO_0019869]
- 1012: chloride transmembrane transport [GO_1902476]
- 1013: chloride transport [GO_0006821]
- 1014: Cho is phosphorylated to PCho by CHK dimer [GO_0004103]
- 1015: cholangiocyte apoptotic process [GO_1902488]
- 1016: cholangiocyte proliferation [GO_1990705]
- 1017: cholesterol binding [GO_0015485]
- 1018: cholesterol dehydrogenase activity [GO_0102294]
- 1019: cholesterol O-acyltransferase activity [GO_0034736]
- 1020: cholesterol transfer activity [GO_0120020]
- 1021: cholesterol-protein transferase activity [GO_0140853]
- 1022: choline transport [GO_0015871]
- 1023: choline:sodium symporter activity [GO_0005307]
- 1024: cholinesterase activity [GO_0004104]
- 1025: chondroblast differentiation [GO_0060591]
- 1026: chondrocyte development [GO_0002063]
- 1027: chondrocyte development involved in endochondral bone morphogenesis [GO_0003433]
- 1028: chondrocyte differentiation [GO_0002062]
- 1029: chondrocyte differentiation involved in endochondral bone morphogenesis [GO_0003413]
- 1030: chondrocyte morphogenesis [GO_0090171]
- 1031: chondrocyte morphogenesis involved in endochondral bone morphogenesis [GO_0003414]
- 1032: chordate embryonic development [GO_0043009]
- 1033: chorion development [GO_0060717]
- 1034: chorionic trophoblast cell development [GO_0060719]
- 1035: chorionic trophoblast cell differentiation [GO_0060718]
- 1036: chorionic trophoblast cell proliferation [GO_0097360]
- 1037: chromatin [GO_0000785]
- 1038: chromatin assembly [GO_0031497]
- 1039: chromatin assembly or disassembly [GO_0006333]
- 1040: chromatin binding [GO_0003682]
- 1041: chromatin disassembly [GO_0031498]
- 1042: chromatin DNA binding [GO_0031490]
- 1043: chromatin insulator sequence binding [GO_0043035]
- 1044: chromatin loop anchoring activity [GO_0140587]
- 1045: chromatin organization [GO_0006325]
- 1046: chromatin remodeling [GO_0006338]
- 1047: chromatin silencing complex [GO_0005677]
- 1048: chromatin-protein adaptor activity [GO_0140463]
- 1049: chromosome [GO_0005694]
- 1050: chromosome condensation [GO_0030261]
- 1051: chromosome localization [GO_0050000]
- 1052: chromosome organization [GO_0051276]
- 1053: chromosome organization involved in meiotic cell cycle [GO_0070192]
- 1054: chromosome segregation [GO_0007059]
- 1055: Chymase hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) [GO_0008236]
- 1056: ciliary basal body-plasma membrane docking [GO_0097711]
- 1057: ciliary body morphogenesis [GO_0061073]
- 1058: ciliary membrane [GO_0060170]
- 1059: ciliary plasm [GO_0097014]
- 1060: ciliary transition zone [GO_0035869]
- 1061: ciliary transition zone assembly [GO_1905349]
- 1062: cilium [GO_0005929]
- 1063: cilium assembly [GO_0060271]
- 1064: cilium disassembly [GO_0061523]
- 1065: cilium organization [GO_0044782]
- 1066: circadian behavior [GO_0048512]
- 1067: circadian mating behavior [GO_0035648]
- 1068: circadian rhythm [GO_0007623]
- 1069: circadian sleep/wake cycle [GO_0042745]
- 1070: circadian sleep/wake cycle process [GO_0022410]
- 1071: circadian sleep/wake cycle, sleep [GO_0050802]
- 1072: circulatory system development [GO_0072359]
- 1073: circulatory system process [GO_0003013]
- 1074: cis-regulatory region sequence-specific DNA binding [GO_0000987]
- 1075: cis-trans isomerase activity [GO_0016859]
- 1076: citrate <=> isocitrate [GO_0003994]
- 1077: citrate secondary active transmembrane transporter activity [GO_0071913]
- 1078: citrate synthase activity [GO_0036440]
- 1079: citrate transmembrane transporter activity [GO_0015137]
- 1080: citrate transport [GO_0015746]
- 1081: class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0140078]
- 1082: class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0052720]
- 1083: clathrin adaptor activity [GO_0035615]
- 1084: clathrin binding [GO_0030276]
- 1085: clathrin heavy chain binding [GO_0032050]
- 1086: clathrin light chain binding [GO_0032051]
- 1087: CLCN4/5/6 exchange Cl- for H+ [GO_0015297]
- 1088: cleavage involved in rRNA processing [GO_0000469]
- 1089: Cleavage of 5-hydroxyluracil by UNG glycosylase [GO_0004844]
- 1090: Cleavage of formamidopyrimidine (FapyA) by NTHL1 glycosylase [GO_0008534]
- 1091: Cleavage of S protein into S1:S2 [GO_0004252]
- 1092: cloaca development [GO_0035844]
- 1093: cloacal gland development [GO_1904484]
- 1094: club cell differentiation [GO_0060486]
- 1095: CNDP2:2Mn2+ dimer hydrolyses CysGly [GO_0004180]
- 1096: co-SMAD binding [GO_0070410]
- 1097: CoA carboxylase activity [GO_0016421]
- 1098: CoA hydrolase activity [GO_0016289]
- 1099: CoA-ligase activity [GO_0016405]
- 1100: CoA-transferase activity [GO_0008410]
- 1101: COASY transfers an adenylyl group from ATP to PPANT [GO_0004595]
- 1102: cobalamin binding [GO_0031419]
- 1103: cocaine binding [GO_0019811]
- 1104: coenzyme A transmembrane transport [GO_0035349]
- 1105: coenzyme A transmembrane transporter activity [GO_0015228]
- 1106: coenzyme A transport [GO_0015880]
- 1107: cognition [GO_0050890]
- 1108: collagen binding [GO_0005518]
- 1109: collagen biosynthetic process [GO_0032964]
- 1110: collagen catabolic process [GO_0030574]
- 1111: collagen fibril binding [GO_0098633]
- 1112: collagen fibril organization [GO_0030199]
- 1113: collagen metabolic process [GO_0032963]
- 1114: collagen network [GO_0098645]
- 1115: collagen receptor activity [GO_0038064]
- 1116: collagen trimer [GO_0005581]
- 1117: collagen type II trimer [GO_0005585]
- 1118: collagen type IV trimer [GO_0005587]
- 1119: collagen-activated signaling pathway [GO_0038065]
- 1120: collagen-activated tyrosine kinase receptor signaling pathway [GO_0038063]
- 1121: collagen-containing extracellular matrix [GO_0062023]
- 1122: colon smooth muscle contraction [GO_1990765]
- 1123: columnar/cuboidal epithelial cell development [GO_0002066]
- 1124: columnar/cuboidal epithelial cell differentiation [GO_0002065]
- 1125: columnar/cuboidal epithelial cell maturation [GO_0002069]
- 1126: common bile duct development [GO_0061009]
- 1127: Complex I oxidises NADH to NAD+, reduces CoQ to QH2 [GO_0008137]
- 1128: complex of collagen trimers [GO_0098644]
- 1129: compound eye development [GO_0048749]
- 1130: compound eye morphogenesis [GO_0001745]
- 1131: compound eye photoreceptor cell differentiation [GO_0001751]
- 1132: compound eye retinal cell apoptotic process [GO_1990010]
- 1133: compound eye retinal cell programmed cell death [GO_0046667]
- 1134: COMT transfers Met to DOPAC to form HVA [GO_0008168]
- 1135: connective tissue development [GO_0061448]
- 1136: contractile fiber [GO_0043292]
- 1137: conus arteriosus development [GO_0003238]
- 1138: conus arteriosus formation [GO_0003240]
- 1139: conus arteriosus morphogenesis [GO_0003239]
- 1140: COP9 signalosome deneddylates nuclear CRL4 E3 ubiquitin ligase complex [GO_0019784]
- 1141: copper chaperone activity [GO_0016531]
- 1142: copper ion binding [GO_0005507]
- 1143: copper ion transmembrane transport [GO_0035434]
- 1144: copper ion transmembrane transporter activity [GO_0005375]
- 1145: copper ion transport [GO_0006825]
- 1146: COPRS:CCND1:CDK4:PRMT5:pT5-WDR77 methylates arginine-4 of histone H4 (H4R3) [GO_0008469]
- 1147: copulation [GO_0007620]
- 1148: corazonin receptor activity [GO_0035237]
- 1149: Core MLL complex methylates H3K4Me2-Nucleosome at the GP1BA gene promoter [GO_0042800]
- 1150: Core MLL complex, SMYD3, PRDM9 methylate dimethyl-lysine-5 of histone H3 (H3K4) [GO_0018024]
- 1151: core promoter sequence-specific DNA binding [GO_0001046]
- 1152: coreceptor activity [GO_0015026]
- 1153: coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060724]
- 1154: coreceptor activity involved in Wnt signaling pathway [GO_0071936]
- 1155: cornea development in camera-type eye [GO_0061303]
- 1156: coronary vasculature development [GO_0060976]
- 1157: coronary vasculature morphogenesis [GO_0060977]
- 1158: coronary vein morphogenesis [GO_0003169]
- 1159: courtship behavior [GO_0007619]
- 1160: CPO transforms COPRO3 to PPGEN9 [GO_0004109]
- 1161: CPT1A,B transfers PALM to CAR [GO_0004095]
- 1162: cranial ganglion development [GO_0061550]
- 1163: cranial ganglion formation [GO_0061560]
- 1164: cranial ganglion maturation [GO_0061558]
- 1165: cranial ganglion morphogenesis [GO_0061559]
- 1166: cranial nerve development [GO_0021545]
- 1167: cranial nerve formation [GO_0021603]
- 1168: cranial nerve maturation [GO_0021605]
- 1169: cranial nerve morphogenesis [GO_0021602]
- 1170: cranial skeletal system development [GO_1904888]
- 1171: CRD domain binding [GO_0071906]
- 1172: creatine + ATP => phosphocreatine + ADP [CK octamer] [GO_0004111]
- 1173: Crotonoyl-CoA+H2O<=>(S)-3-Hydroxybutanoyl-CoA [GO_0004300]
- 1174: CRYL1 dimer dehydrogenates L-gulonate to 3-dehydro-L-gulonate [GO_0050104]
- 1175: CS is cleaved from its proteoglycan [GO_0016798]
- 1176: CTU1:CTU2:URM1 thiolates uridine-34 in tRNAs [GO_0016783]
- 1177: cullin family protein binding [GO_0097602]
- 1178: CYB5Rs reduce MetHb to HbA [GO_0004128]
- 1179: CYBRD1:Heme reduces Fe3+ to Fe2+ [GO_0016722]
- 1180: cyclase activator activity [GO_0010853]
- 1181: cyclase activity [GO_0009975]
- 1182: cyclase inhibitor activity [GO_0010852]
- 1183: cyclase regulator activity [GO_0010851]
- 1184: cyclic GMP-AMP synthase activity [GO_0140699]
- 1185: cyclic nucleotide binding [GO_0030551]
- 1186: cyclic nucleotide biosynthetic process [GO_0009190]
- 1187: cyclic nucleotide metabolic process [GO_0009187]
- 1188: cyclic nucleotide-dependent protein kinase activity [GO_0004690]
- 1189: cyclic nucleotide-gated ion channel activity [GO_0043855]
- 1190: cyclic purine nucleotide metabolic process [GO_0052652]
- 1191: cyclic pyranopterin monophosphate synthase activity [GO_0061799]
- 1192: cyclic-nucleotide phosphodiesterase activity [GO_0004112]
- 1193: cyclic-nucleotide-mediated signaling [GO_0019935]
- 1194: cyclin binding [GO_0030332]
- 1195: cyclin-dependent protein kinase activity [GO_0097472]
- 1196: cyclin-dependent protein serine/threonine kinase activator activity [GO_0061575]
- 1197: cyclin-dependent protein serine/threonine kinase inhibitor activity [GO_0004861]
- 1198: cyclin-dependent protein serine/threonine kinase regulator activity [GO_0016538]
- 1199: Cyclisation of GTP to precursor Z [GO_1904047]
- 1200: cyclo-ligase activity [GO_0016882]
- 1201: cyclohydrolase activity [GO_0019238]
- 1202: cyclosporin A binding [GO_0016018]
- 1203: CYP24A1 24-hydroxylates CTL [GO_0030342]
- 1204: CYP2D6 4-hydroxylates debrisoquine [GO_0016712]
- 1205: CYP4F8 19-hydroxylates PGH2 [GO_0004497]
- 1206: cysteine-S-conjugate beta-lyase activity [GO_0047804]
- 1207: cysteine-type deNEDDylase activity [GO_0140757]
- 1208: cysteine-type endopeptidase activator activity [GO_0140608]
- 1209: cysteine-type endopeptidase activator activity involved in apoptotic process [GO_0008656]
- 1210: cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_0097200]
- 1211: cysteine-type endopeptidase inhibitor activity [GO_0004869]
- 1212: cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO_0043027]
- 1213: cysteine-type endopeptidase regulator activity involved in apoptotic process [GO_0043028]
- 1214: cystic duct development [GO_0035628]
- 1215: cytidine catabolic process [GO_0006216]
- 1216: cytidine deaminase activity [GO_0004126]
- 1217: cytidine deamination [GO_0009972]
- 1218: cytidine metabolic process [GO_0046087]
- 1219: cytidylate kinase activity [GO_0004127]
- 1220: cytidylyltransferase activity [GO_0070567]
- 1221: cytochrome-c oxidase activity [GO_0004129]
- 1222: cytokine activity [GO_0005125]
- 1223: cytokine binding [GO_0019955]
- 1224: cytokine receptor activity [GO_0004896]
- 1225: cytokine receptor binding [GO_0005126]
- 1226: cytokine-mediated signaling pathway [GO_0019221]
- 1227: cytokinesis [GO_0000910]
- 1228: cytoplasm [GO_0005737]
- 1229: cytoplasm organization [GO_0007028]
- 1230: cytoplasmic microtubule [GO_0005881]
- 1231: cytoplasmic microtubule bundle [GO_1905720]
- 1232: cytoplasmic microtubule depolymerization [GO_0010938]
- 1233: cytoplasmic microtubule organization [GO_0031122]
- 1234: cytoplasmic region [GO_0099568]
- 1235: cytoplasmic vesicle [GO_0031410]
- 1236: cytoplasmic vesicle membrane [GO_0030659]
- 1237: cytoskeletal anchor activity [GO_0008093]
- 1238: cytoskeletal motor activator activity [GO_0140660]
- 1239: cytoskeletal motor activity [GO_0003774]
- 1240: cytoskeletal motor inhibitor activity [GO_0140661]
- 1241: cytoskeletal motor regulator activity [GO_0140659]
- 1242: cytoskeletal protein binding [GO_0008092]
- 1243: cytoskeletal protein-membrane anchor activity [GO_0106006]
- 1244: cytoskeletal regulatory protein binding [GO_0005519]
- 1245: cytoskeleton [GO_0005856]
- 1246: cytoskeleton organization [GO_0007010]
- 1247: cytoskeleton-dependent intracellular transport [GO_0030705]
- 1248: Cytosolic chenodeoxycholoyl-CoA or choloyl-CoA are conjugated with glycine or taurine [GO_0016746]
- 1249: Cytosolic PHD2,3 hydroxylates proline residues on HIF1A [GO_0031545]
- 1250: D-amino acid transmembrane transporter activity [GO_0042943]
- 1251: D-amino acid transport [GO_0042940]
- 1252: D-amino-acid oxidase activity [GO_0003884]
- 1253: D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO_0045290]
- 1254: D-fructose 1,6-bisphosphate + H2O => D-fructose 6-phosphate + orthophosphate [GO_0042132]
- 1255: D-fructose 6-phosphate + ATP => D-fructose 2,6-bisphosphate + ADP [GO_0003873]
- 1256: D-fructose 6-phosphate <=> alpha-D-Glucose 6-phosphate [GO_0004347]
- 1257: D-glucono-1,5-lactone 6-phosphate + H2O => 6-phospho-D-gluconate [GO_0017057]
- 1258: D-glyceraldehyde 3-phosphate + orthophosphate + NAD+ <=> 1,3-bisphospho-D-glycerate + NADH + H+ [GO_0004365]
- 1259: D-loop dissociation and strand annealing [GO_0003678]
- 1260: D-ribulokinase activity [GO_0019150]
- 1261: D-ribulose 5-phosphate <=> ribose 5-phosphate [GO_0004751]
- 1262: D-xylose 1-dehydrogenase (NADP+) activity [GO_0047837]
- 1263: D5 dopamine receptor binding [GO_0031752]
- 1264: damaged DNA binding [GO_0003684]
- 1265: DARPP-32 phosphorylated on T34 binds to PP1, inhibiting its function [GO_0019888]
- 1266: DARPP-32 phosphorylated on Thr75 binds to PKA, inhibiting its function [GO_0004862]
- 1267: DCLRE1C (ARTEMIS) processes DNA DSB ends [GO_0004519]
- 1268: DCXR tetramer reduces L-xylulose to xylitol [GO_0050038]
- 1269: DDHD1,2 hydrolyse PA [GO_0004620]
- 1270: DDT-dehydrochlorinase activity [GO_0018833]
- 1271: deacetylase activity [GO_0019213]
- 1272: DEAD/H-box RNA helicase binding [GO_0017151]
- 1273: deaminated base DNA N-glycosylase activity [GO_0097506]
- 1274: death domain binding [GO_0070513]
- 1275: decarboxylation-driven active transmembrane transporter activity [GO_0015451]
- 1276: defecation [GO_0030421]
- 1277: Defective ABCC9 (in KCNJ11:ABCC9) does not transport K+ from extracellular region to cytosol [GO_0005242]
- 1278: Defective B3GAT3 does not transfer GlcA to tetrasaccharide linker [GO_0015018]
- 1279: Defective CFTR does not transport Cl- from cytosol to extracellular region [GO_0015108]
- 1280: Defective CHSY1 does not transfer GalNAc to chondroitin [GO_0047238]
- 1281: Defective CYP11B2 does not oxidise CORST [GO_0008395]
- 1282: Defective EXT1 (in EXT1:EXT2) does not transfer GlcNAc to the heparan chain [GO_0050508]
- 1283: Defective EXT2 (in EXT1:EXT2) does not transfer GlcA to heparan [GO_0050509]
- 1284: Defective FMO3 does not N-oxidise TMA [GO_0004499]
- 1285: Defective GALK1 does not phosphorylate Gal [GO_0004335]
- 1286: Defective GALT does not transfer UMP to Gal1P [GO_0008108]
- 1287: Defective GCK does not phosphorylate Glc to form G6P [GO_0004340]
- 1288: Defective GCLC does not ligate L-Glu to L-Cys [GO_0004357]
- 1289: Defective GFPT1 does not transfer an amino group from L-Gln to F6P to form GlcN6P [GO_0004360]
- 1290: Defective GGT1 does not hydrolyse glutamate from AFXBO-SG, AFNBO-SG [GO_0036374]
- 1291: Defective GNS does not hydrolyse 6-sulfate from GlcNAc6S [GO_0008449]
- 1292: Defective GSS does not synthesize GSH [GO_0004363]
- 1293: Defective HEXA does not cleave the terminal GalNAc from keratan sulfate [GO_0004563]
- 1294: Defective MAN1B1 does not hydrolyse 1,2-linked mannose (a branch) [GO_0004571]
- 1295: Defective MAOA does not oxidatively deaminate 5HT [GO_0008131]
- 1296: Defective MAT1A does not transfer Ado from ATP to L-Met [GO_0004478]
- 1297: Defective OPLAH does not hydrolyse OPRO [GO_0017168]
- 1298: Defective RDH12 does not reduce atRAL to atROL [GO_0052650]
- 1299: Defective RHAG does not transport NH4+ from cytosol to extracellular region (rbc) [GO_0008519]
- 1300: Defective SLC11A2 does not cotransport Fe2+, H+ from extracellular region to cytosol [GO_0005381]
- 1301: Defective SLC12A6 does not cotransport K+, Cl- from cytosol to extracellular region [GO_0015379]
- 1302: Defective SLC20A2 does not cotransport Pi, Na+ from extracellular region to cytosol [GO_0005436]
- 1303: Defective SLC22A18 does not exchange extracellular organic cations for cytosolic H+ [GO_0015299]
- 1304: Defective SLC24A4 does not exchange extracellular 4Na+ for cytosolic Ca2+, K+ [GO_0008273]
- 1305: Defective SLC26A2 does not cotransport extracellular SO4(2-), H+ to cytosol [GO_0015116]
- 1306: Defective SLC37A4 does not exchange G6P and Pi across the ER membrane [GO_0061513]
- 1307: Defective SLC4A1 does not exchange Cl- for HCO3- (in erythrocytes) [GO_0005452]
- 1308: Defective SLC5A7 does not cotransport Cho, Cl-, Na+ from extracellular region to cytosol [GO_0015220]
- 1309: Defective UGT1A1 does not transfer GlcA from UDP-GlcA to BMG [GO_0015020]
- 1310: Dehydration of methylthio-ribulose-P [GO_0046570]
- 1311: dehydroascorbic acid transport [GO_0070837]
- 1312: dehydrodolichyl diphosphate synthase activity [GO_0045547]
- 1313: delayed rectifier potassium channel activity [GO_0005251]
- 1314: delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity [GO_0051750]
- 1315: demethylase activity [GO_0032451]
- 1316: denatured protein binding [GO_0031249]
- 1317: dendrite [GO_0030425]
- 1318: dendrite cytoplasm [GO_0032839]
- 1319: dendritic tree [GO_0097447]
- 1320: deoxyhypusine monooxygenase activity [GO_0019135]
- 1321: deoxyribonuclease I activity [GO_0004530]
- 1322: dephospho-CoA kinase activity [GO_0004140]
- 1323: dephosphorylation [GO_0016311]
- 1324: Dephosphorylation of AKT by PP2A [GO_0008195]
- 1325: Dephosphorylation of CD3-zeta by PD-1 bound phosphatases [GO_0004725]
- 1326: Dephosphorylation of phospho-Cdh1 [GO_0004721]
- 1327: DERA cleaves dR5P to GA3P and CH3CHO [GO_0004139]
- 1328: dermal bone morphogenesis [GO_0061972]
- 1329: dermatome development [GO_0061054]
- 1330: descending aorta development [GO_0035906]
- 1331: descending aorta morphogenesis [GO_0035911]
- 1332: deSUMOylase activity [GO_0016929]
- 1333: detection of abiotic stimulus [GO_0009582]
- 1334: detection of biotic stimulus [GO_0009595]
- 1335: detection of calcium ion [GO_0005513]
- 1336: detection of carbon dioxide [GO_0003031]
- 1337: detection of chemical stimulus [GO_0009593]
- 1338: detection of chemical stimulus involved in sensory perception [GO_0050907]
- 1339: detection of chemical stimulus involved in sensory perception of bitter taste [GO_0001580]
- 1340: detection of chemical stimulus involved in sensory perception of pain [GO_0050968]
- 1341: detection of chemical stimulus involved in sensory perception of salty taste [GO_0001583]
- 1342: detection of chemical stimulus involved in sensory perception of smell [GO_0050911]
- 1343: detection of chemical stimulus involved in sensory perception of sour taste [GO_0001581]
- 1344: detection of chemical stimulus involved in sensory perception of sweet taste [GO_0001582]
- 1345: detection of chemical stimulus involved in sensory perception of taste [GO_0050912]
- 1346: detection of chemical stimulus involved in sensory perception of umami taste [GO_0046535]
- 1347: detection of cold stimulus involved in thermoception [GO_0120169]
- 1348: detection of external biotic stimulus [GO_0098581]
- 1349: detection of external stimulus [GO_0009581]
- 1350: detection of high humidity [GO_0098516]
- 1351: detection of high humidity stimulus involved in sensory perception [GO_0098514]
- 1352: detection of hot stimulus involved in thermoception [GO_0120168]
- 1353: detection of humidity [GO_0098513]
- 1354: detection of humidity stimulus involved in sensory perception [GO_0098512]
- 1355: detection of hydrogen ion [GO_0003030]
- 1356: detection of light stimulus [GO_0009583]
- 1357: detection of light stimulus involved in sensory perception [GO_0050962]
- 1358: detection of light stimulus involved in visual perception [GO_0050908]
- 1359: detection of low humidity [GO_0098517]
- 1360: detection of low humidity stimulus involved in sensory perception [GO_0098515]
- 1361: detection of mechanical stimulus [GO_0050982]
- 1362: detection of mechanical stimulus involved in equilibrioception [GO_0050973]
- 1363: detection of mechanical stimulus involved in sensory perception [GO_0050974]
- 1364: detection of mechanical stimulus involved in sensory perception of pain [GO_0050966]
- 1365: detection of mechanical stimulus involved in sensory perception of sound [GO_0050910]
- 1366: detection of mechanical stimulus involved in sensory perception of touch [GO_0050976]
- 1367: detection of mechanical stimulus involved in sensory perception of wind [GO_0071066]
- 1368: detection of molecule of fungal origin [GO_0032491]
- 1369: detection of osmotic stimulus [GO_0043575]
- 1370: detection of pH by chemoreceptor signaling [GO_0003022]
- 1371: detection of pheromone [GO_0043695]
- 1372: detection of stimulus [GO_0051606]
- 1373: detection of stimulus involved in sensory perception [GO_0050906]
- 1374: detection of stimulus involved in sensory perception of pain [GO_0062149]
- 1375: detection of temperature stimulus [GO_0016048]
- 1376: detection of temperature stimulus involved in sensory perception [GO_0050961]
- 1377: detection of temperature stimulus involved in sensory perception of pain [GO_0050965]
- 1378: detection of temperature stimulus involved in thermoception [GO_0050960]
- 1379: detection of visible light [GO_0009584]
- 1380: detoxification [GO_0098754]
- 1381: detoxification of inorganic compound [GO_0061687]
- 1382: detoxification of nitrogen compound [GO_0051410]
- 1383: deubiquitinase activator activity [GO_0035800]
- 1384: deubiquitinase activity [GO_0101005]
- 1385: development of primary female sexual characteristics [GO_0046545]
- 1386: development of primary sexual characteristics [GO_0045137]
- 1387: developmental cell growth [GO_0048588]
- 1388: developmental growth [GO_0048589]
- 1389: developmental growth involved in morphogenesis [GO_0060560]
- 1390: developmental induction [GO_0031128]
- 1391: developmental maturation [GO_0021700]
- 1392: developmental pigmentation [GO_0048066]
- 1393: developmental process [GO_0032502]
- 1394: developmental process involved in reproduction [GO_0003006]
- 1395: DHAP is converted to 1-acyl GO3P by GNPAT [GO_0016287]
- 1396: DHDDS:NUS1 elongates E,E-FPP with (n)IPPP to form pPPP [GO_0016765]
- 1397: diacylglycerol binding [GO_0019992]
- 1398: diacylglycerol cholinephosphotransferase activity [GO_0004142]
- 1399: diacylglycerol diphosphate phosphatase activity [GO_0000810]
- 1400: diacylglycerol kinase activity [GO_0004143]
- 1401: diaphragm development [GO_0060539]
- 1402: diaphragm morphogenesis [GO_0060540]
- 1403: dibutyl phthalate binding [GO_0035275]
- 1404: dicarboxylic acid biosynthetic process [GO_0043650]
- 1405: dicarboxylic acid catabolic process [GO_0043649]
- 1406: dicarboxylic acid metabolic process [GO_0043648]
- 1407: dicarboxylic acid transport [GO_0006835]
- 1408: digestion [GO_0007586]
- 1409: Digestion of 1-6 linkages of limit dextrins to yield maltose, maltotriose, longer maltosides, and glucose [GO_0004558]
- 1410: Digestion of linear starch (amylose) by extracellular amylase [GO_0004556]
- 1411: Digestion of triacylglycerols by extracellular PTL:colipase [GO_0047372]
- 1412: digestive system development [GO_0055123]
- 1413: digestive system process [GO_0022600]
- 1414: digestive tract development [GO_0048565]
- 1415: digestive tract morphogenesis [GO_0048546]
- 1416: dihydrolipoyllysine-residue acetyltransferase activity [GO_0004742]
- 1417: dihydrolipoyllysine-residue succinyltransferase activity [GO_0004149]
- 1418: dihydroorotate dehydrogenase activity [GO_0004152]
- 1419: dihydropterin deaminase activity [GO_0004153]
- 1420: dihydropyrimidine dehydrogenase (NADP+) activity [GO_0017113]
- 1421: dihydroxyacetone phosphate <=> D-glyceraldehyde 3-phosphate [GO_0004807]
- 1422: dioxygenase activity [GO_0051213]
- 1423: dipeptidase activity [GO_0016805]
- 1424: dipeptide transmembrane transport [GO_0035442]
- 1425: dipeptide transmembrane transporter activity [GO_0071916]
- 1426: dipeptide transport [GO_0042938]
- 1427: dipeptidyl-peptidase activity [GO_0008239]
- 1428: diphenyl phthalate binding [GO_0035274]
- 1429: diphosphoinositol-pentakisphosphate kinase activity [GO_0033857]
- 1430: diphosphoinositol-polyphosphate diphosphatase activity [GO_0008486]
- 1431: diphosphotransferase activity [GO_0016778]
- 1432: direct ossification [GO_0036072]
- 1433: directional locomotion [GO_0033058]
- 1434: disaccharide metabolic process [GO_0005984]
- 1435: disaccharide transmembrane transporter activity [GO_0015154]
- 1436: disaccharide transport [GO_0015766]
- 1437: disordered domain specific binding [GO_0097718]
- 1438: Dissociation of cytosolic HSF1:HSP90:HDAC6:PTGES3 upon sensing protein aggregates [GO_0051787]
- 1439: disulfide oxidoreductase activity [GO_0015036]
- 1440: diterpenoid metabolic process [GO_0016101]
- 1441: diuretic hormone activity [GO_0008613]
- 1442: diuretic hormone receptor activity [GO_0008036]
- 1443: divalent inorganic anion homeostasis [GO_0072505]
- 1444: divalent inorganic cation homeostasis [GO_0072507]
- 1445: DNA 5'-adenosine monophosphate hydrolase activity [GO_0033699]
- 1446: DNA bending complex [GO_1990104]
- 1447: DNA binding [GO_0003677]
- 1448: DNA binding, bending [GO_0008301]
- 1449: DNA biosynthetic process [GO_0071897]
- 1450: DNA conformation change [GO_0071103]
- 1451: DNA damage sensor activity [GO_0140612]
- 1452: DNA demethylase activity [GO_0035514]
- 1453: DNA duplex unwinding [GO_0032508]
- 1454: DNA geometric change [GO_0032392]
- 1455: DNA metabolic process [GO_0006259]
- 1456: DNA packaging [GO_0006323]
- 1457: DNA packaging complex [GO_0044815]
- 1458: DNA polymerase activity [GO_0034061]
- 1459: DNA polymerase binding [GO_0070182]
- 1460: DNA polymerase processivity factor activity [GO_0030337]
- 1461: DNA repair [GO_0006281]
- 1462: DNA replication [GO_0006260]
- 1463: DNA replication origin binding [GO_0003688]
- 1464: DNA secondary structure binding [GO_0000217]
- 1465: DNA synthesis involved in DNA replication [GO_0090592]
- 1466: DNA synthesis involved in mitochondrial DNA replication [GO_0110166]
- 1467: DNA synthesis involved in mitotic DNA replication [GO_1904860]
- 1468: DNA topoisomerase activity [GO_0003916]
- 1469: DNA topoisomerase binding [GO_0044547]
- 1470: DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO_0003917]
- 1471: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO_0072587]
- 1472: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO_0003918]
- 1473: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity [GO_0008657]
- 1474: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity [GO_0072586]
- 1475: DNA translocase activity [GO_0015616]
- 1476: DNA transport [GO_0051027]
- 1477: DNA unwinding involved in DNA replication [GO_0006268]
- 1478: DNA-binding transcription activator activity [GO_0001216]
- 1479: DNA-binding transcription activator activity, RNA polymerase II-specific [GO_0001228]
- 1480: DNA-binding transcription factor activity [GO_0003700]
- 1481: DNA-binding transcription factor activity, RNA polymerase II-specific [GO_0000981]
- 1482: DNA-binding transcription factor binding [GO_0140297]
- 1483: DNA-binding transcription repressor activity [GO_0001217]
- 1484: DNA-binding transcription repressor activity, RNA polymerase II-specific [GO_0001227]
- 1485: DNA-DNA tethering activity [GO_0106260]
- 1486: DNA-templated DNA replication [GO_0006261]
- 1487: DNA-templated transcription [GO_0006351]
- 1488: DNA-templated transcription termination [GO_0006353]
- 1489: DNA/RNA helicase activity [GO_0033677]
- 1490: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO_0042281]
- 1491: dopamine beta-monooxygenase activity [GO_0004500]
- 1492: dopamine binding [GO_0035240]
- 1493: dopamine neurotransmitter receptor activity [GO_0004952]
- 1494: dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO_0001591]
- 1495: dopamine neurotransmitter receptor activity, coupled via Gs [GO_0001588]
- 1496: dopamine receptor binding [GO_0050780]
- 1497: dopamine receptor signaling pathway [GO_0007212]
- 1498: dopamine secretion [GO_0014046]
- 1499: dopamine secretion, neurotransmission [GO_0061527]
- 1500: dopamine transport [GO_0015872]
- 1501: dopamine uptake [GO_0090494]
- 1502: dopamine:sodium symporter activity [GO_0005330]
- 1503: dopaminechrome tautomerase activity [GO_0106417]
- 1504: dormancy process [GO_0022611]
- 1505: dorsal aorta development [GO_0035907]
- 1506: dorsal aorta morphogenesis [GO_0035912]
- 1507: dorsal/ventral axis specification [GO_0009950]
- 1508: dorsal/ventral pattern formation [GO_0009953]
- 1509: double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO_0008311]
- 1510: double-stranded DNA binding [GO_0003690]
- 1511: double-stranded DNA exodeoxyribonuclease activity [GO_0008309]
- 1512: double-stranded DNA helicase activity [GO_0036121]
- 1513: double-stranded RNA adenosine deaminase activity [GO_0003726]
- 1514: double-stranded RNA binding [GO_0003725]
- 1515: double-stranded RNA-specific ribonuclease activity [GO_0032296]
- 1516: double-stranded telomeric DNA binding [GO_0003691]
- 1517: DPH5 transfers four methyl groups from AdoMet to aminocarboxypropyl EEF2 [GO_0004164]
- 1518: DPH6 ligates ammonium to diphthine-EEF2 [GO_0017178]
- 1519: dUTP diphosphatase activity [GO_0004170]
- 1520: dynactin binding [GO_0034452]
- 1521: dynein complex binding [GO_0070840]
- 1522: dynein heavy chain binding [GO_0045504]
- 1523: dynein intermediate chain binding [GO_0045505]
- 1524: dynein light chain binding [GO_0045503]
- 1525: dynein light intermediate chain binding [GO_0051959]
- 1526: E-box binding [GO_0070888]
- 1527: ecdysis-triggering hormone activity [GO_0008255]
- 1528: ecdysone binding [GO_0035100]
- 1529: ecdysone oxidase activity [GO_0047875]
- 1530: ECI2 isomerizes 3Z-enoyl-CoA to 2E-enoyl-CoA [GO_0004165]
- 1531: eclosion [GO_0007562]
- 1532: eclosion rhythm [GO_0008062]
- 1533: ectoderm development [GO_0007398]
- 1534: ectoderm formation [GO_0001705]
- 1535: ectodermal cell differentiation [GO_0010668]
- 1536: ectodermal digestive tract development [GO_0007439]
- 1537: ectodermal placode development [GO_0071696]
- 1538: ectodermal placode formation [GO_0060788]
- 1539: ectodermal placode morphogenesis [GO_0071697]
- 1540: Ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7) hydrolyses sphingomyelin [GO_0004767]
- 1541: ectopic germ cell programmed cell death [GO_0035234]
- 1542: eEF1A complexes with GTP [GO_0019001]
- 1543: efflux transmembrane transporter activity [GO_0015562]
- 1544: egg chorion [GO_0042600]
- 1545: egg coat [GO_0035805]
- 1546: eIF2 activation [GO_0003743]
- 1547: elastic fiber [GO_0071953]
- 1548: elastic fiber assembly [GO_0048251]
- 1549: electron transfer activity [GO_0009055]
- 1550: Electron transfer from ubiquinol to cytochrome c of complex III [GO_0008121]
- 1551: electron transport chain [GO_0022900]
- 1552: electron-transferring-flavoprotein dehydrogenase activity [GO_0004174]
- 1553: Elongation of gamma-lenolenoyl-CoA to dihomo-gamma-lenolenoyl-CoA [GO_0009922]
- 1554: Elongation Of The Telomeric Chromosome End [GO_0003720]
- 1555: embryo development [GO_0009790]
- 1556: embryo development ending in birth or egg hatching [GO_0009792]
- 1557: embryonic camera-type eye development [GO_0031076]
- 1558: embryonic camera-type eye formation [GO_0060900]
- 1559: embryonic camera-type eye morphogenesis [GO_0048596]
- 1560: embryonic cleavage [GO_0040016]
- 1561: embryonic development via the syncytial blastoderm [GO_0001700]
- 1562: embryonic epithelial tube formation [GO_0001838]
- 1563: embryonic eye morphogenesis [GO_0048048]
- 1564: embryonic heart tube development [GO_0035050]
- 1565: embryonic heart tube formation [GO_0003144]
- 1566: embryonic heart tube formation via epithelial folding [GO_0003145]
- 1567: embryonic heart tube morphogenesis [GO_0003143]
- 1568: embryonic morphogenesis [GO_0048598]
- 1569: embryonic organ development [GO_0048568]
- 1570: embryonic organ morphogenesis [GO_0048562]
- 1571: embryonic placenta development [GO_0001892]
- 1572: embryonic placenta morphogenesis [GO_0060669]
- 1573: embryonic process involved in female pregnancy [GO_0060136]
- 1574: endocardial cell development [GO_0060958]
- 1575: endocardial cell differentiation [GO_0060956]
- 1576: endocardial cushion development [GO_0003197]
- 1577: endocardial cushion formation [GO_0003272]
- 1578: endocardial cushion morphogenesis [GO_0003203]
- 1579: endocardial endothelium development [GO_0061147]
- 1580: endocardium development [GO_0003157]
- 1581: endocardium formation [GO_0060214]
- 1582: endocardium morphogenesis [GO_0003160]
- 1583: endochondral bone growth [GO_0003416]
- 1584: endochondral bone morphogenesis [GO_0060350]
- 1585: endocrine hormone secretion [GO_0060986]
- 1586: endocrine pancreas development [GO_0031018]
- 1587: endocrine process [GO_0050886]
- 1588: endocrine system development [GO_0035270]
- 1589: endocytosis [GO_0006897]
- 1590: endodeoxyribonuclease activator activity [GO_0140656]
- 1591: endodeoxyribonuclease activity [GO_0004520]
- 1592: endoderm development [GO_0007492]
- 1593: endoderm formation [GO_0001706]
- 1594: endodermal cell differentiation [GO_0035987]
- 1595: endodermal-mesodermal cell signaling [GO_0003133]
- 1596: endomembrane system [GO_0012505]
- 1597: endomembrane system organization [GO_0010256]
- 1598: endomitotic cell cycle [GO_0007113]
- 1599: endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016893]
- 1600: endonucleolytic cleavage involved in rRNA processing [GO_0000478]
- 1601: endonucleolytic cleavage involved in tRNA processing [GO_1905267]
- 1602: endopeptidase activator activity [GO_0061133]
- 1603: endopeptidase inhibitor activity [GO_0004866]
- 1604: endopeptidase regulator activity [GO_0061135]
- 1605: endoplasmic reticulum signal peptide binding [GO_0030942]
- 1606: endopolyphosphatase activity [GO_0000298]
- 1607: endoribonuclease activity, cleaving miRNA-paired mRNA [GO_0090624]
- 1608: endoribonuclease activity, cleaving siRNA-paired mRNA [GO_0070551]
- 1609: endoribonuclease activity, producing 5'-phosphomonoesters [GO_0016891]
- 1610: endoribonuclease inhibitor activity [GO_0060698]
- 1611: endothelial cell apoptotic process [GO_0072577]
- 1612: endothelial cell development [GO_0001885]
- 1613: endothelial cell differentiation [GO_0045446]
- 1614: endothelial cell morphogenesis [GO_0001886]
- 1615: endothelial cell proliferation [GO_0001935]
- 1616: endothelial tube formation [GO_0120331]
- 1617: endothelial tube morphogenesis [GO_0061154]
- 1618: endothelium development [GO_0003158]
- 1619: energy derivation by oxidation of organic compounds [GO_0015980]
- 1620: energy reserve metabolic process [GO_0006112]
- 1621: energy taxis [GO_0009453]
- 1622: eNoSC dimethylates histone H3 at lysine-9 [GO_0046974]
- 1623: enteric smooth muscle cell differentiation [GO_0035645]
- 1624: enteroendocrine cell differentiation [GO_0035883]
- 1625: entrainment of circadian clock [GO_0009649]
- 1626: entrainment of circadian clock by photoperiod [GO_0043153]
- 1627: entry into diapause [GO_0055115]
- 1628: entry into reproductive diapause [GO_0055116]
- 1629: enucleate erythrocyte development [GO_0048822]
- 1630: enucleate erythrocyte differentiation [GO_0043353]
- 1631: enucleate erythrocyte maturation [GO_0043354]
- 1632: envelope [GO_0031975]
- 1633: Envoplakin, periplakin, involucrin, SPR binding mediated by TGM1 crosslinking [GO_0003810]
- 1634: enzyme activator activity [GO_0008047]
- 1635: enzyme binding [GO_0019899]
- 1636: enzyme inhibitor activity [GO_0004857]
- 1637: enzyme regulator activity [GO_0030234]
- 1638: enzyme-linked receptor protein signaling pathway [GO_0007167]
- 1639: enzyme-substrate adaptor activity [GO_0140767]
- 1640: EP300,CREBBP acetylate FOXO4 [GO_0061733]
- 1641: ephrin receptor activity [GO_0005003]
- 1642: ephrin receptor binding [GO_0046875]
- 1643: ephrin receptor signaling pathway [GO_0048013]
- 1644: epicardium morphogenesis [GO_1905223]
- 1645: epidermal cell differentiation [GO_0009913]
- 1646: epidermal cell division [GO_0010481]
- 1647: epidermal growth factor binding [GO_0048408]
- 1648: epidermal growth factor receptor activity [GO_0005006]
- 1649: epidermal growth factor receptor binding [GO_0005154]
- 1650: epidermal growth factor receptor signaling pathway [GO_0007173]
- 1651: epidermal stem cell homeostasis [GO_0036334]
- 1652: epidermis development [GO_0008544]
- 1653: epidermis morphogenesis [GO_0048730]
- 1654: epigenetic maintenance of chromatin in transcription-competent conformation [GO_0045815]
- 1655: epithelial cell apoptotic process [GO_1904019]
- 1656: epithelial cell development [GO_0002064]
- 1657: epithelial cell differentiation [GO_0030855]
- 1658: epithelial cell differentiation involved in embryonic placenta development [GO_0060671]
- 1659: epithelial cell maturation [GO_0002070]
- 1660: epithelial cell morphogenesis [GO_0003382]
- 1661: epithelial cell morphogenesis involved in gastrulation [GO_0003381]
- 1662: epithelial cell proliferation [GO_0050673]
- 1663: epithelial cell proliferation involved in liver morphogenesis [GO_0072575]
- 1664: epithelial cell proliferation involved in lung morphogenesis [GO_0060502]
- 1665: epithelial to mesenchymal transition [GO_0001837]
- 1666: epithelial tube branching involved in lung morphogenesis [GO_0060441]
- 1667: epithelial tube formation [GO_0072175]
- 1668: epithelial tube morphogenesis [GO_0060562]
- 1669: epithelium development [GO_0060429]
- 1670: EPM2A dimer dephosphorylates phosphoglycogen-GYG2 [GO_0019203]
- 1671: Equilibrative transport (export) of nucleosides and free bases by solute carrier family 29 (nucleoside transporters), member 1 [GO_0005337]
- 1672: equilibrioception [GO_0050957]
- 1673: ER retention sequence binding [GO_0046923]
- 1674: ERBB signaling pathway [GO_0038127]
- 1675: erythrocyte apoptotic process [GO_1902217]
- 1676: erythrocyte development [GO_0048821]
- 1677: erythrocyte differentiation [GO_0030218]
- 1678: erythrocyte homeostasis [GO_0034101]
- 1679: erythrocyte maturation [GO_0043249]
- 1680: ESD dimer hydrolyses S-FGSH to GSH [GO_0018738]
- 1681: esophagus development [GO_1903702]
- 1682: establishment of cell polarity [GO_0030010]
- 1683: establishment of cell polarity involved in ameboidal cell migration [GO_0003365]
- 1684: establishment of cell polarity involved in gastrulation cell migration [GO_0003379]
- 1685: establishment of chromosome localization [GO_0051303]
- 1686: establishment of epithelial cell polarity [GO_0090162]
- 1687: establishment of Golgi localization [GO_0051683]
- 1688: establishment of localization [GO_0051234]
- 1689: establishment of localization in cell [GO_0051649]
- 1690: establishment of neuroblast polarity [GO_0045200]
- 1691: establishment of organelle localization [GO_0051656]
- 1692: establishment of pigment granule localization [GO_0051905]
- 1693: establishment of planar polarity [GO_0001736]
- 1694: establishment of protein localization [GO_0045184]
- 1695: establishment of protein localization to chromatin [GO_0071169]
- 1696: establishment of protein localization to chromosome [GO_0070199]
- 1697: establishment of protein localization to extracellular region [GO_0035592]
- 1698: establishment of protein localization to membrane [GO_0090150]
- 1699: establishment of protein localization to organelle [GO_0072594]
- 1700: establishment of protein localization to plasma membrane [GO_0061951]
- 1701: establishment of protein localization to vacuole [GO_0072666]
- 1702: establishment of RNA localization [GO_0051236]
- 1703: establishment of tissue polarity [GO_0007164]
- 1704: establishment of vesicle localization [GO_0051650]
- 1705: establishment or maintenance of cell polarity [GO_0007163]
- 1706: establishment or maintenance of cytoskeleton polarity [GO_0030952]
- 1707: establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration [GO_0003371]
- 1708: establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO_0003380]
- 1709: establishment or maintenance of microtubule cytoskeleton polarity [GO_0030951]
- 1710: establishment or maintenance of neuroblast polarity [GO_0045196]
- 1711: establishment or maintenance of transmembrane electrochemical gradient [GO_0010248]
- 1712: ETA is phosphorylated to PETA by CHK/ETNK [GO_0004305]
- 1713: ethanolamine-phosphate phospho-lyase activity [GO_0050459]
- 1714: ethanolaminephosphotransferase activity [GO_0004307]
- 1715: euchromatin binding [GO_1990188]
- 1716: eukaryotic initiation factor 4E binding [GO_0008190]
- 1717: eukaryotic initiation factor 4G binding [GO_0031370]
- 1718: eukaryotic initiation factor eIF2 binding [GO_0071074]
- 1719: Exchange of oxygen with sulfur in MoCo [GO_0008265]
- 1720: excitatory chemical synaptic transmission [GO_0098976]
- 1721: excitatory postsynaptic potential [GO_0060079]
- 1722: excretion [GO_0007588]
- 1723: execution phase of apoptosis [GO_0097194]
- 1724: EXO1 interacting with MSH2:MSH6 excises single strand DNA containing a mismatch [GO_0008409]
- 1725: exocrine pancreas development [GO_0031017]
- 1726: exocrine system development [GO_0035272]
- 1727: exocytic process [GO_0140029]
- 1728: exocytic vesicle [GO_0070382]
- 1729: exocytic vesicle membrane [GO_0099501]
- 1730: exocytosis [GO_0006887]
- 1731: exodeoxyribonuclease activity [GO_0004529]
- 1732: exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO_0016895]
- 1733: exonuclease activity [GO_0004527]
- 1734: exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016796]
- 1735: exonucleolytic trimming involved in rRNA processing [GO_0000459]
- 1736: exopeptidase activity [GO_0008238]
- 1737: exoribonuclease activator activity [GO_0044692]
- 1738: exoribonuclease activity [GO_0004532]
- 1739: exoribonuclease activity, producing 5'-phosphomonoesters [GO_0016896]
- 1740: exosomal secretion [GO_1990182]
- 1741: export from cell [GO_0140352]
- 1742: Exportin-5 recognizes 3' overhang of pre-miRNA [GO_0003723]
- 1743: external encapsulating structure [GO_0030312]
- 1744: external encapsulating structure organization [GO_0045229]
- 1745: external genitalia morphogenesis [GO_0035261]
- 1746: extracellular amino acid transport [GO_0006860]
- 1747: extracellular carbohydrate transport [GO_0006859]
- 1748: extracellular exosome [GO_0070062]
- 1749: extracellular exosome assembly [GO_0071971]
- 1750: extracellular exosome biogenesis [GO_0097734]
- 1751: extracellular ligand-gated ion channel activity [GO_0005230]
- 1752: extracellular matrix [GO_0031012]
- 1753: extracellular matrix assembly [GO_0085029]
- 1754: extracellular matrix binding [GO_0050840]
- 1755: extracellular matrix disassembly [GO_0022617]
- 1756: extracellular matrix organization [GO_0030198]
- 1757: extracellular matrix organization involved in endocardium development [GO_0061148]
- 1758: extracellular matrix protein binding [GO_1990430]
- 1759: extracellular matrix structural constituent [GO_0005201]
- 1760: extracellular membrane-bounded organelle [GO_0065010]
- 1761: extracellular negative regulation of signal transduction [GO_1900116]
- 1762: extracellular non-membrane-bounded organelle [GO_0043264]
- 1763: extracellular organelle [GO_0043230]
- 1764: extracellular region [GO_0005576]
- 1765: extracellular regulation of signal transduction [GO_1900115]
- 1766: extracellular space [GO_0005615]
- 1767: extracellular structure organization [GO_0043062]
- 1768: extracellular transport [GO_0006858]
- 1769: extracellular vesicle [GO_1903561]
- 1770: extracellular vesicle biogenesis [GO_0140112]
- 1771: extracellularly glutamate-gated chloride channel activity [GO_0008068]
- 1772: extracellularly glutamate-gated ion channel activity [GO_0005234]
- 1773: extraembryonic membrane development [GO_1903867]
- 1774: eye development [GO_0001654]
- 1775: eye morphogenesis [GO_0048592]
- 1776: eye photoreceptor cell development [GO_0042462]
- 1777: eye photoreceptor cell differentiation [GO_0001754]
- 1778: face development [GO_0060324]
- 1779: face morphogenesis [GO_0060325]
- 1780: FAD binding [GO_0071949]
- 1781: FAD transmembrane transport [GO_0035350]
- 1782: FAD transmembrane transporter activity [GO_0015230]
- 1783: FAD transport [GO_0015883]
- 1784: FANCD2 deubiquitination by USP1:WDR48 [GO_0004843]
- 1785: fat cell apoptotic process [GO_1904606]
- 1786: fat cell differentiation [GO_0045444]
- 1787: fat cell proliferation [GO_0070341]
- 1788: fatty acid alpha-hydroxylase activity [GO_0080132]
- 1789: fatty acid amide hydrolase activity [GO_0017064]
- 1790: fatty acid binding [GO_0005504]
- 1791: fatty acid biosynthetic process [GO_0006633]
- 1792: fatty acid derivative binding [GO_1901567]
- 1793: fatty acid ligase activity [GO_0015645]
- 1794: fatty acid metabolic process [GO_0006631]
- 1795: fatty acid transport [GO_0015908]
- 1796: fatty-acyl-CoA binding [GO_0000062]
- 1797: fatty-acyl-CoA reductase (alcohol-forming) activity [GO_0080019]
- 1798: fatty-acyl-CoA transport [GO_0015916]
- 1799: FECH binds Fe2+ to PRIN9 to form heme [GO_0004325]
- 1800: feeding behavior [GO_0007631]
- 1801: female gamete generation [GO_0007292]
- 1802: female germ cell nucleus [GO_0001674]
- 1803: female germ-line stem cell asymmetric division [GO_0048132]
- 1804: female gonad development [GO_0008585]
- 1805: female gonad morphogenesis [GO_0061040]
- 1806: female mating behavior [GO_0060180]
- 1807: female meiosis chromosome segregation [GO_0016321]
- 1808: female meiotic nuclear division [GO_0007143]
- 1809: female pregnancy [GO_0007565]
- 1810: female sex differentiation [GO_0046660]
- 1811: ferric iron binding [GO_0008199]
- 1812: ferrous iron binding [GO_0008198]
- 1813: ferrous iron transmembrane transporter activity [GO_0015093]
- 1814: fertilization [GO_0009566]
- 1815: FFAT motif binding [GO_0033149]
- 1816: FGAR + L-Glutamine + ATP + H2O => FGAM + L-Glutamate + ADP + Pi [GO_0004642]
- 1817: Fgd1 reactivates F420 [GO_0016614]
- 1818: FGFR1-associated PI3K phosphorylates PIP2 to PIP3 [GO_0046934]
- 1819: fibrillar collagen trimer [GO_0005583]
- 1820: fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator (one-chain):plasminogen activator inhibitor 1 [GO_0004867]
- 1821: fibrinogen binding [GO_0070051]
- 1822: fibrinogen complex [GO_0005577]
- 1823: fibroblast apoptotic process [GO_0044346]
- 1824: fibroblast growth factor binding [GO_0017134]
- 1825: fibroblast growth factor receptor activity [GO_0005007]
- 1826: fibroblast growth factor receptor binding [GO_0005104]
- 1827: fibroblast growth factor receptor signaling pathway [GO_0008543]
- 1828: fibroblast proliferation [GO_0048144]
- 1829: fibroblast proliferation involved in heart morphogenesis [GO_0061385]
- 1830: filamin binding [GO_0031005]
- 1831: FK506 binding [GO_0005528]
- 1832: flap endonuclease activity [GO_0048256]
- 1833: flavin adenine dinucleotide binding [GO_0050660]
- 1834: flavin-linked sulfhydryl oxidase activity [GO_0016971]
- 1835: flight [GO_0060361]
- 1836: flippase activity [GO_0140327]
- 1837: fluid transport [GO_0042044]
- 1838: FMN binding [GO_0010181]
- 1839: FMN transmembrane transporter activity [GO_0044610]
- 1840: FN3KRP phosphorylates PsiAm, RibAm [GO_0016301]
- 1841: folic acid transport [GO_0015884]
- 1842: foregut morphogenesis [GO_0007440]
- 1843: formaldehyde dehydrogenase activity [GO_0018467]
- 1844: formate transmembrane transporter activity [GO_0015499]
- 1845: formate transport [GO_0015724]
- 1846: formate-tetrahydrofolate ligase activity [GO_0004329]
- 1847: formation of anatomical boundary [GO_0048859]
- 1848: formation of animal organ boundary [GO_0010160]
- 1849: formation of primary germ layer [GO_0001704]
- 1850: formation of translation initiation ternary complex [GO_0001677]
- 1851: forward locomotion [GO_0043056]
- 1852: four-way junction DNA binding [GO_0000400]
- 1853: frizzled binding [GO_0005109]
- 1854: fructokinase activity [GO_0008865]
- 1855: fructose transmembrane transport [GO_0015755]
- 1856: fructose-6-phosphate binding [GO_0070095]
- 1857: fructose-bisphosphate aldolase activity [GO_0004332]
- 1858: FTMT 24mer oxidises 4Fe2+ to 4Fe(3+)O(OH) [GO_0004322]
- 1859: fucosyltransferase activity [GO_0008417]
- 1860: Fumarate + H2O <=> (S)-Malate [GO_0004333]
- 1861: FUOM isomerises alpha-Fuc to beta-Fuc [GO_0016857]
- 1862: FUT4,5,9,(10,11) transfer Fuc to Type 2 chains to form LeX [GO_0046920]
- 1863: G protein activity [GO_0003925]
- 1864: G protein-coupled acetylcholine receptor activity [GO_0016907]
- 1865: G protein-coupled acetylcholine receptor signaling pathway [GO_0007213]
- 1866: G protein-coupled acetylcholine receptor signaling pathway involved in positive regulation of acetylcholine secretion, neurotransmission [GO_1904065]
- 1867: G protein-coupled adenosine receptor activity [GO_0001609]
- 1868: G protein-coupled adenosine receptor signaling pathway [GO_0001973]
- 1869: G protein-coupled amine receptor activity [GO_0008227]
- 1870: G protein-coupled glutamate receptor activity [GO_0098988]
- 1871: G protein-coupled glutamate receptor binding [GO_0035256]
- 1872: G protein-coupled glutamate receptor signaling pathway [GO_0007216]
- 1873: G protein-coupled neurotransmitter receptor activity [GO_0099528]
- 1874: G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099579]
- 1875: G protein-coupled peptide receptor activity [GO_0008528]
- 1876: G protein-coupled photoreceptor activity [GO_0008020]
- 1877: G protein-coupled purinergic receptor signaling pathway [GO_0035588]
- 1878: G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO_0099530]
- 1879: G protein-coupled receptor binding [GO_0001664]
- 1880: G protein-coupled receptor kinase activity [GO_0004703]
- 1881: G protein-coupled receptor signaling pathway [GO_0007186]
- 1882: G protein-coupled serotonin receptor activity [GO_0004993]
- 1883: G protein-coupled serotonin receptor signaling pathway [GO_0098664]
- 1884: G-protein alpha-subunit binding [GO_0001965]
- 1885: G-protein beta-subunit binding [GO_0031681]
- 1886: G-protein beta/gamma-subunit complex binding [GO_0031683]
- 1887: G-protein coupled receptor activity [GO_0004930]
- 1888: G-quadruplex DNA binding [GO_0051880]
- 1889: G/U mismatch-specific uracil-DNA glycosylase activity [GO_0043739]
- 1890: GABA receptor activity [GO_0016917]
- 1891: GABA receptor binding [GO_0050811]
- 1892: GABA-A receptor activity [GO_0004890]
- 1893: GABA-gated chloride ion channel activity [GO_0022851]
- 1894: galactose binding [GO_0005534]
- 1895: galactosidase activity [GO_0015925]
- 1896: galactoside binding [GO_0016936]
- 1897: galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO_0046989]
- 1898: Galactosylation of collagen propeptide hydroxylysines by PLOD3 [GO_0050211]
- 1899: galactosyltransferase activity [GO_0008378]
- 1900: GALE:NAD+ dimer reversibly epimerises UDP-Gal to UDP-Glc [GO_0003978]
- 1901: gall bladder development [GO_0061010]
- 1902: gamete generation [GO_0007276]
- 1903: gamma-aminobutyric acid secretion [GO_0014051]
- 1904: gamma-aminobutyric acid secretion, neurotransmission [GO_0061534]
- 1905: gamma-aminobutyric acid transmembrane transporter activity [GO_0015185]
- 1906: gamma-aminobutyric acid transport [GO_0015812]
- 1907: gamma-aminobutyric acid:sodium:chloride symporter activity [GO_0005332]
- 1908: gamma-glutamyl-peptidase activity [GO_0034722]
- 1909: gamma-glutamylaminecyclotransferase activity [GO_0061929]
- 1910: gamma-glutamylcyclotransferase activity [GO_0003839]
- 1911: gamma-tubulin binding [GO_0043015]
- 1912: ganglion development [GO_0061548]
- 1913: ganglion formation [GO_0061554]
- 1914: ganglion maturation [GO_0061553]
- 1915: ganglion morphogenesis [GO_0061552]
- 1916: gap junction channel activity [GO_0005243]
- 1917: gap junction hemi-channel activity [GO_0055077]
- 1918: gas homeostasis [GO_0033483]
- 1919: gas transport [GO_0015669]
- 1920: gastric acid secretion [GO_0001696]
- 1921: gastric mucosal blood circulation [GO_1990768]
- 1922: gastro-intestinal system smooth muscle contraction [GO_0014831]
- 1923: gastrulation [GO_0007369]
- 1924: gated channel activity [GO_0022836]
- 1925: GCH1 reduces GTP to dihydroneopterin triphosphate [GO_0003934]
- 1926: GDP binding [GO_0019003]
- 1927: GDP metabolic process [GO_0046710]
- 1928: GDP phosphatase activity [GO_0004382]
- 1929: GDP-D-glucose phosphorylase activity [GO_0080048]
- 1930: GDP-dissociation inhibitor activity [GO_0005092]
- 1931: gene expression [GO_0010467]
- 1932: gene expression involved in extracellular matrix organization [GO_1901148]
- 1933: general transcription initiation factor activity [GO_0140223]
- 1934: general transcription initiation factor binding [GO_0140296]
- 1935: generation of neurons [GO_0048699]
- 1936: generation of precursor metabolites and energy [GO_0006091]
- 1937: genitalia development [GO_0048806]
- 1938: genitalia morphogenesis [GO_0035112]
- 1939: geranyltranstransferase activity [GO_0004337]
- 1940: germ cell development [GO_0007281]
- 1941: germ cell nucleus [GO_0043073]
- 1942: germ cell proliferation [GO_0036093]
- 1943: germ-line stem cell division [GO_0042078]
- 1944: germarium-derived egg chamber formation [GO_0007293]
- 1945: germline stem cell asymmetric division [GO_0098728]
- 1946: GGT transfers GSH to 16S,17S-epoxy-DHA to form PCTR1 [GO_0004364]
- 1947: Gi/o-coupled serotonin receptor activity [GO_0001586]
- 1948: gland development [GO_0048732]
- 1949: gland morphogenesis [GO_0022612]
- 1950: glandular epithelial cell development [GO_0002068]
- 1951: glandular epithelial cell differentiation [GO_0002067]
- 1952: glandular epithelial cell maturation [GO_0002071]
- 1953: Glc6P is isomerised to I3P by ISYNA1 in the cytosol [GO_0004512]
- 1954: GlcNAc1P is dephosphorylated to UDP-N-acetyl-glucosamine [GO_0003977]
- 1955: glial cell apoptotic process [GO_0034349]
- 1956: glial cell development [GO_0021782]
- 1957: glial cell differentiation [GO_0010001]
- 1958: glial cell growth [GO_0042065]
- 1959: glial cell projection [GO_0097386]
- 1960: glial cell proliferation [GO_0014009]
- 1961: glial cell-neuron signaling [GO_0150098]
- 1962: glioblast division [GO_0048860]
- 1963: gliogenesis [GO_0042063]
- 1964: glucagon secretion [GO_0070091]
- 1965: glucan biosynthetic process [GO_0009250]
- 1966: glucan catabolic process [GO_0009251]
- 1967: glucan metabolic process [GO_0044042]
- 1968: gluconeogenesis [GO_0006094]
- 1969: gluconolactonase activity [GO_0004341]
- 1970: glucosamine 6-phosphate N-acetyltransferase activity [GO_0004343]
- 1971: glucosamine-6-phosphate deaminase activity [GO_0004342]
- 1972: glucose 6-phosphate metabolic process [GO_0051156]
- 1973: glucose binding [GO_0005536]
- 1974: glucose catabolic process [GO_0006007]
- 1975: glucose homeostasis [GO_0042593]
- 1976: glucose metabolic process [GO_0006006]
- 1977: glucose transmembrane transport [GO_1904659]
- 1978: glucose-6-phosphate 1-epimerase activity [GO_0047938]
- 1979: glucose-6-phosphate transmembrane transporter activity [GO_0015152]
- 1980: glucose-6-phosphate transport [GO_0015760]
- 1981: glucosidase activity [GO_0015926]
- 1982: Glucosylation of collagen propeptide hydroxylysines [GO_0033823]
- 1983: Glucosylceramidase cleaves the glucosidic bond of glucocerebroside to form ceramide [GO_0004348]
- 1984: glucosyltransferase activity [GO_0046527]
- 1985: glutamate 5-kinase activity [GO_0004349]
- 1986: glutamate binding [GO_0016595]
- 1987: glutamate dehydrogenase (NAD+) activity [GO_0004352]
- 1988: glutamate dehydrogenase [NAD(P)+] activity [GO_0004353]
- 1989: glutamate receptor activity [GO_0008066]
- 1990: glutamate receptor binding [GO_0035254]
- 1991: glutamate receptor signaling pathway [GO_0007215]
- 1992: glutamate secretion [GO_0014047]
- 1993: glutamate secretion, neurotransmission [GO_0061535]
- 1994: glutamate synthase (NADH) activity [GO_0016040]
- 1995: glutamate synthase activity [GO_0015930]
- 1996: glutamate synthase activity, NAD(P)H as acceptor [GO_0045181]
- 1997: glutamate-5-semialdehyde dehydrogenase activity [GO_0004350]
- 1998: glutamate-ammonia ligase activity [GO_0004356]
- 1999: glutamate-cysteine ligase catalytic subunit binding [GO_0035226]
- 2000: glutamate-cysteine ligase regulator activity [GO_1990609]
- 2001: glutamate-gated calcium ion channel activity [GO_0022849]
- 2002: glutamate:sodium symporter activity [GO_0015501]
- 2003: glutamine + H2O => glutamate + NH4+ [GLS] [GO_0004359]
- 2004: glutaminyl-peptide cyclotransferase activity [GO_0016603]
- 2005: glutathione binding [GO_0043295]
- 2006: glutathione biosynthetic process [GO_0006750]
- 2007: glutathione disulfide oxidoreductase activity [GO_0015038]
- 2008: Glutathione is taken up by the bacterium [GO_1904680]
- 2009: glutathione metabolic process [GO_0006749]
- 2010: glutathione oxidoreductase activity [GO_0097573]
- 2011: glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO_0043891]
- 2012: glycerate dehydrogenase activity [GO_0008465]
- 2013: glycerol kinase activity [GO_0004370]
- 2014: glycerol-3-phosphate dehydrogenase (quinone) activity [GO_0004368]
- 2015: glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO_0047952]
- 2016: glycerol-3-phosphate O-acyltransferase activity [GO_0004366]
- 2017: glycerolipid biosynthetic process [GO_0045017]
- 2018: glycerolipid metabolic process [GO_0046486]
- 2019: glycerophosphocholine phosphodiesterase activity [GO_0047389]
- 2020: glycerophospholipid biosynthetic process [GO_0046474]
- 2021: glycerophospholipid metabolic process [GO_0006650]
- 2022: glycine binding [GO_0016594]
- 2023: glycine N-acyltransferase activity [GO_0047961]
- 2024: glycine secretion [GO_0061536]
- 2025: glycine secretion, neurotransmission [GO_0061537]
- 2026: glycine transmembrane transporter activity [GO_0015187]
- 2027: glycine transport [GO_0015816]
- 2028: glycine-gated chloride ion channel activity [GO_0022852]
- 2029: glycogen binding [GO_2001069]
- 2030: glycogen biosynthetic process [GO_0005978]
- 2031: glycogen catabolic process [GO_0005980]
- 2032: glycogen metabolic process [GO_0005977]
- 2033: glycogen phosphorylase (PYGM) dimer b + 2 ATP => glycogen phosphorylase (PYGM) dimer a + 2 ADP [GO_0004689]
- 2034: glycolipid binding [GO_0051861]
- 2035: glycolytic process [GO_0006096]
- 2036: glycolytic process through fructose-6-phosphate [GO_0061615]
- 2037: glycoprotein 3-alpha-L-fucosyltransferase activity [GO_0018392]
- 2038: glycoprotein biosynthetic process [GO_0009101]
- 2039: glycoprotein catabolic process [GO_0006516]
- 2040: glycoprotein metabolic process [GO_0009100]
- 2041: glycoprotein transport [GO_0034436]
- 2042: glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO_0016263]
- 2043: glycosaminoglycan binding [GO_0005539]
- 2044: glycosaminoglycan biosynthetic process [GO_0006024]
- 2045: glycosaminoglycan catabolic process [GO_0006027]
- 2046: glycosaminoglycan metabolic process [GO_0030203]
- 2047: glycosphingolipid binding [GO_0043208]
- 2048: glycosyl compound catabolic process [GO_1901658]
- 2049: glycosyl compound metabolic process [GO_1901657]
- 2050: glycosylation [GO_0070085]
- 2051: Glycosylation of Pre-NOTCH by FRINGE [GO_0033829]
- 2052: glyoxylate reductase (NADP+) activity [GO_0030267]
- 2053: glyoxylate reductase activity [GO_0106345]
- 2054: GMDS dehydrates GDP-Man to GDP-DHDMan [GO_0008446]
- 2055: GMP biosynthetic process [GO_0006177]
- 2056: GMP metabolic process [GO_0046037]
- 2057: GMP synthase activity [GO_0003921]
- 2058: GNMT tetramer transfers methyl group from AdoMet to Gly to form AdoHyc and SARC [GO_0017174]
- 2059: Golgi apparatus [GO_0005794]
- 2060: Golgi disassembly [GO_0090166]
- 2061: Golgi inheritance [GO_0048313]
- 2062: Golgi localization [GO_0051645]
- 2063: Golgi membrane [GO_0000139]
- 2064: Golgi membrane fusion [GO_0036504]
- 2065: Golgi organization [GO_0007030]
- 2066: Golgi reassembly [GO_0090168]
- 2067: Golgi to plasma membrane protein transport [GO_0043001]
- 2068: Golgi to plasma membrane transport [GO_0006893]
- 2069: Golgi to secretory granule transport [GO_0055107]
- 2070: Golgi to transport vesicle transport [GO_0055108]
- 2071: Golgi to vacuole transport [GO_0006896]
- 2072: Golgi transport complex binding [GO_0140164]
- 2073: Golgi vesicle transport [GO_0048193]
- 2074: Golgi-associated vesicle [GO_0005798]
- 2075: Golgi-associated vesicle membrane [GO_0030660]
- 2076: gonad development [GO_0008406]
- 2077: gonad morphogenesis [GO_0035262]
- 2078: gonadal mesoderm development [GO_0007506]
- 2079: GPI anchor binding [GO_0034235]
- 2080: GPX5,6 reduce H2O2 to H2O [GO_0004602]
- 2081: Gq/11-coupled serotonin receptor activity [GO_0001587]
- 2082: gravitaxis [GO_0042332]
- 2083: GRK1,4,7 phosphorylate MII to p-MII [GO_0050254]
- 2084: grooming behavior [GO_0007625]
- 2085: Group 3 - Selective Cl- transport [GO_0005254]
- 2086: group II metabotropic glutamate receptor activity [GO_0001641]
- 2087: Growing HA is extruded from the cell by ABCC5 [GO_0008514]
- 2088: growth [GO_0040007]
- 2089: growth factor activity [GO_0008083]
- 2090: growth factor binding [GO_0019838]
- 2091: growth factor receptor binding [GO_0070851]
- 2092: growth involved in heart morphogenesis [GO_0003241]
- 2093: GSTO dimers reduce DeHA to AscH- [GO_0045174]
- 2094: GTP 3',8'-cyclase activity [GO_0061798]
- 2095: GTP cyclohydrolase activity [GO_0003933]
- 2096: GTP cyclohydrolase binding [GO_0044549]
- 2097: GTP cyclohydrolase I regulator activity [GO_0060308]
- 2098: GTP-dependent protein binding [GO_0030742]
- 2099: GTPase activating protein binding [GO_0032794]
- 2100: GTPase binding [GO_0051020]
- 2101: GTPase inhibitor activity [GO_0005095]
- 2102: GTPase regulator activity [GO_0030695]
- 2103: guanine deaminase activity [GO_0008892]
- 2104: guanyl ribonucleotide binding [GO_0032561]
- 2105: guanyl-nucleotide exchange factor activity [GO_0005085]
- 2106: guanylate cyclase activator activity [GO_0030250]
- 2107: guanylate cyclase activity [GO_0004383]
- 2108: guanylate cyclase inhibitor activity [GO_0030251]
- 2109: guanylate cyclase regulator activity [GO_0030249]
- 2110: guanylyltransferase activity [GO_0070568]
- 2111: GUSB tetramer hydrolyses GlcA-1,3-GlcNAc [GO_0004566]
- 2112: H2O2 diffuses from the mitochondrial matrix to the cytosol [GO_0015267]
- 2113: HAGH hydrolyses (R)-S-LGSH to GSH and LACT [GO_0004416]
- 2114: hatching [GO_0035188]
- 2115: hatching behavior [GO_0035187]
- 2116: HCO3- transport through ion channel [GO_0017081]
- 2117: HDAC4 deacetylates RUNX3 [GO_0033558]
- 2118: head development [GO_0060322]
- 2119: head morphogenesis [GO_0060323]
- 2120: heart capillary growth [GO_0003248]
- 2121: heart contraction [GO_0060047]
- 2122: heart development [GO_0007507]
- 2123: heart formation [GO_0060914]
- 2124: heart growth [GO_0060419]
- 2125: heart morphogenesis [GO_0003007]
- 2126: heart process [GO_0003015]
- 2127: heart rudiment development [GO_0003313]
- 2128: heart rudiment formation [GO_0003315]
- 2129: heart rudiment morphogenesis [GO_0003314]
- 2130: heat shock protein binding [GO_0031072]
- 2131: hedgehog family protein binding [GO_0097108]
- 2132: hedgehog receptor activity [GO_0008158]
- 2133: hematopoietic or lymphoid organ development [GO_0048534]
- 2134: hematopoietic progenitor cell differentiation [GO_0002244]
- 2135: hematopoietic stem cell differentiation [GO_0060218]
- 2136: hematopoietic stem cell homeostasis [GO_0061484]
- 2137: hematopoietic stem cell proliferation [GO_0071425]
- 2138: heme binding [GO_0020037]
- 2139: heme transmembrane transport [GO_0035351]
- 2140: heme transport [GO_0015886]
- 2141: hemopoiesis [GO_0030097]
- 2142: heparan sulfate N-deacetylase activity [GO_0102140]
- 2143: heparan sulfate proteoglycan binding [GO_0043395]
- 2144: heparan sulfate sulfotransferase activity [GO_0034483]
- 2145: heparin binding [GO_0008201]
- 2146: hepatic duct development [GO_0061011]
- 2147: hepatic immune response [GO_0002384]
- 2148: hepaticobiliary system development [GO_0061008]
- 2149: hepaticobiliary system process [GO_0061007]
- 2150: hepatoblast apoptotic process [GO_1902489]
- 2151: hepatoblast differentiation [GO_0061017]
- 2152: hepatocyte apoptotic process [GO_0097284]
- 2153: hepatocyte differentiation [GO_0070365]
- 2154: hepatocyte homeostasis [GO_0036333]
- 2155: heterochromatin [GO_0000792]
- 2156: heterochromatin assembly [GO_0031507]
- 2157: heterochromatin boundary formation [GO_0033696]
- 2158: heterochromatin organization [GO_0070828]
- 2159: heterocycle biosynthetic process [GO_0018130]
- 2160: heterocycle catabolic process [GO_0046700]
- 2161: heterocycle metabolic process [GO_0046483]
- 2162: heterocyclic compound binding [GO_1901363]
- 2163: heterotrimeric G-protein binding [GO_0032795]
- 2164: hexacosanoyl-CoA + O2 => trans-2,3-dehydrohexacosanoyl-CoA + H2O2 [GO_0003997]
- 2165: hexokinase activity [GO_0004396]
- 2166: hexosaminidase activity [GO_0015929]
- 2167: hexose biosynthetic process [GO_0019319]
- 2168: hexose catabolic process [GO_0019320]
- 2169: hexose metabolic process [GO_0019318]
- 2170: hexose phosphate transmembrane transporter activity [GO_0015119]
- 2171: hexose phosphate transport [GO_0015712]
- 2172: hexose transmembrane transport [GO_0008645]
- 2173: hexose-phosphate:inorganic phosphate antiporter activity [GO_0015526]
- 2174: hexosyltransferase activity [GO_0016758]
- 2175: HHAT palmitoylates Hh N-terminal fragment [GO_0008374]
- 2176: high mobility group box 1 binding [GO_0070379]
- 2177: high voltage-gated calcium channel activity [GO_0008331]
- 2178: hindbrain development [GO_0030902]
- 2179: hindbrain formation [GO_0021576]
- 2180: hindbrain maturation [GO_0021578]
- 2181: hindbrain morphogenesis [GO_0021575]
- 2182: hindbrain-spinal cord boundary formation [GO_0021906]
- 2183: hindgut contraction [GO_0043133]
- 2184: hindgut development [GO_0061525]
- 2185: hindgut morphogenesis [GO_0007442]
- 2186: His-Purkinje system cell development [GO_0060933]
- 2187: His-Purkinje system cell differentiation [GO_0060932]
- 2188: His-Purkinje system development [GO_0003164]
- 2189: histamine secretion [GO_0001821]
- 2190: histamine secretion, neurotransmission [GO_0061538]
- 2191: histamine transport [GO_0051608]
- 2192: histamine-gated chloride channel activity [GO_0019182]
- 2193: histidine + tRNA(His) + ATP => His-tRNA(His) + AMP + pyrophosphate [GO_0004821]
- 2194: histone acetyltransferase binding [GO_0035035]
- 2195: histone acetyltransferase regulator activity [GO_0035034]
- 2196: histone binding [GO_0042393]
- 2197: histone chaperone activity [GO_0140713]
- 2198: histone deacetylase binding [GO_0042826]
- 2199: histone deacetylase inhibitor activity [GO_0046811]
- 2200: histone deacetylase regulator activity [GO_0035033]
- 2201: histone deacetylation [GO_0016575]
- 2202: histone glutamine N-methyltransferase activity [GO_1990259]
- 2203: histone H3 acetyltransferase activity [GO_0010484]
- 2204: histone H3 methyltransferase activity [GO_0140938]
- 2205: histone H3K14 acetyltransferase activity [GO_0036408]
- 2206: histone H3K18 acetyltransferase activity [GO_0043993]
- 2207: histone H3K23 acetyltransferase activity [GO_0043994]
- 2208: histone H3K27 acetyltransferase activity [GO_0044017]
- 2209: histone H3K27me2/H3K27me3 demethylase activity [GO_0071558]
- 2210: histone H3K36 demethylase activity [GO_0051864]
- 2211: histone H3K36 methyltransferase activity [GO_0046975]
- 2212: histone H3K4 demethylase activity [GO_0032453]
- 2213: histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO_0034647]
- 2214: histone H3K79 methyltransferase activity [GO_0031151]
- 2215: histone H3R17 methyltransferase activity [GO_0035642]
- 2216: histone H3R2 methyltransferase activity [GO_0070611]
- 2217: histone H3R3 demethylase activity [GO_0033749]
- 2218: histone H3S10 kinase activity [GO_0035175]
- 2219: histone H3T3 kinase activity [GO_0072354]
- 2220: histone H4 acetyltransferase activity [GO_0010485]
- 2221: histone H4 methyltransferase activity [GO_0140939]
- 2222: histone H4K20 methyltransferase activity [GO_0042799]
- 2223: histone kinase activity [GO_0035173]
- 2224: histone methyltransferase activity [GO_0042054]
- 2225: histone methyltransferase binding [GO_1990226]
- 2226: histone modification [GO_0016570]
- 2227: histone octamer slider activity [GO_0140751]
- 2228: histone reader activity [GO_0140566]
- 2229: histone serine kinase activity [GO_0035174]
- 2230: histone threonine kinase activity [GO_0035184]
- 2231: HMG box domain binding [GO_0071837]
- 2232: HMGCR dimer reduces bHMG-CoA to MVA [GO_0004420]
- 2233: HMOX1 dimer, HMOX2 cleave heme [GO_0004392]
- 2234: holocytochrome-c synthase activity [GO_0004408]
- 2235: homeostasis of number of cells [GO_0048872]
- 2236: homeostasis of number of cells within a tissue [GO_0048873]
- 2237: homeostatic process [GO_0042592]
- 2238: hormone activity [GO_0005179]
- 2239: hormone binding [GO_0042562]
- 2240: hormone metabolic process [GO_0042445]
- 2241: hormone receptor binding [GO_0051427]
- 2242: hormone secretion [GO_0046879]
- 2243: hormone transport [GO_0009914]
- 2244: hormone-mediated signaling pathway [GO_0009755]
- 2245: HRSP12 deaminates 2AA to 2OBUTA [GO_0019239]
- 2246: HS6STs sulfate GlcN at C6 in heparan sulfate/heparin [GO_0017095]
- 2247: HSD17B2 oxidises estradiol (E2) to estrone (E1) [GO_0004303]
- 2248: HSD17B4 dehydrogenates 3-hydroxyhexacosanoyl-CoA [GO_0003857]
- 2249: HSF1 acetylation at Lys80 [GO_0034212]
- 2250: HSP110s exchange ATP for ADP on HSP70s:ADP [GO_0000774]
- 2251: Hsp70 protein binding [GO_0030544]
- 2252: Hsp90 protein binding [GO_0051879]
- 2253: Hv1 Mediated H+ Permeability [GO_0022843]
- 2254: hyaluronan biosynthetic process [GO_0030213]
- 2255: hyaluronan catabolic process [GO_0030214]
- 2256: hyaluronan metabolic process [GO_0030212]
- 2257: hyaluronic acid binding [GO_0005540]
- 2258: hydro-lyase activity [GO_0016836]
- 2259: hydrolase activity, acting on acid anhydrides [GO_0016817]
- 2260: hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO_0016818]
- 2261: hydrolase activity, acting on acid carbon-carbon bonds [GO_0016822]
- 2262: hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances [GO_0016823]
- 2263: hydrolase activity, acting on acid phosphorus-nitrogen bonds [GO_0016825]
- 2264: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO_0016812]
- 2265: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines [GO_0016814]
- 2266: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO_0016811]
- 2267: hydrolase activity, acting on ether bonds [GO_0016801]
- 2268: hydrolase activity, hydrolyzing N-glycosyl compounds [GO_0016799]
- 2269: Hydroperoxy reductase reduces 4(S)-Hp-17(S)-HDHA to RvD6 [GO_0016491]
- 2270: hydroxyisourate hydrolase activity [GO_0033971]
- 2271: hydroxylysine kinase activity [GO_0047992]
- 2272: hydroxymethyl-, formyl- and related transferase activity [GO_0016742]
- 2273: hydroxymethylbilane synthase activity [GO_0004418]
- 2274: hydroxypyruvate isomerase activity [GO_0008903]
- 2275: hydroxypyruvate reductase activity [GO_0016618]
- 2276: I(1,3,4,5,6)P5 is phosphorylated to 5-PP-IP4 by IP6K1/2 in the nucleus [GO_0000827]
- 2277: I(1,4)P2 is dephosphorylated to I4P by INPP1 in the cytosol [GO_0004441]
- 2278: I(1,4,5)P3 is phosphorylated to I(1,3,4,5)P4 by IPMK in the nucleus [GO_0008440]
- 2279: I-SMAD binding [GO_0070411]
- 2280: I1P is dephosphorylated to Ins by IMPA1/2 in the cytosol [GO_0008934]
- 2281: identical protein binding [GO_0042802]
- 2282: IFNL1:IFNLR1:p-JAK1:IL10RB:p-TYK2 phosphorylates IFNLR1 [GO_0004714]
- 2283: IL12B dimerizes [GO_0003756]
- 2284: IL4R, IL2RG, JAK1 in IL4-bound IL4R1:JAK1 are phosphorylated [GO_0004715]
- 2285: imaginal disc growth factor receptor binding [GO_0008084]
- 2286: immune effector process [GO_0002252]
- 2287: immune receptor activity [GO_0140375]
- 2288: immune response [GO_0006955]
- 2289: immune system development [GO_0002520]
- 2290: immune system process [GO_0002376]
- 2291: IMP cyclohydrolase activity [GO_0003937]
- 2292: IMP dehydrogenase activity [GO_0003938]
- 2293: import into cell [GO_0098657]
- 2294: import into nucleus [GO_0051170]
- 2295: Importin-8 imports AGO2:miRNA into the nucleus [GO_0017056]
- 2296: in utero embryonic development [GO_0001701]
- 2297: indolalkylamine biosynthetic process [GO_0046219]
- 2298: indolalkylamine metabolic process [GO_0006586]
- 2299: indole alkaloid biosynthetic process [GO_0035835]
- 2300: indole alkaloid metabolic process [GO_0035834]
- 2301: indole-containing compound biosynthetic process [GO_0042435]
- 2302: indole-containing compound catabolic process [GO_0042436]
- 2303: indole-containing compound metabolic process [GO_0042430]
- 2304: inhibition of neuroepithelial cell differentiation [GO_0002085]
- 2305: inner cell mass cell differentiation [GO_0001826]
- 2306: inner cell mass cell proliferation [GO_0001833]
- 2307: inorganic anion transmembrane transport [GO_0098661]
- 2308: inorganic anion transmembrane transporter activity [GO_0015103]
- 2309: inorganic anion transport [GO_0015698]
- 2310: inorganic cation transmembrane transport [GO_0098662]
- 2311: inorganic cation transmembrane transporter activity [GO_0022890]
- 2312: inorganic ion homeostasis [GO_0098771]
- 2313: inorganic ion transmembrane transport [GO_0098660]
- 2314: inorganic molecular entity transmembrane transporter activity [GO_0015318]
- 2315: inorganic phosphate transmembrane transporter activity [GO_0005315]
- 2316: inositol 1,4,5 trisphosphate binding [GO_0070679]
- 2317: inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0005220]
- 2318: inositol bisphosphate phosphatase activity [GO_0016312]
- 2319: inositol hexakisphosphate 5-kinase activity [GO_0000832]
- 2320: inositol hexakisphosphate binding [GO_0000822]
- 2321: inositol monophosphate phosphatase activity [GO_0052834]
- 2322: inositol pentakisphosphate 2-kinase activity [GO_0035299]
- 2323: inositol phosphate phosphatase activity [GO_0052745]
- 2324: inositol phosphate-mediated signaling [GO_0048016]
- 2325: inositol tetrakisphosphate 5-kinase activity [GO_0047326]
- 2326: inositol tetrakisphosphate kinase activity [GO_0051765]
- 2327: inositol tetrakisphosphate phosphatase activity [GO_0052743]
- 2328: inositol trisphosphate kinase activity [GO_0051766]
- 2329: inositol trisphosphate phosphatase activity [GO_0046030]
- 2330: inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO_0051717]
- 2331: inositol-1,4,5-trisphosphate 6-kinase activity [GO_0000823]
- 2332: inositol-polyphosphate 5-phosphatase activity [GO_0004445]
- 2333: insemination [GO_0007320]
- 2334: insulin binding [GO_0043559]
- 2335: insulin catabolic process [GO_1901143]
- 2336: insulin metabolic process [GO_1901142]
- 2337: insulin receptor activity [GO_0005009]
- 2338: insulin receptor binding [GO_0005158]
- 2339: insulin receptor signaling pathway [GO_0008286]
- 2340: insulin receptor substrate binding [GO_0043560]
- 2341: insulin secretion [GO_0030073]
- 2342: Insulin secretory granule docks at the plasma membrane [GO_0000149]
- 2343: insulin-like growth factor binding [GO_0005520]
- 2344: insulin-like growth factor receptor binding [GO_0005159]
- 2345: integral component of Golgi membrane [GO_0030173]
- 2346: integral component of membrane [GO_0016021]
- 2347: integral component of muscle cell projection membrane [GO_0061455]
- 2348: integral component of nuclear outer membrane [GO_0031309]
- 2349: integral component of organelle membrane [GO_0031301]
- 2350: integral component of pigment granule membrane [GO_0090740]
- 2351: integral component of plasma membrane [GO_0005887]
- 2352: integral component of synaptic membrane [GO_0099699]
- 2353: integral component of vacuolar membrane [GO_0031166]
- 2354: integrin binding [GO_0005178]
- 2355: intercellular transport [GO_0010496]
- 2356: intermediate mesoderm development [GO_0048389]
- 2357: intermediate mesoderm formation [GO_0048391]
- 2358: intermediate mesoderm morphogenesis [GO_0048390]
- 2359: intermembrane lipid transfer [GO_0120009]
- 2360: internal genitalia morphogenesis [GO_0035260]
- 2361: interphase [GO_0051325]
- 2362: interstitial cell of Cajal differentiation [GO_0061453]
- 2363: intestinal absorption [GO_0050892]
- 2364: intestinal epithelial cell development [GO_0060576]
- 2365: intestinal epithelial cell differentiation [GO_0060575]
- 2366: intestinal epithelial cell maturation [GO_0060574]
- 2367: intestinal lipid catabolic process [GO_0044258]
- 2368: intestine smooth muscle contraction [GO_0014827]
- 2369: intracellular anatomical structure [GO_0005622]
- 2370: intracellular calcium activated chloride channel activity [GO_0005229]
- 2371: intracellular cAMP-activated cation channel activity [GO_0005222]
- 2372: intracellular cGMP-activated cation channel activity [GO_0005223]
- 2373: intracellular chloride channel activity [GO_0061778]
- 2374: intracellular ligand-gated ion channel activity [GO_0005217]
- 2375: intracellular lipid transport [GO_0032365]
- 2376: intracellular membrane-bounded organelle [GO_0043231]
- 2377: intracellular non-membrane-bounded organelle [GO_0043232]
- 2378: intracellular nucleoside transport [GO_0015859]
- 2379: intracellular organelle [GO_0043229]
- 2380: intracellular organelle lumen [GO_0070013]
- 2381: intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO_0097682]
- 2382: intracellular protein transmembrane transport [GO_0065002]
- 2383: intracellular protein transport [GO_0006886]
- 2384: intracellular receptor signaling pathway [GO_0030522]
- 2385: intracellular signal transduction [GO_0035556]
- 2386: intracellular signal transduction involved in positive regulation of cell growth [GO_1905427]
- 2387: intracellular sodium activated potassium channel activity [GO_0005228]
- 2388: intracellular sterol transport [GO_0032366]
- 2389: intracellular transport [GO_0046907]
- 2390: intracellular vesicle [GO_0097708]
- 2391: intraciliary transport [GO_0042073]
- 2392: intraciliary transport involved in cilium assembly [GO_0035735]
- 2393: intraciliary transport particle [GO_0030990]
- 2394: intrahepatic bile duct development [GO_0035622]
- 2395: intramembrane lipid transporter activity [GO_0140303]
- 2396: intramembranous bone growth [GO_0098867]
- 2397: intramembranous bone morphogenesis [GO_1904770]
- 2398: intramembranous ossification [GO_0001957]
- 2399: intramolecular lyase activity [GO_0016872]
- 2400: intramolecular oxidoreductase activity, interconverting aldoses and ketoses [GO_0016861]
- 2401: intramolecular oxidoreductase activity, transposing C=C bonds [GO_0016863]
- 2402: intramolecular oxidoreductase activity, transposing S-S bonds [GO_0016864]
- 2403: intramolecular transferase activity [GO_0016866]
- 2404: intramolecular transferase activity, phosphotransferases [GO_0016868]
- 2405: intrinsic component of Golgi membrane [GO_0031228]
- 2406: intrinsic component of membrane [GO_0031224]
- 2407: intrinsic component of nuclear outer membrane [GO_0031308]
- 2408: intrinsic component of organelle membrane [GO_0031300]
- 2409: intrinsic component of plasma membrane [GO_0031226]
- 2410: intrinsic component of synaptic membrane [GO_0099240]
- 2411: intrinsic component of vacuolar membrane [GO_0031310]
- 2412: inward rectifier potassium channel inhibitor activity [GO_0070320]
- 2413: ion binding [GO_0043167]
- 2414: ion channel activity [GO_0005216]
- 2415: ion channel inhibitor activity [GO_0008200]
- 2416: ion channel modulating, G protein-coupled receptor signaling pathway [GO_0099105]
- 2417: ion channel regulator activity [GO_0099106]
- 2418: ion channel regulator activity involved in G protein-coupled receptor signaling pathway [GO_0099107]
- 2419: ion gated channel activity [GO_0022839]
- 2420: ion homeostasis [GO_0050801]
- 2421: ion transmembrane transport [GO_0034220]
- 2422: ion transmembrane transporter activity [GO_0015075]
- 2423: ion transport [GO_0006811]
- 2424: ionotropic glutamate receptor activity [GO_0004970]
- 2425: ionotropic glutamate receptor binding [GO_0035255]
- 2426: ionotropic glutamate receptor signaling pathway [GO_0035235]
- 2427: IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol [GO_0005262]
- 2428: IP6 is phosphorylated to 5-PP-IP5 by IP6K1/3 in the cytosol [GO_0000828]
- 2429: IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation [GO_0004672]
- 2430: IRE1alpha hydrolyzes Xbp1 mRNA and Xbp1 mRNA is spliced [GO_0004521]
- 2431: iRHOM2 transports ADAM17:Zn2+ from Golgi to the plasma membrane [GO_0140318]
- 2432: iris morphogenesis [GO_0061072]
- 2433: iron coordination entity transport [GO_1901678]
- 2434: iron ion binding [GO_0005506]
- 2435: iron ion transmembrane transport [GO_0034755]
- 2436: iron ion transmembrane transporter inhibitor activity [GO_0097690]
- 2437: iron ion transport [GO_0006826]
- 2438: iron-sulfur cluster binding [GO_0051536]
- 2439: isocitrate + NADP+ => 2-oxoglutarate + CO2 + NADPH + H+ [GO_0004450]
- 2440: isocitrate dehydrogenase (NAD+) activity [GO_0004449]
- 2441: isocitrate dehydrogenase [NAD(P)+] activity [GO_0004448]
- 2442: Isomerization of 3-trans-decenoyl-CoA to form trans-dec-2-enoyl-CoA [GO_0016860]
- 2443: Isomerization of GlcNAc6P to GlcNAc1P [GO_0004610]
- 2444: isoprenoid binding [GO_0019840]
- 2445: isoprenoid metabolic process [GO_0006720]
- 2446: JAK3 in IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3 is phosphorylated [GO_0019199]
- 2447: JMJD1C demethylates H3K9 mono- and di-methylation [GO_0032454]
- 2448: JNK cascade [GO_0007254]
- 2449: jump response [GO_0007630]
- 2450: JUN kinase binding [GO_0008432]
- 2451: JUN kinase kinase kinase activity [GO_0004706]
- 2452: JUN kinase kinase kinase kinase activity [GO_0042656]
- 2453: JUN kinase phosphatase activity [GO_0008579]
- 2454: juvenile hormone binding [GO_0005500]
- 2455: juvenile hormone epoxide hydrolase activity [GO_0008096]
- 2456: juvenile hormone response element binding [GO_0070594]
- 2457: K+-independent Li+/Ca2+ exchanger transport [GO_0015368]
- 2458: K11-linked polyubiquitin modification-dependent protein binding [GO_0071795]
- 2459: K48-linked polyubiquitin modification-dependent protein binding [GO_0036435]
- 2460: K63-linked polyubiquitin modification-dependent protein binding [GO_0070530]
- 2461: kainate selective glutamate receptor activity [GO_0015277]
- 2462: KAMKMT transfers 3xCH3 groups from 3xAdoMet to CALM1 [GO_0018025]
- 2463: karyogamy [GO_0000741]
- 2464: KAT5 acetylates ATM at DNA DSBs [GO_0016407]
- 2465: KAT7-containing ING4/5 complexes acetylate Me3K-histone H3 [GO_0004402]
- 2466: KBTBD7:CUL3:RBX1 ubiquitinates NF1 [GO_0061630]
- 2467: KCNJ11 tetramer:ABCC8 tetramer binds 4xATP, closing the channel [GO_0005524]
- 2468: KDEL sequence binding [GO_0005046]
- 2469: KDM2A, KDM2B, KDM4A demethylate MeK37-histone H3 [GO_0032452]
- 2470: ketone biosynthetic process [GO_0042181]
- 2471: ketone catabolic process [GO_0042182]
- 2472: kinase activator activity [GO_0019209]
- 2473: kinase binding [GO_0019900]
- 2474: kinase inhibitor activity [GO_0019210]
- 2475: kinase regulator activity [GO_0019207]
- 2476: kinesin binding [GO_0019894]
- 2477: kynurenine aminotransferase activity [GO_0036137]
- 2478: kynurenine metabolic process [GO_0070189]
- 2479: kynurenine-oxoglutarate transaminase activity [GO_0016212]
- 2480: L-allo-threonine aldolase activity [GO_0008732]
- 2481: L-alpha-amino acid transmembrane transport [GO_1902475]
- 2482: L-amino acid transmembrane transporter activity [GO_0015179]
- 2483: L-amino acid transport [GO_0015807]
- 2484: L-ascorbate oxidase activity [GO_0008447]
- 2485: L-ascorbic acid binding [GO_0031418]
- 2486: L-aspartate transmembrane transport [GO_0070778]
- 2487: L-aspartate transmembrane transporter activity [GO_0015183]
- 2488: L-aspartate:2-oxoglutarate aminotransferase activity [GO_0004069]
- 2489: L-cystine transmembrane transporter activity [GO_0015184]
- 2490: L-cystine transport [GO_0015811]
- 2491: L-dopa decarboxylase activator activity [GO_0036478]
- 2492: L-dopa decarboxylase activity [GO_0036468]
- 2493: L-galactose dehydrogenase activity [GO_0010349]
- 2494: L-glutamate import [GO_0051938]
- 2495: L-glutamate transmembrane transport [GO_0015813]
- 2496: L-glutamate transmembrane transporter activity [GO_0005313]
- 2497: L-glutamine aminotransferase activity [GO_0070548]
- 2498: L-iditol 2-dehydrogenase activity [GO_0003939]
- 2499: L-isoleucine transaminase activity [GO_0052656]
- 2500: L-kynurenine metabolic process [GO_0097052]
- 2501: L-lactate dehydrogenase activity [GO_0004459]
- 2502: L-leucine transaminase activity [GO_0052654]
- 2503: L-lysine transmembrane transport [GO_1903401]
- 2504: L-lysine transmembrane transporter activity [GO_0015189]
- 2505: L-lysine transport [GO_1902022]
- 2506: L-methionine-(S)-S-oxide reductase activity [GO_0036456]
- 2507: L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO_0033744]
- 2508: L-ornithine transmembrane transport [GO_1903352]
- 2509: L-phosphoserine phosphatase activity [GO_0036424]
- 2510: L-serine ammonia-lyase activity [GO_0003941]
- 2511: L-serine-phosphatidylcholine phosphatidyltransferase activity [GO_0106258]
- 2512: L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO_0106245]
- 2513: L-threonine ammonia-lyase activity [GO_0004794]
- 2514: L-tyrosine aminotransferase activity [GO_0070547]
- 2515: L-valine transaminase activity [GO_0052655]
- 2516: labyrinthine layer blood vessel development [GO_0060716]
- 2517: labyrinthine layer development [GO_0060711]
- 2518: labyrinthine layer formation [GO_0060714]
- 2519: labyrinthine layer morphogenesis [GO_0060713]
- 2520: lactate dehydrogenase activity [GO_0004457]
- 2521: lactoylglutathione lyase activity [GO_0004462]
- 2522: lamin binding [GO_0005521]
- 2523: laminin binding [GO_0043236]
- 2524: laminin receptor activity [GO_0005055]
- 2525: large conductance calcium-activated potassium channel activity [GO_0060072]
- 2526: large ribosomal subunit rRNA binding [GO_0070180]
- 2527: larval behavior [GO_0030537]
- 2528: larval locomotory behavior [GO_0008345]
- 2529: larval turning behavior [GO_0035179]
- 2530: lateral mesoderm development [GO_0048368]
- 2531: lateral mesoderm formation [GO_0048370]
- 2532: lateral mesoderm morphogenesis [GO_0048369]
- 2533: latrotoxin receptor activity [GO_0016524]
- 2534: LCMT2 methylates yW-72 yielding yW-58 at nucleotide 37 of tRNA(Phe) [GO_0008175]
- 2535: leading edge membrane [GO_0031256]
- 2536: leak channel activity [GO_0022840]
- 2537: learning [GO_0007612]
- 2538: learning or memory [GO_0007611]
- 2539: left lung development [GO_0060459]
- 2540: left lung morphogenesis [GO_0060460]
- 2541: left ventricular cardiac muscle tissue morphogenesis [GO_0003220]
- 2542: lens development in camera-type eye [GO_0002088]
- 2543: lens morphogenesis in camera-type eye [GO_0002089]
- 2544: lens placode formation [GO_0001743]
- 2545: leucine binding [GO_0070728]
- 2546: leucokinin receptor activity [GO_0042071]
- 2547: leukocyte apoptotic process [GO_0071887]
- 2548: leukocyte differentiation [GO_0002521]
- 2549: leukocyte homeostasis [GO_0001776]
- 2550: leukocyte mediated immunity [GO_0002443]
- 2551: leukocyte proliferation [GO_0070661]
- 2552: ligand-activated transcription factor activity [GO_0098531]
- 2553: ligand-gated anion channel activity [GO_0099095]
- 2554: ligand-gated calcium channel activity [GO_0099604]
- 2555: ligand-gated cation channel activity [GO_0099094]
- 2556: ligand-gated channel activity [GO_0022834]
- 2557: ligand-gated ion channel signaling pathway [GO_1990806]
- 2558: ligase activity [GO_0016874]
- 2559: ligase activity, forming carbon-carbon bonds [GO_0016885]
- 2560: ligase activity, forming carbon-nitrogen bonds [GO_0016879]
- 2561: ligase activity, forming carbon-oxygen bonds [GO_0016875]
- 2562: ligase activity, forming carbon-sulfur bonds [GO_0016877]
- 2563: ligase regulator activity [GO_0055103]
- 2564: light-activated ion channel activity [GO_0010461]
- 2565: limb development [GO_0060173]
- 2566: limit dextrin-glycogenin => ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl) glycogenin [GO_0004134]
- 2567: linear polyubiquitin binding [GO_1990450]
- 2568: lipase activator activity [GO_0060229]
- 2569: lipase activity [GO_0016298]
- 2570: LIPG dimer hydrolyzes HDL-associated TAG to DAG and LCFA [GO_0004465]
- 2571: lipid antigen binding [GO_0030882]
- 2572: lipid binding [GO_0008289]
- 2573: lipid biosynthetic process [GO_0008610]
- 2574: lipid catabolic process [GO_0016042]
- 2575: lipid digestion [GO_0044241]
- 2576: lipid export from cell [GO_0140353]
- 2577: lipid homeostasis [GO_0055088]
- 2578: lipid import into cell [GO_0140354]
- 2579: lipid kinase activity [GO_0001727]
- 2580: lipid localization [GO_0010876]
- 2581: lipid metabolic process [GO_0006629]
- 2582: lipid modification [GO_0030258]
- 2583: lipid phosphatase activity [GO_0042577]
- 2584: lipid phosphorylation [GO_0046834]
- 2585: lipid storage [GO_0019915]
- 2586: lipid transfer activity [GO_0120013]
- 2587: lipid translocation [GO_0034204]
- 2588: lipid transport [GO_0006869]
- 2589: lipid transport involved in lipid storage [GO_0010877]
- 2590: lipo-PDH decarboxylates PYR to Ac-CoA [GO_0004738]
- 2591: lipopolysaccharide binding [GO_0001530]
- 2592: lipopolysaccharide immune receptor activity [GO_0001875]
- 2593: lipopolysaccharide-mediated signaling pathway [GO_0031663]
- 2594: lipoprotein lipase activator activity [GO_0060230]
- 2595: lipoprotein particle binding [GO_0071813]
- 2596: lipoprotein particle receptor activity [GO_0030228]
- 2597: lipoprotein particle receptor binding [GO_0070325]
- 2598: lipoteichoic acid binding [GO_0070891]
- 2599: lipoyltransferase activity [GO_0017118]
- 2600: liver development [GO_0001889]
- 2601: liver morphogenesis [GO_0072576]
- 2602: lncRNA binding [GO_0106222]
- 2603: Loading of acetylcholine in synaptic vesicles [GO_0005277]
- 2604: loading of Serotonin in synaptic vesicles [GO_0008504]
- 2605: localization [GO_0051179]
- 2606: localization of cell [GO_0051674]
- 2607: localization within membrane [GO_0051668]
- 2608: locomotion [GO_0040011]
- 2609: locomotion involved in locomotory behavior [GO_0031987]
- 2610: locomotor rhythm [GO_0045475]
- 2611: locomotory behavior [GO_0007626]
- 2612: locus ceruleus development [GO_0021703]
- 2613: locus ceruleus formation [GO_0021705]
- 2614: locus ceruleus maturation [GO_0021706]
- 2615: locus ceruleus morphogenesis [GO_0021704]
- 2616: long-chain fatty acid metabolic process [GO_0001676]
- 2617: long-chain fatty acid transport [GO_0015909]
- 2618: long-chain fatty acid transporter activity [GO_0005324]
- 2619: long-chain fatty acid-CoA ligase activity [GO_0004467]
- 2620: long-chain fatty acyl-CoA binding [GO_0036042]
- 2621: long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO_0016509]
- 2622: long-chain-acyl-CoA dehydrogenase activity [GO_0004466]
- 2623: long-chain-fatty-acyl-CoA reductase activity [GO_0050062]
- 2624: Long-range resection of DNA DSBs by EXO1 or DNA2 [GO_0004536]
- 2625: long-term memory [GO_0007616]
- 2626: low voltage-gated calcium channel activity [GO_0008332]
- 2627: low-density lipoprotein particle binding [GO_0030169]
- 2628: low-density lipoprotein particle receptor activity [GO_0005041]
- 2629: low-density lipoprotein particle receptor binding [GO_0050750]
- 2630: lpdC dimer reactivates dlaT [GO_0004148]
- 2631: LRAT esterifies RBP1:atROL and FACYLs to atREs [GO_0016416]
- 2632: LTA4H:Zn2+ hydrolyses 16S,17S-epoxy-DHA to (N)PD1 [GO_0004301]
- 2633: lung cell differentiation [GO_0060479]
- 2634: lung ciliated cell differentiation [GO_0061141]
- 2635: lung connective tissue development [GO_0060427]
- 2636: lung development [GO_0030324]
- 2637: lung epithelial cell differentiation [GO_0060487]
- 2638: lung epithelium development [GO_0060428]
- 2639: lung growth [GO_0060437]
- 2640: lung morphogenesis [GO_0060425]
- 2641: lung neuroendocrine cell differentiation [GO_0061100]
- 2642: lung secretory cell differentiation [GO_0061140]
- 2643: lung vasculature development [GO_0060426]
- 2644: luteinization [GO_0001553]
- 2645: LYPLA2 hydrolyses PALM-C3,4-GAP43 [GO_0008474]
- 2646: Lys48-specific deubiquitinase activity [GO_1990380]
- 2647: lysine-acetylated histone binding [GO_0070577]
- 2648: lysophosphatidic acid acyltransferase activity [GO_0042171]
- 2649: lysophosphatidic acid phosphatase activity [GO_0052642]
- 2650: lysophospholipid acyltransferase activity [GO_0071617]
- 2651: LYZ hydrolyzes peptidoglycans in the bacterial cell wall [GO_0003796]
- 2652: M phase [GO_0000279]
- 2653: m7G(5')pppN diphosphatase activator activity [GO_1990521]
- 2654: m7G(5')pppN diphosphatase activity [GO_0050072]
- 2655: macrolide binding [GO_0005527]
- 2656: macromolecule biosynthetic process [GO_0009059]
- 2657: macromolecule catabolic process [GO_0009057]
- 2658: macromolecule deacylation [GO_0098732]
- 2659: macromolecule depalmitoylation [GO_0098734]
- 2660: macromolecule localization [GO_0033036]
- 2661: macromolecule metabolic process [GO_0043170]
- 2662: macromolecule methylation [GO_0043414]
- 2663: macromolecule modification [GO_0043412]
- 2664: macromolecule transmembrane transporter activity [GO_0022884]
- 2665: magnesium ion binding [GO_0000287]
- 2666: magnesium ion transmembrane transport [GO_1903830]
- 2667: magnesium ion transport [GO_0015693]
- 2668: maintenance of location [GO_0051235]
- 2669: maintenance of location in cell [GO_0051651]
- 2670: maintenance of presynaptic active zone structure [GO_0048790]
- 2671: maintenance of synapse structure [GO_0099558]
- 2672: malate + NAD+ <=> oxaloacetate + NADH + H+ [GO_0030060]
- 2673: malate dehydrogenase (decarboxylating) (NAD+) activity [GO_0004471]
- 2674: malate dehydrogenase activity [GO_0016615]
- 2675: malate transmembrane transport [GO_0071423]
- 2676: malate transmembrane transporter activity [GO_0015140]
- 2677: malate transport [GO_0015743]
- 2678: male courtship behavior [GO_0008049]
- 2679: male courtship behavior, veined wing extension [GO_0048065]
- 2680: male courtship behavior, veined wing generated song production [GO_0045433]
- 2681: male courtship behavior, veined wing vibration [GO_0016545]
- 2682: male mating behavior [GO_0060179]
- 2683: malic enzyme activity [GO_0004470]
- 2684: malonate-semialdehyde dehydrogenase (acetylating) activity [GO_0018478]
- 2685: maltose alpha-glucosidase activity [GO_0032450]
- 2686: maltose metabolic process [GO_0000023]
- 2687: MAN2B1 hydrolyses GlcNAc (Man)5 to GlcNAc (Man)3 [GO_0004559]
- 2688: manganese ion binding [GO_0030145]
- 2689: manganese ion transmembrane transport [GO_0071421]
- 2690: manganese ion transmembrane transporter activity [GO_0005384]
- 2691: manganese ion transport [GO_0006828]
- 2692: mannose binding [GO_0005537]
- 2693: mannose(a1-4)glucosaminyl-acyl-PI + phosphatidylethanolamine -> (ethanolamineP) mannose(al1-4)glucosaminyl-acyl-PI + diacylglycerol [GO_0051377]
- 2694: mannose-1-phosphate guanylyltransferase (GTP) activity [GO_0004475]
- 2695: mannose-6-phosphate isomerase activity [GO_0004476]
- 2696: mannosidase activity [GO_0015923]
- 2697: mannosyl-oligosaccharide 1,6-alpha-mannosidase activity [GO_0052767]
- 2698: mannosyl-oligosaccharide mannosidase activity [GO_0015924]
- 2699: mannosylation [GO_0097502]
- 2700: mannosyltransferase activity [GO_0000030]
- 2701: MAP kinase phosphatase activity [GO_0033549]
- 2702: MAP kinase tyrosine phosphatase activity [GO_0033550]
- 2703: MAP kinase tyrosine/serine/threonine phosphatase activity [GO_0017017]
- 2704: MAP-kinase scaffold activity [GO_0005078]
- 2705: MAPK cascade [GO_0000165]
- 2706: mastication [GO_0071626]
- 2707: mating [GO_0007618]
- 2708: mating behavior [GO_0007617]
- 2709: MCM8 mediated fork unwinding [GO_0004386]
- 2710: ME1:Mg2+ tetramer oxidatively decarboxylates MAL to PYR [GO_0004473]
- 2711: mechanosensitive cation channel activity [GO_0140135]
- 2712: mechanosensitive ion channel activity [GO_0008381]
- 2713: mechanosensitive voltage-gated sodium channel activity [GO_0101013]
- 2714: medium-chain fatty acid-CoA ligase activity [GO_0031956]
- 2715: medium-chain-acyl-CoA dehydrogenase activity [GO_0070991]
- 2716: medium-term memory [GO_0072375]
- 2717: medulla oblongata development [GO_0021550]
- 2718: medulla oblongata formation [GO_0021580]
- 2719: medulla oblongata maturation [GO_0021582]
- 2720: medulla oblongata morphogenesis [GO_0021579]
- 2721: megakaryocyte development [GO_0035855]
- 2722: megakaryocyte differentiation [GO_0030219]
- 2723: meiotic cell cycle [GO_0051321]
- 2724: meiotic cell cycle phase [GO_0098762]
- 2725: meiotic cell cycle process [GO_1903046]
- 2726: meiotic cell cycle process involved in oocyte maturation [GO_1903537]
- 2727: meiotic chromosome condensation [GO_0010032]
- 2728: meiotic chromosome segregation [GO_0045132]
- 2729: meiotic interphase [GO_0051328]
- 2730: meiotic M phase [GO_0051327]
- 2731: meiotic nuclear division [GO_0140013]
- 2732: meiotic nuclear membrane disassembly [GO_0051078]
- 2733: membrane [GO_0016020]
- 2734: membrane assembly [GO_0071709]
- 2735: membrane biogenesis [GO_0044091]
- 2736: membrane bone morphogenesis [GO_0061973]
- 2737: membrane disassembly [GO_0030397]
- 2738: membrane docking [GO_0022406]
- 2739: membrane fission [GO_0090148]
- 2740: membrane fusion [GO_0061025]
- 2741: membrane invagination [GO_0010324]
- 2742: membrane organization [GO_0061024]
- 2743: membrane protein complex [GO_0098796]
- 2744: membrane-bounded organelle [GO_0043227]
- 2745: membrane-enclosed lumen [GO_0031974]
- 2746: membranous septum morphogenesis [GO_0003149]
- 2747: memory [GO_0007613]
- 2748: mesenchymal cell apoptotic process [GO_0097152]
- 2749: mesenchymal cell development [GO_0014031]
- 2750: mesenchymal cell differentiation [GO_0048762]
- 2751: mesenchymal cell differentiation involved in bone development [GO_1901706]
- 2752: mesenchymal cell differentiation involved in lung development [GO_0060915]
- 2753: mesenchymal cell differentiation involved in renal system development [GO_2001012]
- 2754: mesenchymal cell proliferation [GO_0010463]
- 2755: mesenchymal cell proliferation involved in lung development [GO_0060916]
- 2756: mesenchymal to epithelial transition [GO_0060231]
- 2757: mesenchyme development [GO_0060485]
- 2758: mesenchyme morphogenesis [GO_0072132]
- 2759: mesoderm development [GO_0007498]
- 2760: mesoderm formation [GO_0001707]
- 2761: mesoderm morphogenesis [GO_0048332]
- 2762: mesodermal cell differentiation [GO_0048333]
- 2763: Met1-linked polyubiquitin deubiquitinase activity [GO_0061815]
- 2764: metabolic process [GO_0008152]
- 2765: metal cation:monoatomic cation antiporter activity [GO_0140828]
- 2766: metal cluster binding [GO_0051540]
- 2767: metal ion binding [GO_0046872]
- 2768: metal ion homeostasis [GO_0055065]
- 2769: metal ion sensor activity [GO_0140784]
- 2770: metal ion transmembrane transporter activity [GO_0046873]
- 2771: metal ion transport [GO_0030001]
- 2772: metal-dependent deNEDDylase activity [GO_0140758]
- 2773: metal-dependent deubiquitinase activity [GO_0140492]
- 2774: metalloaminopeptidase activity [GO_0070006]
- 2775: metallochaperone activity [GO_0016530]
- 2776: metalloendopeptidase inhibitor activity [GO_0008191]
- 2777: metalloexopeptidase activity [GO_0008235]
- 2778: metencephalon development [GO_0022037]
- 2779: methionine + tRNA(Met) + ATP => Met-tRNA(Met) + AMP + pyrophosphate [GO_0004825]
- 2780: methionine adenosyltransferase regulator activity [GO_0048270]
- 2781: methyl transfer-driven active transmembrane transporter activity [GO_0015452]
- 2782: methylated histone binding [GO_0035064]
- 2783: methylation [GO_0032259]
- 2784: Methylation of N-acetyl-5-HT to form melatonin [GO_0008172]
- 2785: methylation-dependent protein binding [GO_0140034]
- 2786: methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO_0004487]
- 2787: methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO_0004488]
- 2788: methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO_0004486]
- 2789: methylmalonate semialdehyde + NAD+ + CoA => propionyl-CoA + CO2 + NADH + H+ [GO_0004491]
- 2790: methylmalonyl semialdehyde + NADH + H+ <=> beta-hydroxyisobutyrate + NAD+ [GO_0008442]
- 2791: Methylthio-ribulose-P = Methylthio-ribose-P [GO_0046523]
- 2792: METTL1:WDR4 methylates guanosine-46 of tRNA(Phe) yielding 7-methylguanosine-46 [GO_0008176]
- 2793: Mevalonate is phosphorylated to mevalonate-5-phosphate [GO_0004496]
- 2794: MHC protein binding [GO_0042287]
- 2795: MIA40:ERV1 (CHCHD4:GFER) oxidizes cysteine residues to cystine disulfide bonds [GO_0015035]
- 2796: microfilament motor activity [GO_0000146]
- 2797: microtubule [GO_0005874]
- 2798: microtubule bundle [GO_0097427]
- 2799: microtubule bundle formation [GO_0001578]
- 2800: microtubule cytoskeleton [GO_0015630]
- 2801: microtubule cytoskeleton organization [GO_0000226]
- 2802: microtubule cytoskeleton organization involved in mitosis [GO_1902850]
- 2803: microtubule depolymerization [GO_0007019]
- 2804: microtubule minus-end binding [GO_0051011]
- 2805: microtubule motor activity [GO_0003777]
- 2806: microtubule nucleation [GO_0007020]
- 2807: microtubule plus end polymerase [GO_0061863]
- 2808: microtubule plus-end binding [GO_0051010]
- 2809: microtubule polymerization [GO_0046785]
- 2810: microtubule polymerization based movement [GO_0099098]
- 2811: microtubule polymerization based protein transport [GO_0099112]
- 2812: microtubule polymerization or depolymerization [GO_0031109]
- 2813: microtubule-based movement [GO_0007018]
- 2814: microtubule-based process [GO_0007017]
- 2815: microtubule-based protein transport [GO_0099118]
- 2816: microtubule-based transport [GO_0099111]
- 2817: microvillus [GO_0005902]
- 2818: microvillus assembly [GO_0030033]
- 2819: microvillus organization [GO_0032528]
- 2820: midbrain development [GO_0030901]
- 2821: midbrain morphogenesis [GO_1904693]
- 2822: midbrain-hindbrain boundary development [GO_0030917]
- 2823: midbrain-hindbrain boundary initiation [GO_0021547]
- 2824: midbrain-hindbrain boundary maturation [GO_0021732]
- 2825: midbrain-hindbrain boundary morphogenesis [GO_0021555]
- 2826: midgut development [GO_0007494]
- 2827: minor groove of adenine-thymine-rich DNA binding [GO_0003680]
- 2828: minus-end-directed microtubule motor activity [GO_0008569]
- 2829: MIOX oxidises Ins to GlcA [GO_0050113]
- 2830: miRNA binding [GO_0035198]
- 2831: miRNA-mediated gene silencing [GO_0035195]
- 2832: miRNA-mediated gene silencing by mRNA destabilization [GO_0035279]
- 2833: mismatch base pair DNA N-glycosylase activity [GO_0000700]
- 2834: mismatched DNA binding [GO_0030983]
- 2835: mitochondrial calcium ion homeostasis [GO_0051560]
- 2836: mitochondrial chromosome [GO_0000262]
- 2837: mitochondrial chromosome packaging [GO_0090139]
- 2838: mitochondrial DNA metabolic process [GO_0032042]
- 2839: mitochondrial DNA replication [GO_0006264]
- 2840: mitochondrial envelope [GO_0005740]
- 2841: mitochondrial gene expression [GO_0140053]
- 2842: mitochondrial genome maintenance [GO_0000002]
- 2843: mitochondrial matrix [GO_0005759]
- 2844: mitochondrial membrane [GO_0031966]
- 2845: mitochondrial membrane organization [GO_0007006]
- 2846: mitochondrial mRNA catabolic process [GO_0000958]
- 2847: mitochondrial nucleoid [GO_0042645]
- 2848: mitochondrial promoter sequence-specific DNA binding [GO_0001018]
- 2849: mitochondrial protein catabolic process [GO_0035694]
- 2850: mitochondrial protein-containing complex [GO_0098798]
- 2851: mitochondrial protein-transporting ATPase activity [GO_0008566]
- 2852: mitochondrial ribosome [GO_0005761]
- 2853: mitochondrial ribosome binding [GO_0097177]
- 2854: mitochondrial RNA catabolic process [GO_0000957]
- 2855: mitochondrial RNA metabolic process [GO_0000959]
- 2856: mitochondrial RNA modification [GO_1900864]
- 2857: mitochondrial RNA processing [GO_0000963]
- 2858: mitochondrial single-subunit type RNA polymerase binding [GO_0001001]
- 2859: Mitochondrial tetrahydrofolate export across the inner mitochondrial membrane [GO_0008517]
- 2860: mitochondrial transcription [GO_0006390]
- 2861: mitochondrial transcription factor activity [GO_0034246]
- 2862: mitochondrial translation [GO_0032543]
- 2863: mitochondrial translational elongation [GO_0070125]
- 2864: mitochondrial translational initiation [GO_0070124]
- 2865: mitochondrial translational termination [GO_0070126]
- 2866: mitochondrial tRNA methylation [GO_0070901]
- 2867: mitochondrial tRNA modification [GO_0070900]
- 2868: mitochondrial tRNA processing [GO_0090646]
- 2869: mitochondrion [GO_0005739]
- 2870: mitochondrion organization [GO_0007005]
- 2871: mitochondrion targeting sequence binding [GO_0030943]
- 2872: mitogen-activated protein kinase binding [GO_0051019]
- 2873: mitogen-activated protein kinase kinase binding [GO_0031434]
- 2874: mitotic cell cycle [GO_0000278]
- 2875: mitotic cell cycle phase [GO_0098763]
- 2876: mitotic cell cycle process [GO_1903047]
- 2877: mitotic cell cycle, embryonic [GO_0045448]
- 2878: mitotic chromosome condensation [GO_0007076]
- 2879: mitotic DNA replication [GO_1902969]
- 2880: mitotic DNA replication DNA duplex unwinding [GO_1902971]
- 2881: mitotic interphase [GO_0051329]
- 2882: mitotic M phase [GO_0000087]
- 2883: mitotic nuclear division [GO_0140014]
- 2884: mitotic nuclear membrane disassembly [GO_0007077]
- 2885: mitotic nuclear membrane organization [GO_0101024]
- 2886: mitotic sister chromatid segregation [GO_0000070]
- 2887: modification-dependent macromolecule catabolic process [GO_0043632]
- 2888: modification-dependent protein binding [GO_0140030]
- 2889: modification-dependent protein catabolic process [GO_0019941]
- 2890: modified amino acid binding [GO_0072341]
- 2891: modified amino acid transmembrane transporter activity [GO_0072349]
- 2892: modified amino acid transport [GO_0072337]
- 2893: modulation of chemical synaptic transmission [GO_0050804]
- 2894: modulation of excitatory postsynaptic potential [GO_0098815]
- 2895: molecular adaptor activity [GO_0060090]
- 2896: molecular carrier activity [GO_0140104]
- 2897: molecular function activator activity [GO_0140677]
- 2898: molecular function inhibitor activity [GO_0140678]
- 2899: molecular function regulator [GO_0098772]
- 2900: molecular transducer activity [GO_0060089]
- 2901: molecular_function [GO_0003674]
- 2902: molybdenum ion binding [GO_0030151]
- 2903: monoamine transport [GO_0015844]
- 2904: monocarboxylate:sodium symporter activity [GO_0140161]
- 2905: monocarboxylic acid binding [GO_0033293]
- 2906: monocarboxylic acid biosynthetic process [GO_0072330]
- 2907: monocarboxylic acid catabolic process [GO_0072329]
- 2908: monocarboxylic acid metabolic process [GO_0032787]
- 2909: monocarboxylic acid transport [GO_0015718]
- 2910: mononuclear cell differentiation [GO_1903131]
- 2911: mononuclear cell proliferation [GO_0032943]
- 2912: monosaccharide binding [GO_0048029]
- 2913: monosaccharide biosynthetic process [GO_0046364]
- 2914: monosaccharide catabolic process [GO_0046365]
- 2915: monosaccharide metabolic process [GO_0005996]
- 2916: monosaccharide transmembrane transport [GO_0015749]
- 2917: monosaccharide transmembrane transporter activity [GO_0015145]
- 2918: monovalent cation:proton antiporter activity [GO_0005451]
- 2919: monovalent inorganic anion homeostasis [GO_0055083]
- 2920: monovalent inorganic cation homeostasis [GO_0055067]
- 2921: morphogen activity [GO_0016015]
- 2922: morphogenesis of a branching epithelium [GO_0061138]
- 2923: morphogenesis of a branching structure [GO_0001763]
- 2924: morphogenesis of a polarized epithelium [GO_0001738]
- 2925: morphogenesis of an endothelium [GO_0003159]
- 2926: morphogenesis of an epithelial bud [GO_0060572]
- 2927: morphogenesis of an epithelial fold [GO_0060571]
- 2928: morphogenesis of an epithelial fold involved in embryonic heart tube formation [GO_0003152]
- 2929: morphogenesis of an epithelial sheet [GO_0002011]
- 2930: morphogenesis of an epithelium [GO_0002009]
- 2931: morphogenesis of embryonic epithelium [GO_0016331]
- 2932: motor neuron apoptotic process [GO_0097049]
- 2933: movement of cell or subcellular component [GO_0006928]
- 2934: MPC1:MPC2 cotransports PYR, H+ from cytosol to mitochondrial matrix [GO_0050833]
- 2935: MRN:CtIP exonucleolytically hydrolyzes DNA 3' to SPO11 and SPO11:double-strand break dissociates to SPO11:oligonucleotide and resected 5' end [GO_0008296]
- 2936: mRNA 3'-UTR AU-rich region binding [GO_0035925]
- 2937: mRNA 3'-UTR binding [GO_0003730]
- 2938: mRNA 5'-UTR binding [GO_0048027]
- 2939: mRNA base-pairing translational repressor activity [GO_1903231]
- 2940: mRNA binding [GO_0003729]
- 2941: mRNA cap binding complex binding [GO_0140262]
- 2942: mRNA catabolic process [GO_0006402]
- 2943: mRNA destabilization [GO_0061157]
- 2944: mRNA metabolic process [GO_0016071]
- 2945: mRNA polyadenylation [GO_0004652]
- 2946: mRNA regulatory element binding translation repressor activity [GO_0000900]
- 2947: MRSBs reduce L-methyl-(R)-S-oxide to L-methionine [GO_0033743]
- 2948: MscR reduces nitrosomycothiol to ammonia [GO_0016620]
- 2949: MsrA/B reduces peptide-methionine S/R-sulfoxides [GO_0008113]
- 2950: MTA2-NuRD complex deacetylates TP53 [GO_0004407]
- 2951: MTHFD2, D2L oxidise 5,10-methylene-THF to 5,10-methenyl-THF [GO_0004477]
- 2952: MTHFS transforms 5-formyl-THFPG to 5,10-methenyl-THFPG [GO_0030272]
- 2953: mucopolysaccharide metabolic process [GO_1903510]
- 2954: mucus secretion [GO_0070254]
- 2955: multi-ciliated epithelial cell differentiation [GO_1903251]
- 2956: multi-multicellular organism process [GO_0044706]
- 2957: multi-organism process [GO_0051704]
- 2958: multi-organism reproductive process [GO_0044703]
- 2959: multicellular organism development [GO_0007275]
- 2960: multicellular organism growth [GO_0035264]
- 2961: multicellular organism reproduction [GO_0032504]
- 2962: multicellular organismal homeostasis [GO_0048871]
- 2963: multicellular organismal movement [GO_0050879]
- 2964: multicellular organismal process [GO_0032501]
- 2965: multicellular organismal reproductive process [GO_0048609]
- 2966: multicellular organismal response to stress [GO_0033555]
- 2967: multicellular organismal signaling [GO_0035637]
- 2968: muscle adaptation [GO_0043500]
- 2969: muscle alpha-actinin binding [GO_0051371]
- 2970: muscle cell apoptotic process [GO_0010657]
- 2971: muscle cell cellular homeostasis [GO_0046716]
- 2972: muscle cell development [GO_0055001]
- 2973: muscle cell differentiation [GO_0042692]
- 2974: muscle cell projection [GO_0036194]
- 2975: muscle cell projection membrane [GO_0036195]
- 2976: muscle cell proliferation [GO_0033002]
- 2977: muscle contraction [GO_0006936]
- 2978: muscle hypertrophy [GO_0014896]
- 2979: muscle organ development [GO_0007517]
- 2980: muscle organ morphogenesis [GO_0048644]
- 2981: muscle structure development [GO_0061061]
- 2982: muscle system process [GO_0003012]
- 2983: muscle tissue development [GO_0060537]
- 2984: muscle tissue morphogenesis [GO_0060415]
- 2985: muscular septum morphogenesis [GO_0003150]
- 2986: musculoskeletal movement [GO_0050881]
- 2987: myeloid cell apoptotic process [GO_0033028]
- 2988: myeloid cell development [GO_0061515]
- 2989: myeloid cell differentiation [GO_0030099]
- 2990: myeloid cell homeostasis [GO_0002262]
- 2991: myeloid leukocyte differentiation [GO_0002573]
- 2992: myeloid leukocyte mediated immunity [GO_0002444]
- 2993: myeloid progenitor cell differentiation [GO_0002318]
- 2994: myoblast development [GO_0048627]
- 2995: myoblast differentiation [GO_0045445]
- 2996: myoblast division [GO_0014872]
- 2997: myoblast maturation [GO_0048628]
- 2998: myoblast proliferation [GO_0051450]
- 2999: myofibril [GO_0030016]
- 3000: myofibril assembly [GO_0030239]
- 3001: myosin binding [GO_0017022]
- 3002: myosin head/neck binding [GO_0032028]
- 3003: myosin heavy chain binding [GO_0032036]
- 3004: myosin II binding [GO_0045159]
- 3005: myosin II heavy chain binding [GO_0032038]
- 3006: myosin II light chain binding [GO_0032033]
- 3007: myosin III binding [GO_0031473]
- 3008: myosin light chain binding [GO_0032027]
- 3009: myosin light chain kinase activity [GO_0004687]
- 3010: myosin phosphatase activity [GO_0017018]
- 3011: myosin phosphatase regulator activity [GO_0017020]
- 3012: myosin V binding [GO_0031489]
- 3013: myosin VI binding [GO_0070853]
- 3014: myosin VI head/neck binding [GO_0070855]
- 3015: myosin VI heavy chain binding [GO_0070854]
- 3016: myosin VI light chain binding [GO_0070856]
- 3017: myostimulatory hormone activity [GO_0016084]
- 3018: myosuppressin receptor activity [GO_0035013]
- 3019: myotome development [GO_0061055]
- 3020: myotube cell development [GO_0014904]
- 3021: myotube differentiation [GO_0014902]
- 3022: myristoyl-CoA+FAD<=>trans-Tetradec-2-enoyl-CoA+FADH2 [GO_0003995]
- 3023: N-acetylation of serotonin [GO_0004059]
- 3024: N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO_0050510]
- 3025: N-acetylglucosamine 6-O-sulfotransferase activity [GO_0001517]
- 3026: N-acetylglucosamine kinase activity [GO_0045127]
- 3027: N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO_0046987]
- 3028: N-acylneuraminate-9-phosphatase activity [GO_0050124]
- 3029: N-acyltransferase activity [GO_0016410]
- 3030: N-glycan trimming of Spike [GO_0033919]
- 3031: N-hydroxy-2-acetylaminofluorene + PAPS => 2-acetylaminofluorene-N-sulfate + PAP [GO_0008146]
- 3032: N-methyltransferase activity [GO_0008170]
- 3033: N-succinyltransferase activity [GO_0016749]
- 3034: N6-methyladenosine-containing RNA binding [GO_1990247]
- 3035: NAAA hydrolyses NAEs to FAs and ethanolamine [GO_0016810]
- 3036: NAADP-sensitive calcium-release channel activity [GO_0072345]
- 3037: NAD binding [GO_0051287]
- 3038: NAD transmembrane transport [GO_0035352]
- 3039: NAD transmembrane transporter activity [GO_0051724]
- 3040: NAD transport [GO_0043132]
- 3041: NAD(P)H dehydrogenase (quinone) activity [GO_0003955]
- 3042: NAD+ binding [GO_0070403]
- 3043: NAD+ kinase activity [GO_0003951]
- 3044: NAD+-protein ADP-ribosyltransferase activity [GO_1990404]
- 3045: NAD-dependent histone deacetylase activity [GO_0017136]
- 3046: NAD-independent histone deacetylase activity [GO_0045129]
- 3047: NADH dehydrogenase (quinone) activity [GO_0050136]
- 3048: NADH dehydrogenase activity [GO_0003954]
- 3049: NADP binding [GO_0050661]
- 3050: NADP phosphatase activity [GO_0019178]
- 3051: NADPH phosphatase activity [GO_0102757]
- 3052: NADPH-adrenodoxin reductase activity [GO_0015039]
- 3053: NADSYN1 hexamer amidates NAAD to NAD+ [GO_0003952]
- 3054: narrow pore channel activity [GO_0022842]
- 3055: NAT10 acetylates cytidine-1337 and cytidine-1842 of 18S rRNA yielding 4-acetylcytidine-1377 and 4-acetylcytidine-1842 [GO_0008080]
- 3056: NatC acetylates ARFFRP1 [GO_0004596]
- 3057: NCEH1 hydrolyzes cholesterol esters [GO_0004771]
- 3058: ncRNA metabolic process [GO_0034660]
- 3059: ncRNA processing [GO_0034470]
- 3060: NEDD8 conjugating enzyme activity [GO_0061654]
- 3061: NEDD8 ligase activity [GO_0061663]
- 3062: NEDD8 transferase activity [GO_0019788]
- 3063: negative chemotaxis [GO_0050919]
- 3064: negative energy taxis [GO_0052129]
- 3065: negative gravitaxis [GO_0048060]
- 3066: negative phototaxis [GO_0046957]
- 3067: negative regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043127]
- 3068: negative regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061902]
- 3069: negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090217]
- 3070: negative regulation of acetylcholine secretion, neurotransmission [GO_0014058]
- 3071: negative regulation of acetylcholine-gated cation channel activity [GO_1903049]
- 3072: negative regulation of acid-sensing ion channel activity [GO_1901586]
- 3073: negative regulation of acinar cell proliferation [GO_1904698]
- 3074: negative regulation of aconitate hydratase activity [GO_1904233]
- 3075: negative regulation of actin binding [GO_1904617]
- 3076: negative regulation of actin filament binding [GO_1904530]
- 3077: negative regulation of actin filament bundle assembly [GO_0032232]
- 3078: negative regulation of action potential [GO_0045759]
- 3079: negative regulation of activin receptor signaling pathway [GO_0032926]
- 3080: negative regulation of adenosine receptor signaling pathway [GO_0060169]
- 3081: negative regulation of adenylate cyclase activity [GO_0007194]
- 3082: negative regulation of adipose tissue development [GO_1904178]
- 3083: negative regulation of alkaline phosphatase activity [GO_0010693]
- 3084: negative regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905620]
- 3085: negative regulation of amine transport [GO_0051953]
- 3086: negative regulation of amino acid transport [GO_0051956]
- 3087: negative regulation of aminoacyl-tRNA ligase activity [GO_1903631]
- 3088: negative regulation of amyloid precursor protein catabolic process [GO_1902992]
- 3089: negative regulation of androgen secretion [GO_2000835]
- 3090: negative regulation of angiogenesis [GO_0016525]
- 3091: negative regulation of animal organ morphogenesis [GO_0110111]
- 3092: negative regulation of anion channel activity [GO_0010360]
- 3093: negative regulation of anion transmembrane transport [GO_1903960]
- 3094: negative regulation of anion transport [GO_1903792]
- 3095: negative regulation of aorta morphogenesis [GO_1903848]
- 3096: negative regulation of aortic smooth muscle cell differentiation [GO_1904830]
- 3097: negative regulation of apical ectodermal ridge formation [GO_1905141]
- 3098: negative regulation of apolipoprotein binding [GO_2000657]
- 3099: negative regulation of apoptotic process [GO_0043066]
- 3100: negative regulation of apoptotic process involved in development [GO_1904746]
- 3101: negative regulation of apoptotic process involved in morphogenesis [GO_1902338]
- 3102: negative regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902257]
- 3103: negative regulation of apoptotic signaling pathway [GO_2001234]
- 3104: negative regulation of artery morphogenesis [GO_1905652]
- 3105: negative regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120288]
- 3106: negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902960]
- 3107: negative regulation of aspartic-type peptidase activity [GO_1905246]
- 3108: negative regulation of asymmetric cell division [GO_0045769]
- 3109: negative regulation of ATP biosynthetic process [GO_2001170]
- 3110: negative regulation of ATP citrate synthase activity [GO_2000984]
- 3111: negative regulation of ATP metabolic process [GO_1903579]
- 3112: negative regulation of ATP-dependent activity [GO_0032780]
- 3113: negative regulation of ATP:ADP antiporter activity [GO_0070927]
- 3114: negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901895]
- 3115: negative regulation of AV node cell action potential [GO_1903950]
- 3116: negative regulation of axo-dendritic protein transport [GO_1905127]
- 3117: negative regulation of axon guidance [GO_1902668]
- 3118: negative regulation of axonemal microtubule depolymerization [GO_0007027]
- 3119: negative regulation of axonogenesis [GO_0050771]
- 3120: negative regulation of backward locomotion [GO_1905851]
- 3121: negative regulation of behavior [GO_0048521]
- 3122: negative regulation of beta-galactosidase activity [GO_1903770]
- 3123: negative regulation of bile acid biosynthetic process [GO_0070858]
- 3124: negative regulation of bile acid metabolic process [GO_1904252]
- 3125: negative regulation of bile acid secretion [GO_0120190]
- 3126: negative regulation of binding [GO_0051100]
- 3127: negative regulation of biological process [GO_0048519]
- 3128: negative regulation of biosynthetic process [GO_0009890]
- 3129: negative regulation of bleb assembly [GO_1904171]
- 3130: negative regulation of blood circulation [GO_1903523]
- 3131: negative regulation of blood vessel endothelial cell differentiation [GO_0110059]
- 3132: negative regulation of blood vessel morphogenesis [GO_2000181]
- 3133: negative regulation of BMP signaling pathway [GO_0030514]
- 3134: negative regulation of bone development [GO_1903011]
- 3135: negative regulation of branching involved in lung morphogenesis [GO_0061048]
- 3136: negative regulation of branching morphogenesis of a nerve [GO_2000173]
- 3137: negative regulation of calcium ion binding [GO_1901877]
- 3138: negative regulation of calcium ion transmembrane transport [GO_1903170]
- 3139: negative regulation of calcium ion transmembrane transporter activity [GO_1901020]
- 3140: negative regulation of calcium ion transport [GO_0051926]
- 3141: negative regulation of calcium-dependent ATPase activity [GO_1903611]
- 3142: negative regulation of calcium-mediated signaling [GO_0050849]
- 3143: negative regulation of calcium:sodium antiporter activity [GO_1903280]
- 3144: negative regulation of cAMP-dependent protein kinase activity [GO_2000480]
- 3145: negative regulation of cAMP-mediated signaling [GO_0043951]
- 3146: negative regulation of carbohydrate metabolic process [GO_0045912]
- 3147: negative regulation of cardiac chamber formation [GO_1901211]
- 3148: negative regulation of cardiac chamber morphogenesis [GO_1901220]
- 3149: negative regulation of cardiac conduction [GO_1903780]
- 3150: negative regulation of cardiac muscle adaptation [GO_0010616]
- 3151: negative regulation of cardiac muscle cell apoptotic process [GO_0010667]
- 3152: negative regulation of cardiac muscle cell differentiation [GO_2000726]
- 3153: negative regulation of cardiac muscle cell myoblast differentiation [GO_2000691]
- 3154: negative regulation of cardiac muscle cell proliferation [GO_0060044]
- 3155: negative regulation of cardiac muscle contraction [GO_0055118]
- 3156: negative regulation of cardiac muscle fiber development [GO_0055019]
- 3157: negative regulation of cardiac muscle hypertrophy [GO_0010614]
- 3158: negative regulation of cardiac muscle myoblast proliferation [GO_0110023]
- 3159: negative regulation of cardiac muscle tissue development [GO_0055026]
- 3160: negative regulation of cardiac muscle tissue growth [GO_0055022]
- 3161: negative regulation of cardiac myofibril assembly [GO_1905305]
- 3162: negative regulation of cardiac ventricle development [GO_1904413]
- 3163: negative regulation of cardiac ventricle formation [GO_1904943]
- 3164: negative regulation of cardioblast differentiation [GO_0051892]
- 3165: negative regulation of cardiocyte differentiation [GO_1905208]
- 3166: negative regulation of cartilage development [GO_0061037]
- 3167: negative regulation of catabolic process [GO_0009895]
- 3168: negative regulation of catalase activity [GO_1902552]
- 3169: negative regulation of catalytic activity [GO_0043086]
- 3170: negative regulation of catecholamine metabolic process [GO_0045914]
- 3171: negative regulation of catecholamine secretion [GO_0033604]
- 3172: negative regulation of cation channel activity [GO_2001258]
- 3173: negative regulation of cation transmembrane transport [GO_1904063]
- 3174: negative regulation of CD4 production [GO_0045225]
- 3175: negative regulation of cell adhesion [GO_0007162]
- 3176: negative regulation of cell communication [GO_0010648]
- 3177: negative regulation of cell cycle [GO_0045786]
- 3178: negative regulation of cell cycle process [GO_0010948]
- 3179: negative regulation of cell death [GO_0060548]
- 3180: negative regulation of cell development [GO_0010721]
- 3181: negative regulation of cell differentiation [GO_0045596]
- 3182: negative regulation of cell differentiation involved in embryonic placenta development [GO_0060806]
- 3183: negative regulation of cell division [GO_0051782]
- 3184: negative regulation of cell fate commitment [GO_0010454]
- 3185: negative regulation of cell growth [GO_0030308]
- 3186: negative regulation of cell growth involved in cardiac muscle cell development [GO_0061052]
- 3187: negative regulation of cell junction assembly [GO_1901889]
- 3188: negative regulation of cell maturation [GO_1903430]
- 3189: negative regulation of cell migration [GO_0030336]
- 3190: negative regulation of cell morphogenesis involved in differentiation [GO_0010771]
- 3191: negative regulation of cell motility [GO_2000146]
- 3192: negative regulation of cell population proliferation [GO_0008285]
- 3193: negative regulation of cell projection organization [GO_0031345]
- 3194: negative regulation of cell proliferation in midbrain [GO_1904934]
- 3195: negative regulation of cell proliferation involved in compound eye morphogenesis [GO_2000496]
- 3196: negative regulation of cell proliferation involved in heart morphogenesis [GO_2000137]
- 3197: negative regulation of cell-cell adhesion [GO_0022408]
- 3198: negative regulation of cellular amide metabolic process [GO_0034249]
- 3199: negative regulation of cellular amine catabolic process [GO_0033242]
- 3200: negative regulation of cellular amine metabolic process [GO_0033239]
- 3201: negative regulation of cellular amino acid biosynthetic process [GO_2000283]
- 3202: negative regulation of cellular amino acid metabolic process [GO_0045763]
- 3203: negative regulation of cellular biosynthetic process [GO_0031327]
- 3204: negative regulation of cellular carbohydrate metabolic process [GO_0010677]
- 3205: negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated [GO_0010678]
- 3206: negative regulation of cellular catabolic process [GO_0031330]
- 3207: negative regulation of cellular component movement [GO_0051271]
- 3208: negative regulation of cellular component organization [GO_0051129]
- 3209: negative regulation of cellular macromolecule biosynthetic process [GO_2000113]
- 3210: negative regulation of cellular metabolic process [GO_0031324]
- 3211: negative regulation of cellular process [GO_0048523]
- 3212: negative regulation of cellular protein metabolic process [GO_0032269]
- 3213: negative regulation of cellular respiration [GO_1901856]
- 3214: negative regulation of cellular response to alcohol [GO_1905958]
- 3215: negative regulation of cellular response to caffeine [GO_1901181]
- 3216: negative regulation of cellular response to drug [GO_2001039]
- 3217: negative regulation of cellular response to growth factor stimulus [GO_0090288]
- 3218: negative regulation of cellular response to insulin stimulus [GO_1900077]
- 3219: negative regulation of cellular response to oxidative stress [GO_1900408]
- 3220: negative regulation of chemokine activity [GO_1900137]
- 3221: negative regulation of chemorepellent activity [GO_1903668]
- 3222: negative regulation of chemotaxis [GO_0050922]
- 3223: negative regulation of chloride transport [GO_2001226]
- 3224: negative regulation of cholangiocyte apoptotic process [GO_1904193]
- 3225: negative regulation of cholangiocyte proliferation [GO_1904055]
- 3226: negative regulation of cholesterol transporter activity [GO_0060695]
- 3227: negative regulation of chondrocyte development [GO_0061182]
- 3228: negative regulation of chondrocyte differentiation [GO_0032331]
- 3229: negative regulation of chorionic trophoblast cell proliferation [GO_1901383]
- 3230: negative regulation of chromatin assembly or disassembly [GO_0045798]
- 3231: negative regulation of chromatin binding [GO_0035562]
- 3232: negative regulation of chromatin organization [GO_1905268]
- 3233: negative regulation of chromosome condensation [GO_1902340]
- 3234: negative regulation of chromosome organization [GO_2001251]
- 3235: negative regulation of chromosome segregation [GO_0051985]
- 3236: negative regulation of cilium assembly [GO_1902018]
- 3237: negative regulation of circadian rhythm [GO_0042754]
- 3238: negative regulation of circadian sleep/wake cycle, sleep [GO_0042321]
- 3239: negative regulation of CoA-transferase activity [GO_1905919]
- 3240: negative regulation of collagen binding [GO_0033342]
- 3241: negative regulation of collagen biosynthetic process [GO_0032966]
- 3242: negative regulation of collagen catabolic process [GO_0010711]
- 3243: negative regulation of collagen fibril organization [GO_1904027]
- 3244: negative regulation of collagen metabolic process [GO_0010713]
- 3245: negative regulation of colon smooth muscle contraction [GO_1904342]
- 3246: negative regulation of compound eye photoreceptor cell differentiation [GO_0110118]
- 3247: negative regulation of compound eye retinal cell apoptotic process [GO_1901693]
- 3248: negative regulation of compound eye retinal cell programmed cell death [GO_0046673]
- 3249: negative regulation of copper ion transmembrane transport [GO_1902312]
- 3250: negative regulation of core promoter binding [GO_1904797]
- 3251: negative regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060728]
- 3252: negative regulation of cyclase activity [GO_0031280]
- 3253: negative regulation of cyclic nucleotide-gated ion channel activity [GO_1902160]
- 3254: negative regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051344]
- 3255: negative regulation of cyclin-dependent protein kinase activity [GO_1904030]
- 3256: negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045736]
- 3257: negative regulation of cystathionine beta-synthase activity [GO_1904042]
- 3258: negative regulation of cysteine-type endopeptidase activity [GO_2000117]
- 3259: negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043154]
- 3260: negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001271]
- 3261: negative regulation of cytochrome-c oxidase activity [GO_1905376]
- 3262: negative regulation of cytokine activity [GO_0060302]
- 3263: negative regulation of cytokine-mediated signaling pathway [GO_0001960]
- 3264: negative regulation of cytokinesis [GO_0032466]
- 3265: negative regulation of cytoskeleton organization [GO_0051494]
- 3266: negative regulation of D-amino-acid oxidase activity [GO_1900758]
- 3267: negative regulation of deacetylase activity [GO_0150066]
- 3268: negative regulation of defecation [GO_2000293]
- 3269: negative regulation of delayed rectifier potassium channel activity [GO_1902260]
- 3270: negative regulation of deoxyribonuclease activity [GO_0032076]
- 3271: negative regulation of dephosphorylation [GO_0035305]
- 3272: negative regulation of dermatome development [GO_0061185]
- 3273: negative regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905788]
- 3274: negative regulation of developmental growth [GO_0048640]
- 3275: negative regulation of developmental pigmentation [GO_0048086]
- 3276: negative regulation of developmental process [GO_0051093]
- 3277: negative regulation of diacylglycerol kinase activity [GO_1905688]
- 3278: negative regulation of digestive system process [GO_0060457]
- 3279: negative regulation of dipeptide transmembrane transport [GO_2001149]
- 3280: negative regulation of dipeptide transport [GO_2000879]
- 3281: negative regulation of DNA binding [GO_0043392]
- 3282: negative regulation of DNA biosynthetic process [GO_2000279]
- 3283: negative regulation of DNA duplex unwinding [GO_1905463]
- 3284: negative regulation of DNA helicase activity [GO_1905775]
- 3285: negative regulation of DNA metabolic process [GO_0051053]
- 3286: negative regulation of DNA N-glycosylase activity [GO_1902545]
- 3287: negative regulation of DNA repair [GO_0045738]
- 3288: negative regulation of DNA replication [GO_0008156]
- 3289: negative regulation of DNA replication origin binding [GO_1902596]
- 3290: negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000372]
- 3291: negative regulation of DNA-binding transcription factor activity [GO_0043433]
- 3292: negative regulation of DNA-directed DNA polymerase activity [GO_1900263]
- 3293: negative regulation of DNA-templated DNA replication [GO_2000104]
- 3294: negative regulation of DNA-templated transcription [GO_0045892]
- 3295: negative regulation of dopamine receptor signaling pathway [GO_0060160]
- 3296: negative regulation of dopamine secretion [GO_0033602]
- 3297: negative regulation of double-stranded telomeric DNA binding [GO_1905768]
- 3298: negative regulation of dUTP diphosphatase activity [GO_1903628]
- 3299: negative regulation of eclosion [GO_0045804]
- 3300: negative regulation of ectoderm development [GO_2000384]
- 3301: negative regulation of electron transfer activity [GO_1904733]
- 3302: negative regulation of embryonic camera-type eye development [GO_1902864]
- 3303: negative regulation of embryonic development [GO_0045992]
- 3304: negative regulation of endocytosis [GO_0045806]
- 3305: negative regulation of endodeoxyribonuclease activity [GO_0032078]
- 3306: negative regulation of endodermal cell differentiation [GO_1903225]
- 3307: negative regulation of endopeptidase activity [GO_0010951]
- 3308: negative regulation of endoribonuclease activity [GO_0060702]
- 3309: negative regulation of endothelial cell apoptotic process [GO_2000352]
- 3310: negative regulation of endothelial cell development [GO_1901551]
- 3311: negative regulation of endothelial cell differentiation [GO_0045602]
- 3312: negative regulation of endothelial cell proliferation [GO_0001937]
- 3313: negative regulation of endothelial tube morphogenesis [GO_1905955]
- 3314: negative regulation of entry into reproductive diapause [GO_0061964]
- 3315: negative regulation of ephrin receptor signaling pathway [GO_1901188]
- 3316: negative regulation of epidermal cell differentiation [GO_0045605]
- 3317: negative regulation of epidermal growth factor receptor signaling pathway [GO_0042059]
- 3318: negative regulation of epidermal growth factor-activated receptor activity [GO_0007175]
- 3319: negative regulation of epidermis development [GO_0045683]
- 3320: negative regulation of epithelial cell apoptotic process [GO_1904036]
- 3321: negative regulation of epithelial cell differentiation [GO_0030857]
- 3322: negative regulation of epithelial cell proliferation [GO_0050680]
- 3323: negative regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000795]
- 3324: negative regulation of epithelial to mesenchymal transition [GO_0010719]
- 3325: negative regulation of epithelial tube formation [GO_1905277]
- 3326: negative regulation of ERBB signaling pathway [GO_1901185]
- 3327: negative regulation of erythrocyte apoptotic process [GO_1902251]
- 3328: negative regulation of erythrocyte differentiation [GO_0045647]
- 3329: negative regulation of establishment of protein localization [GO_1904950]
- 3330: negative regulation of establishment or maintenance of neuroblast polarity [GO_2000248]
- 3331: negative regulation of euchromatin binding [GO_1904794]
- 3332: negative regulation of excitatory postsynaptic potential [GO_0090394]
- 3333: negative regulation of execution phase of apoptosis [GO_1900118]
- 3334: negative regulation of exocytosis [GO_0045920]
- 3335: negative regulation of exodeoxyribonuclease activity [GO_1902393]
- 3336: negative regulation of exonuclease activity [GO_1905778]
- 3337: negative regulation of exoribonuclease activity [GO_1901918]
- 3338: negative regulation of exosomal secretion [GO_1903542]
- 3339: negative regulation of extracellular exosome assembly [GO_1903552]
- 3340: negative regulation of extracellular matrix assembly [GO_1901202]
- 3341: negative regulation of extracellular matrix disassembly [GO_0010716]
- 3342: negative regulation of extracellular matrix organization [GO_1903054]
- 3343: negative regulation of eye photoreceptor cell development [GO_0042480]
- 3344: negative regulation of fat cell apoptotic process [GO_1904650]
- 3345: negative regulation of fat cell differentiation [GO_0045599]
- 3346: negative regulation of fat cell proliferation [GO_0070345]
- 3347: negative regulation of fatty acid biosynthetic process [GO_0045717]
- 3348: negative regulation of fatty acid metabolic process [GO_0045922]
- 3349: negative regulation of fatty acid transport [GO_2000192]
- 3350: negative regulation of feeding behavior [GO_2000252]
- 3351: negative regulation of female gonad development [GO_2000195]
- 3352: negative regulation of ferrous iron binding [GO_1904433]
- 3353: negative regulation of fertilization [GO_0060467]
- 3354: negative regulation of fibroblast apoptotic process [GO_2000270]
- 3355: negative regulation of fibroblast growth factor receptor signaling pathway [GO_0040037]
- 3356: negative regulation of fibroblast proliferation [GO_0048147]
- 3357: negative regulation of formation of translation initiation ternary complex [GO_1901191]
- 3358: negative regulation of forward locomotion [GO_1905849]
- 3359: negative regulation of G protein-coupled receptor signaling pathway [GO_0045744]
- 3360: negative regulation of G-quadruplex DNA binding [GO_1905494]
- 3361: negative regulation of GABA-A receptor activity [GO_0106042]
- 3362: negative regulation of gamma-aminobutyric acid secretion [GO_0014053]
- 3363: negative regulation of gastric acid secretion [GO_0060455]
- 3364: negative regulation of gastric mucosal blood circulation [GO_1904345]
- 3365: negative regulation of gastro-intestinal system smooth muscle contraction [GO_1904305]
- 3366: negative regulation of gastrulation [GO_2000542]
- 3367: negative regulation of gene expression [GO_0010629]
- 3368: negative regulation of gene expression, epigenetic [GO_0045814]
- 3369: negative regulation of gene silencing by RNA [GO_0060967]
- 3370: negative regulation of germ cell proliferation [GO_1905937]
- 3371: negative regulation of glial cell apoptotic process [GO_0034351]
- 3372: negative regulation of glial cell differentiation [GO_0045686]
- 3373: negative regulation of glial cell proliferation [GO_0060253]
- 3374: negative regulation of gliogenesis [GO_0014014]
- 3375: negative regulation of glucagon secretion [GO_0070093]
- 3376: negative regulation of glucokinase activity [GO_0033132]
- 3377: negative regulation of gluconeogenesis [GO_0045721]
- 3378: negative regulation of glucose transmembrane transport [GO_0010829]
- 3379: negative regulation of glucosylceramidase activity [GO_1905124]
- 3380: negative regulation of glucuronosyltransferase activity [GO_1904224]
- 3381: negative regulation of glutamate receptor signaling pathway [GO_1900450]
- 3382: negative regulation of glutamate secretion [GO_0014050]
- 3383: negative regulation of glutamate secretion, neurotransmission [GO_1903295]
- 3384: negative regulation of glutamate-ammonia ligase activity [GO_1905479]
- 3385: negative regulation of glutamate-cysteine ligase activity [GO_0035228]
- 3386: negative regulation of glutathione biosynthetic process [GO_1903787]
- 3387: negative regulation of glutathione peroxidase activity [GO_1903283]
- 3388: negative regulation of glycine secretion, neurotransmission [GO_1904625]
- 3389: negative regulation of glycogen (starch) synthase activity [GO_2000466]
- 3390: negative regulation of glycogen biosynthetic process [GO_0045719]
- 3391: negative regulation of glycogen catabolic process [GO_0045818]
- 3392: negative regulation of glycogen metabolic process [GO_0070874]
- 3393: negative regulation of glycolytic process [GO_0045820]
- 3394: negative regulation of glycolytic process through fructose-6-phosphate [GO_1904539]
- 3395: negative regulation of glycoprotein biosynthetic process [GO_0010561]
- 3396: negative regulation of glycoprotein metabolic process [GO_1903019]
- 3397: negative regulation of Golgi to plasma membrane protein transport [GO_0042997]
- 3398: negative regulation of gonad development [GO_1905940]
- 3399: negative regulation of growth [GO_0045926]
- 3400: negative regulation of GTP binding [GO_1904425]
- 3401: negative regulation of GTP cyclohydrolase I activity [GO_0043105]
- 3402: negative regulation of GTPase activity [GO_0034260]
- 3403: negative regulation of guanyl-nucleotide exchange factor activity [GO_1905098]
- 3404: negative regulation of guanylate cyclase activity [GO_0031283]
- 3405: negative regulation of heart contraction [GO_0045822]
- 3406: negative regulation of heart growth [GO_0061117]
- 3407: negative regulation of helicase activity [GO_0051097]
- 3408: negative regulation of hematopoietic progenitor cell differentiation [GO_1901533]
- 3409: negative regulation of hematopoietic stem cell differentiation [GO_1902037]
- 3410: negative regulation of hematopoietic stem cell proliferation [GO_1902034]
- 3411: negative regulation of heme oxygenase activity [GO_0061962]
- 3412: negative regulation of hemopoiesis [GO_1903707]
- 3413: negative regulation of heparan sulfate proteoglycan binding [GO_1905859]
- 3414: negative regulation of hepatocyte apoptotic process [GO_1903944]
- 3415: negative regulation of hepatocyte differentiation [GO_0070367]
- 3416: negative regulation of heterochromatin assembly [GO_0031452]
- 3417: negative regulation of heterochromatin organization [GO_0120262]
- 3418: negative regulation of hexokinase activity [GO_1903300]
- 3419: negative regulation of high voltage-gated calcium channel activity [GO_1901842]
- 3420: negative regulation of hindgut contraction [GO_0060451]
- 3421: negative regulation of histone deacetylase activity [GO_1901726]
- 3422: negative regulation of histone deacetylation [GO_0031064]
- 3423: negative regulation of histone demethylase activity (H3-K4 specific) [GO_1904174]
- 3424: negative regulation of histone modification [GO_0031057]
- 3425: negative regulation of hormone metabolic process [GO_0032351]
- 3426: negative regulation of hormone secretion [GO_0046888]
- 3427: negative regulation of hyaluronan biosynthetic process [GO_1900126]
- 3428: negative regulation of hydrolase activity [GO_0051346]
- 3429: negative regulation of immune effector process [GO_0002698]
- 3430: negative regulation of immune response [GO_0050777]
- 3431: negative regulation of immune system process [GO_0002683]
- 3432: negative regulation of inorganic anion transmembrane transport [GO_1903796]
- 3433: negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031586]
- 3434: negative regulation of insulin receptor signaling pathway [GO_0046627]
- 3435: negative regulation of insulin secretion [GO_0046676]
- 3436: negative regulation of intestinal absorption [GO_1904479]
- 3437: negative regulation of intestinal epithelial cell development [GO_1905299]
- 3438: negative regulation of intracellular calcium activated chloride channel activity [GO_1902939]
- 3439: negative regulation of intracellular lipid transport [GO_0032378]
- 3440: negative regulation of intracellular protein transport [GO_0090317]
- 3441: negative regulation of intracellular signal transduction [GO_1902532]
- 3442: negative regulation of intracellular sterol transport [GO_0032381]
- 3443: negative regulation of intracellular transport [GO_0032387]
- 3444: negative regulation of inward rectifier potassium channel activity [GO_1903609]
- 3445: negative regulation of ion transmembrane transport [GO_0034766]
- 3446: negative regulation of ion transmembrane transporter activity [GO_0032413]
- 3447: negative regulation of ion transport [GO_0043271]
- 3448: negative regulation of iron ion transmembrane transport [GO_0034760]
- 3449: negative regulation of iron ion transmembrane transporter activity [GO_1904255]
- 3450: negative regulation of iron ion transport [GO_0034757]
- 3451: negative regulation of isoprenoid metabolic process [GO_0045827]
- 3452: negative regulation of JNK cascade [GO_0046329]
- 3453: negative regulation of JUN kinase activity [GO_0043508]
- 3454: negative regulation of kinase activity [GO_0033673]
- 3455: negative regulation of L-dopa decarboxylase activity [GO_1903199]
- 3456: negative regulation of large conductance calcium-activated potassium channel activity [GO_1902607]
- 3457: negative regulation of leukocyte apoptotic process [GO_2000107]
- 3458: negative regulation of leukocyte differentiation [GO_1902106]
- 3459: negative regulation of leukocyte mediated immunity [GO_0002704]
- 3460: negative regulation of leukocyte proliferation [GO_0070664]
- 3461: negative regulation of ligase activity [GO_0051352]
- 3462: negative regulation of light-activated channel activity [GO_0045831]
- 3463: negative regulation of lipase activity [GO_0060192]
- 3464: negative regulation of lipid binding [GO_1900131]
- 3465: negative regulation of lipid biosynthetic process [GO_0051055]
- 3466: negative regulation of lipid catabolic process [GO_0050995]
- 3467: negative regulation of lipid kinase activity [GO_0090219]
- 3468: negative regulation of lipid localization [GO_1905953]
- 3469: negative regulation of lipid metabolic process [GO_0045833]
- 3470: negative regulation of lipid storage [GO_0010888]
- 3471: negative regulation of lipid transport [GO_0032369]
- 3472: negative regulation of lipid transporter activity [GO_0110114]
- 3473: negative regulation of lipopolysaccharide-mediated signaling pathway [GO_0031665]
- 3474: negative regulation of lipoprotein lipase activity [GO_0051005]
- 3475: negative regulation of locomotion [GO_0040013]
- 3476: negative regulation of locomotion involved in locomotory behavior [GO_0090327]
- 3477: negative regulation of locomotor rhythm [GO_1904060]
- 3478: negative regulation of low-density lipoprotein particle receptor binding [GO_1905596]
- 3479: negative regulation of low-density lipoprotein receptor activity [GO_1905598]
- 3480: negative regulation of lung ciliated cell differentiation [GO_1901247]
- 3481: negative regulation of lyase activity [GO_0051350]
- 3482: negative regulation of lysozyme activity [GO_1903591]
- 3483: negative regulation of macromolecule biosynthetic process [GO_0010558]
- 3484: negative regulation of macromolecule metabolic process [GO_0010605]
- 3485: negative regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903219]
- 3486: negative regulation of male mating behavior [GO_1902436]
- 3487: negative regulation of MAP kinase activity [GO_0043407]
- 3488: negative regulation of MAPK cascade [GO_0043409]
- 3489: negative regulation of megakaryocyte differentiation [GO_0045653]
- 3490: negative regulation of meiotic cell cycle [GO_0051447]
- 3491: negative regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904145]
- 3492: negative regulation of meiotic nuclear division [GO_0045835]
- 3493: negative regulation of membrane invagination [GO_1905154]
- 3494: negative regulation of mesenchymal cell apoptotic process [GO_2001054]
- 3495: negative regulation of mesenchymal cell proliferation [GO_0072201]
- 3496: negative regulation of mesenchymal cell proliferation involved in lung development [GO_2000791]
- 3497: negative regulation of mesoderm development [GO_2000381]
- 3498: negative regulation of mesoderm formation [GO_1905903]
- 3499: negative regulation of mesodermal cell differentiation [GO_1905771]
- 3500: negative regulation of metabolic process [GO_0009892]
- 3501: negative regulation of metalloendopeptidase activity [GO_1904684]
- 3502: negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902963]
- 3503: negative regulation of metallopeptidase activity [GO_1905049]
- 3504: negative regulation of methionine-tRNA ligase activity [GO_1905019]
- 3505: negative regulation of microtubule binding [GO_1904527]
- 3506: negative regulation of microtubule depolymerization [GO_0007026]
- 3507: negative regulation of microtubule nucleation [GO_1905833]
- 3508: negative regulation of microtubule plus-end binding [GO_1903032]
- 3509: negative regulation of microtubule polymerization [GO_0031115]
- 3510: negative regulation of microtubule polymerization or depolymerization [GO_0031111]
- 3511: negative regulation of microvillus assembly [GO_1903697]
- 3512: negative regulation of miRNA-mediated gene silencing [GO_0060965]
- 3513: negative regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905707]
- 3514: negative regulation of mitochondrial DNA metabolic process [GO_1901859]
- 3515: negative regulation of mitochondrial DNA replication [GO_0090298]
- 3516: negative regulation of mitochondrial mRNA catabolic process [GO_1905638]
- 3517: negative regulation of mitochondrial RNA catabolic process [GO_0000961]
- 3518: negative regulation of mitochondrial translation [GO_0070130]
- 3519: negative regulation of mitochondrial translational elongation [GO_1905083]
- 3520: negative regulation of mitochondrial translational initiation [GO_0070133]
- 3521: negative regulation of mitochondrion organization [GO_0010823]
- 3522: negative regulation of mitotic cell cycle [GO_0045930]
- 3523: negative regulation of mitotic cell cycle DNA replication [GO_1903464]
- 3524: negative regulation of mitotic cell cycle, embryonic [GO_0045976]
- 3525: negative regulation of mitotic chromosome condensation [GO_1905213]
- 3526: negative regulation of mitotic nuclear division [GO_0045839]
- 3527: negative regulation of mitotic nuclear envelope disassembly [GO_1905558]
- 3528: negative regulation of mitotic sister chromatid segregation [GO_0033048]
- 3529: negative regulation of molecular function [GO_0044092]
- 3530: negative regulation of mononuclear cell proliferation [GO_0032945]
- 3531: negative regulation of monooxygenase activity [GO_0032769]
- 3532: negative regulation of morphogenesis of an epithelium [GO_1905331]
- 3533: negative regulation of motor neuron apoptotic process [GO_2000672]
- 3534: negative regulation of mRNA 3'-UTR binding [GO_1903838]
- 3535: negative regulation of mRNA binding [GO_1904572]
- 3536: negative regulation of mRNA catabolic process [GO_1902373]
- 3537: negative regulation of mRNA metabolic process [GO_1903312]
- 3538: negative regulation of mucus secretion [GO_0070256]
- 3539: negative regulation of multicellular organism growth [GO_0040015]
- 3540: negative regulation of multicellular organismal process [GO_0051241]
- 3541: negative regulation of muscle adaptation [GO_0014745]
- 3542: negative regulation of muscle cell apoptotic process [GO_0010656]
- 3543: negative regulation of muscle cell differentiation [GO_0051148]
- 3544: negative regulation of muscle contraction [GO_0045932]
- 3545: negative regulation of muscle hypertrophy [GO_0014741]
- 3546: negative regulation of muscle organ development [GO_0048635]
- 3547: negative regulation of muscle tissue development [GO_1901862]
- 3548: negative regulation of myeloid cell apoptotic process [GO_0033033]
- 3549: negative regulation of myeloid cell differentiation [GO_0045638]
- 3550: negative regulation of myeloid leukocyte differentiation [GO_0002762]
- 3551: negative regulation of myeloid leukocyte mediated immunity [GO_0002887]
- 3552: negative regulation of myeloid progenitor cell differentiation [GO_1905454]
- 3553: negative regulation of myoblast differentiation [GO_0045662]
- 3554: negative regulation of myoblast proliferation [GO_2000818]
- 3555: negative regulation of myosin light chain kinase activity [GO_0035506]
- 3556: negative regulation of myotube differentiation [GO_0010832]
- 3557: negative regulation of NAD+ ADP-ribosyltransferase activity [GO_1901665]
- 3558: negative regulation of NAD+ kinase activity [GO_0033671]
- 3559: negative regulation of negative chemotaxis [GO_0050925]
- 3560: negative regulation of nervous system development [GO_0051961]
- 3561: negative regulation of nervous system process [GO_0031645]
- 3562: negative regulation of netrin-activated signaling pathway [GO_1902842]
- 3563: negative regulation of neural crest cell differentiation [GO_1905293]
- 3564: negative regulation of neural crest formation [GO_0090301]
- 3565: negative regulation of neural precursor cell proliferation [GO_2000178]
- 3566: negative regulation of neural retina development [GO_0061076]
- 3567: negative regulation of neuroblast proliferation [GO_0007406]
- 3568: negative regulation of neurogenesis [GO_0050768]
- 3569: negative regulation of neuromuscular junction development [GO_1904397]
- 3570: negative regulation of neuron apoptotic process [GO_0043524]
- 3571: negative regulation of neuron death [GO_1901215]
- 3572: negative regulation of neuron differentiation [GO_0045665]
- 3573: negative regulation of neuron maturation [GO_0014043]
- 3574: negative regulation of neuron projection development [GO_0010977]
- 3575: negative regulation of neuronal action potential [GO_1904456]
- 3576: negative regulation of neurotransmitter secretion [GO_0046929]
- 3577: negative regulation of neurotransmitter transport [GO_0051589]
- 3578: negative regulation of neurotransmitter uptake [GO_0051581]
- 3579: negative regulation of nitric-oxide synthase activity [GO_0051001]
- 3580: negative regulation of nitrogen compound metabolic process [GO_0051172]
- 3581: negative regulation of NMDA glutamate receptor activity [GO_1904782]
- 3582: negative regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903996]
- 3583: negative regulation of norepinephrine secretion [GO_0010700]
- 3584: negative regulation of norepinephrine uptake [GO_0051622]
- 3585: negative regulation of nuclear cell cycle DNA replication [GO_1902576]
- 3586: negative regulation of nuclear division [GO_0051784]
- 3587: negative regulation of nuclear migration along microtubule [GO_1902839]
- 3588: negative regulation of nuclease activity [GO_0032074]
- 3589: negative regulation of nucleic acid-templated transcription [GO_1903507]
- 3590: negative regulation of nucleobase-containing compound metabolic process [GO_0045934]
- 3591: negative regulation of nucleobase-containing compound transport [GO_0032240]
- 3592: negative regulation of nucleocytoplasmic transport [GO_0046823]
- 3593: negative regulation of nucleoside metabolic process [GO_0045978]
- 3594: negative regulation of nucleoside transport [GO_0032243]
- 3595: negative regulation of nucleotide biosynthetic process [GO_0030809]
- 3596: negative regulation of nucleotide metabolic process [GO_0045980]
- 3597: negative regulation of oligopeptide transport [GO_2000877]
- 3598: negative regulation of oocyte development [GO_0060283]
- 3599: negative regulation of oocyte maturation [GO_1900194]
- 3600: negative regulation of oogenesis [GO_1905880]
- 3601: negative regulation of organ growth [GO_0046621]
- 3602: negative regulation of organelle assembly [GO_1902116]
- 3603: negative regulation of organelle organization [GO_0010639]
- 3604: negative regulation of organic acid transport [GO_0032891]
- 3605: negative regulation of ossification [GO_0030279]
- 3606: negative regulation of oviposition [GO_1901045]
- 3607: negative regulation of oxidative phosphorylation [GO_0090324]
- 3608: negative regulation of oxidoreductase activity [GO_0051354]
- 3609: negative regulation of oxygen metabolic process [GO_2000375]
- 3610: negative regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903407]
- 3611: negative regulation of pancreatic A cell differentiation [GO_2000227]
- 3612: negative regulation of peptidase activity [GO_0010466]
- 3613: negative regulation of peptide hormone secretion [GO_0090278]
- 3614: negative regulation of peptide secretion [GO_0002792]
- 3615: negative regulation of peptidyl-tyrosine phosphorylation [GO_0050732]
- 3616: negative regulation of peroxidase activity [GO_2000469]
- 3617: negative regulation of pharynx morphogenesis [GO_0110042]
- 3618: negative regulation of phosphatase activity [GO_0010923]
- 3619: negative regulation of phosphate metabolic process [GO_0045936]
- 3620: negative regulation of phosphate transmembrane transport [GO_2000186]
- 3621: negative regulation of phosphatidate phosphatase activity [GO_1903741]
- 3622: negative regulation of phosphatidylcholine biosynthetic process [GO_2001246]
- 3623: negative regulation of phosphatidylcholine metabolic process [GO_0150174]
- 3624: negative regulation of phosphatidylinositol 3-kinase activity [GO_0043553]
- 3625: negative regulation of phosphatidylinositol biosynthetic process [GO_0010512]
- 3626: negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120140]
- 3627: negative regulation of phospholipase A2 activity [GO_1900138]
- 3628: negative regulation of phospholipase activity [GO_0010519]
- 3629: negative regulation of phospholipase C activity [GO_1900275]
- 3630: negative regulation of phospholipase D activity [GO_1904006]
- 3631: negative regulation of phospholipid biosynthetic process [GO_0071072]
- 3632: negative regulation of phospholipid metabolic process [GO_1903726]
- 3633: negative regulation of phospholipid scramblase activity [GO_1900162]
- 3634: negative regulation of phospholipid translocation [GO_0061093]
- 3635: negative regulation of phospholipid transport [GO_2001139]
- 3636: negative regulation of phosphoprotein phosphatase activity [GO_0032515]
- 3637: negative regulation of phosphorus metabolic process [GO_0010563]
- 3638: negative regulation of phosphorylation [GO_0042326]
- 3639: negative regulation of photoreceptor cell differentiation [GO_0046533]
- 3640: negative regulation of pigment cell differentiation [GO_0050941]
- 3641: negative regulation of placenta blood vessel development [GO_0110081]
- 3642: negative regulation of plasma membrane bounded cell projection assembly [GO_0120033]
- 3643: negative regulation of poly(A)-specific ribonuclease activity [GO_0106247]
- 3644: negative regulation of polyamine transmembrane transport [GO_1902268]
- 3645: negative regulation of polynucleotide adenylyltransferase activity [GO_1904246]
- 3646: negative regulation of polysome binding [GO_1905697]
- 3647: negative regulation of positive chemotaxis [GO_0050928]
- 3648: negative regulation of post-embryonic development [GO_0048581]
- 3649: negative regulation of post-transcriptional gene silencing [GO_0060149]
- 3650: negative regulation of post-transcriptional gene silencing by RNA [GO_1900369]
- 3651: negative regulation of potassium ion transmembrane transport [GO_1901380]
- 3652: negative regulation of potassium ion transmembrane transporter activity [GO_1901017]
- 3653: negative regulation of potassium ion transport [GO_0043267]
- 3654: negative regulation of presynapse assembly [GO_1905607]
- 3655: negative regulation of primary amine oxidase activity [GO_1902283]
- 3656: negative regulation of programmed cell death [GO_0043069]
- 3657: negative regulation of prostaglandin-E synthase activity [GO_2000362]
- 3658: negative regulation of proteasomal protein catabolic process [GO_1901799]
- 3659: negative regulation of protein ADP-ribosylation [GO_0010836]
- 3660: negative regulation of protein binding [GO_0032091]
- 3661: negative regulation of protein catabolic process [GO_0042177]
- 3662: negative regulation of protein catabolic process in the vacuole [GO_1904351]
- 3663: negative regulation of protein dephosphorylation [GO_0035308]
- 3664: negative regulation of protein depolymerization [GO_1901880]
- 3665: negative regulation of protein deubiquitination [GO_0090086]
- 3666: negative regulation of protein folding [GO_1903333]
- 3667: negative regulation of protein homodimerization activity [GO_0090074]
- 3668: negative regulation of protein K48-linked deubiquitination [GO_1903094]
- 3669: negative regulation of protein K63-linked deubiquitination [GO_1903005]
- 3670: negative regulation of protein kinase activity [GO_0006469]
- 3671: negative regulation of protein localization [GO_1903828]
- 3672: negative regulation of protein localization to cell cortex [GO_1904777]
- 3673: negative regulation of protein localization to cell leading edge [GO_1905872]
- 3674: negative regulation of protein localization to cell periphery [GO_1904376]
- 3675: negative regulation of protein localization to cell-cell junction [GO_0150119]
- 3676: negative regulation of protein localization to chromatin [GO_0120186]
- 3677: negative regulation of protein localization to ciliary membrane [GO_1903568]
- 3678: negative regulation of protein localization to cilium [GO_1903565]
- 3679: negative regulation of protein localization to membrane [GO_1905476]
- 3680: negative regulation of protein localization to microtubule [GO_1902817]
- 3681: negative regulation of protein localization to nucleolus [GO_1904750]
- 3682: negative regulation of protein localization to nucleus [GO_1900181]
- 3683: negative regulation of protein localization to plasma membrane [GO_1903077]
- 3684: negative regulation of protein localization to presynapse [GO_1905385]
- 3685: negative regulation of protein metabolic process [GO_0051248]
- 3686: negative regulation of protein modification by small protein conjugation or removal [GO_1903321]
- 3687: negative regulation of protein modification process [GO_0031400]
- 3688: negative regulation of protein phosphorylation [GO_0001933]
- 3689: negative regulation of protein polymerization [GO_0032272]
- 3690: negative regulation of protein secretion [GO_0050709]
- 3691: negative regulation of protein serine/threonine kinase activity [GO_0071901]
- 3692: negative regulation of protein serine/threonine phosphatase activity [GO_1905183]
- 3693: negative regulation of protein sumoylation [GO_0033234]
- 3694: negative regulation of protein transport [GO_0051224]
- 3695: negative regulation of protein tyrosine kinase activity [GO_0061099]
- 3696: negative regulation of protein tyrosine phosphatase activity [GO_1903614]
- 3697: negative regulation of protein ubiquitination [GO_0031397]
- 3698: negative regulation of protein-containing complex assembly [GO_0031333]
- 3699: negative regulation of protein-containing complex disassembly [GO_0043242]
- 3700: negative regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150075]
- 3701: negative regulation of proteolysis [GO_0045861]
- 3702: negative regulation of proteolysis involved in protein catabolic process [GO_1903051]
- 3703: negative regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905272]
- 3704: negative regulation of purine nucleotide biosynthetic process [GO_1900372]
- 3705: negative regulation of purine nucleotide metabolic process [GO_1900543]
- 3706: negative regulation of pyrimidine nucleotide biosynthetic process [GO_1900398]
- 3707: negative regulation of pyruvate dehydrogenase activity [GO_1904183]
- 3708: negative regulation of pyruvate kinase activity [GO_1903303]
- 3709: negative regulation of reactive oxygen species metabolic process [GO_2000378]
- 3710: negative regulation of receptor binding [GO_1900121]
- 3711: negative regulation of receptor-mediated endocytosis [GO_0048261]
- 3712: negative regulation of release of sequestered calcium ion into cytosol [GO_0051280]
- 3713: negative regulation of removal of superoxide radicals [GO_1904832]
- 3714: negative regulation of reproductive process [GO_2000242]
- 3715: negative regulation of respiratory gaseous exchange [GO_1903941]
- 3716: negative regulation of response to alcohol [GO_1901420]
- 3717: negative regulation of response to biotic stimulus [GO_0002832]
- 3718: negative regulation of response to calcium ion [GO_1905946]
- 3719: negative regulation of response to cytokine stimulus [GO_0060761]
- 3720: negative regulation of response to DNA damage stimulus [GO_2001021]
- 3721: negative regulation of response to drug [GO_2001024]
- 3722: negative regulation of response to external stimulus [GO_0032102]
- 3723: negative regulation of response to extracellular stimulus [GO_0032105]
- 3724: negative regulation of response to nutrient levels [GO_0032108]
- 3725: negative regulation of response to oxidative stress [GO_1902883]
- 3726: negative regulation of response to reactive oxygen species [GO_1901032]
- 3727: negative regulation of response to stimulus [GO_0048585]
- 3728: negative regulation of response to wounding [GO_1903035]
- 3729: negative regulation of retina development in camera-type eye [GO_1902867]
- 3730: negative regulation of retinal cell programmed cell death [GO_0046671]
- 3731: negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905433]
- 3732: negative regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000299]
- 3733: negative regulation of ribonuclease activity [GO_0060701]
- 3734: negative regulation of ribosome biogenesis [GO_0090071]
- 3735: negative regulation of RNA binding [GO_1905215]
- 3736: negative regulation of RNA biosynthetic process [GO_1902679]
- 3737: negative regulation of RNA catabolic process [GO_1902369]
- 3738: negative regulation of RNA helicase activity [GO_1902281]
- 3739: negative regulation of RNA metabolic process [GO_0051253]
- 3740: negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901840]
- 3741: negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903026]
- 3742: negative regulation of RNA polymerase III activity [GO_1903623]
- 3743: negative regulation of rRNA processing [GO_2000233]
- 3744: negative regulation of ryanodine-sensitive calcium-release channel activity [GO_0060315]
- 3745: negative regulation of saliva secretion [GO_1905747]
- 3746: negative regulation of sarcomere organization [GO_0060299]
- 3747: negative regulation of secondary metabolite biosynthetic process [GO_1900377]
- 3748: negative regulation of secretion [GO_0051048]
- 3749: negative regulation of secretion by cell [GO_1903531]
- 3750: negative regulation of secretory granule organization [GO_1904410]
- 3751: negative regulation of semaphorin-plexin signaling pathway [GO_2001261]
- 3752: negative regulation of sensory perception of bitter taste [GO_1904661]
- 3753: negative regulation of sensory perception of pain [GO_1904057]
- 3754: negative regulation of sensory perception of sweet taste [GO_1904657]
- 3755: negative regulation of sequestering of calcium ion [GO_0051283]
- 3756: negative regulation of serine C-palmitoyltransferase activity [GO_1904221]
- 3757: negative regulation of serine-type endopeptidase activity [GO_1900004]
- 3758: negative regulation of serine-type peptidase activity [GO_1902572]
- 3759: negative regulation of serotonin biosynthetic process [GO_1905628]
- 3760: negative regulation of serotonin secretion [GO_0014063]
- 3761: negative regulation of serotonin uptake [GO_0051612]
- 3762: negative regulation of signal transduction [GO_0009968]
- 3763: negative regulation of signaling [GO_0023057]
- 3764: negative regulation of signaling receptor activity [GO_2000272]
- 3765: negative regulation of sister chromatid segregation [GO_0033046]
- 3766: negative regulation of skeletal muscle cell differentiation [GO_2001015]
- 3767: negative regulation of skeletal muscle cell proliferation [GO_0014859]
- 3768: negative regulation of skeletal muscle fiber development [GO_0048744]
- 3769: negative regulation of skeletal muscle fiber differentiation [GO_1902810]
- 3770: negative regulation of skeletal muscle hypertrophy [GO_1904205]
- 3771: negative regulation of skeletal muscle tissue development [GO_0048642]
- 3772: negative regulation of skeletal muscle tissue growth [GO_0048632]
- 3773: negative regulation of small GTPase binding [GO_1904476]
- 3774: negative regulation of small intestine smooth muscle contraction [GO_1904348]
- 3775: negative regulation of small molecule metabolic process [GO_0062014]
- 3776: negative regulation of smooth muscle cell apoptotic process [GO_0034392]
- 3777: negative regulation of smooth muscle cell differentiation [GO_0051151]
- 3778: negative regulation of smooth muscle cell proliferation [GO_0048662]
- 3779: negative regulation of smooth muscle contraction [GO_0045986]
- 3780: negative regulation of smooth muscle hypertrophy [GO_1905148]
- 3781: negative regulation of smooth muscle tissue development [GO_1905900]
- 3782: negative regulation of sodium ion transmembrane transport [GO_1902306]
- 3783: negative regulation of sodium ion transmembrane transporter activity [GO_2000650]
- 3784: negative regulation of sodium ion transport [GO_0010766]
- 3785: negative regulation of sodium:proton antiporter activity [GO_0032416]
- 3786: negative regulation of somatic stem cell division [GO_1904676]
- 3787: negative regulation of somatostatin secretion [GO_0090275]
- 3788: negative regulation of stem cell differentiation [GO_2000737]
- 3789: negative regulation of stem cell proliferation [GO_2000647]
- 3790: negative regulation of steroid biosynthetic process [GO_0010894]
- 3791: negative regulation of steroid hormone secretion [GO_2000832]
- 3792: negative regulation of steroid metabolic process [GO_0045939]
- 3793: negative regulation of sterol transport [GO_0032372]
- 3794: negative regulation of stomach neuroendocrine cell differentiation [GO_0061106]
- 3795: negative regulation of store-operated calcium channel activity [GO_1901340]
- 3796: negative regulation of stress-activated MAPK cascade [GO_0032873]
- 3797: negative regulation of stress-activated protein kinase signaling cascade [GO_0070303]
- 3798: negative regulation of striated muscle cell apoptotic process [GO_0010664]
- 3799: negative regulation of striated muscle cell differentiation [GO_0051154]
- 3800: negative regulation of striated muscle contraction [GO_0045988]
- 3801: negative regulation of striated muscle tissue development [GO_0045843]
- 3802: negative regulation of succinate dehydrogenase activity [GO_1904230]
- 3803: negative regulation of sulfur metabolic process [GO_0051175]
- 3804: negative regulation of SUMO transferase activity [GO_1903183]
- 3805: negative regulation of superoxide dismutase activity [GO_1901670]
- 3806: negative regulation of supramolecular fiber organization [GO_1902904]
- 3807: negative regulation of synapse assembly [GO_0051964]
- 3808: negative regulation of synapse organization [GO_1905809]
- 3809: negative regulation of synapse pruning [GO_1905807]
- 3810: negative regulation of synaptic transmission [GO_0050805]
- 3811: negative regulation of synaptic transmission, cholinergic [GO_0032223]
- 3812: negative regulation of synaptic transmission, dopaminergic [GO_0032227]
- 3813: negative regulation of synaptic transmission, GABAergic [GO_0032229]
- 3814: negative regulation of synaptic transmission, glutamatergic [GO_0051967]
- 3815: negative regulation of synaptic transmission, glycinergic [GO_0060093]
- 3816: negative regulation of syncytium formation by plasma membrane fusion [GO_0034242]
- 3817: negative regulation of tau-protein kinase activity [GO_1902948]
- 3818: negative regulation of telomerase activity [GO_0051974]
- 3819: negative regulation of telomeric DNA binding [GO_1904743]
- 3820: negative regulation of termination of DNA-templated transcription [GO_0060567]
- 3821: negative regulation of tetrapyrrole biosynthetic process [GO_1901464]
- 3822: negative regulation of tetrapyrrole catabolic process [GO_1901405]
- 3823: negative regulation of tetrapyrrole metabolic process [GO_1901402]
- 3824: negative regulation of thioredoxin peroxidase activity [GO_1903124]
- 3825: negative regulation of threonine-tRNA ligase activity [GO_1905022]
- 3826: negative regulation of transcription by RNA polymerase I [GO_0016479]
- 3827: negative regulation of transcription by RNA polymerase II [GO_0000122]
- 3828: negative regulation of transcription by RNA polymerase III [GO_0016480]
- 3829: negative regulation of transcription regulatory region DNA binding [GO_2000678]
- 3830: negative regulation of transferase activity [GO_0051348]
- 3831: negative regulation of translation [GO_0017148]
- 3832: negative regulation of translation in response to oxidative stress [GO_0032938]
- 3833: negative regulation of translation in response to stress [GO_0032055]
- 3834: negative regulation of translational elongation [GO_0045900]
- 3835: negative regulation of translational initiation [GO_0045947]
- 3836: negative regulation of translational initiation in response to stress [GO_0032057]
- 3837: negative regulation of translational termination [GO_0045904]
- 3838: negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090101]
- 3839: negative regulation of transmembrane transport [GO_0034763]
- 3840: negative regulation of transmission of nerve impulse [GO_0051970]
- 3841: negative regulation of transport [GO_0051051]
- 3842: negative regulation of transporter activity [GO_0032410]
- 3843: negative regulation of triglyceride biosynthetic process [GO_0010868]
- 3844: negative regulation of triglyceride metabolic process [GO_0090209]
- 3845: negative regulation of tRNA metabolic process [GO_1903327]
- 3846: negative regulation of tRNA processing [GO_2000236]
- 3847: negative regulation of trophectodermal cell proliferation [GO_1904074]
- 3848: negative regulation of tube lumen cavitation [GO_1903133]
- 3849: negative regulation of turning behavior involved in mating [GO_0061096]
- 3850: negative regulation of type B pancreatic cell apoptotic process [GO_2000675]
- 3851: negative regulation of type B pancreatic cell development [GO_2000077]
- 3852: negative regulation of type B pancreatic cell proliferation [GO_1904691]
- 3853: negative regulation of tyrosinase activity [GO_0032772]
- 3854: negative regulation of tyrosine 3-monooxygenase activity [GO_1903177]
- 3855: negative regulation of ubiquitin protein ligase activity [GO_1904667]
- 3856: negative regulation of ubiquitin-dependent protein catabolic process [GO_2000059]
- 3857: negative regulation of ubiquitin-protein transferase activity [GO_0051444]
- 3858: negative regulation of ubiquitin-specific protease activity [GO_2000157]
- 3859: negative regulation of vacuolar transport [GO_1903336]
- 3860: negative regulation of vascular associated smooth muscle cell apoptotic process [GO_1905460]
- 3861: negative regulation of vascular associated smooth muscle cell differentiation [GO_1905064]
- 3862: negative regulation of vascular associated smooth muscle cell proliferation [GO_1904706]
- 3863: negative regulation of vascular endothelial cell proliferation [GO_1905563]
- 3864: negative regulation of vasculature development [GO_1901343]
- 3865: negative regulation of vasculogenesis [GO_2001213]
- 3866: negative regulation of vesicle fusion [GO_0031339]
- 3867: negative regulation of vesicle fusion with Golgi apparatus [GO_0106215]
- 3868: negative regulation of vesicle transport along microtubule [GO_1901609]
- 3869: negative regulation of vessel branching [GO_1905554]
- 3870: negative regulation of vitamin metabolic process [GO_0046137]
- 3871: negative regulation of voltage-gated calcium channel activity [GO_1901386]
- 3872: negative regulation of voltage-gated chloride channel activity [GO_1902942]
- 3873: negative regulation of voltage-gated potassium channel activity [GO_1903817]
- 3874: negative regulation of voltage-gated sodium channel activity [GO_1905151]
- 3875: negative regulation of water channel activity [GO_1902428]
- 3876: negative regulation of Wnt signaling pathway [GO_0030178]
- 3877: negative regulation of wound healing [GO_0061045]
- 3878: negative regulation of zinc ion transmembrane transport [GO_0071583]
- 3879: negative regulation of zinc ion transport [GO_0071582]
- 3880: NEIL1,NEIL2 incises DNA strand 5' to the AP site [GO_0003906]
- 3881: NEIL3 cleaves 5-guanidinohydantoin [GO_0019104]
- 3882: nephrocyte filtration [GO_0097206]
- 3883: nerve development [GO_0021675]
- 3884: nerve maturation [GO_0021682]
- 3885: nervous system development [GO_0007399]
- 3886: nervous system process [GO_0050877]
- 3887: netrin receptor activity [GO_0005042]
- 3888: netrin receptor activity involved in chemoattraction [GO_0038006]
- 3889: netrin receptor activity involved in chemorepulsion [GO_0005043]
- 3890: netrin-activated signaling pathway [GO_0038007]
- 3891: network-forming collagen trimer [GO_0098642]
- 3892: neural crest cell development [GO_0014032]
- 3893: neural crest cell differentiation [GO_0014033]
- 3894: neural crest formation [GO_0014029]
- 3895: neural fold formation [GO_0001842]
- 3896: neural keel formation [GO_0014025]
- 3897: neural nucleus development [GO_0048857]
- 3898: neural plate anterior/posterior regionalization [GO_0021999]
- 3899: neural plate development [GO_0001840]
- 3900: neural plate formation [GO_0021990]
- 3901: neural plate morphogenesis [GO_0001839]
- 3902: neural plate pattern specification [GO_0060896]
- 3903: neural plate regionalization [GO_0060897]
- 3904: neural precursor cell proliferation [GO_0061351]
- 3905: neural retina development [GO_0003407]
- 3906: neural rod cavitation [GO_0014024]
- 3907: neural rod formation [GO_0014023]
- 3908: neural tube development [GO_0021915]
- 3909: neural tube formation [GO_0001841]
- 3910: neural tube patterning [GO_0021532]
- 3911: neurexin family protein binding [GO_0042043]
- 3912: neuroblast development [GO_0014019]
- 3913: neuroblast differentiation [GO_0014016]
- 3914: neuroblast division [GO_0055057]
- 3915: neuroblast proliferation [GO_0007405]
- 3916: neuroendocrine cell differentiation [GO_0061101]
- 3917: neuroepithelial cell differentiation [GO_0060563]
- 3918: neurogenesis [GO_0022008]
- 3919: neuroligin family protein binding [GO_0097109]
- 3920: neuromedin U binding [GO_0042924]
- 3921: neuromedin U receptor activity [GO_0001607]
- 3922: neuromuscular junction [GO_0031594]
- 3923: neuromuscular junction development [GO_0007528]
- 3924: neuromuscular junction of myotube [GO_0098523]
- 3925: neuromuscular process [GO_0050905]
- 3926: neuromuscular process controlling balance [GO_0050885]
- 3927: neuromuscular process controlling posture [GO_0050884]
- 3928: neuron apoptotic process [GO_0051402]
- 3929: neuron cellular homeostasis [GO_0070050]
- 3930: neuron death [GO_0070997]
- 3931: neuron development [GO_0048666]
- 3932: neuron differentiation [GO_0030182]
- 3933: neuron maturation [GO_0042551]
- 3934: neuron projection [GO_0043005]
- 3935: neuron projection cytoplasm [GO_0120111]
- 3936: neuron projection development [GO_0031175]
- 3937: neuron projection guidance [GO_0097485]
- 3938: neuron projection membrane [GO_0032589]
- 3939: neuron projection morphogenesis [GO_0048812]
- 3940: neuron projection organization [GO_0106027]
- 3941: neuron-glial cell signaling [GO_0150099]
- 3942: neuron-neuron synaptic transmission [GO_0007270]
- 3943: neuronal action potential [GO_0019228]
- 3944: neuronal cell body [GO_0043025]
- 3945: neuropeptide binding [GO_0042923]
- 3946: neuropeptide F receptor activity [GO_0042263]
- 3947: neuropeptide F receptor binding [GO_0071859]
- 3948: neuropeptide hormone activity [GO_0005184]
- 3949: neuropeptide receptor activity [GO_0008188]
- 3950: neuropeptide receptor binding [GO_0071855]
- 3951: neuropeptide signaling pathway [GO_0007218]
- 3952: neuropeptide Y receptor activity [GO_0004983]
- 3953: neurotransmitter binding [GO_0042165]
- 3954: neurotransmitter receptor activity [GO_0030594]
- 3955: neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099529]
- 3956: neurotransmitter receptor regulator activity [GO_0099602]
- 3957: neurotransmitter reuptake [GO_0098810]
- 3958: neurotransmitter secretion [GO_0007269]
- 3959: neurotransmitter transport [GO_0006836]
- 3960: neurotransmitter uptake [GO_0001504]
- 3961: neurotransmitter:sodium symporter activity [GO_0005328]
- 3962: neurotrophin binding [GO_0043121]
- 3963: neurotrophin receptor activity [GO_0005030]
- 3964: neurotrophin signaling pathway [GO_0038179]
- 3965: neutral amino acid transmembrane transporter activity [GO_0015175]
- 3966: neutral amino acid transport [GO_0015804]
- 3967: neutral lipid biosynthetic process [GO_0046460]
- 3968: neutral lipid metabolic process [GO_0006638]
- 3969: NF-kappaB binding [GO_0051059]
- 3970: nicotinamidase activity [GO_0008936]
- 3971: nicotinate phosphoribosyltransferase activity [GO_0004516]
- 3972: nitric-oxide synthase activity [GO_0004517]
- 3973: nitric-oxide synthase binding [GO_0050998]
- 3974: nitric-oxide synthase inhibitor activity [GO_0036487]
- 3975: nitric-oxide synthase regulator activity [GO_0030235]
- 3976: nitrite reductase (NO-forming) activity [GO_0050421]
- 3977: nitrite reductase activity [GO_0098809]
- 3978: nitrogen compound metabolic process [GO_0006807]
- 3979: nitrogen compound transport [GO_0071705]
- 3980: NMDA glutamate receptor activity [GO_0004972]
- 3981: NMNAT1 transfers an adenylyl group from ATP to NAMN to yield NAAD [GO_0004515]
- 3982: NMNAT2 transfers an adenylyl group from ATP to NMN to yield NAD+ [GO_0000309]
- 3983: NMRK2 phosphorylates NR to yield NMN [GO_0050262]
- 3984: non-membrane spanning protein tyrosine phosphatase activity [GO_0004726]
- 3985: non-membrane-bounded organelle [GO_0043228]
- 3986: non-membrane-bounded organelle assembly [GO_0140694]
- 3987: non-ribosomal peptide synthetase activity [GO_1904091]
- 3988: nonribosomal peptide biosynthetic process [GO_0019184]
- 3989: Noradrenaline clearance from the synaptic cleft [GO_0005326]
- 3990: norepinephrine binding [GO_0051380]
- 3991: norepinephrine biosynthetic process [GO_0042421]
- 3992: norepinephrine catabolic process [GO_0042422]
- 3993: norepinephrine metabolic process [GO_0042415]
- 3994: norepinephrine secretion [GO_0048243]
- 3995: norepinephrine transport [GO_0015874]
- 3996: norepinephrine uptake [GO_0051620]
- 3997: Notch binding [GO_0005112]
- 3998: notochord development [GO_0030903]
- 3999: notochord formation [GO_0014028]
- 4000: notochord morphogenesis [GO_0048570]
- 4001: NOX3 complex:RAC1:GTP generates superoxide from oxygen [GO_0016175]
- 4002: NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages [GO_0051139]
- 4003: NSF-dependent ATP hydrolysis disassembles the cis-SNARE at the TGN [GO_0016887]
- 4004: nsp13 helicase melts secondary structures in SARS-CoV-2 genomic RNA template [GO_0032574]
- 4005: nsp14 acts as a 3'-to-5' exonuclease to remove misincorporated nucleotides from nascent RNA [GO_0000175]
- 4006: nsp3-4 cleaves itself [GO_0004197]
- 4007: NTPDase2 hydrolyzes nucleoside triphosphates [GO_0017111]
- 4008: nuclear chromosome [GO_0000228]
- 4009: nuclear chromosome segregation [GO_0098813]
- 4010: nuclear division [GO_0000280]
- 4011: nuclear DNA replication [GO_0033260]
- 4012: nuclear DNA replication DNA duplex unwinding [GO_1902320]
- 4013: Nuclear DUSPs dephosphorylate MAPKs [GO_0008138]
- 4014: nuclear envelope [GO_0005635]
- 4015: nuclear envelope organization [GO_0006998]
- 4016: nuclear export [GO_0051168]
- 4017: nuclear export signal receptor activity [GO_0005049]
- 4018: nuclear fragmentation involved in apoptotic nuclear change [GO_0030264]
- 4019: nuclear glucocorticoid receptor binding [GO_0035259]
- 4020: nuclear import signal receptor activity [GO_0061608]
- 4021: nuclear localization sequence binding [GO_0008139]
- 4022: nuclear lumen [GO_0031981]
- 4023: nuclear membrane [GO_0031965]
- 4024: nuclear membrane biogenesis [GO_0101025]
- 4025: nuclear membrane disassembly [GO_0051081]
- 4026: nuclear membrane fusion [GO_0000740]
- 4027: nuclear membrane fusion involved in karyogamy [GO_0048288]
- 4028: nuclear membrane organization [GO_0071763]
- 4029: nuclear microtubule [GO_0005880]
- 4030: nuclear migration [GO_0007097]
- 4031: nuclear migration along microfilament [GO_0031022]
- 4032: nuclear migration along microtubule [GO_0030473]
- 4033: nuclear outer membrane [GO_0005640]
- 4034: nuclear outer membrane organization [GO_0071764]
- 4035: nuclear outer membrane-endoplasmic reticulum membrane network [GO_0042175]
- 4036: nuclear pore [GO_0005643]
- 4037: nuclear protein-containing complex [GO_0140513]
- 4038: nuclear receptor activity [GO_0004879]
- 4039: nuclear receptor binding [GO_0016922]
- 4040: nuclear receptor coactivator activity [GO_0030374]
- 4041: nuclear steroid receptor activity [GO_0003707]
- 4042: nuclear transport [GO_0051169]
- 4043: nuclease activity [GO_0004518]
- 4044: nuclease inhibitor activity [GO_0140721]
- 4045: nucleate erythrocyte development [GO_0048823]
- 4046: nucleate erythrocyte differentiation [GO_0043363]
- 4047: nucleate erythrocyte maturation [GO_0043362]
- 4048: nucleic acid binding [GO_0003676]
- 4049: nucleic acid metabolic process [GO_0090304]
- 4050: nucleic acid phosphodiester bond hydrolysis [GO_0090305]
- 4051: nucleic acid transmembrane transporter activity [GO_0051032]
- 4052: nucleic acid transport [GO_0050657]
- 4053: nucleic acid-templated transcription [GO_0097659]
- 4054: nucleobase binding [GO_0002054]
- 4055: nucleobase biosynthetic process [GO_0046112]
- 4056: nucleobase catabolic process [GO_0046113]
- 4057: nucleobase metabolic process [GO_0009112]
- 4058: nucleobase transmembrane transporter activity [GO_0015205]
- 4059: nucleobase transport [GO_0015851]
- 4060: nucleobase-containing compound biosynthetic process [GO_0034654]
- 4061: nucleobase-containing compound catabolic process [GO_0034655]
- 4062: nucleobase-containing compound kinase activity [GO_0019205]
- 4063: nucleobase-containing compound metabolic process [GO_0006139]
- 4064: nucleobase-containing compound transmembrane transporter activity [GO_0015932]
- 4065: nucleobase-containing compound transport [GO_0015931]
- 4066: nucleobase-containing small molecule catabolic process [GO_0034656]
- 4067: nucleobase-containing small molecule metabolic process [GO_0055086]
- 4068: nucleocytoplasmic carrier activity [GO_0140142]
- 4069: nucleocytoplasmic transport [GO_0006913]
- 4070: nucleoid [GO_0009295]
- 4071: nucleologenesis [GO_0017126]
- 4072: nucleolus [GO_0005730]
- 4073: nucleolus organization [GO_0007000]
- 4074: nucleoside binding [GO_0001882]
- 4075: nucleoside catabolic process [GO_0009164]
- 4076: nucleoside diphosphate metabolic process [GO_0009132]
- 4077: nucleoside diphosphate phosphatase activity [GO_0017110]
- 4078: nucleoside diphosphate phosphorylation [GO_0006165]
- 4079: nucleoside kinase activity [GO_0019206]
- 4080: nucleoside metabolic process [GO_0009116]
- 4081: nucleoside monophosphate biosynthetic process [GO_0009124]
- 4082: nucleoside monophosphate metabolic process [GO_0009123]
- 4083: nucleoside monophosphate phosphorylation [GO_0046940]
- 4084: nucleoside phosphate binding [GO_1901265]
- 4085: nucleoside phosphate biosynthetic process [GO_1901293]
- 4086: nucleoside phosphate metabolic process [GO_0006753]
- 4087: nucleoside transmembrane transport [GO_1901642]
- 4088: nucleoside transport [GO_0015858]
- 4089: nucleoside triphosphate adenylate kinase activity [GO_0046899]
- 4090: nucleoside triphosphate biosynthetic process [GO_0009142]
- 4091: nucleoside triphosphate diphosphatase activity [GO_0047429]
- 4092: nucleoside triphosphate metabolic process [GO_0009141]
- 4093: nucleoside-triphosphatase regulator activity [GO_0060589]
- 4094: nucleosomal DNA binding [GO_0031492]
- 4095: nucleosome [GO_0000786]
- 4096: nucleosome array spacer activity [GO_0140750]
- 4097: nucleosome binding [GO_0031491]
- 4098: nucleotidase activity [GO_0008252]
- 4099: nucleotide binding [GO_0000166]
- 4100: nucleotide biosynthetic process [GO_0009165]
- 4101: nucleotide metabolic process [GO_0009117]
- 4102: nucleotide phosphorylation [GO_0046939]
- 4103: nucleotide transmembrane transport [GO_1901679]
- 4104: nucleotide transmembrane transporter activity [GO_0015215]
- 4105: nucleotide transport [GO_0006862]
- 4106: nucleotide-sugar transmembrane transport [GO_0015780]
- 4107: nucleotide-sugar transmembrane transporter activity [GO_0005338]
- 4108: nucleus [GO_0005634]
- 4109: nucleus disassembly [GO_1905690]
- 4110: nucleus localization [GO_0051647]
- 4111: nucleus organization [GO_0006997]
- 4112: NUDT12 hydrolyses NADH to NMNH [GO_0035529]
- 4113: NUDT16 hydrolyses IDP to IMP [GO_1990003]
- 4114: NUDT18 hydrolyses 8-oxo-dGDP to 8-oxo-dGMP [GO_0044715]
- 4115: nutrient reservoir activity [GO_0045735]
- 4116: O-acetyltransferase activity [GO_0016413]
- 4117: O-glycosylation of 3a is terminated [GO_0008373]
- 4118: O-linoleoyltransferase activity [GO_0032576]
- 4119: O-methyltransferase activity [GO_0008171]
- 4120: O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO_0004648]
- 4121: OCT1 transports organic cations out of hepatic cells [GO_0015101]
- 4122: octanol dehydrogenase activity [GO_0004552]
- 4123: octopamine receptor activity [GO_0004989]
- 4124: octopamine secretion [GO_0061539]
- 4125: octopamine secretion, neurotransmission [GO_0061540]
- 4126: odorant binding [GO_0005549]
- 4127: olefinic compound metabolic process [GO_0120254]
- 4128: olfactory behavior [GO_0042048]
- 4129: olfactory learning [GO_0008355]
- 4130: olfactory receptor activity [GO_0004984]
- 4131: oligopeptidase activity [GO_0070012]
- 4132: oligopeptide binding [GO_1900750]
- 4133: oligopeptide transmembrane transport [GO_0035672]
- 4134: oligopeptide transmembrane transporter activity [GO_0035673]
- 4135: oligopeptide transport [GO_0006857]
- 4136: oligosaccharide metabolic process [GO_0009311]
- 4137: oligosaccharide transmembrane transporter activity [GO_0015157]
- 4138: oligosaccharide transport [GO_0015772]
- 4139: oligosaccharide-lipid intermediate biosynthetic process [GO_0006490]
- 4140: oligosaccharyl transferase activity [GO_0004576]
- 4141: OMA1 hydrolyses OPA1 [GO_0004222]
- 4142: omega peptidase activity [GO_0008242]
- 4143: one-carbon compound transport [GO_0019755]
- 4144: oocyte construction [GO_0007308]
- 4145: oocyte development [GO_0048599]
- 4146: oocyte differentiation [GO_0009994]
- 4147: oocyte growth [GO_0001555]
- 4148: oocyte localization involved in germarium-derived egg chamber formation [GO_0030720]
- 4149: oocyte maturation [GO_0001556]
- 4150: oocyte microtubule cytoskeleton organization [GO_0016325]
- 4151: oocyte morphogenesis [GO_0048601]
- 4152: oogenesis [GO_0048477]
- 4153: ooplasm [GO_1990917]
- 4154: opsin binding [GO_0002046]
- 4155: optic cup morphogenesis involved in camera-type eye development [GO_0002072]
- 4156: optic vesicle formation [GO_0003403]
- 4157: optic vesicle morphogenesis [GO_0003404]
- 4158: optokinetic behavior [GO_0007634]
- 4159: optomotor response [GO_0071632]
- 4160: organ growth [GO_0035265]
- 4161: organ or tissue specific immune response [GO_0002251]
- 4162: organellar ribosome [GO_0000313]
- 4163: organelle [GO_0043226]
- 4164: organelle assembly [GO_0070925]
- 4165: organelle disassembly [GO_1903008]
- 4166: organelle envelope [GO_0031967]
- 4167: organelle fission [GO_0048285]
- 4168: organelle fusion [GO_0048284]
- 4169: organelle inheritance [GO_0048308]
- 4170: organelle localization [GO_0051640]
- 4171: organelle localization by membrane tethering [GO_0140056]
- 4172: organelle lumen [GO_0043233]
- 4173: organelle membrane [GO_0031090]
- 4174: organelle membrane fusion [GO_0090174]
- 4175: organelle organization [GO_0006996]
- 4176: organelle outer membrane [GO_0031968]
- 4177: organelle transport along microtubule [GO_0072384]
- 4178: organic acid binding [GO_0043177]
- 4179: organic acid biosynthetic process [GO_0016053]
- 4180: organic acid catabolic process [GO_0016054]
- 4181: organic acid metabolic process [GO_0006082]
- 4182: organic acid transmembrane transport [GO_1903825]
- 4183: organic acid transmembrane transporter activity [GO_0005342]
- 4184: organic acid transport [GO_0015849]
- 4185: organic anion transport [GO_0015711]
- 4186: organic cation transport [GO_0015695]
- 4187: organic cyclic compound binding [GO_0097159]
- 4188: organic cyclic compound biosynthetic process [GO_1901362]
- 4189: organic cyclic compound catabolic process [GO_1901361]
- 4190: organic cyclic compound metabolic process [GO_1901360]
- 4191: organic hydroxy compound biosynthetic process [GO_1901617]
- 4192: organic hydroxy compound catabolic process [GO_1901616]
- 4193: organic hydroxy compound metabolic process [GO_1901615]
- 4194: organic hydroxy compound transmembrane transporter activity [GO_1901618]
- 4195: organic hydroxy compound transport [GO_0015850]
- 4196: organic substance biosynthetic process [GO_1901576]
- 4197: organic substance catabolic process [GO_1901575]
- 4198: organic substance metabolic process [GO_0071704]
- 4199: organic substance transport [GO_0071702]
- 4200: organism emergence from protective structure [GO_0071684]
- 4201: organonitrogen compound biosynthetic process [GO_1901566]
- 4202: organonitrogen compound catabolic process [GO_1901565]
- 4203: organonitrogen compound metabolic process [GO_1901564]
- 4204: organophosphate biosynthetic process [GO_0090407]
- 4205: organophosphate ester transmembrane transporter activity [GO_0015605]
- 4206: organophosphate ester transport [GO_0015748]
- 4207: organophosphate metabolic process [GO_0019637]
- 4208: organophosphate:inorganic phosphate antiporter activity [GO_0015315]
- 4209: ornithine (cytosolic) + citrulline (mitochondrial) => ornithine (mitochondrial) + citrulline (cytosolic) [GO_0000064]
- 4210: ornithine => putrescine + CO2 [GO_0004586]
- 4211: ornithine decarboxylase activator activity [GO_0042978]
- 4212: ornithine decarboxylase inhibitor activity [GO_0008073]
- 4213: ornithine decarboxylase regulator activity [GO_0042979]
- 4214: ornithine transport [GO_0015822]
- 4215: ornithine-oxo-acid transaminase activity [GO_0004587]
- 4216: osmosensor activity [GO_0005034]
- 4217: ossification [GO_0001503]
- 4218: ossification involved in bone maturation [GO_0043931]
- 4219: outer membrane [GO_0019867]
- 4220: outflow tract morphogenesis [GO_0003151]
- 4221: outflow tract septum morphogenesis [GO_0003148]
- 4222: outward rectifier potassium channel activity [GO_0015271]
- 4223: outward rectifier potassium channel inhibitor activity [GO_0140628]
- 4224: oviduct development [GO_0060066]
- 4225: oviduct epithelium development [GO_0035846]
- 4226: oviduct morphogenesis [GO_0035848]
- 4227: oviposition [GO_0018991]
- 4228: ovulation cycle [GO_0042698]
- 4229: ovulation cycle process [GO_0022602]
- 4230: oxalate transmembrane transporter activity [GO_0019531]
- 4231: oxalate transport [GO_0019532]
- 4232: oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol] [GO_0004613]
- 4233: oxaloacetate transmembrane transporter activity [GO_0015131]
- 4234: oxaloacetate transport [GO_0015729]
- 4235: oxaloacetate(2-) transmembrane transport [GO_1902356]
- 4236: oxidative DNA demethylase activity [GO_0035516]
- 4237: oxidative phosphorylation [GO_0006119]
- 4238: oxidized base lesion DNA N-glycosylase activity [GO_0000702]
- 4239: oxidized DNA binding [GO_0032356]
- 4240: oxidized purine DNA binding [GO_0032357]
- 4241: oxidoreductase activity, acting on a heme group of donors [GO_0016675]
- 4242: oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO_0016671]
- 4243: oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor [GO_0016668]
- 4244: oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor [GO_0016670]
- 4245: oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor [GO_0016672]
- 4246: oxidoreductase activity, acting on diphenols and related substances as donors [GO_0016679]
- 4247: oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor [GO_0016682]
- 4248: oxidoreductase activity, acting on iron-sulfur proteins as donors [GO_0016730]
- 4249: oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO_0016731]
- 4250: oxidoreductase activity, acting on metal ions, oxygen as acceptor [GO_0016724]
- 4251: oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO_0016653]
- 4252: oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO_0016657]
- 4253: oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO_0050664]
- 4254: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO_0016655]
- 4255: oxidoreductase activity, acting on other nitrogenous compounds as donors [GO_0016661]
- 4256: oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor [GO_0016662]
- 4257: oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor [GO_0016663]
- 4258: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO_0016705]
- 4259: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO_0016716]
- 4260: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO_0016709]
- 4261: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO_0016715]
- 4262: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen [GO_0016713]
- 4263: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen [GO_0016714]
- 4264: oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO_0016717]
- 4265: oxidoreductase activity, acting on peroxide as acceptor [GO_0016684]
- 4266: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO_0016701]
- 4267: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO_0016702]
- 4268: oxidoreductase activity, acting on superoxide radicals as acceptor [GO_0016721]
- 4269: oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO_0016903]
- 4270: oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO_0016624]
- 4271: oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor [GO_0016623]
- 4272: oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor [GO_0016634]
- 4273: oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor [GO_0016635]
- 4274: oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO_0052890]
- 4275: oxidoreductase activity, acting on the CH-NH group of donors [GO_0016645]
- 4276: oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO_0016646]
- 4277: oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor [GO_0016647]
- 4278: oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor [GO_0016649]
- 4279: oxidoreductase activity, acting on the CH-NH2 group of donors [GO_0016638]
- 4280: oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO_0016639]
- 4281: oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor [GO_0016641]
- 4282: oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor [GO_0016899]
- 4283: oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO_0016901]
- 4284: oxidoreduction-driven active transmembrane transporter activity [GO_0015453]
- 4285: oxoacid metabolic process [GO_0043436]
- 4286: oxoglutarate dehydrogenase (succinyl-transferring) activity [GO_0004591]
- 4287: oxygen binding [GO_0019825]
- 4288: oxygen carrier activity [GO_0005344]
- 4289: oxygen homeostasis [GO_0032364]
- 4290: oxygen metabolic process [GO_0072592]
- 4291: oxygen transport [GO_0015671]
- 4292: p-AMPK phosphorylates TSC1:TSC2 [GO_0004679]
- 4293: P-element binding [GO_0003693]
- 4294: p-hydroxyphenylpyruvate + glutamate <=> tyrosine + alpha-ketoglutarate [GO_0004838]
- 4295: p-S256-Aquaporin-2 passively transports water into cell [GO_0015250]
- 4296: p-S295-PDE3B hydrolyses cAMP to AMP [GO_0004114]
- 4297: p-S400-Cot phosphorylates NIK [GO_0004709]
- 4298: p-S54-PDE4B hydrolyses cAMP [GO_0004115]
- 4299: p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate [GO_0017050]
- 4300: P-TEFb complex binding [GO_0106140]
- 4301: P-type ATPases type IV transport internal-facing APLs to external side of the plasma membrane [GO_0140326]
- 4302: P-type manganese transporter activity [GO_0140613]
- 4303: P-type potassium transmembrane transporter activity [GO_0008556]
- 4304: P-type sodium transporter activity [GO_0008554]
- 4305: P-type sodium:potassium-exchanging transporter activity [GO_0005391]
- 4306: P-type transmembrane transporter activity [GO_0140358]
- 4307: p120-RasGAP activates GTP hydrolysis on RAS, inactivating it [GO_0005096]
- 4308: p53 binding [GO_0002039]
- 4309: PA is converted to CDP-DAG by CDS2 [GO_0004605]
- 4310: pagA(197-794):ANTRX2 oligomer transports cya and lef (target cell endosome to cytosol) [GO_0008320]
- 4311: palmitoyl hydrolase activity [GO_0098599]
- 4312: palmitoyl-CoA + serine => 3-ketosphinganine + CoASH + CO2 [GO_0004758]
- 4313: palmitoylation of eNOS [GO_0016409]
- 4314: pancreas development [GO_0031016]
- 4315: pancreas morphogenesis [GO_0061113]
- 4316: pancreatic A cell development [GO_0003322]
- 4317: pancreatic A cell differentiation [GO_0003310]
- 4318: pancreatic bud formation [GO_0061130]
- 4319: pancreatic D cell development [GO_0003324]
- 4320: pancreatic D cell differentiation [GO_0003311]
- 4321: pancreatic PP cell development [GO_0003325]
- 4322: pancreatic PP cell differentiation [GO_0003312]
- 4323: pantothenate kinase activity [GO_0004594]
- 4324: paramesonephric duct development [GO_0061205]
- 4325: paraxial mesoderm development [GO_0048339]
- 4326: paraxial mesoderm formation [GO_0048341]
- 4327: paraxial mesoderm morphogenesis [GO_0048340]
- 4328: parietal peritoneum development [GO_1904819]
- 4329: PARN deadenylates mRNA [GO_0004535]
- 4330: PARPs transfer ADP-D-ribose to proteins (poly(ADP-ribosyl)ation) [GO_0003950]
- 4331: Passive I- efflux mediated by SMCT1 [GO_0022803]
- 4332: patched binding [GO_0005113]
- 4333: pattern recognition receptor activity [GO_0038187]
- 4334: pattern specification process [GO_0007389]
- 4335: PC is converted to PS by PTDSS1 [GO_0016740]
- 4336: PC is hydrolyzed to 2-acyl LPC by PLA2G4C [GO_0008970]
- 4337: PC is hydrolyzed to PA and choline by PLD1/2 [GO_0004630]
- 4338: PCho and CTP are condensed to CDP-Cho by PCYT1 dimer [GO_0004105]
- 4339: PCMT1 transfers CH3 from AdoMet to isoAsp to form MetAsp [GO_0004719]
- 4340: PDE6 hydrolyses cGMP to GMP [GO_0047555]
- 4341: PDK isoforms phosphorylate lipo-PDH [GO_0004740]
- 4342: PDPK1 activates PRKCZ [GO_0004676]
- 4343: PDZ domain binding [GO_0030165]
- 4344: Pellino ubiquitinates hp-IRAK1 [GO_0034450]
- 4345: pentosyltransferase activity [GO_0016763]
- 4346: peptidase activator activity [GO_0016504]
- 4347: peptidase activator activity involved in apoptotic process [GO_0016505]
- 4348: peptidase inhibitor activity [GO_0030414]
- 4349: peptidase regulator activity [GO_0061134]
- 4350: peptide binding [GO_0042277]
- 4351: peptide biosynthetic process [GO_0043043]
- 4352: peptide catabolic process [GO_0043171]
- 4353: peptide deformylase activity [GO_0042586]
- 4354: peptide hormone binding [GO_0017046]
- 4355: peptide hormone receptor binding [GO_0051428]
- 4356: peptide hormone secretion [GO_0030072]
- 4357: peptide metabolic process [GO_0006518]
- 4358: peptide receptor activity [GO_0001653]
- 4359: peptide secretion [GO_0002790]
- 4360: peptide transport [GO_0015833]
- 4361: peptidoglycan binding [GO_0042834]
- 4362: peptidoglycan immune receptor activity [GO_0016019]
- 4363: peptidoglycan muralytic activity [GO_0061783]
- 4364: peptidyl-amino acid modification [GO_0018193]
- 4365: peptidyl-aspartic acid 3-dioxygenase activity [GO_0062101]
- 4366: peptidyl-cysteine S-nitrosylase activity [GO_0035605]
- 4367: peptidyl-dipeptidase activity [GO_0008241]
- 4368: peptidyl-lysine 5-dioxygenase activity [GO_0070815]
- 4369: peptidyl-lysine modification [GO_0018205]
- 4370: peptidyl-proline dioxygenase activity [GO_0031543]
- 4371: peptidyl-proline hydroxylation [GO_0019511]
- 4372: peptidyl-proline modification [GO_0018208]
- 4373: peptidyl-tyrosine modification [GO_0018212]
- 4374: peptidyl-tyrosine phosphorylation [GO_0018108]
- 4375: peptidylamidoglycolate lyase activity [GO_0004598]
- 4376: peptidylglycine monooxygenase activity [GO_0004504]
- 4377: pericardium development [GO_0060039]
- 4378: pericardium morphogenesis [GO_0003344]
- 4379: peripheral nervous system development [GO_0007422]
- 4380: peripheral nervous system neuron development [GO_0048935]
- 4381: peripheral nervous system neuron differentiation [GO_0048934]
- 4382: peristalsis [GO_0030432]
- 4383: peritoneum development [GO_1904820]
- 4384: peroxidase activity [GO_0004601]
- 4385: peroxisome matrix targeting signal-1 binding [GO_0005052]
- 4386: peroxisome membrane targeting sequence binding [GO_0033328]
- 4387: peroxisome targeting sequence binding [GO_0000268]
- 4388: Peroxynitrite is reduced by AhpE [GO_0051920]
- 4389: PETA and CTP are condensed to CDP-ETA by PCY2 [GO_0004306]
- 4390: PEX1:PEX6:PEX26:ZFAND6:Ub:PEX5S,L:PEX14:PEX13:PEX2:PEX10:PEX12 dissociates yielding cytosolic Ub:PEX5S,L and membrane PEX14:PEX13:PEX2:PEX10:PEX12 [GO_0042626]
- 4391: PGLYRP2 hydrolyzes bacterial peptidoglycan [GO_0008745]
- 4392: PGM2:Mg2+ isomerises dR1P to dR5P [GO_0008973]
- 4393: PGM:Mg2+ isomerise G1P to G6P [GO_0004614]
- 4394: pH-gated chloride channel activity [GO_0061797]
- 4395: pharyngeal arch artery morphogenesis [GO_0061626]
- 4396: pharyngeal gland morphogenesis [GO_1905905]
- 4397: pharyngeal system development [GO_0060037]
- 4398: pharynx development [GO_0060465]
- 4399: pharynx morphogenesis [GO_0110040]
- 4400: phasic smooth muscle contraction [GO_0014821]
- 4401: phenol-containing compound biosynthetic process [GO_0046189]
- 4402: phenol-containing compound catabolic process [GO_0019336]
- 4403: phenol-containing compound metabolic process [GO_0018958]
- 4404: phenylalkylamine binding [GO_0008145]
- 4405: pheromone binding [GO_0005550]
- 4406: pheromone receptor activity [GO_0016503]
- 4407: PHF8 demethylates histone H4K20me1 [GO_0035575]
- 4408: PHGHD tetramer dehydrogenates 3PG [GO_0004617]
- 4409: phosphatase activator activity [GO_0019211]
- 4410: phosphatase activity [GO_0016791]
- 4411: phosphatase binding [GO_0019902]
- 4412: phosphatase inhibitor activity [GO_0019212]
- 4413: phosphatase regulator activity [GO_0019208]
- 4414: phosphate ion binding [GO_0042301]
- 4415: phosphate ion homeostasis [GO_0055062]
- 4416: phosphate ion transmembrane transport [GO_0035435]
- 4417: phosphate ion transmembrane transporter activity [GO_0015114]
- 4418: phosphate ion transport [GO_0006817]
- 4419: phosphate-containing compound metabolic process [GO_0006796]
- 4420: phosphatidic acid binding [GO_0070300]
- 4421: phosphatidic acid transfer activity [GO_1990050]
- 4422: phosphatidylcholine binding [GO_0031210]
- 4423: phosphatidylcholine biosynthetic process [GO_0006656]
- 4424: phosphatidylcholine metabolic process [GO_0046470]
- 4425: phosphatidylcholine transporter activity [GO_0008525]
- 4426: phosphatidylcholine:cardiolipin O-linoleoyltransferase activity [GO_0032577]
- 4427: phosphatidylethanolamine binding [GO_0008429]
- 4428: phosphatidylinositol + UDP-N-acetyl-D-glucosamine -> N-acetylglucosaminyl-PI + UDP [GO_0008194]
- 4429: phosphatidylinositol 3-kinase binding [GO_0043548]
- 4430: phosphatidylinositol 3-kinase catalytic subunit binding [GO_0036313]
- 4431: phosphatidylinositol 3-kinase regulator activity [GO_0035014]
- 4432: phosphatidylinositol binding [GO_0035091]
- 4433: phosphatidylinositol biosynthetic process [GO_0006661]
- 4434: phosphatidylinositol bisphosphate binding [GO_1902936]
- 4435: phosphatidylinositol bisphosphate kinase activity [GO_0052813]
- 4436: phosphatidylinositol bisphosphate phosphatase activity [GO_0034593]
- 4437: phosphatidylinositol kinase activity [GO_0052742]
- 4438: phosphatidylinositol metabolic process [GO_0046488]
- 4439: phosphatidylinositol monophosphate phosphatase activity [GO_0052744]
- 4440: phosphatidylinositol phosphate 5-phosphatase activity [GO_0034595]
- 4441: phosphatidylinositol phosphate binding [GO_1901981]
- 4442: phosphatidylinositol phosphate biosynthetic process [GO_0046854]
- 4443: phosphatidylinositol phosphate kinase activity [GO_0016307]
- 4444: phosphatidylinositol phosphate phosphatase activity [GO_0052866]
- 4445: phosphatidylinositol trisphosphate phosphatase activity [GO_0034594]
- 4446: phosphatidylinositol-3,4,5-trisphosphate binding [GO_0005547]
- 4447: phosphatidylinositol-3,4-bisphosphate binding [GO_0043325]
- 4448: phosphatidylinositol-3,4-bisphosphate phosphatase activity [GO_0106017]
- 4449: phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO_0052629]
- 4450: phosphatidylinositol-3,5-bisphosphate binding [GO_0080025]
- 4451: phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO_0106018]
- 4452: phosphatidylinositol-3-phosphate binding [GO_0032266]
- 4453: phosphatidylinositol-3-phosphate biosynthetic process [GO_0036092]
- 4454: phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO_0034597]
- 4455: phosphatidylinositol-4,5-bisphosphate binding [GO_0005546]
- 4456: phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO_0106019]
- 4457: phosphatidylinositol-4-phosphate binding [GO_0070273]
- 4458: phosphatidylinositol-4-phosphate phosphatase activity [GO_0043812]
- 4459: phosphatidylinositol-5-phosphate binding [GO_0010314]
- 4460: phosphatidylserine binding [GO_0001786]
- 4461: phosphatidylserine decarboxylase activity [GO_0004609]
- 4462: phosphoenolpyruvate + ADP => pyruvate + ATP [GO_0004743]
- 4463: phosphoenolpyruvate carboxykinase activity [GO_0004611]
- 4464: phosphofructokinase activity [GO_0008443]
- 4465: phosphogluconate dehydrogenase (decarboxylating) activity [GO_0004616]
- 4466: phospholipase A2 activator activity [GO_0016005]
- 4467: phospholipase activator activity [GO_0016004]
- 4468: phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO_0030845]
- 4469: phospholipase D activator activity [GO_1990583]
- 4470: phospholipid binding [GO_0005543]
- 4471: phospholipid biosynthetic process [GO_0008654]
- 4472: phospholipid metabolic process [GO_0006644]
- 4473: phospholipid scramblase activity [GO_0017128]
- 4474: phospholipid transfer activity [GO_0120014]
- 4475: phospholipid translocation [GO_0045332]
- 4476: phospholipid transport [GO_0015914]
- 4477: phosphopantetheine binding [GO_0031177]
- 4478: phosphopantetheine-dependent carrier activity [GO_0140414]
- 4479: phosphoprotein binding [GO_0051219]
- 4480: phosphoribosylaminoimidazole carboxylase activity [GO_0004638]
- 4481: phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO_0004643]
- 4482: phosphoribosylformylglycinamidine cyclo-ligase activity [GO_0004641]
- 4483: phosphoribosylglycinamide formyltransferase activity [GO_0004644]
- 4484: phosphoric diester hydrolase activity [GO_0008081]
- 4485: phosphoric ester hydrolase activity [GO_0042578]
- 4486: phosphorus metabolic process [GO_0006793]
- 4487: phosphorus-oxygen lyase activity [GO_0016849]
- 4488: phosphorylase kinase regulator activity [GO_0008607]
- 4489: Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 [GO_0004373]
- 4490: phosphorylation [GO_0016310]
- 4491: Phosphorylation of NEFL by the P-TEFb(Cyclin T1:Cdk9) complex [GO_0008353]
- 4492: Phosphorylation of human JNKs by activated MKK4/MKK7 [GO_0008545]
- 4493: Phosphorylation of STAT1 at Ser727 [GO_0004697]
- 4494: phosphoserine residue binding [GO_0050815]
- 4495: phosphotransferase activity, alcohol group as acceptor [GO_0016773]
- 4496: phosphotransferase activity, carboxyl group as acceptor [GO_0016774]
- 4497: phosphotransferase activity, for other substituted phosphate groups [GO_0016780]
- 4498: phosphotransferase activity, nitrogenous group as acceptor [GO_0016775]
- 4499: phosphotransferase activity, phosphate group as acceptor [GO_0016776]
- 4500: phosphotyrosine residue binding [GO_0001784]
- 4501: photoperiodism [GO_0009648]
- 4502: photoreceptor activity [GO_0009881]
- 4503: photoreceptor cell development [GO_0042461]
- 4504: photoreceptor cell differentiation [GO_0046530]
- 4505: photoreceptor cell morphogenesis [GO_0008594]
- 4506: phototaxis [GO_0042331]
- 4507: phototransduction [GO_0007602]
- 4508: phototransduction, visible light [GO_0007603]
- 4509: physiological cardiac muscle hypertrophy [GO_0003301]
- 4510: physiological muscle hypertrophy [GO_0003298]
- 4511: PI is phosphorylated to PI4P by PI4KB at the Golgi membrane [GO_0004430]
- 4512: PI(3,4)P2 is dephosphorylated to PI4P by PTEN at the plasma membrane [GO_0051800]
- 4513: PI(3,5)P2 is dephosphorylated to PI3P by SYNJ at the plasma membrane [GO_0043813]
- 4514: PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3 are dephosphorylated to PI5P, PI3P and PI(3,4)P by INPP5F at the endosome membrane [GO_0034596]
- 4515: PI3K-containing complexes phosphorylate PIP2 to PIP3 [GO_0016303]
- 4516: PI3P is dephosphorylated to PI by MTMR9-bound MTMR8 or MTMR6 at the plasma membrane [GO_0004438]
- 4517: PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A/G at the Golgi membrane [GO_0035005]
- 4518: PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma membrane [GO_0016308]
- 4519: pigment binding [GO_0031409]
- 4520: pigment cell development [GO_0070285]
- 4521: pigment cell differentiation [GO_0050931]
- 4522: pigment granule [GO_0048770]
- 4523: pigment granule localization [GO_0051875]
- 4524: pigment granule membrane [GO_0090741]
- 4525: pigment granule organization [GO_0048753]
- 4526: pigment granule transport [GO_0051904]
- 4527: pigmentation [GO_0043473]
- 4528: piRNA binding [GO_0034584]
- 4529: PITPNM1,2,3 exchange PI for PA [GO_0008526]
- 4530: PLA2G15 hydrolyses LPC to GPCho and LCFA(-) [GO_0047499]
- 4531: placenta blood vessel development [GO_0060674]
- 4532: placenta development [GO_0001890]
- 4533: plasma membrane [GO_0005886]
- 4534: plasma membrane bounded cell projection [GO_0120025]
- 4535: plasma membrane bounded cell projection assembly [GO_0120031]
- 4536: plasma membrane bounded cell projection cytoplasm [GO_0032838]
- 4537: plasma membrane bounded cell projection morphogenesis [GO_0120039]
- 4538: plasma membrane bounded cell projection organization [GO_0120036]
- 4539: plasma membrane fusion [GO_0045026]
- 4540: plasma membrane organization [GO_0007009]
- 4541: plasma membrane phospholipid scrambling [GO_0017121]
- 4542: plasma membrane protein complex [GO_0098797]
- 4543: plasma membrane region [GO_0098590]
- 4544: PLC gamma 2-mediated PIP2 hydrolysis [GO_0004629]
- 4545: plus-end directed microfilament motor activity [GO_0060002]
- 4546: plus-end-directed microtubule motor activity [GO_0008574]
- 4547: PNPLA4 hydrolyzes TAG [GO_0004806]
- 4548: POLB incorporates a single nucleotide in place of excised AP residue in NEIL1,NEIL2-mediated AP site resolution [GO_0003887]
- 4549: poly((1,4)-alpha-glycosyl) glycogenin-1 + n orthophosphate => glycogenin-1 + n D-glucose 1-phosphate [PYGM,PYGB] [GO_0008184]
- 4550: poly(A) binding [GO_0008143]
- 4551: poly(G) binding [GO_0034046]
- 4552: poly(U) RNA binding [GO_0008266]
- 4553: poly-ADP-D-ribose binding [GO_0072572]
- 4554: poly-purine tract binding [GO_0070717]
- 4555: poly-pyrimidine tract binding [GO_0008187]
- 4556: polyamine oxidase activity [GO_0046592]
- 4557: polyamine transmembrane transport [GO_1902047]
- 4558: polyamine transmembrane transporter activity [GO_0015203]
- 4559: polyamine transport [GO_0015846]
- 4560: Polyglutamylase complex (TTLL1) polyglutamylates alpha subunits of tubulin [GO_0070740]
- 4561: polymeric cytoskeletal fiber [GO_0099513]
- 4562: polynucleotide 5'-hydroxyl-kinase activity [GO_0051731]
- 4563: polynucleotide adenylyltransferase activator activity [GO_1990749]
- 4564: polypeptide N-acetylgalactosaminyltransferase activity [GO_0004653]
- 4565: polysaccharide binding [GO_0030247]
- 4566: polysaccharide biosynthetic process [GO_0000271]
- 4567: polysaccharide catabolic process [GO_0000272]
- 4568: polysaccharide localization [GO_0033037]
- 4569: polysaccharide metabolic process [GO_0005976]
- 4570: polysaccharide transmembrane transporter activity [GO_0015159]
- 4571: polysaccharide transport [GO_0015774]
- 4572: polysome binding [GO_1905538]
- 4573: polyubiquitin modification-dependent protein binding [GO_0031593]
- 4574: POMGNT2 transfers GlcNAc to Man-DAG1 [GO_0008375]
- 4575: pons development [GO_0021548]
- 4576: pons formation [GO_0021584]
- 4577: pons maturation [GO_0021586]
- 4578: pons morphogenesis [GO_0021583]
- 4579: POR reduces CYP450:Fe3+ to CYP450:Fe2+ [GO_0003958]
- 4580: porin activity [GO_0015288]
- 4581: positive chemotaxis [GO_0050918]
- 4582: positive regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043128]
- 4583: positive regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061903]
- 4584: positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090216]
- 4585: positive regulation of acetylcholine secretion, neurotransmission [GO_0014057]
- 4586: positive regulation of acid-sensing ion channel activity [GO_1901587]
- 4587: positive regulation of acinar cell proliferation [GO_1904699]
- 4588: positive regulation of aconitate hydratase activity [GO_1904234]
- 4589: positive regulation of actin binding [GO_1904618]
- 4590: positive regulation of actin filament binding [GO_1904531]
- 4591: positive regulation of actin filament bundle assembly [GO_0032233]
- 4592: positive regulation of actin filament-based movement [GO_1903116]
- 4593: positive regulation of action potential [GO_0045760]
- 4594: positive regulation of activin receptor signaling pathway [GO_0032927]
- 4595: positive regulation of adenosine receptor signaling pathway [GO_0060168]
- 4596: positive regulation of adenylate cyclase activity [GO_0045762]
- 4597: positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO_0071879]
- 4598: positive regulation of adipose tissue development [GO_1904179]
- 4599: positive regulation of alkaline phosphatase activity [GO_0010694]
- 4600: positive regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905621]
- 4601: positive regulation of amine transport [GO_0051954]
- 4602: positive regulation of amino acid transport [GO_0051957]
- 4603: positive regulation of aminoacyl-tRNA ligase activity [GO_1903632]
- 4604: positive regulation of amyloid precursor protein catabolic process [GO_1902993]
- 4605: positive regulation of androgen receptor activity [GO_2000825]
- 4606: positive regulation of androgen secretion [GO_2000836]
- 4607: positive regulation of angiogenesis [GO_0045766]
- 4608: positive regulation of animal organ morphogenesis [GO_0110110]
- 4609: positive regulation of anion channel activity [GO_1901529]
- 4610: positive regulation of anion transmembrane transport [GO_1903961]
- 4611: positive regulation of anion transport [GO_1903793]
- 4612: positive regulation of aorta morphogenesis [GO_1903849]
- 4613: positive regulation of aortic smooth muscle cell differentiation [GO_1904831]
- 4614: positive regulation of apical ectodermal ridge formation [GO_1905142]
- 4615: positive regulation of apolipoprotein binding [GO_2000658]
- 4616: positive regulation of apoptotic process [GO_0043065]
- 4617: positive regulation of apoptotic process involved in development [GO_1904747]
- 4618: positive regulation of apoptotic process involved in morphogenesis [GO_1902339]
- 4619: positive regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902258]
- 4620: positive regulation of apoptotic signaling pathway [GO_2001235]
- 4621: positive regulation of argininosuccinate synthase activity [GO_1905753]
- 4622: positive regulation of artery morphogenesis [GO_1905653]
- 4623: positive regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120289]
- 4624: positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902961]
- 4625: positive regulation of aspartic-type peptidase activity [GO_1905247]
- 4626: positive regulation of asymmetric cell division [GO_0045770]
- 4627: positive regulation of ATP biosynthetic process [GO_2001171]
- 4628: positive regulation of ATP citrate synthase activity [GO_2000985]
- 4629: positive regulation of ATP metabolic process [GO_1903580]
- 4630: positive regulation of ATP-dependent activity [GO_0032781]
- 4631: positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901896]
- 4632: positive regulation of AV node cell action potential [GO_1903951]
- 4633: positive regulation of axo-dendritic protein transport [GO_1905128]
- 4634: positive regulation of axon guidance [GO_1902669]
- 4635: positive regulation of axonogenesis [GO_0050772]
- 4636: positive regulation of backward locomotion [GO_1905852]
- 4637: positive regulation of behavior [GO_0048520]
- 4638: positive regulation of beta-galactosidase activity [GO_1903771]
- 4639: positive regulation of bile acid biosynthetic process [GO_0070859]
- 4640: positive regulation of bile acid metabolic process [GO_1904253]
- 4641: positive regulation of bile acid secretion [GO_0120189]
- 4642: positive regulation of binding [GO_0051099]
- 4643: positive regulation of biological process [GO_0048518]
- 4644: positive regulation of biosynthetic process [GO_0009891]
- 4645: positive regulation of bleb assembly [GO_1904172]
- 4646: positive regulation of blood circulation [GO_1903524]
- 4647: positive regulation of blood vessel branching [GO_1905555]
- 4648: positive regulation of blood vessel endothelial cell differentiation [GO_0110058]
- 4649: positive regulation of BMP signaling pathway [GO_0030513]
- 4650: positive regulation of bone development [GO_1903012]
- 4651: positive regulation of branching involved in lung morphogenesis [GO_0061047]
- 4652: positive regulation of branching morphogenesis of a nerve [GO_1905492]
- 4653: positive regulation of calcium ion binding [GO_1901878]
- 4654: positive regulation of calcium ion transmembrane transport [GO_1904427]
- 4655: positive regulation of calcium ion transmembrane transporter activity [GO_1901021]
- 4656: positive regulation of calcium ion transport [GO_0051928]
- 4657: positive regulation of calcium-dependent ATPase activity [GO_1903612]
- 4658: positive regulation of calcium-mediated signaling [GO_0050850]
- 4659: positive regulation of calcium:sodium antiporter activity [GO_1903281]
- 4660: positive regulation of cAMP-dependent protein kinase activity [GO_2000481]
- 4661: positive regulation of cAMP-mediated signaling [GO_0043950]
- 4662: positive regulation of carbohydrate metabolic process [GO_0045913]
- 4663: positive regulation of cardiac chamber formation [GO_1901212]
- 4664: positive regulation of cardiac chamber morphogenesis [GO_1901221]
- 4665: positive regulation of cardiac conduction [GO_1903781]
- 4666: positive regulation of cardiac muscle adaptation [GO_0010615]
- 4667: positive regulation of cardiac muscle cell apoptotic process [GO_0010666]
- 4668: positive regulation of cardiac muscle cell differentiation [GO_2000727]
- 4669: positive regulation of cardiac muscle cell myoblast differentiation [GO_2000700]
- 4670: positive regulation of cardiac muscle cell proliferation [GO_0060045]
- 4671: positive regulation of cardiac muscle contraction [GO_0060452]
- 4672: positive regulation of cardiac muscle fiber development [GO_0055020]
- 4673: positive regulation of cardiac muscle hypertrophy [GO_0010613]
- 4674: positive regulation of cardiac muscle myoblast proliferation [GO_0110024]
- 4675: positive regulation of cardiac muscle tissue development [GO_0055025]
- 4676: positive regulation of cardiac muscle tissue growth [GO_0055023]
- 4677: positive regulation of cardiac myofibril assembly [GO_1905306]
- 4678: positive regulation of cardiac ventricle development [GO_1904414]
- 4679: positive regulation of cardiac ventricle formation [GO_1904944]
- 4680: positive regulation of cardioblast differentiation [GO_0051891]
- 4681: positive regulation of cardiocyte differentiation [GO_1905209]
- 4682: positive regulation of cartilage development [GO_0061036]
- 4683: positive regulation of catabolic process [GO_0009896]
- 4684: positive regulation of catalase activity [GO_1902553]
- 4685: positive regulation of catalytic activity [GO_0043085]
- 4686: positive regulation of catecholamine metabolic process [GO_0045915]
- 4687: positive regulation of catecholamine secretion [GO_0033605]
- 4688: positive regulation of cation channel activity [GO_2001259]
- 4689: positive regulation of cation transmembrane transport [GO_1904064]
- 4690: positive regulation of CD4 production [GO_0045224]
- 4691: positive regulation of cell adhesion [GO_0045785]
- 4692: positive regulation of cell communication [GO_0010647]
- 4693: positive regulation of cell cycle [GO_0045787]
- 4694: positive regulation of cell cycle process [GO_0090068]
- 4695: positive regulation of cell death [GO_0010942]
- 4696: positive regulation of cell development [GO_0010720]
- 4697: positive regulation of cell differentiation [GO_0045597]
- 4698: positive regulation of cell division [GO_0051781]
- 4699: positive regulation of cell fate commitment [GO_0010455]
- 4700: positive regulation of cell growth [GO_0030307]
- 4701: positive regulation of cell growth involved in cardiac muscle cell development [GO_0061051]
- 4702: positive regulation of cell junction assembly [GO_1901890]
- 4703: positive regulation of cell maturation [GO_1903431]
- 4704: positive regulation of cell migration [GO_0030335]
- 4705: positive regulation of cell morphogenesis involved in differentiation [GO_0010770]
- 4706: positive regulation of cell motility [GO_2000147]
- 4707: positive regulation of cell population proliferation [GO_0008284]
- 4708: positive regulation of cell projection organization [GO_0031346]
- 4709: positive regulation of cell proliferation in midbrain [GO_1904935]
- 4710: positive regulation of cell proliferation involved in compound eye morphogenesis [GO_2000497]
- 4711: positive regulation of cell proliferation involved in heart morphogenesis [GO_2000138]
- 4712: positive regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901964]
- 4713: positive regulation of cell-cell adhesion [GO_0022409]
- 4714: positive regulation of cellular amide metabolic process [GO_0034250]
- 4715: positive regulation of cellular amine catabolic process [GO_0033243]
- 4716: positive regulation of cellular amine metabolic process [GO_0033240]
- 4717: positive regulation of cellular amino acid biosynthetic process [GO_2000284]
- 4718: positive regulation of cellular amino acid metabolic process [GO_0045764]
- 4719: positive regulation of cellular biosynthetic process [GO_0031328]
- 4720: positive regulation of cellular carbohydrate metabolic process [GO_0010676]
- 4721: positive regulation of cellular catabolic process [GO_0031331]
- 4722: positive regulation of cellular component biogenesis [GO_0044089]
- 4723: positive regulation of cellular component movement [GO_0051272]
- 4724: positive regulation of cellular component organization [GO_0051130]
- 4725: positive regulation of cellular metabolic process [GO_0031325]
- 4726: positive regulation of cellular process [GO_0048522]
- 4727: positive regulation of cellular protein metabolic process [GO_0032270]
- 4728: positive regulation of cellular respiration [GO_1901857]
- 4729: positive regulation of cellular response to alcohol [GO_1905959]
- 4730: positive regulation of cellular response to drug [GO_2001040]
- 4731: positive regulation of cellular response to insulin stimulus [GO_1900078]
- 4732: positive regulation of cellular response to oxidative stress [GO_1900409]
- 4733: positive regulation of chemorepellent activity [GO_1903669]
- 4734: positive regulation of chemotaxis [GO_0050921]
- 4735: positive regulation of cholangiocyte apoptotic process [GO_1904194]
- 4736: positive regulation of cholangiocyte proliferation [GO_1904056]
- 4737: positive regulation of chondrocyte development [GO_1902761]
- 4738: positive regulation of chondrocyte differentiation [GO_0032332]
- 4739: positive regulation of chorionic trophoblast cell proliferation [GO_1901384]
- 4740: positive regulation of chromatin assembly or disassembly [GO_0045799]
- 4741: positive regulation of chromatin binding [GO_0035563]
- 4742: positive regulation of chromatin organization [GO_1905269]
- 4743: positive regulation of chromosome condensation [GO_1905821]
- 4744: positive regulation of chromosome organization [GO_2001252]
- 4745: positive regulation of chromosome segregation [GO_0051984]
- 4746: positive regulation of cilium assembly [GO_0045724]
- 4747: positive regulation of circadian rhythm [GO_0042753]
- 4748: positive regulation of circadian sleep/wake cycle, sleep [GO_0045938]
- 4749: positive regulation of CoA-transferase activity [GO_1905920]
- 4750: positive regulation of collagen binding [GO_0033343]
- 4751: positive regulation of collagen biosynthetic process [GO_0032967]
- 4752: positive regulation of collagen catabolic process [GO_0120158]
- 4753: positive regulation of collagen fibril organization [GO_1904028]
- 4754: positive regulation of collagen metabolic process [GO_0010714]
- 4755: positive regulation of colon smooth muscle contraction [GO_1904343]
- 4756: positive regulation of compound eye photoreceptor cell differentiation [GO_0110117]
- 4757: positive regulation of compound eye retinal cell apoptotic process [GO_1901694]
- 4758: positive regulation of compound eye retinal cell programmed cell death [GO_0046672]
- 4759: positive regulation of copper ion transmembrane transport [GO_1902313]
- 4760: positive regulation of core promoter binding [GO_1904798]
- 4761: positive regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060727]
- 4762: positive regulation of cyclase activity [GO_0031281]
- 4763: positive regulation of cyclic nucleotide-gated ion channel activity [GO_1902161]
- 4764: positive regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051343]
- 4765: positive regulation of cyclin-dependent protein kinase activity [GO_1904031]
- 4766: positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045737]
- 4767: positive regulation of cystathionine beta-synthase activity [GO_1904043]
- 4768: positive regulation of cysteine-type endopeptidase activity [GO_2001056]
- 4769: positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043280]
- 4770: positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001272]
- 4771: positive regulation of cytochrome-c oxidase activity [GO_1904960]
- 4772: positive regulation of cytokine activity [GO_0060301]
- 4773: positive regulation of cytokine-mediated signaling pathway [GO_0001961]
- 4774: positive regulation of cytokinesis [GO_0032467]
- 4775: positive regulation of cytoskeleton organization [GO_0051495]
- 4776: positive regulation of D-amino-acid oxidase activity [GO_1900759]
- 4777: positive regulation of D-erythro-sphingosine kinase activity [GO_1900023]
- 4778: positive regulation of deacetylase activity [GO_0090045]
- 4779: positive regulation of defecation [GO_2000294]
- 4780: positive regulation of delayed rectifier potassium channel activity [GO_1902261]
- 4781: positive regulation of deoxyribonuclease activity [GO_0032077]
- 4782: positive regulation of dephosphorylation [GO_0035306]
- 4783: positive regulation of dermatome development [GO_0061184]
- 4784: positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905789]
- 4785: positive regulation of developmental growth [GO_0048639]
- 4786: positive regulation of developmental pigmentation [GO_0048087]
- 4787: positive regulation of developmental process [GO_0051094]
- 4788: positive regulation of diacylglycerol kinase activity [GO_1905689]
- 4789: positive regulation of digestive system process [GO_0060456]
- 4790: positive regulation of dipeptide transmembrane transport [GO_2001150]
- 4791: positive regulation of dipeptide transport [GO_2000880]
- 4792: positive regulation of DNA binding [GO_0043388]
- 4793: positive regulation of DNA biosynthetic process [GO_2000573]
- 4794: positive regulation of DNA duplex unwinding [GO_1905464]
- 4795: positive regulation of DNA helicase activity [GO_1905776]
- 4796: positive regulation of DNA metabolic process [GO_0051054]
- 4797: positive regulation of DNA N-glycosylase activity [GO_1902546]
- 4798: positive regulation of DNA repair [GO_0045739]
- 4799: positive regulation of DNA replication [GO_0045740]
- 4800: positive regulation of DNA replication origin binding [GO_1902597]
- 4801: positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000373]
- 4802: positive regulation of DNA-binding transcription factor activity [GO_0051091]
- 4803: positive regulation of DNA-directed DNA polymerase activity [GO_1900264]
- 4804: positive regulation of DNA-templated DNA replication [GO_2000105]
- 4805: positive regulation of DNA-templated transcription [GO_0045893]
- 4806: positive regulation of dopamine receptor signaling pathway [GO_0060161]
- 4807: positive regulation of dopamine secretion [GO_0033603]
- 4808: positive regulation of double-stranded telomeric DNA binding [GO_1905769]
- 4809: positive regulation of dUTP diphosphatase activity [GO_1903629]
- 4810: positive regulation of eclosion [GO_0045805]
- 4811: positive regulation of ectoderm development [GO_2000385]
- 4812: positive regulation of electron transfer activity [GO_1904734]
- 4813: positive regulation of embryonic camera-type eye development [GO_1902865]
- 4814: positive regulation of embryonic development [GO_0040019]
- 4815: positive regulation of endocytosis [GO_0045807]
- 4816: positive regulation of endodeoxyribonuclease activity [GO_0032079]
- 4817: positive regulation of endodermal cell differentiation [GO_1903226]
- 4818: positive regulation of endopeptidase activity [GO_0010950]
- 4819: positive regulation of endoribonuclease activity [GO_1902380]
- 4820: positive regulation of endothelial cell apoptotic process [GO_2000353]
- 4821: positive regulation of endothelial cell development [GO_1901552]
- 4822: positive regulation of endothelial cell differentiation [GO_0045603]
- 4823: positive regulation of endothelial cell proliferation [GO_0001938]
- 4824: positive regulation of endothelial tube morphogenesis [GO_1905956]
- 4825: positive regulation of entry into reproductive diapause [GO_0061965]
- 4826: positive regulation of ephrin receptor signaling pathway [GO_1901189]
- 4827: positive regulation of epidermal cell differentiation [GO_0045606]
- 4828: positive regulation of epidermal growth factor receptor signaling pathway [GO_0045742]
- 4829: positive regulation of epidermal growth factor-activated receptor activity [GO_0045741]
- 4830: positive regulation of epidermis development [GO_0045684]
- 4831: positive regulation of epithelial cell apoptotic process [GO_1904037]
- 4832: positive regulation of epithelial cell differentiation [GO_0030858]
- 4833: positive regulation of epithelial cell proliferation [GO_0050679]
- 4834: positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO_0060501]
- 4835: positive regulation of epithelial to mesenchymal transition [GO_0010718]
- 4836: positive regulation of epithelial tube formation [GO_1905278]
- 4837: positive regulation of ERBB signaling pathway [GO_1901186]
- 4838: positive regulation of erythrocyte apoptotic process [GO_1902252]
- 4839: positive regulation of erythrocyte differentiation [GO_0045648]
- 4840: positive regulation of establishment of protein localization [GO_1904951]
- 4841: positive regulation of euchromatin binding [GO_1904795]
- 4842: positive regulation of excitatory postsynaptic potential [GO_2000463]
- 4843: positive regulation of execution phase of apoptosis [GO_1900119]
- 4844: positive regulation of exocytosis [GO_0045921]
- 4845: positive regulation of exodeoxyribonuclease activity [GO_1902394]
- 4846: positive regulation of exonuclease activity [GO_1905779]
- 4847: positive regulation of exoribonuclease activity [GO_1901919]
- 4848: positive regulation of exosomal secretion [GO_1903543]
- 4849: positive regulation of extracellular exosome assembly [GO_1903553]
- 4850: positive regulation of extracellular matrix assembly [GO_1901203]
- 4851: positive regulation of extracellular matrix disassembly [GO_0090091]
- 4852: positive regulation of extracellular matrix organization [GO_1903055]
- 4853: positive regulation of eye photoreceptor cell development [GO_0042479]
- 4854: positive regulation of fat cell apoptotic process [GO_1904651]
- 4855: positive regulation of fat cell differentiation [GO_0045600]
- 4856: positive regulation of fat cell proliferation [GO_0070346]
- 4857: positive regulation of fatty acid biosynthetic process [GO_0045723]
- 4858: positive regulation of fatty acid metabolic process [GO_0045923]
- 4859: positive regulation of fatty acid transport [GO_2000193]
- 4860: positive regulation of feeding behavior [GO_2000253]
- 4861: positive regulation of female gonad development [GO_2000196]
- 4862: positive regulation of ferrous iron binding [GO_1904434]
- 4863: positive regulation of fertilization [GO_1905516]
- 4864: positive regulation of fibroblast apoptotic process [GO_2000271]
- 4865: positive regulation of fibroblast growth factor receptor signaling pathway [GO_0045743]
- 4866: positive regulation of fibroblast proliferation [GO_0048146]
- 4867: positive regulation of formation of translation initiation ternary complex [GO_1901192]
- 4868: positive regulation of forward locomotion [GO_1905850]
- 4869: positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060550]
- 4870: positive regulation of G protein-coupled receptor signaling pathway [GO_0045745]
- 4871: positive regulation of G-quadruplex DNA binding [GO_1905495]
- 4872: positive regulation of GABA-A receptor activity [GO_0106041]
- 4873: positive regulation of gamma-aminobutyric acid secretion [GO_0014054]
- 4874: positive regulation of gastric acid secretion [GO_0060454]
- 4875: positive regulation of gastric mucosal blood circulation [GO_1904346]
- 4876: positive regulation of gastro-intestinal system smooth muscle contraction [GO_1904306]
- 4877: positive regulation of gastrulation [GO_2000543]
- 4878: positive regulation of gene expression [GO_0010628]
- 4879: positive regulation of germ cell proliferation [GO_1905938]
- 4880: positive regulation of glial cell apoptotic process [GO_0034352]
- 4881: positive regulation of glial cell differentiation [GO_0045687]
- 4882: positive regulation of glial cell proliferation [GO_0060252]
- 4883: positive regulation of gliogenesis [GO_0014015]
- 4884: positive regulation of glucagon secretion [GO_0070094]
- 4885: positive regulation of glucokinase activity [GO_0033133]
- 4886: positive regulation of gluconeogenesis [GO_0045722]
- 4887: positive regulation of glucose metabolic process [GO_0010907]
- 4888: positive regulation of glucose transmembrane transport [GO_0010828]
- 4889: positive regulation of glucosylceramidase activity [GO_1905125]
- 4890: positive regulation of glucuronosyltransferase activity [GO_1904225]
- 4891: positive regulation of glutamate receptor signaling pathway [GO_1900451]
- 4892: positive regulation of glutamate secretion [GO_0014049]
- 4893: positive regulation of glutamate secretion, neurotransmission [GO_1903296]
- 4894: positive regulation of glutamate-ammonia ligase activity [GO_1905480]
- 4895: positive regulation of glutamate-cysteine ligase activity [GO_0035229]
- 4896: positive regulation of glutathione biosynthetic process [GO_1903788]
- 4897: positive regulation of glutathione peroxidase activity [GO_1903284]
- 4898: positive regulation of glycine hydroxymethyltransferase activity [GO_0080114]
- 4899: positive regulation of glycine secretion, neurotransmission [GO_1904626]
- 4900: positive regulation of glycogen (starch) synthase activity [GO_2000467]
- 4901: positive regulation of glycogen biosynthetic process [GO_0045725]
- 4902: positive regulation of glycogen catabolic process [GO_0045819]
- 4903: positive regulation of glycogen metabolic process [GO_0070875]
- 4904: positive regulation of glycolytic process [GO_0045821]
- 4905: positive regulation of glycolytic process through fructose-6-phosphate [GO_1904540]
- 4906: positive regulation of glycoprotein biosynthetic process [GO_0010560]
- 4907: positive regulation of glycoprotein metabolic process [GO_1903020]
- 4908: positive regulation of Golgi to plasma membrane protein transport [GO_0042998]
- 4909: positive regulation of gonad development [GO_1905941]
- 4910: positive regulation of growth [GO_0045927]
- 4911: positive regulation of GTP binding [GO_1904426]
- 4912: positive regulation of GTP cyclohydrolase I activity [GO_0043104]
- 4913: positive regulation of GTPase activity [GO_0043547]
- 4914: positive regulation of guanyl-nucleotide exchange factor activity [GO_1905099]
- 4915: positive regulation of guanylate cyclase activity [GO_0031284]
- 4916: positive regulation of heart contraction [GO_0045823]
- 4917: positive regulation of heart growth [GO_0060421]
- 4918: positive regulation of helicase activity [GO_0051096]
- 4919: positive regulation of hematopoietic progenitor cell differentiation [GO_1901534]
- 4920: positive regulation of hematopoietic stem cell differentiation [GO_1902038]
- 4921: positive regulation of hematopoietic stem cell proliferation [GO_1902035]
- 4922: positive regulation of heme oxygenase activity [GO_0061961]
- 4923: positive regulation of hemopoiesis [GO_1903708]
- 4924: positive regulation of heparan sulfate proteoglycan binding [GO_1905860]
- 4925: positive regulation of hepatocyte apoptotic process [GO_1903945]
- 4926: positive regulation of hepatocyte differentiation [GO_0070368]
- 4927: positive regulation of heterochromatin assembly [GO_0031453]
- 4928: positive regulation of heterochromatin organization [GO_0120263]
- 4929: positive regulation of hexokinase activity [GO_1903301]
- 4930: positive regulation of high voltage-gated calcium channel activity [GO_1901843]
- 4931: positive regulation of hindgut contraction [GO_0060450]
- 4932: positive regulation of histone deacetylase activity [GO_1901727]
- 4933: positive regulation of histone deacetylation [GO_0031065]
- 4934: positive regulation of histone demethylase activity (H3-K4 specific) [GO_1904175]
- 4935: positive regulation of histone modification [GO_0031058]
- 4936: positive regulation of hormone metabolic process [GO_0032352]
- 4937: positive regulation of hormone secretion [GO_0046887]
- 4938: positive regulation of hyaluronan biosynthetic process [GO_1900127]
- 4939: positive regulation of hydrolase activity [GO_0051345]
- 4940: positive regulation of immune effector process [GO_0002699]
- 4941: positive regulation of immune response [GO_0050778]
- 4942: positive regulation of immune system process [GO_0002684]
- 4943: positive regulation of inorganic anion transmembrane transport [GO_1903797]
- 4944: positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031587]
- 4945: positive regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010925]
- 4946: positive regulation of insulin receptor signaling pathway [GO_0046628]
- 4947: positive regulation of insulin secretion [GO_0032024]
- 4948: positive regulation of intestinal absorption [GO_1904480]
- 4949: positive regulation of intestinal epithelial cell development [GO_1905300]
- 4950: positive regulation of intracellular calcium activated chloride channel activity [GO_1902940]
- 4951: positive regulation of intracellular lipid transport [GO_0032379]
- 4952: positive regulation of intracellular protein transport [GO_0090316]
- 4953: positive regulation of intracellular signal transduction [GO_1902533]
- 4954: positive regulation of intracellular sterol transport [GO_0032382]
- 4955: positive regulation of intracellular transport [GO_0032388]
- 4956: positive regulation of inward rectifier potassium channel activity [GO_1901980]
- 4957: positive regulation of ion transmembrane transport [GO_0034767]
- 4958: positive regulation of ion transmembrane transporter activity [GO_0032414]
- 4959: positive regulation of ion transport [GO_0043270]
- 4960: positive regulation of iron ion transmembrane transport [GO_0034761]
- 4961: positive regulation of iron ion transmembrane transporter activity [GO_1904256]
- 4962: positive regulation of iron ion transport [GO_0034758]
- 4963: positive regulation of isomerase activity [GO_0010912]
- 4964: positive regulation of isoprenoid metabolic process [GO_0045828]
- 4965: positive regulation of JNK cascade [GO_0046330]
- 4966: positive regulation of JUN kinase activity [GO_0043507]
- 4967: positive regulation of kinase activity [GO_0033674]
- 4968: positive regulation of L-dopa decarboxylase activity [GO_1903200]
- 4969: positive regulation of large conductance calcium-activated potassium channel activity [GO_1902608]
- 4970: positive regulation of leukocyte apoptotic process [GO_2000108]
- 4971: positive regulation of leukocyte differentiation [GO_1902107]
- 4972: positive regulation of leukocyte mediated immunity [GO_0002705]
- 4973: positive regulation of leukocyte proliferation [GO_0070665]
- 4974: positive regulation of ligase activity [GO_0051351]
- 4975: positive regulation of light-activated channel activity [GO_0045832]
- 4976: positive regulation of lipase activity [GO_0060193]
- 4977: positive regulation of lipid binding [GO_1900132]
- 4978: positive regulation of lipid biosynthetic process [GO_0046889]
- 4979: positive regulation of lipid catabolic process [GO_0050996]
- 4980: positive regulation of lipid kinase activity [GO_0090218]
- 4981: positive regulation of lipid localization [GO_1905954]
- 4982: positive regulation of lipid metabolic process [GO_0045834]
- 4983: positive regulation of lipid storage [GO_0010884]
- 4984: positive regulation of lipid transport [GO_0032370]
- 4985: positive regulation of lipid transporter activity [GO_0110113]
- 4986: positive regulation of lipopolysaccharide-mediated signaling pathway [GO_0031666]
- 4987: positive regulation of lipoprotein lipase activity [GO_0051006]
- 4988: positive regulation of locomotion [GO_0040017]
- 4989: positive regulation of locomotion involved in locomotory behavior [GO_0090326]
- 4990: positive regulation of locomotor rhythm [GO_1904061]
- 4991: positive regulation of low-density lipoprotein particle receptor binding [GO_1905597]
- 4992: positive regulation of low-density lipoprotein receptor activity [GO_1905599]
- 4993: positive regulation of lung ciliated cell differentiation [GO_1901248]
- 4994: positive regulation of lyase activity [GO_0051349]
- 4995: positive regulation of Lys63-specific deubiquitinase activity [GO_1903007]
- 4996: positive regulation of lysozyme activity [GO_1903592]
- 4997: positive regulation of m7G(5')pppN diphosphatase activity [GO_1903399]
- 4998: positive regulation of macromolecule biosynthetic process [GO_0010557]
- 4999: positive regulation of macromolecule metabolic process [GO_0010604]
- 5000: positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903220]
- 5001: positive regulation of male mating behavior [GO_1902437]
- 5002: positive regulation of MAP kinase activity [GO_0043406]
- 5003: positive regulation of MAPK cascade [GO_0043410]
- 5004: positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO_0090080]
- 5005: positive regulation of megakaryocyte differentiation [GO_0045654]
- 5006: positive regulation of meiotic cell cycle [GO_0051446]
- 5007: positive regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904146]
- 5008: positive regulation of meiotic nuclear division [GO_0045836]
- 5009: positive regulation of membrane invagination [GO_1905155]
- 5010: positive regulation of mesenchymal cell apoptotic process [GO_2001055]
- 5011: positive regulation of mesenchymal cell proliferation [GO_0002053]
- 5012: positive regulation of mesenchymal cell proliferation involved in lung development [GO_2000792]
- 5013: positive regulation of mesoderm development [GO_2000382]
- 5014: positive regulation of mesoderm formation [GO_1905904]
- 5015: positive regulation of mesodermal cell differentiation [GO_1905772]
- 5016: positive regulation of metabolic process [GO_0009893]
- 5017: positive regulation of metalloendopeptidase activity [GO_1904685]
- 5018: positive regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902964]
- 5019: positive regulation of metallopeptidase activity [GO_1905050]
- 5020: positive regulation of methionine-tRNA ligase activity [GO_1905020]
- 5021: positive regulation of microtubule binding [GO_1904528]
- 5022: positive regulation of microtubule depolymerization [GO_0031117]
- 5023: positive regulation of microtubule minus-end binding [GO_1902620]
- 5024: positive regulation of microtubule nucleation [GO_0090063]
- 5025: positive regulation of microtubule plus-end binding [GO_1903033]
- 5026: positive regulation of microtubule polymerization [GO_0031116]
- 5027: positive regulation of microtubule polymerization or depolymerization [GO_0031112]
- 5028: positive regulation of microvillus assembly [GO_1903698]
- 5029: positive regulation of miRNA-mediated gene silencing [GO_2000637]
- 5030: positive regulation of mitochondrial DNA metabolic process [GO_1901860]
- 5031: positive regulation of mitochondrial DNA replication [GO_0090297]
- 5032: positive regulation of mitochondrial mRNA catabolic process [GO_1905639]
- 5033: positive regulation of mitochondrial RNA catabolic process [GO_0000962]
- 5034: positive regulation of mitochondrial transcription [GO_1903109]
- 5035: positive regulation of mitochondrial translation [GO_0070131]
- 5036: positive regulation of mitochondrial translation in response to stress [GO_0010892]
- 5037: positive regulation of mitochondrial translational elongation [GO_1905084]
- 5038: positive regulation of mitochondrial translational initiation [GO_0070134]
- 5039: positive regulation of mitochondrion organization [GO_0010822]
- 5040: positive regulation of mitotic cell cycle [GO_0045931]
- 5041: positive regulation of mitotic cell cycle DNA replication [GO_1903465]
- 5042: positive regulation of mitotic cell cycle, embryonic [GO_0045977]
- 5043: positive regulation of mitotic chromosome condensation [GO_1903380]
- 5044: positive regulation of mitotic nuclear division [GO_0045840]
- 5045: positive regulation of mitotic nuclear envelope disassembly [GO_1905559]
- 5046: positive regulation of mitotic sister chromatid segregation [GO_0062033]
- 5047: positive regulation of molecular function [GO_0044093]
- 5048: positive regulation of mononuclear cell proliferation [GO_0032946]
- 5049: positive regulation of monooxygenase activity [GO_0032770]
- 5050: positive regulation of morphogenesis of an epithelium [GO_1905332]
- 5051: positive regulation of motor neuron apoptotic process [GO_2000673]
- 5052: positive regulation of mRNA 3'-UTR binding [GO_1903839]
- 5053: positive regulation of mRNA binding [GO_1902416]
- 5054: positive regulation of mRNA catabolic process [GO_0061014]
- 5055: positive regulation of mRNA metabolic process [GO_1903313]
- 5056: positive regulation of mucus secretion [GO_0070257]
- 5057: positive regulation of multicellular organism growth [GO_0040018]
- 5058: positive regulation of multicellular organismal process [GO_0051240]
- 5059: positive regulation of muscle adaptation [GO_0014744]
- 5060: positive regulation of muscle cell apoptotic process [GO_0010661]
- 5061: positive regulation of muscle cell differentiation [GO_0051149]
- 5062: positive regulation of muscle contraction [GO_0045933]
- 5063: positive regulation of muscle hypertrophy [GO_0014742]
- 5064: positive regulation of muscle organ development [GO_0048636]
- 5065: positive regulation of muscle tissue development [GO_1901863]
- 5066: positive regulation of myeloid cell apoptotic process [GO_0033034]
- 5067: positive regulation of myeloid cell differentiation [GO_0045639]
- 5068: positive regulation of myeloid leukocyte differentiation [GO_0002763]
- 5069: positive regulation of myeloid leukocyte mediated immunity [GO_0002888]
- 5070: positive regulation of myeloid progenitor cell differentiation [GO_1905455]
- 5071: positive regulation of myoblast differentiation [GO_0045663]
- 5072: positive regulation of myoblast proliferation [GO_2000288]
- 5073: positive regulation of myosin light chain kinase activity [GO_0035505]
- 5074: positive regulation of myotome development [GO_2000287]
- 5075: positive regulation of myotube differentiation [GO_0010831]
- 5076: positive regulation of NAD+ ADP-ribosyltransferase activity [GO_1901666]
- 5077: positive regulation of NAD+ kinase activity [GO_0033672]
- 5078: positive regulation of negative chemotaxis [GO_0050924]
- 5079: positive regulation of nervous system development [GO_0051962]
- 5080: positive regulation of nervous system process [GO_0031646]
- 5081: positive regulation of netrin-activated signaling pathway [GO_1902843]
- 5082: positive regulation of neural crest cell differentiation [GO_1905294]
- 5083: positive regulation of neural crest formation [GO_0090300]
- 5084: positive regulation of neural precursor cell proliferation [GO_2000179]
- 5085: positive regulation of neural retina development [GO_0061075]
- 5086: positive regulation of neuroblast proliferation [GO_0002052]
- 5087: positive regulation of neuroepithelial cell differentiation [GO_1902913]
- 5088: positive regulation of neurogenesis [GO_0050769]
- 5089: positive regulation of neuromuscular junction development [GO_1904398]
- 5090: positive regulation of neuron apoptotic process [GO_0043525]
- 5091: positive regulation of neuron death [GO_1901216]
- 5092: positive regulation of neuron differentiation [GO_0045666]
- 5093: positive regulation of neuron maturation [GO_0014042]
- 5094: positive regulation of neuron projection development [GO_0010976]
- 5095: positive regulation of neuronal action potential [GO_1904457]
- 5096: positive regulation of neurotransmitter secretion [GO_0001956]
- 5097: positive regulation of neurotransmitter transport [GO_0051590]
- 5098: positive regulation of neurotransmitter uptake [GO_0051582]
- 5099: positive regulation of nitric-oxide synthase activity [GO_0051000]
- 5100: positive regulation of nitrogen compound metabolic process [GO_0051173]
- 5101: positive regulation of NMDA glutamate receptor activity [GO_1904783]
- 5102: positive regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903997]
- 5103: positive regulation of norepinephrine secretion [GO_0010701]
- 5104: positive regulation of norepinephrine uptake [GO_0051623]
- 5105: positive regulation of nuclear cell cycle DNA replication [GO_0010571]
- 5106: positive regulation of nuclear division [GO_0051785]
- 5107: positive regulation of nuclear migration along microtubule [GO_1902840]
- 5108: positive regulation of nuclease activity [GO_0032075]
- 5109: positive regulation of nucleic acid-templated transcription [GO_1903508]
- 5110: positive regulation of nucleobase-containing compound metabolic process [GO_0045935]
- 5111: positive regulation of nucleobase-containing compound transport [GO_0032241]
- 5112: positive regulation of nucleocytoplasmic transport [GO_0046824]
- 5113: positive regulation of nucleoside metabolic process [GO_0045979]
- 5114: positive regulation of nucleoside transport [GO_0032244]
- 5115: positive regulation of nucleotide biosynthetic process [GO_0030810]
- 5116: positive regulation of nucleotide metabolic process [GO_0045981]
- 5117: positive regulation of oligopeptide transport [GO_2000878]
- 5118: positive regulation of oocyte development [GO_0060282]
- 5119: positive regulation of oocyte maturation [GO_1900195]
- 5120: positive regulation of oogenesis [GO_1905881]
- 5121: positive regulation of organ growth [GO_0046622]
- 5122: positive regulation of organelle assembly [GO_1902117]
- 5123: positive regulation of organelle organization [GO_0010638]
- 5124: positive regulation of organic acid transport [GO_0032892]
- 5125: positive regulation of ossification [GO_0045778]
- 5126: positive regulation of oviposition [GO_1901046]
- 5127: positive regulation of oxidative phosphorylation [GO_1903862]
- 5128: positive regulation of oxidoreductase activity [GO_0051353]
- 5129: positive regulation of oxygen metabolic process [GO_2000376]
- 5130: positive regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903408]
- 5131: positive regulation of pancreatic A cell differentiation [GO_2000228]
- 5132: positive regulation of peptidase activity [GO_0010952]
- 5133: positive regulation of peptide hormone secretion [GO_0090277]
- 5134: positive regulation of peptide secretion [GO_0002793]
- 5135: positive regulation of peptidyl-tyrosine phosphorylation [GO_0050731]
- 5136: positive regulation of peroxidase activity [GO_2000470]
- 5137: positive regulation of pharynx morphogenesis [GO_0110043]
- 5138: positive regulation of phosphatase activity [GO_0010922]
- 5139: positive regulation of phosphate metabolic process [GO_0045937]
- 5140: positive regulation of phosphate transmembrane transport [GO_2000187]
- 5141: positive regulation of phosphatidate phosphatase activity [GO_1903740]
- 5142: positive regulation of phosphatidylcholine biosynthetic process [GO_2001247]
- 5143: positive regulation of phosphatidylcholine metabolic process [GO_0150173]
- 5144: positive regulation of phosphatidylinositol 3-kinase activity [GO_0043552]
- 5145: positive regulation of phosphatidylinositol biosynthetic process [GO_0010513]
- 5146: positive regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120139]
- 5147: positive regulation of phospholipase A2 activity [GO_0032430]
- 5148: positive regulation of phospholipase activity [GO_0010518]
- 5149: positive regulation of phospholipase C activity [GO_0010863]
- 5150: positive regulation of phospholipase D activity [GO_1904007]
- 5151: positive regulation of phospholipid biosynthetic process [GO_0071073]
- 5152: positive regulation of phospholipid metabolic process [GO_1903727]
- 5153: positive regulation of phospholipid scramblase activity [GO_1900163]
- 5154: positive regulation of phospholipid translocation [GO_0061092]
- 5155: positive regulation of phospholipid transport [GO_2001140]
- 5156: positive regulation of phosphoprotein phosphatase activity [GO_0032516]
- 5157: positive regulation of phosphorus metabolic process [GO_0010562]
- 5158: positive regulation of phosphorylation [GO_0042327]
- 5159: positive regulation of photoreceptor cell differentiation [GO_0046534]
- 5160: positive regulation of pigment cell differentiation [GO_0050942]
- 5161: positive regulation of placenta blood vessel development [GO_0110080]
- 5162: positive regulation of plasma membrane bounded cell projection assembly [GO_0120034]
- 5163: positive regulation of poly(A)-specific ribonuclease activity [GO_0106248]
- 5164: positive regulation of polyamine transmembrane transport [GO_1902269]
- 5165: positive regulation of polynucleotide adenylyltransferase activity [GO_1904247]
- 5166: positive regulation of polysome binding [GO_1905698]
- 5167: positive regulation of positive chemotaxis [GO_0050927]
- 5168: positive regulation of post-embryonic development [GO_0048582]
- 5169: positive regulation of post-transcriptional gene silencing [GO_0060148]
- 5170: positive regulation of post-transcriptional gene silencing by RNA [GO_1900370]
- 5171: positive regulation of potassium ion transmembrane transport [GO_1901381]
- 5172: positive regulation of potassium ion transmembrane transporter activity [GO_1901018]
- 5173: positive regulation of potassium ion transport [GO_0043268]
- 5174: positive regulation of presynapse assembly [GO_1905608]
- 5175: positive regulation of programmed cell death [GO_0043068]
- 5176: positive regulation of prostaglandin-E synthase activity [GO_2000363]
- 5177: positive regulation of proteasomal protein catabolic process [GO_1901800]
- 5178: positive regulation of protein binding [GO_0032092]
- 5179: positive regulation of protein catabolic process [GO_0045732]
- 5180: positive regulation of protein catabolic process in the vacuole [GO_1904352]
- 5181: positive regulation of protein deacetylation [GO_0090312]
- 5182: positive regulation of protein dephosphorylation [GO_0035307]
- 5183: positive regulation of protein depolymerization [GO_1901881]
- 5184: positive regulation of protein deubiquitination [GO_1903003]
- 5185: positive regulation of protein folding [GO_1903334]
- 5186: positive regulation of protein homodimerization activity [GO_0090073]
- 5187: positive regulation of protein K63-linked deubiquitination [GO_1903006]
- 5188: positive regulation of protein kinase activity [GO_0045860]
- 5189: positive regulation of protein kinase C activity [GO_1900020]
- 5190: positive regulation of protein localization [GO_1903829]
- 5191: positive regulation of protein localization to cell cortex [GO_1904778]
- 5192: positive regulation of protein localization to cell leading edge [GO_1905873]
- 5193: positive regulation of protein localization to cell periphery [GO_1904377]
- 5194: positive regulation of protein localization to cell-cell junction [GO_0150107]
- 5195: positive regulation of protein localization to chromatin [GO_0120187]
- 5196: positive regulation of protein localization to ciliary membrane [GO_1903569]
- 5197: positive regulation of protein localization to cilium [GO_1903566]
- 5198: positive regulation of protein localization to membrane [GO_1905477]
- 5199: positive regulation of protein localization to nucleolus [GO_1904751]
- 5200: positive regulation of protein localization to nucleus [GO_1900182]
- 5201: positive regulation of protein localization to plasma membrane [GO_1903078]
- 5202: positive regulation of protein localization to presynapse [GO_1905386]
- 5203: positive regulation of protein localization to synapse [GO_1902474]
- 5204: positive regulation of protein metabolic process [GO_0051247]
- 5205: positive regulation of protein modification by small protein conjugation or removal [GO_1903322]
- 5206: positive regulation of protein modification process [GO_0031401]
- 5207: positive regulation of protein phosphorylation [GO_0001934]
- 5208: positive regulation of protein polymerization [GO_0032273]
- 5209: positive regulation of protein secretion [GO_0050714]
- 5210: positive regulation of protein serine/threonine kinase activity [GO_0071902]
- 5211: positive regulation of protein serine/threonine phosphatase activity [GO_1905184]
- 5212: positive regulation of protein sumoylation [GO_0033235]
- 5213: positive regulation of protein transport [GO_0051222]
- 5214: positive regulation of protein tyrosine kinase activity [GO_0061098]
- 5215: positive regulation of protein tyrosine phosphatase activity [GO_1903615]
- 5216: positive regulation of protein ubiquitination [GO_0031398]
- 5217: positive regulation of protein-containing complex assembly [GO_0031334]
- 5218: positive regulation of protein-containing complex disassembly [GO_0043243]
- 5219: positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150074]
- 5220: positive regulation of proteolysis [GO_0045862]
- 5221: positive regulation of proteolysis involved in protein catabolic process [GO_1903052]
- 5222: positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905273]
- 5223: positive regulation of purine nucleotide biosynthetic process [GO_1900373]
- 5224: positive regulation of purine nucleotide metabolic process [GO_1900544]
- 5225: positive regulation of pyrimidine nucleotide biosynthetic process [GO_1900399]
- 5226: positive regulation of pyrroline-5-carboxylate reductase activity [GO_1903168]
- 5227: positive regulation of pyruvate dehydrogenase activity [GO_1904184]
- 5228: positive regulation of pyruvate kinase activity [GO_1903304]
- 5229: positive regulation of reactive oxygen species metabolic process [GO_2000379]
- 5230: positive regulation of receptor binding [GO_1900122]
- 5231: positive regulation of receptor-mediated endocytosis [GO_0048260]
- 5232: positive regulation of release of sequestered calcium ion into cytosol [GO_0051281]
- 5233: positive regulation of removal of superoxide radicals [GO_1904833]
- 5234: positive regulation of reproductive process [GO_2000243]
- 5235: positive regulation of respiratory gaseous exchange [GO_1903942]
- 5236: positive regulation of response to alcohol [GO_1901421]
- 5237: positive regulation of response to biotic stimulus [GO_0002833]
- 5238: positive regulation of response to calcium ion [GO_1905947]
- 5239: positive regulation of response to cytokine stimulus [GO_0060760]
- 5240: positive regulation of response to DNA damage stimulus [GO_2001022]
- 5241: positive regulation of response to drug [GO_2001025]
- 5242: positive regulation of response to external stimulus [GO_0032103]
- 5243: positive regulation of response to extracellular stimulus [GO_0032106]
- 5244: positive regulation of response to nutrient levels [GO_0032109]
- 5245: positive regulation of response to oxidative stress [GO_1902884]
- 5246: positive regulation of response to reactive oxygen species [GO_1901033]
- 5247: positive regulation of response to stimulus [GO_0048584]
- 5248: positive regulation of response to wounding [GO_1903036]
- 5249: positive regulation of retina development in camera-type eye [GO_1902868]
- 5250: positive regulation of retinal cell programmed cell death [GO_0046670]
- 5251: positive regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905434]
- 5252: positive regulation of ribosome biogenesis [GO_0090070]
- 5253: positive regulation of RNA binding [GO_1905216]
- 5254: positive regulation of RNA biosynthetic process [GO_1902680]
- 5255: positive regulation of RNA metabolic process [GO_0051254]
- 5256: positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1905636]
- 5257: positive regulation of rRNA processing [GO_2000234]
- 5258: positive regulation of ryanodine-sensitive calcium-release channel activity [GO_0060316]
- 5259: positive regulation of saliva secretion [GO_0046878]
- 5260: positive regulation of sarcomere organization [GO_0060298]
- 5261: positive regulation of sclerotome development [GO_0061189]
- 5262: positive regulation of secondary metabolite biosynthetic process [GO_1900378]
- 5263: positive regulation of secretion [GO_0051047]
- 5264: positive regulation of secretion by cell [GO_1903532]
- 5265: positive regulation of secretory granule organization [GO_1904411]
- 5266: positive regulation of semaphorin-plexin signaling pathway [GO_2001262]
- 5267: positive regulation of sensory perception of bitter taste [GO_1904662]
- 5268: positive regulation of sensory perception of pain [GO_1904058]
- 5269: positive regulation of sensory perception of sweet taste [GO_1904658]
- 5270: positive regulation of sequestering of calcium ion [GO_0051284]
- 5271: positive regulation of serine C-palmitoyltransferase activity [GO_1904222]
- 5272: positive regulation of serine-type endopeptidase activity [GO_1900005]
- 5273: positive regulation of serine-type peptidase activity [GO_1902573]
- 5274: positive regulation of serotonin biosynthetic process [GO_1905629]
- 5275: positive regulation of serotonin secretion [GO_0014064]
- 5276: positive regulation of serotonin uptake [GO_0051613]
- 5277: positive regulation of signal transduction [GO_0009967]
- 5278: positive regulation of signaling [GO_0023056]
- 5279: positive regulation of signaling receptor activity [GO_2000273]
- 5280: positive regulation of single-stranded telomeric DNA binding [GO_0060381]
- 5281: positive regulation of skeletal muscle cell differentiation [GO_2001016]
- 5282: positive regulation of skeletal muscle cell proliferation [GO_0014858]
- 5283: positive regulation of skeletal muscle fiber development [GO_0048743]
- 5284: positive regulation of skeletal muscle fiber differentiation [GO_1902811]
- 5285: positive regulation of skeletal muscle hypertrophy [GO_1904206]
- 5286: positive regulation of skeletal muscle tissue development [GO_0048643]
- 5287: positive regulation of skeletal muscle tissue growth [GO_0048633]
- 5288: positive regulation of small GTPase binding [GO_1904477]
- 5289: positive regulation of small intestine smooth muscle contraction [GO_1904349]
- 5290: positive regulation of small molecule metabolic process [GO_0062013]
- 5291: positive regulation of smooth muscle cell apoptotic process [GO_0034393]
- 5292: positive regulation of smooth muscle cell differentiation [GO_0051152]
- 5293: positive regulation of smooth muscle cell proliferation [GO_0048661]
- 5294: positive regulation of smooth muscle contraction [GO_0045987]
- 5295: positive regulation of smooth muscle hypertrophy [GO_1905149]
- 5296: positive regulation of smooth muscle tissue development [GO_1905901]
- 5297: positive regulation of sodium ion transmembrane transport [GO_1902307]
- 5298: positive regulation of sodium ion transmembrane transporter activity [GO_2000651]
- 5299: positive regulation of sodium ion transport [GO_0010765]
- 5300: positive regulation of sodium:proton antiporter activity [GO_0032417]
- 5301: positive regulation of somatic stem cell division [GO_1904677]
- 5302: positive regulation of somatostatin secretion [GO_0090274]
- 5303: positive regulation of stem cell differentiation [GO_2000738]
- 5304: positive regulation of stem cell proliferation [GO_2000648]
- 5305: positive regulation of steroid biosynthetic process [GO_0010893]
- 5306: positive regulation of steroid hormone secretion [GO_2000833]
- 5307: positive regulation of steroid metabolic process [GO_0045940]
- 5308: positive regulation of sterol transport [GO_0032373]
- 5309: positive regulation of store-operated calcium channel activity [GO_1901341]
- 5310: positive regulation of stress-activated MAPK cascade [GO_0032874]
- 5311: positive regulation of stress-activated protein kinase signaling cascade [GO_0070304]
- 5312: positive regulation of striated muscle cell apoptotic process [GO_0010663]
- 5313: positive regulation of striated muscle cell differentiation [GO_0051155]
- 5314: positive regulation of striated muscle contraction [GO_0045989]
- 5315: positive regulation of striated muscle tissue development [GO_0045844]
- 5316: positive regulation of succinate dehydrogenase activity [GO_1904231]
- 5317: positive regulation of sulfur metabolic process [GO_0051176]
- 5318: positive regulation of SUMO transferase activity [GO_1903755]
- 5319: positive regulation of superoxide dismutase activity [GO_1901671]
- 5320: positive regulation of supramolecular fiber organization [GO_1902905]
- 5321: positive regulation of synapse assembly [GO_0051965]
- 5322: positive regulation of synapse pruning [GO_1905808]
- 5323: positive regulation of synaptic transmission [GO_0050806]
- 5324: positive regulation of synaptic transmission, cholinergic [GO_0032224]
- 5325: positive regulation of synaptic transmission, dopaminergic [GO_0032226]
- 5326: positive regulation of synaptic transmission, GABAergic [GO_0032230]
- 5327: positive regulation of synaptic transmission, glutamatergic [GO_0051968]
- 5328: positive regulation of synaptic transmission, glycinergic [GO_0060094]
- 5329: positive regulation of syncytium formation by plasma membrane fusion [GO_0060143]
- 5330: positive regulation of tau-protein kinase activity [GO_1902949]
- 5331: positive regulation of telomerase activity [GO_0051973]
- 5332: positive regulation of telomeric DNA binding [GO_1904744]
- 5333: positive regulation of termination of DNA-templated transcription [GO_0060566]
- 5334: positive regulation of tetrapyrrole biosynthetic process [GO_1901465]
- 5335: positive regulation of tetrapyrrole catabolic process [GO_1901406]
- 5336: positive regulation of tetrapyrrole metabolic process [GO_1901403]
- 5337: positive regulation of threonine-tRNA ligase activity [GO_1905023]
- 5338: positive regulation of transcription by RNA polymerase I [GO_0045943]
- 5339: positive regulation of transcription by RNA polymerase II [GO_0045944]
- 5340: positive regulation of transcription by RNA polymerase III [GO_0045945]
- 5341: positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO_1901522]
- 5342: positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation [GO_1904081]
- 5343: positive regulation of transcription regulatory region DNA binding [GO_2000679]
- 5344: positive regulation of transferase activity [GO_0051347]
- 5345: positive regulation of translation [GO_0045727]
- 5346: positive regulation of translation in response to oxidative stress [GO_0032939]
- 5347: positive regulation of translation in response to stress [GO_0032056]
- 5348: positive regulation of translational elongation [GO_0045901]
- 5349: positive regulation of translational initiation [GO_0045948]
- 5350: positive regulation of translational initiation in response to stress [GO_0032058]
- 5351: positive regulation of translational termination [GO_0045905]
- 5352: positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090100]
- 5353: positive regulation of transmembrane transport [GO_0034764]
- 5354: positive regulation of transmission of nerve impulse [GO_0051971]
- 5355: positive regulation of transport [GO_0051050]
- 5356: positive regulation of transporter activity [GO_0032411]
- 5357: positive regulation of triglyceride biosynthetic process [GO_0010867]
- 5358: positive regulation of triglyceride lipase activity [GO_0061365]
- 5359: positive regulation of triglyceride metabolic process [GO_0090208]
- 5360: positive regulation of tRNA metabolic process [GO_1903328]
- 5361: positive regulation of tRNA methylation [GO_0110004]
- 5362: positive regulation of tRNA processing [GO_2000237]
- 5363: positive regulation of trophectodermal cell proliferation [GO_1904075]
- 5364: positive regulation of turning behavior involved in mating [GO_0061095]
- 5365: positive regulation of type B pancreatic cell apoptotic process [GO_2000676]
- 5366: positive regulation of type B pancreatic cell development [GO_2000078]
- 5367: positive regulation of type B pancreatic cell proliferation [GO_1904692]
- 5368: positive regulation of tyrosinase activity [GO_0032773]
- 5369: positive regulation of tyrosine 3-monooxygenase activity [GO_1903178]
- 5370: positive regulation of ubiquitin protein ligase activity [GO_1904668]
- 5371: positive regulation of ubiquitin-dependent protein catabolic process [GO_2000060]
- 5372: positive regulation of ubiquitin-protein transferase activity [GO_0051443]
- 5373: positive regulation of ubiquitin-specific protease activity [GO_2000158]
- 5374: positive regulation of vacuolar transport [GO_1903337]
- 5375: positive regulation of vacuole organization [GO_0044090]
- 5376: positive regulation of vascular associated smooth muscle cell apoptotic process [GO_1905461]
- 5377: positive regulation of vascular associated smooth muscle cell differentiation [GO_1905065]
- 5378: positive regulation of vascular associated smooth muscle cell proliferation [GO_1904707]
- 5379: positive regulation of vascular endothelial cell proliferation [GO_1905564]
- 5380: positive regulation of vasculature development [GO_1904018]
- 5381: positive regulation of vasculogenesis [GO_2001214]
- 5382: positive regulation of vesicle fusion [GO_0031340]
- 5383: positive regulation of vesicle fusion with Golgi apparatus [GO_0106216]
- 5384: positive regulation of vesicle transport along microtubule [GO_1901610]
- 5385: positive regulation of vitamin D 24-hydroxylase activity [GO_0010980]
- 5386: positive regulation of vitamin metabolic process [GO_0046136]
- 5387: positive regulation of voltage-gated calcium channel activity [GO_1901387]
- 5388: positive regulation of voltage-gated chloride channel activity [GO_1902943]
- 5389: positive regulation of voltage-gated potassium channel activity [GO_1903818]
- 5390: positive regulation of voltage-gated sodium channel activity [GO_1905152]
- 5391: positive regulation of water channel activity [GO_1902429]
- 5392: positive regulation of Wnt signaling pathway [GO_0030177]
- 5393: positive regulation of Wnt signaling pathway by BMP signaling pathway [GO_0060804]
- 5394: positive regulation of wound healing [GO_0090303]
- 5395: post-embryonic development [GO_0009791]
- 5396: post-Golgi vesicle-mediated transport [GO_0006892]
- 5397: post-transcriptional gene silencing [GO_0016441]
- 5398: postsynapse [GO_0098794]
- 5399: postsynapse assembly [GO_0099068]
- 5400: postsynapse of neuromuscular junction [GO_0098975]
- 5401: postsynapse organization [GO_0099173]
- 5402: postsynaptic actin cytoskeleton [GO_0098871]
- 5403: postsynaptic actin cytoskeleton organization [GO_0098974]
- 5404: postsynaptic cytoskeleton [GO_0099571]
- 5405: postsynaptic cytoskeleton organization [GO_0099188]
- 5406: postsynaptic endocytosis [GO_0140239]
- 5407: postsynaptic membrane [GO_0045211]
- 5408: postsynaptic modulation of chemical synaptic transmission [GO_0099170]
- 5409: postsynaptic neurotransmitter receptor activity [GO_0098960]
- 5410: postsynaptic signal transduction [GO_0098926]
- 5411: posttranscriptional regulation of gene expression [GO_0010608]
- 5412: potassium channel activating, G protein-coupled receptor signaling pathway [GO_0099109]
- 5413: potassium channel activator activity [GO_0099104]
- 5414: potassium channel activator activity involved in G protein-coupled receptor signaling pathway [GO_0099108]
- 5415: potassium channel inhibitor activity [GO_0019870]
- 5416: potassium channel regulator activity [GO_0015459]
- 5417: potassium ion binding [GO_0030955]
- 5418: potassium ion leak channel activity [GO_0022841]
- 5419: potassium ion transmembrane transport [GO_0071805]
- 5420: potassium ion transmembrane transporter activity [GO_0015079]
- 5421: potassium ion transport [GO_0006813]
- 5422: potassium:proton antiporter activity [GO_0015386]
- 5423: potassium:sodium symporter activity [GO_0009674]
- 5424: POZ domain binding [GO_0031208]
- 5425: PP2A dephosphorylates RAF1 [GO_0004722]
- 5426: pPR-AP:pAP cleaves the MCP:pPR-AP:pAP Complex [GO_0004176]
- 5427: PRC2-EZH2 trimethylates nucleosomes associated with CDKN2A promoter [GO_0046976]
- 5428: pre-miRNA binding [GO_0070883]
- 5429: pre-mRNA 5'-splice site binding [GO_0030627]
- 5430: pre-mRNA binding [GO_0036002]
- 5431: pre-mRNA branch point binding [GO_0045131]
- 5432: pre-mRNA intronic binding [GO_0097157]
- 5433: Pre-snRNA transcript initiation, Integrator binding, LEC binding [GO_0001055]
- 5434: prechordal plate formation [GO_0021501]
- 5435: prekallikrein:kininogen:C1q binding protein tetramer -> kallikrein:kininogen:C1q binding protein tetramer [GO_0004185]
- 5436: prenyltransferase activity [GO_0004659]
- 5437: presynapse [GO_0098793]
- 5438: presynapse assembly [GO_0099054]
- 5439: presynapse organization [GO_0099172]
- 5440: presynaptic actin cytoskeleton [GO_0099143]
- 5441: presynaptic actin cytoskeleton organization [GO_0099140]
- 5442: presynaptic active zone [GO_0048786]
- 5443: presynaptic active zone organization [GO_1990709]
- 5444: presynaptic cytoskeleton [GO_0099569]
- 5445: presynaptic cytoskeleton organization [GO_0099187]
- 5446: presynaptic endocytosis [GO_0140238]
- 5447: presynaptic membrane [GO_0042734]
- 5448: presynaptic modulation of chemical synaptic transmission [GO_0099171]
- 5449: presynaptic process involved in chemical synaptic transmission [GO_0099531]
- 5450: presynaptic signal transduction [GO_0098928]
- 5451: primary active transmembrane transporter activity [GO_0015399]
- 5452: primary alcohol metabolic process [GO_0034308]
- 5453: primary amine secretion [GO_0061531]
- 5454: primary amine secretion, neurotransmission [GO_0061532]
- 5455: primary amino compound biosynthetic process [GO_1901162]
- 5456: primary amino compound catabolic process [GO_1901161]
- 5457: primary amino compound metabolic process [GO_1901160]
- 5458: primary lung bud formation [GO_0060431]
- 5459: primary metabolic process [GO_0044238]
- 5460: primary miRNA binding [GO_0070878]
- 5461: primary neural tube formation [GO_0014020]
- 5462: pristanoyl-CoA oxidase activity [GO_0016402]
- 5463: PRMT1 methylates arginine-12 of histone H2A (H2AR11) [GO_0016274]
- 5464: PRMT1 methylates ESRs [GO_0008276]
- 5465: PRMT5 methylates TP53 [GO_0035243]
- 5466: pro-RAS proteins are farnesylated [GO_0004660]
- 5467: proboscis extension reflex [GO_0007637]
- 5468: Procollagen triple helix formation [GO_0003755]
- 5469: procollagen-lysine 5-dioxygenase activity [GO_0008475]
- 5470: procollagen-proline dioxygenase activity [GO_0019798]
- 5471: proctolin receptor activity [GO_0035236]
- 5472: proctolin receptor binding [GO_0071860]
- 5473: Production of AA by iPLA2 upon FCGR activation [GO_0016787]
- 5474: proepicardium development [GO_0003342]
- 5475: programmed cell death [GO_0012501]
- 5476: programmed cell death involved in cell development [GO_0010623]
- 5477: proline dehydrogenase activity [GO_0004657]
- 5478: proline-rich region binding [GO_0070064]
- 5479: Prolyl 4-hydroxylase converts collagen prolines to 4-hydroxyprolines [GO_0004656]
- 5480: promoter-enhancer loop anchoring activity [GO_0140585]
- 5481: promoter-specific chromatin binding [GO_1990841]
- 5482: propionate-CoA ligase activity [GO_0050218]
- 5483: proprioception [GO_0019230]
- 5484: proprioception involved in equilibrioception [GO_0051355]
- 5485: Prorenin:Prorenin Receptor hydrolyzes Angiotensinogen to Angiotensin-(1-10) [GO_0004190]
- 5486: Prostaglandin E synthase isomerizes PGH2 to PGE2 [GO_0050220]
- 5487: prostaglandin-D synthase activity [GO_0004667]
- 5488: prosthetic group binding [GO_0051192]
- 5489: proteasomal protein catabolic process [GO_0010498]
- 5490: proteasome binding [GO_0070628]
- 5491: proteasome-activating activity [GO_0036402]
- 5492: protein alkylation [GO_0008213]
- 5493: protein arginine phosphatase activity [GO_0098627]
- 5494: protein arginylation [GO_0016598]
- 5495: protein binding [GO_0005515]
- 5496: protein C-terminus binding [GO_0008022]
- 5497: protein carboxyl O-methyltransferase activity [GO_0051998]
- 5498: protein carrier chaperone [GO_0140597]
- 5499: protein catabolic process [GO_0030163]
- 5500: protein catabolic process at postsynapse [GO_0140249]
- 5501: protein catabolic process at presynapse [GO_0140247]
- 5502: protein catabolic process at synapse [GO_0140246]
- 5503: protein catabolic process in the vacuole [GO_0007039]
- 5504: protein catabolic process, modulating synaptic transmission [GO_0099546]
- 5505: protein complex involved in cell adhesion [GO_0098636]
- 5506: protein deacetylation [GO_0006476]
- 5507: protein deacylation [GO_0035601]
- 5508: protein demethylase activity [GO_0140457]
- 5509: protein dephosphorylation [GO_0006470]
- 5510: protein depolymerization [GO_0051261]
- 5511: protein deubiquitination [GO_0016579]
- 5512: protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO_0071947]
- 5513: protein dimerization activity [GO_0046983]
- 5514: protein domain specific binding [GO_0019904]
- 5515: protein folding [GO_0006457]
- 5516: protein folding chaperone [GO_0044183]
- 5517: protein geranylgeranyltransferase activity [GO_0004661]
- 5518: protein heterodimerization activity [GO_0046982]
- 5519: protein histidine phosphatase activity [GO_0101006]
- 5520: protein homodimerization activity [GO_0042803]
- 5521: protein hydroxylation [GO_0018126]
- 5522: protein K48-linked deubiquitination [GO_0071108]
- 5523: protein K63-linked deubiquitination [GO_0070536]
- 5524: protein kinase A binding [GO_0051018]
- 5525: protein kinase A catalytic subunit binding [GO_0034236]
- 5526: protein kinase A regulatory subunit binding [GO_0034237]
- 5527: protein kinase activator activity [GO_0030295]
- 5528: protein kinase binding [GO_0019901]
- 5529: protein kinase C binding [GO_0005080]
- 5530: protein kinase C inhibitor activity [GO_0008426]
- 5531: protein kinase inhibitor activity [GO_0004860]
- 5532: protein kinase regulator activity [GO_0019887]
- 5533: protein localization [GO_0008104]
- 5534: protein localization to actin cytoskeleton [GO_1903119]
- 5535: protein localization to actin filament bundle [GO_1903120]
- 5536: protein localization to cell cortex [GO_0072697]
- 5537: protein localization to cell junction [GO_1902414]
- 5538: protein localization to cell leading edge [GO_1902463]
- 5539: protein localization to cell periphery [GO_1990778]
- 5540: protein localization to cell-cell junction [GO_0150105]
- 5541: protein localization to chromatin [GO_0071168]
- 5542: protein localization to chromosome [GO_0034502]
- 5543: protein localization to ciliary membrane [GO_1903441]
- 5544: protein localization to ciliary transition zone [GO_1904491]
- 5545: protein localization to cilium [GO_0061512]
- 5546: protein localization to cytoplasmic microtubule [GO_1905755]
- 5547: protein localization to cytoskeleton [GO_0044380]
- 5548: protein localization to extracellular region [GO_0071692]
- 5549: protein localization to Golgi apparatus [GO_0034067]
- 5550: protein localization to Golgi membrane [GO_1903292]
- 5551: protein localization to heterochromatin [GO_0097355]
- 5552: protein localization to membrane [GO_0072657]
- 5553: protein localization to microtubule [GO_0035372]
- 5554: protein localization to microtubule cytoskeleton [GO_0072698]
- 5555: protein localization to microvillus [GO_1904106]
- 5556: protein localization to nuclear envelope [GO_0090435]
- 5557: protein localization to nucleolus [GO_1902570]
- 5558: protein localization to nucleus [GO_0034504]
- 5559: protein localization to organelle [GO_0033365]
- 5560: protein localization to plasma membrane [GO_0072659]
- 5561: protein localization to postsynapse [GO_0062237]
- 5562: protein localization to presynapse [GO_1905383]
- 5563: protein localization to secretory granule [GO_0033366]
- 5564: protein localization to somatodendritic compartment [GO_0061938]
- 5565: protein localization to synapse [GO_0035418]
- 5566: protein localization to vacuolar membrane [GO_1903778]
- 5567: protein localization to vacuole [GO_0072665]
- 5568: protein metabolic process [GO_0019538]
- 5569: protein methylation [GO_0006479]
- 5570: protein modification by small protein conjugation [GO_0032446]
- 5571: protein modification by small protein conjugation or removal [GO_0070647]
- 5572: protein modification by small protein removal [GO_0070646]
- 5573: protein modification process [GO_0036211]
- 5574: protein N-acetylglucosaminyltransferase activity [GO_0016262]
- 5575: protein N-terminus binding [GO_0047485]
- 5576: protein O-acetylglucosaminyltransferase activity [GO_0097363]
- 5577: protein phosphatase 1 binding [GO_0008157]
- 5578: protein phosphatase 2A binding [GO_0051721]
- 5579: protein phosphatase activator activity [GO_0072542]
- 5580: protein phosphatase binding [GO_0019903]
- 5581: protein phosphatase inhibitor activity [GO_0004864]
- 5582: protein phosphorylated amino acid binding [GO_0045309]
- 5583: protein phosphorylation [GO_0006468]
- 5584: protein polymerization [GO_0051258]
- 5585: protein prenyltransferase activity [GO_0008318]
- 5586: protein secretion [GO_0009306]
- 5587: protein self-association [GO_0043621]
- 5588: protein serine/threonine kinase activator activity [GO_0043539]
- 5589: protein serine/threonine kinase inhibitor activity [GO_0030291]
- 5590: protein serine/threonine phosphatase inhibitor activity [GO_0004865]
- 5591: protein sumoylation [GO_0016925]
- 5592: protein tag [GO_0031386]
- 5593: protein transmembrane transport [GO_0071806]
- 5594: protein transport [GO_0015031]
- 5595: protein transport along microtubule [GO_0098840]
- 5596: protein transport within lipid bilayer [GO_0032594]
- 5597: protein transport within plasma membrane [GO_0099632]
- 5598: protein tyrosine kinase activator activity [GO_0030296]
- 5599: protein tyrosine kinase binding [GO_1990782]
- 5600: protein tyrosine kinase collagen receptor activity [GO_0038062]
- 5601: protein tyrosine kinase inhibitor activity [GO_0030292]
- 5602: protein tyrosine phosphatase activator activity [GO_0008160]
- 5603: protein tyrosine phosphatase activity, metal-dependent [GO_0030946]
- 5604: protein tyrosine/threonine phosphatase activity [GO_0008330]
- 5605: protein ubiquitination [GO_0016567]
- 5606: protein-arginine omega-N asymmetric methyltransferase activity [GO_0035242]
- 5607: protein-arginine omega-N monomethyltransferase activity [GO_0035241]
- 5608: protein-containing complex [GO_0032991]
- 5609: protein-containing complex assembly [GO_0065003]
- 5610: protein-containing complex binding [GO_0044877]
- 5611: protein-containing complex destabilizing activity [GO_0140776]
- 5612: protein-containing complex disassembly [GO_0032984]
- 5613: protein-containing complex localization [GO_0031503]
- 5614: protein-containing complex organization [GO_0043933]
- 5615: protein-cysteine methyltransferase activity [GO_0106363]
- 5616: protein-cysteine S-acyltransferase activity [GO_0019707]
- 5617: protein-cysteine S-palmitoyltransferase activity [GO_0019706]
- 5618: protein-disulfide reductase (NAD(P)) activity [GO_0047134]
- 5619: protein-DNA complex [GO_0032993]
- 5620: protein-glutamic acid ligase activity [GO_0070739]
- 5621: protein-glutamine N-methyltransferase activity [GO_0036009]
- 5622: protein-glycine ligase activity [GO_0070735]
- 5623: protein-glycine ligase activity, elongating [GO_0070737]
- 5624: protein-glycine ligase activity, initiating [GO_0070736]
- 5625: protein-hormone receptor activity [GO_0016500]
- 5626: protein-lipid complex binding [GO_0071814]
- 5627: protein-lysine N-methyltransferase activity [GO_0016279]
- 5628: protein-macromolecule adaptor activity [GO_0030674]
- 5629: protein-membrane adaptor activity [GO_0043495]
- 5630: protein-N-terminal asparagine amidohydrolase activity [GO_0008418]
- 5631: protein-N-terminal glutamine amidohydrolase activity [GO_0070773]
- 5632: protein-RNA adaptor activity [GO_0140517]
- 5633: protein-tyrosine sulfotransferase activity [GO_0008476]
- 5634: proteoglycan binding [GO_0043394]
- 5635: proteolysis [GO_0006508]
- 5636: proteolysis involved in protein catabolic process [GO_0051603]
- 5637: proton channel activity [GO_0015252]
- 5638: proton motive force-driven ATP synthesis [GO_0015986]
- 5639: proton motive force-driven mitochondrial ATP synthesis [GO_0042776]
- 5640: proton transmembrane transport [GO_1902600]
- 5641: proton-dependent oligopeptide secondary active transmembrane transporter activity [GO_0005427]
- 5642: proton-transporting ATP synthase activity, rotational mechanism [GO_0046933]
- 5643: proton-transporting ATPase activity, rotational mechanism [GO_0046961]
- 5644: PS is hydrolyzed to 2-acyl LPS by PLA2[10] [GO_0004623]
- 5645: pseudouridine synthase activity [GO_0009982]
- 5646: PTB domain binding [GO_0051425]
- 5647: PTEN cancer mutants do not dephosphorylate PIP3 [GO_0016314]
- 5648: PTPLs dehydrate VLC3HA-CoA to VLCTDA-CoA [GO_0080023]
- 5649: PTPS is phosphorylated by cGMP-dependant protein kinase II [GO_0004692]
- 5650: pulmonary artery endothelial tube morphogenesis [GO_0061155]
- 5651: pulmonary artery morphogenesis [GO_0061156]
- 5652: pulmonary vein morphogenesis [GO_0060577]
- 5653: purine nucleoside binding [GO_0001883]
- 5654: purine nucleoside diphosphate metabolic process [GO_0009135]
- 5655: purine nucleoside monophosphate biosynthetic process [GO_0009127]
- 5656: purine nucleoside monophosphate metabolic process [GO_0009126]
- 5657: purine nucleoside triphosphate biosynthetic process [GO_0009145]
- 5658: purine nucleoside triphosphate metabolic process [GO_0009144]
- 5659: purine nucleotide binding [GO_0017076]
- 5660: purine nucleotide biosynthetic process [GO_0006164]
- 5661: purine nucleotide metabolic process [GO_0006163]
- 5662: purine nucleotide transmembrane transporter activity [GO_0015216]
- 5663: purine nucleotide transport [GO_0015865]
- 5664: purine ribonucleoside diphosphate metabolic process [GO_0009179]
- 5665: purine ribonucleoside monophosphate biosynthetic process [GO_0009168]
- 5666: purine ribonucleoside monophosphate metabolic process [GO_0009167]
- 5667: purine ribonucleoside triphosphate binding [GO_0035639]
- 5668: purine ribonucleoside triphosphate biosynthetic process [GO_0009206]
- 5669: purine ribonucleoside triphosphate metabolic process [GO_0009205]
- 5670: purine ribonucleotide binding [GO_0032555]
- 5671: purine ribonucleotide biosynthetic process [GO_0009152]
- 5672: purine ribonucleotide metabolic process [GO_0009150]
- 5673: purine ribonucleotide transmembrane transporter activity [GO_0005346]
- 5674: purine ribonucleotide transport [GO_0015868]
- 5675: purine-containing compound biosynthetic process [GO_0072522]
- 5676: purine-containing compound metabolic process [GO_0072521]
- 5677: purine-containing compound transmembrane transport [GO_0072530]
- 5678: purine-nucleoside phosphorylase activity [GO_0004731]
- 5679: purine-rich negative regulatory element binding [GO_0032422]
- 5680: purinergic nucleotide receptor signaling pathway [GO_0035590]
- 5681: Purkinje myocyte action potential [GO_0086017]
- 5682: Purkinje myocyte development [GO_0003165]
- 5683: Purkinje myocyte differentiation [GO_0003168]
- 5684: Purkinje myocyte to ventricular cardiac muscle cell communication [GO_0086068]
- 5685: Purkinje myocyte to ventricular cardiac muscle cell signaling [GO_0086029]
- 5686: PXLP-CBS tetramers condenses HCYS and L-Ser to form L-Cystathionine [GO_0004122]
- 5687: PXLP-K212-CTH cleaves L-Cystathionine [GO_0004123]
- 5688: PXLP-K314-GPT transaminates PYR to form L-Ala [GO_0004021]
- 5689: PXLP-K333-GADL1 decarboxylates CSA to HTAU [GO_0016831]
- 5690: PXLP-K357-ABAT dimer:2Fe-2S transforms GABA to SUCCSA [GO_0003867]
- 5691: PYCR1 decamer reduces (S)-1-pyrroline-5-carboxylate to L-Pro [GO_0004735]
- 5692: pyridine-containing compound biosynthetic process [GO_0072525]
- 5693: pyridine-containing compound metabolic process [GO_0072524]
- 5694: pyridoxal oxidase activity [GO_0004732]
- 5695: pyridoxal phosphate binding [GO_0030170]
- 5696: pyridoxal phosphate biosynthetic process [GO_0042823]
- 5697: pyridoxal phosphate metabolic process [GO_0042822]
- 5698: pyrimidine nucleobase binding [GO_0002061]
- 5699: pyrimidine nucleoside catabolic process [GO_0046135]
- 5700: pyrimidine nucleoside metabolic process [GO_0006213]
- 5701: pyrimidine nucleoside monophosphate biosynthetic process [GO_0009130]
- 5702: pyrimidine nucleoside monophosphate metabolic process [GO_0009129]
- 5703: pyrimidine nucleotide biosynthetic process [GO_0006221]
- 5704: pyrimidine nucleotide metabolic process [GO_0006220]
- 5705: pyrimidine nucleotide transmembrane transporter activity [GO_0015218]
- 5706: pyrimidine nucleotide transport [GO_0006864]
- 5707: pyrimidine nucleotide-sugar transmembrane transport [GO_0090481]
- 5708: pyrimidine nucleotide-sugar transmembrane transporter activity [GO_0015165]
- 5709: pyrimidine ribonucleoside catabolic process [GO_0046133]
- 5710: pyrimidine ribonucleoside metabolic process [GO_0046131]
- 5711: pyrimidine ribonucleoside monophosphate biosynthetic process [GO_0009174]
- 5712: pyrimidine ribonucleoside monophosphate metabolic process [GO_0009173]
- 5713: pyrimidine ribonucleotide biosynthetic process [GO_0009220]
- 5714: pyrimidine ribonucleotide metabolic process [GO_0009218]
- 5715: pyrimidine-containing compound biosynthetic process [GO_0072528]
- 5716: pyrimidine-containing compound catabolic process [GO_0072529]
- 5717: pyrimidine-containing compound metabolic process [GO_0072527]
- 5718: pyrimidine-containing compound transmembrane transport [GO_0072531]
- 5719: pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO_0008263]
- 5720: pyroglutamyl-peptidase activity [GO_0016920]
- 5721: pyrophosphatase activity [GO_0016462]
- 5722: pyrophosphate + H2O => 2 orthophosphate [cytosolic] [GO_0004427]
- 5723: pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO_0009678]
- 5724: pyruvate carboxylase activity [GO_0004736]
- 5725: pyruvate dehydrogenase (acetyl-transferring) activity [GO_0004739]
- 5726: pyruvate metabolic process [GO_0006090]
- 5727: pyruvate transmembrane transport [GO_1901475]
- 5728: pyruvate transport [GO_0006848]
- 5729: quaternary ammonium group binding [GO_0050997]
- 5730: quaternary ammonium group transmembrane transporter activity [GO_0015651]
- 5731: quaternary ammonium group transport [GO_0015697]
- 5732: quinone binding [GO_0048038]
- 5733: Rab GDP-dissociation inhibitor activity [GO_0005093]
- 5734: racemase activity, acting on amino acids and derivatives [GO_0036361]
- 5735: racemase and epimerase activity [GO_0016854]
- 5736: racemase and epimerase activity, acting on amino acids and derivatives [GO_0016855]
- 5737: RBKS phosphorylates ribose to R5P [GO_0004747]
- 5738: RDH11 reduces RBP2:atRAL to RBP2:atROL [GO_0016616]
- 5739: RDH5 oxidises 11cROL to 11cRAL [GO_0004745]
- 5740: rDNA binding [GO_0000182]
- 5741: reactive oxygen species metabolic process [GO_0072593]
- 5742: receptor antagonist activity [GO_0048019]
- 5743: receptor ligand activity [GO_0048018]
- 5744: receptor serine/threonine kinase binding [GO_0033612]
- 5745: receptor tyrosine kinase binding [GO_0030971]
- 5746: receptor-mediated endocytosis [GO_0006898]
- 5747: Reduction of disulphide bonds in MHC II antigens [GO_0016667]
- 5748: reflex [GO_0060004]
- 5749: regeneration [GO_0031099]
- 5750: regionalization [GO_0003002]
- 5751: regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043126]
- 5752: regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061901]
- 5753: regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090215]
- 5754: regulation of acetylcholine secretion, neurotransmission [GO_0014056]
- 5755: regulation of acetylcholine-gated cation channel activity [GO_1903048]
- 5756: regulation of acid-sensing ion channel activity [GO_1901585]
- 5757: regulation of acinar cell proliferation [GO_1904697]
- 5758: regulation of aconitate hydratase activity [GO_1904232]
- 5759: regulation of actin binding [GO_1904616]
- 5760: regulation of actin cytoskeleton organization [GO_0032956]
- 5761: regulation of actin filament binding [GO_1904529]
- 5762: regulation of actin filament bundle assembly [GO_0032231]
- 5763: regulation of actin filament organization [GO_0110053]
- 5764: regulation of actin filament-based movement [GO_1903115]
- 5765: regulation of actin filament-based process [GO_0032970]
- 5766: regulation of action potential [GO_0098900]
- 5767: regulation of activin receptor signaling pathway [GO_0032925]
- 5768: regulation of actomyosin structure organization [GO_0110020]
- 5769: regulation of adenosine receptor signaling pathway [GO_0060167]
- 5770: regulation of adenylate cyclase activity [GO_0045761]
- 5771: regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO_0010578]
- 5772: regulation of adipose tissue development [GO_1904177]
- 5773: regulation of aerobic respiration [GO_1903715]
- 5774: regulation of alkaline phosphatase activity [GO_0010692]
- 5775: regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905619]
- 5776: regulation of amine transport [GO_0051952]
- 5777: regulation of amino acid transmembrane transport [GO_1903789]
- 5778: regulation of amino acid transport [GO_0051955]
- 5779: regulation of aminoacyl-tRNA ligase activity [GO_1903630]
- 5780: regulation of amyloid precursor protein catabolic process [GO_1902991]
- 5781: regulation of anatomical structure morphogenesis [GO_0022603]
- 5782: regulation of androgen secretion [GO_2000834]
- 5783: regulation of angiogenesis [GO_0045765]
- 5784: regulation of animal organ formation [GO_0003156]
- 5785: regulation of animal organ morphogenesis [GO_2000027]
- 5786: regulation of anion channel activity [GO_0010359]
- 5787: regulation of anion transmembrane transport [GO_1903959]
- 5788: regulation of anion transport [GO_0044070]
- 5789: regulation of aorta morphogenesis [GO_1903847]
- 5790: regulation of aortic smooth muscle cell differentiation [GO_1904829]
- 5791: regulation of apical ectodermal ridge formation [GO_1905140]
- 5792: regulation of apolipoprotein binding [GO_2000656]
- 5793: regulation of apoptosis involved in tissue homeostasis [GO_0060785]
- 5794: regulation of apoptotic process [GO_0042981]
- 5795: regulation of apoptotic process involved in development [GO_1904748]
- 5796: regulation of apoptotic process involved in morphogenesis [GO_1902337]
- 5797: regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902256]
- 5798: regulation of apoptotic signaling pathway [GO_2001233]
- 5799: regulation of argininosuccinate synthase activity [GO_1905752]
- 5800: regulation of artery morphogenesis [GO_1905651]
- 5801: regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120287]
- 5802: regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902959]
- 5803: regulation of aspartic-type peptidase activity [GO_1905245]
- 5804: regulation of asymmetric cell division [GO_0009786]
- 5805: regulation of ATP biosynthetic process [GO_2001169]
- 5806: regulation of ATP citrate synthase activity [GO_2000983]
- 5807: regulation of ATP metabolic process [GO_1903578]
- 5808: regulation of ATP-dependent activity [GO_0043462]
- 5809: regulation of ATP:ADP antiporter activity [GO_0070926]
- 5810: regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901894]
- 5811: regulation of AV node cell action potential [GO_0098904]
- 5812: regulation of axo-dendritic protein transport [GO_1905126]
- 5813: regulation of axon guidance [GO_1902667]
- 5814: regulation of axonogenesis [GO_0050770]
- 5815: regulation of backward locomotion [GO_0043058]
- 5816: regulation of basement membrane organization [GO_0110011]
- 5817: regulation of behavior [GO_0050795]
- 5818: regulation of bile acid biosynthetic process [GO_0070857]
- 5819: regulation of bile acid metabolic process [GO_1904251]
- 5820: regulation of bile acid secretion [GO_0120188]
- 5821: regulation of binding [GO_0051098]
- 5822: regulation of biological process [GO_0050789]
- 5823: regulation of biological quality [GO_0065008]
- 5824: regulation of biosynthetic process [GO_0009889]
- 5825: regulation of blastocyst development [GO_0120222]
- 5826: regulation of bleb assembly [GO_1904170]
- 5827: regulation of blood circulation [GO_1903522]
- 5828: regulation of blood vessel branching [GO_1905553]
- 5829: regulation of blood vessel endothelial cell differentiation [GO_0110057]
- 5830: regulation of BMP signaling pathway [GO_0030510]
- 5831: regulation of body fluid levels [GO_0050878]
- 5832: regulation of bone development [GO_1903010]
- 5833: regulation of branching involved in lung morphogenesis [GO_0061046]
- 5834: regulation of branching morphogenesis of a nerve [GO_2000172]
- 5835: regulation of calcium ion binding [GO_1901876]
- 5836: regulation of calcium ion transmembrane transport [GO_1903169]
- 5837: regulation of calcium ion transmembrane transporter activity [GO_1901019]
- 5838: regulation of calcium ion transport [GO_0051924]
- 5839: regulation of calcium-dependent ATPase activity [GO_1903610]
- 5840: regulation of calcium-mediated signaling [GO_0050848]
- 5841: regulation of calcium:sodium antiporter activity [GO_1903279]
- 5842: regulation of cAMP-dependent protein kinase activity [GO_2000479]
- 5843: regulation of cAMP-mediated signaling [GO_0043949]
- 5844: regulation of carbohydrate biosynthetic process [GO_0043255]
- 5845: regulation of carbohydrate catabolic process [GO_0043470]
- 5846: regulation of carbohydrate metabolic process [GO_0006109]
- 5847: regulation of carbohydrate phosphatase activity [GO_0032113]
- 5848: regulation of cardiac chamber formation [GO_1901210]
- 5849: regulation of cardiac chamber morphogenesis [GO_1901219]
- 5850: regulation of cardiac conduction [GO_1903779]
- 5851: regulation of cardiac muscle adaptation [GO_0010612]
- 5852: regulation of cardiac muscle cell action potential [GO_0098901]
- 5853: regulation of cardiac muscle cell apoptotic process [GO_0010665]
- 5854: regulation of cardiac muscle cell differentiation [GO_2000725]
- 5855: regulation of cardiac muscle cell myoblast differentiation [GO_2000690]
- 5856: regulation of cardiac muscle cell proliferation [GO_0060043]
- 5857: regulation of cardiac muscle contraction [GO_0055117]
- 5858: regulation of cardiac muscle fiber development [GO_0055018]
- 5859: regulation of cardiac muscle hypertrophy [GO_0010611]
- 5860: regulation of cardiac muscle myoblast proliferation [GO_0110022]
- 5861: regulation of cardiac muscle tissue development [GO_0055024]
- 5862: regulation of cardiac muscle tissue growth [GO_0055021]
- 5863: regulation of cardiac myofibril assembly [GO_1905304]
- 5864: regulation of cardiac ventricle development [GO_1904412]
- 5865: regulation of cardiac ventricle formation [GO_1904942]
- 5866: regulation of cardioblast differentiation [GO_0051890]
- 5867: regulation of cardiocyte differentiation [GO_1905207]
- 5868: regulation of cartilage development [GO_0061035]
- 5869: regulation of catabolic process [GO_0009894]
- 5870: regulation of catalase activity [GO_1902551]
- 5871: regulation of catalytic activity [GO_0050790]
- 5872: regulation of catecholamine metabolic process [GO_0042069]
- 5873: regulation of catecholamine secretion [GO_0050433]
- 5874: regulation of cation channel activity [GO_2001257]
- 5875: regulation of cation transmembrane transport [GO_1904062]
- 5876: regulation of CD4 production [GO_0045223]
- 5877: regulation of cell adhesion [GO_0030155]
- 5878: regulation of cell adhesion involved in heart morphogenesis [GO_0061344]
- 5879: regulation of cell communication [GO_0010646]
- 5880: regulation of cell cycle [GO_0051726]
- 5881: regulation of cell cycle process [GO_0010564]
- 5882: regulation of cell death [GO_0010941]
- 5883: regulation of cell development [GO_0060284]
- 5884: regulation of cell differentiation [GO_0045595]
- 5885: regulation of cell differentiation involved in embryonic placenta development [GO_0060800]
- 5886: regulation of cell differentiation involved in tissue homeostasis [GO_0060786]
- 5887: regulation of cell division [GO_0051302]
- 5888: regulation of cell fate commitment [GO_0010453]
- 5889: regulation of cell growth [GO_0001558]
- 5890: regulation of cell growth involved in cardiac muscle cell development [GO_0061050]
- 5891: regulation of cell junction assembly [GO_1901888]
- 5892: regulation of cell maturation [GO_1903429]
- 5893: regulation of cell migration [GO_0030334]
- 5894: regulation of cell morphogenesis [GO_0022604]
- 5895: regulation of cell morphogenesis involved in differentiation [GO_0010769]
- 5896: regulation of cell motility [GO_2000145]
- 5897: regulation of cell population proliferation [GO_0042127]
- 5898: regulation of cell projection assembly [GO_0060491]
- 5899: regulation of cell projection organization [GO_0031344]
- 5900: regulation of cell proliferation in midbrain [GO_1904933]
- 5901: regulation of cell proliferation involved in compound eye morphogenesis [GO_2000495]
- 5902: regulation of cell proliferation involved in embryonic placenta development [GO_0060723]
- 5903: regulation of cell proliferation involved in heart morphogenesis [GO_2000136]
- 5904: regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901963]
- 5905: regulation of cell proliferation involved in tissue homeostasis [GO_0060784]
- 5906: regulation of cell-cell adhesion [GO_0022407]
- 5907: regulation of cellular amide metabolic process [GO_0034248]
- 5908: regulation of cellular amine catabolic process [GO_0033241]
- 5909: regulation of cellular amine metabolic process [GO_0033238]
- 5910: regulation of cellular amino acid biosynthetic process [GO_2000282]
- 5911: regulation of cellular amino acid metabolic process [GO_0006521]
- 5912: regulation of cellular biosynthetic process [GO_0031326]
- 5913: regulation of cellular carbohydrate catabolic process [GO_0043471]
- 5914: regulation of cellular carbohydrate metabolic process [GO_0010675]
- 5915: regulation of cellular catabolic process [GO_0031329]
- 5916: regulation of cellular component biogenesis [GO_0044087]
- 5917: regulation of cellular component movement [GO_0051270]
- 5918: regulation of cellular component organization [GO_0051128]
- 5919: regulation of cellular ketone metabolic process [GO_0010565]
- 5920: regulation of cellular localization [GO_0060341]
- 5921: regulation of cellular macromolecule biosynthetic process [GO_2000112]
- 5922: regulation of cellular metabolic process [GO_0031323]
- 5923: regulation of cellular process [GO_0050794]
- 5924: regulation of cellular protein metabolic process [GO_0032268]
- 5925: regulation of cellular respiration [GO_0043457]
- 5926: regulation of cellular response to alcohol [GO_1905957]
- 5927: regulation of cellular response to drug [GO_2001038]
- 5928: regulation of cellular response to growth factor stimulus [GO_0090287]
- 5929: regulation of cellular response to insulin stimulus [GO_1900076]
- 5930: regulation of cellular response to oxidative stress [GO_1900407]
- 5931: regulation of cellular response to stress [GO_0080135]
- 5932: regulation of chemokine activity [GO_1900136]
- 5933: regulation of chemorepellent activity [GO_1903667]
- 5934: regulation of chemotaxis [GO_0050920]
- 5935: regulation of chloride transport [GO_2001225]
- 5936: regulation of cholangiocyte apoptotic process [GO_1904192]
- 5937: regulation of cholangiocyte proliferation [GO_1904054]
- 5938: regulation of cholesterol transporter activity [GO_0060694]
- 5939: regulation of chondrocyte development [GO_0061181]
- 5940: regulation of chondrocyte differentiation [GO_0032330]
- 5941: regulation of chondrocyte differentiation involved in endochondral bone morphogenesis [GO_1902738]
- 5942: regulation of chorionic trophoblast cell proliferation [GO_1901382]
- 5943: regulation of chromatin assembly [GO_0010847]
- 5944: regulation of chromatin assembly or disassembly [GO_0001672]
- 5945: regulation of chromatin binding [GO_0035561]
- 5946: regulation of chromatin disassembly [GO_0010848]
- 5947: regulation of chromatin organization [GO_1902275]
- 5948: regulation of chromosome condensation [GO_0060623]
- 5949: regulation of chromosome organization [GO_0033044]
- 5950: regulation of chromosome segregation [GO_0051983]
- 5951: regulation of cilium assembly [GO_1902017]
- 5952: regulation of circadian rhythm [GO_0042752]
- 5953: regulation of circadian sleep/wake cycle [GO_0042749]
- 5954: regulation of circadian sleep/wake cycle, sleep [GO_0045187]
- 5955: regulation of CoA-transferase activity [GO_1905918]
- 5956: regulation of collagen binding [GO_0033341]
- 5957: regulation of collagen biosynthetic process [GO_0032965]
- 5958: regulation of collagen catabolic process [GO_0010710]
- 5959: regulation of collagen fibril organization [GO_1904026]
- 5960: regulation of collagen metabolic process [GO_0010712]
- 5961: regulation of colon smooth muscle contraction [GO_1904341]
- 5962: regulation of compound eye photoreceptor cell differentiation [GO_0110116]
- 5963: regulation of compound eye retinal cell apoptotic process [GO_1901692]
- 5964: regulation of compound eye retinal cell programmed cell death [GO_0046669]
- 5965: regulation of copper ion transmembrane transport [GO_1902311]
- 5966: regulation of core promoter binding [GO_1904796]
- 5967: regulation of coreceptor activity [GO_0060725]
- 5968: regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060726]
- 5969: regulation of cyclase activity [GO_0031279]
- 5970: regulation of cyclic nucleotide-gated ion channel activity [GO_1902159]
- 5971: regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051342]
- 5972: regulation of cyclin-dependent protein kinase activity [GO_1904029]
- 5973: regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0000079]
- 5974: regulation of cystathionine beta-synthase activity [GO_1904041]
- 5975: regulation of cysteine-type endopeptidase activity [GO_2000116]
- 5976: regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043281]
- 5977: regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001270]
- 5978: regulation of cytochrome-c oxidase activity [GO_1904959]
- 5979: regulation of cytokine activity [GO_0060300]
- 5980: regulation of cytokine-mediated signaling pathway [GO_0001959]
- 5981: regulation of cytokinesis [GO_0032465]
- 5982: regulation of cytoplasmic microtubule depolymerization [GO_0010937]
- 5983: regulation of cytoskeleton organization [GO_0051493]
- 5984: regulation of D-amino-acid oxidase activity [GO_1900757]
- 5985: regulation of D-erythro-sphingosine kinase activity [GO_1900022]
- 5986: regulation of deacetylase activity [GO_0150065]
- 5987: regulation of defecation [GO_2000292]
- 5988: regulation of delayed rectifier potassium channel activity [GO_1902259]
- 5989: regulation of deoxyribonuclease activity [GO_0032070]
- 5990: regulation of dephosphorylation [GO_0035303]
- 5991: regulation of dermatome development [GO_0061183]
- 5992: regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905787]
- 5993: regulation of development, heterochronic [GO_0040034]
- 5994: regulation of developmental growth [GO_0048638]
- 5995: regulation of developmental pigmentation [GO_0048070]
- 5996: regulation of developmental process [GO_0050793]
- 5997: regulation of diacylglycerol kinase activity [GO_1905687]
- 5998: regulation of digestive system process [GO_0044058]
- 5999: regulation of dipeptide transmembrane transport [GO_2001148]
- 6000: regulation of dipeptide transport [GO_0090089]
- 6001: regulation of DNA binding [GO_0051101]
- 6002: regulation of DNA biosynthetic process [GO_2000278]
- 6003: regulation of DNA duplex unwinding [GO_1905462]
- 6004: regulation of DNA helicase activity [GO_1905774]
- 6005: regulation of DNA metabolic process [GO_0051052]
- 6006: regulation of DNA N-glycosylase activity [GO_1902544]
- 6007: regulation of DNA repair [GO_0006282]
- 6008: regulation of DNA replication [GO_0006275]
- 6009: regulation of DNA replication origin binding [GO_1902595]
- 6010: regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000371]
- 6011: regulation of DNA-binding transcription factor activity [GO_0051090]
- 6012: regulation of DNA-directed DNA polymerase activity [GO_1900262]
- 6013: regulation of DNA-templated DNA replication [GO_0090329]
- 6014: regulation of DNA-templated transcription [GO_0006355]
- 6015: regulation of dopamine receptor signaling pathway [GO_0060159]
- 6016: regulation of dopamine secretion [GO_0014059]
- 6017: regulation of double-stranded telomeric DNA binding [GO_1905767]
- 6018: regulation of dUTP diphosphatase activity [GO_1903627]
- 6019: regulation of eclosion [GO_0007563]
- 6020: regulation of ectoderm development [GO_2000383]
- 6021: regulation of electron transfer activity [GO_1904732]
- 6022: regulation of embryonic camera-type eye development [GO_1902863]
- 6023: regulation of embryonic development [GO_0045995]
- 6024: regulation of endocrine process [GO_0044060]
- 6025: regulation of endocytosis [GO_0030100]
- 6026: regulation of endodeoxyribonuclease activity [GO_0032071]
- 6027: regulation of endodermal cell differentiation [GO_1903224]
- 6028: regulation of endopeptidase activity [GO_0052548]
- 6029: regulation of endoribonuclease activity [GO_0060699]
- 6030: regulation of endothelial cell apoptotic process [GO_2000351]
- 6031: regulation of endothelial cell development [GO_1901550]
- 6032: regulation of endothelial cell differentiation [GO_0045601]
- 6033: regulation of endothelial cell proliferation [GO_0001936]
- 6034: regulation of endothelial tube morphogenesis [GO_1901509]
- 6035: regulation of entry into reproductive diapause [GO_0061963]
- 6036: regulation of ephrin receptor signaling pathway [GO_1901187]
- 6037: regulation of epidermal cell differentiation [GO_0045604]
- 6038: regulation of epidermal cell division [GO_0010482]
- 6039: regulation of epidermal growth factor receptor signaling pathway [GO_0042058]
- 6040: regulation of epidermal growth factor-activated receptor activity [GO_0007176]
- 6041: regulation of epidermis development [GO_0045682]
- 6042: regulation of epithelial cell apoptotic process [GO_1904035]
- 6043: regulation of epithelial cell differentiation [GO_0030856]
- 6044: regulation of epithelial cell proliferation [GO_0050678]
- 6045: regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000794]
- 6046: regulation of epithelial to mesenchymal transition [GO_0010717]
- 6047: regulation of epithelial tube formation [GO_1905276]
- 6048: regulation of ERBB signaling pathway [GO_1901184]
- 6049: regulation of erythrocyte apoptotic process [GO_1902250]
- 6050: regulation of erythrocyte differentiation [GO_0045646]
- 6051: regulation of establishment of cell polarity [GO_2000114]
- 6052: regulation of establishment of planar polarity [GO_0090175]
- 6053: regulation of establishment of protein localization [GO_0070201]
- 6054: regulation of establishment of protein localization to chromosome [GO_0070202]
- 6055: regulation of establishment or maintenance of cell polarity [GO_0032878]
- 6056: regulation of euchromatin binding [GO_1904793]
- 6057: regulation of excretion [GO_0044062]
- 6058: regulation of execution phase of apoptosis [GO_1900117]
- 6059: regulation of exocytosis [GO_0017157]
- 6060: regulation of exodeoxyribonuclease activity [GO_1902392]
- 6061: regulation of exonuclease activity [GO_1905777]
- 6062: regulation of exoribonuclease activity [GO_1901917]
- 6063: regulation of exosomal secretion [GO_1903541]
- 6064: regulation of extracellular exosome assembly [GO_1903551]
- 6065: regulation of extracellular matrix assembly [GO_1901201]
- 6066: regulation of extracellular matrix disassembly [GO_0010715]
- 6067: regulation of extracellular matrix organization [GO_1903053]
- 6068: regulation of eye photoreceptor cell development [GO_0042478]
- 6069: regulation of fat cell apoptotic process [GO_1904649]
- 6070: regulation of fat cell differentiation [GO_0045598]
- 6071: regulation of fat cell proliferation [GO_0070344]
- 6072: regulation of fatty acid biosynthetic process [GO_0042304]
- 6073: regulation of fatty acid metabolic process [GO_0019217]
- 6074: regulation of fatty acid transport [GO_2000191]
- 6075: regulation of feeding behavior [GO_0060259]
- 6076: regulation of female gonad development [GO_2000194]
- 6077: regulation of female receptivity [GO_0045924]
- 6078: regulation of ferrochelatase activity [GO_0010722]
- 6079: regulation of ferrous iron binding [GO_1904432]
- 6080: regulation of fertilization [GO_0080154]
- 6081: regulation of fibroblast apoptotic process [GO_2000269]
- 6082: regulation of fibroblast growth factor receptor signaling pathway [GO_0040036]
- 6083: regulation of fibroblast proliferation [GO_0048145]
- 6084: regulation of formation of translation initiation ternary complex [GO_1901190]
- 6085: regulation of forward locomotion [GO_0043059]
- 6086: regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060549]
- 6087: regulation of G protein-coupled receptor signaling pathway [GO_0008277]
- 6088: regulation of G-quadruplex DNA binding [GO_1905493]
- 6089: regulation of GABA-A receptor activity [GO_0106040]
- 6090: regulation of gamma-aminobutyric acid secretion [GO_0014052]
- 6091: regulation of gastric acid secretion [GO_0060453]
- 6092: regulation of gastric mucosal blood circulation [GO_1904344]
- 6093: regulation of gastro-intestinal system smooth muscle contraction [GO_1904304]
- 6094: regulation of gastrulation [GO_0010470]
- 6095: regulation of gene expression [GO_0010468]
- 6096: regulation of gene expression, epigenetic [GO_0040029]
- 6097: regulation of gene silencing by RNA [GO_0060966]
- 6098: regulation of generation of precursor metabolites and energy [GO_0043467]
- 6099: regulation of germ cell proliferation [GO_1905936]
- 6100: regulation of glial cell apoptotic process [GO_0034350]
- 6101: regulation of glial cell differentiation [GO_0045685]
- 6102: regulation of glial cell proliferation [GO_0060251]
- 6103: regulation of gliogenesis [GO_0014013]
- 6104: regulation of glucagon secretion [GO_0070092]
- 6105: regulation of glucan biosynthetic process [GO_0010962]
- 6106: regulation of glucokinase activity [GO_0033131]
- 6107: regulation of gluconeogenesis [GO_0006111]
- 6108: regulation of glucose metabolic process [GO_0010906]
- 6109: regulation of glucose transmembrane transport [GO_0010827]
- 6110: regulation of glucosylceramidase activity [GO_1905123]
- 6111: regulation of glucuronosyltransferase activity [GO_1904223]
- 6112: regulation of glutamate receptor signaling pathway [GO_1900449]
- 6113: regulation of glutamate secretion [GO_0014048]
- 6114: regulation of glutamate secretion, neurotransmission [GO_1903294]
- 6115: regulation of glutamate-ammonia ligase activity [GO_1905478]
- 6116: regulation of glutamate-cysteine ligase activity [GO_0035227]
- 6117: regulation of glutathione biosynthetic process [GO_1903786]
- 6118: regulation of glutathione peroxidase activity [GO_1903282]
- 6119: regulation of glycine secretion, neurotransmission [GO_1904624]
- 6120: regulation of glycogen (starch) synthase activity [GO_2000465]
- 6121: regulation of glycogen biosynthetic process [GO_0005979]
- 6122: regulation of glycogen catabolic process [GO_0005981]
- 6123: regulation of glycogen metabolic process [GO_0070873]
- 6124: regulation of glycolytic process [GO_0006110]
- 6125: regulation of glycolytic process through fructose-6-phosphate [GO_1904538]
- 6126: regulation of glycoprotein biosynthetic process [GO_0010559]
- 6127: regulation of glycoprotein metabolic process [GO_1903018]
- 6128: regulation of Golgi inheritance [GO_0090170]
- 6129: regulation of Golgi organization [GO_1903358]
- 6130: regulation of Golgi to plasma membrane protein transport [GO_0042996]
- 6131: regulation of gonad development [GO_1905939]
- 6132: regulation of grooming behavior [GO_2000821]
- 6133: regulation of growth [GO_0040008]
- 6134: regulation of GTP binding [GO_1904424]
- 6135: regulation of GTP cyclohydrolase I activity [GO_0043095]
- 6136: regulation of GTPase activity [GO_0043087]
- 6137: regulation of guanyl-nucleotide exchange factor activity [GO_1905097]
- 6138: regulation of guanylate cyclase activity [GO_0031282]
- 6139: regulation of heart contraction [GO_0008016]
- 6140: regulation of heart growth [GO_0060420]
- 6141: regulation of heart morphogenesis [GO_2000826]
- 6142: regulation of heart rate [GO_0002027]
- 6143: regulation of helicase activity [GO_0051095]
- 6144: regulation of hematopoietic progenitor cell differentiation [GO_1901532]
- 6145: regulation of hematopoietic stem cell differentiation [GO_1902036]
- 6146: regulation of hematopoietic stem cell proliferation [GO_1902033]
- 6147: regulation of heme oxygenase activity [GO_0061960]
- 6148: regulation of hemopoiesis [GO_1903706]
- 6149: regulation of heparan sulfate proteoglycan binding [GO_1905858]
- 6150: regulation of hepatocyte apoptotic process [GO_1903943]
- 6151: regulation of hepatocyte differentiation [GO_0070366]
- 6152: regulation of heterochromatin assembly [GO_0031445]
- 6153: regulation of heterochromatin organization [GO_0120261]
- 6154: regulation of hexokinase activity [GO_1903299]
- 6155: regulation of high voltage-gated calcium channel activity [GO_1901841]
- 6156: regulation of hindgut contraction [GO_0043134]
- 6157: regulation of histone deacetylase activity [GO_1901725]
- 6158: regulation of histone deacetylation [GO_0031063]
- 6159: regulation of histone demethylase activity (H3-K4 specific) [GO_1904173]
- 6160: regulation of histone modification [GO_0031056]
- 6161: regulation of hormone levels [GO_0010817]
- 6162: regulation of hormone metabolic process [GO_0032350]
- 6163: regulation of hormone secretion [GO_0046883]
- 6164: regulation of hyaluronan biosynthetic process [GO_1900125]
- 6165: regulation of hydrolase activity [GO_0051336]
- 6166: regulation of immune effector process [GO_0002697]
- 6167: regulation of immune response [GO_0050776]
- 6168: regulation of immune system process [GO_0002682]
- 6169: regulation of inorganic anion transmembrane transport [GO_1903795]
- 6170: regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031585]
- 6171: regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010924]
- 6172: regulation of insulin receptor signaling pathway [GO_0046626]
- 6173: regulation of insulin secretion [GO_0050796]
- 6174: regulation of intestinal absorption [GO_1904478]
- 6175: regulation of intestinal epithelial cell development [GO_1905298]
- 6176: regulation of intracellular calcium activated chloride channel activity [GO_1902938]
- 6177: regulation of intracellular lipid transport [GO_0032377]
- 6178: regulation of intracellular protein transport [GO_0033157]
- 6179: regulation of intracellular signal transduction [GO_1902531]
- 6180: regulation of intracellular sterol transport [GO_0032380]
- 6181: regulation of intracellular transport [GO_0032386]
- 6182: regulation of inward rectifier potassium channel activity [GO_1901979]
- 6183: regulation of ion transmembrane transport [GO_0034765]
- 6184: regulation of ion transmembrane transporter activity [GO_0032412]
- 6185: regulation of ion transport [GO_0043269]
- 6186: regulation of iron ion transmembrane transport [GO_0034759]
- 6187: regulation of iron ion transmembrane transporter activity [GO_1904254]
- 6188: regulation of iron ion transport [GO_0034756]
- 6189: regulation of isomerase activity [GO_0010911]
- 6190: regulation of isoprenoid metabolic process [GO_0019747]
- 6191: regulation of JNK cascade [GO_0046328]
- 6192: regulation of JUN kinase activity [GO_0043506]
- 6193: regulation of kainate selective glutamate receptor activity [GO_2000312]
- 6194: regulation of karyogamy [GO_0032871]
- 6195: regulation of ketone biosynthetic process [GO_0010566]
- 6196: regulation of ketone catabolic process [GO_0010567]
- 6197: regulation of kinase activity [GO_0043549]
- 6198: regulation of L-dopa decarboxylase activity [GO_1903198]
- 6199: regulation of large conductance calcium-activated potassium channel activity [GO_1902606]
- 6200: regulation of leukocyte apoptotic process [GO_2000106]
- 6201: regulation of leukocyte differentiation [GO_1902105]
- 6202: regulation of leukocyte mediated immunity [GO_0002703]
- 6203: regulation of leukocyte proliferation [GO_0070663]
- 6204: regulation of ligase activity [GO_0051340]
- 6205: regulation of light-activated channel activity [GO_0016061]
- 6206: regulation of lipase activity [GO_0060191]
- 6207: regulation of lipid binding [GO_1900130]
- 6208: regulation of lipid biosynthetic process [GO_0046890]
- 6209: regulation of lipid catabolic process [GO_0050994]
- 6210: regulation of lipid kinase activity [GO_0043550]
- 6211: regulation of lipid localization [GO_1905952]
- 6212: regulation of lipid metabolic process [GO_0019216]
- 6213: regulation of lipid storage [GO_0010883]
- 6214: regulation of lipid transport [GO_0032368]
- 6215: regulation of lipid transporter activity [GO_0110112]
- 6216: regulation of lipopolysaccharide-mediated signaling pathway [GO_0031664]
- 6217: regulation of lipoprotein lipase activity [GO_0051004]
- 6218: regulation of localization [GO_0032879]
- 6219: regulation of locomotion [GO_0040012]
- 6220: regulation of locomotion involved in locomotory behavior [GO_0090325]
- 6221: regulation of locomotor rhythm [GO_1904059]
- 6222: regulation of low-density lipoprotein particle receptor binding [GO_1905595]
- 6223: regulation of lung ciliated cell differentiation [GO_1901246]
- 6224: regulation of lyase activity [GO_0051339]
- 6225: regulation of lysozyme activity [GO_1903590]
- 6226: regulation of m7G(5')pppN diphosphatase activity [GO_1903398]
- 6227: regulation of macromolecule biosynthetic process [GO_0010556]
- 6228: regulation of macromolecule metabolic process [GO_0060255]
- 6229: regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903218]
- 6230: regulation of male mating behavior [GO_1902435]
- 6231: regulation of MAP kinase activity [GO_0043405]
- 6232: regulation of MAPK cascade [GO_0043408]
- 6233: regulation of megakaryocyte differentiation [GO_0045652]
- 6234: regulation of meiotic cell cycle [GO_0051445]
- 6235: regulation of meiotic cell cycle process involved in oocyte maturation [GO_1903538]
- 6236: regulation of meiotic nuclear division [GO_0040020]
- 6237: regulation of membrane disassembly [GO_0010549]
- 6238: regulation of membrane invagination [GO_1905153]
- 6239: regulation of membrane lipid distribution [GO_0097035]
- 6240: regulation of membrane potential [GO_0042391]
- 6241: regulation of membrane potential in photoreceptor cell [GO_0016057]
- 6242: regulation of mesenchymal cell apoptotic process [GO_2001053]
- 6243: regulation of mesenchymal cell proliferation [GO_0010464]
- 6244: regulation of mesenchymal cell proliferation involved in lung development [GO_2000790]
- 6245: regulation of mesoderm development [GO_2000380]
- 6246: regulation of mesoderm formation [GO_1905902]
- 6247: regulation of mesodermal cell differentiation [GO_1905770]
- 6248: regulation of metabolic process [GO_0019222]
- 6249: regulation of metal ion transport [GO_0010959]
- 6250: regulation of metalloendopeptidase activity [GO_1904683]
- 6251: regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902962]
- 6252: regulation of metallopeptidase activity [GO_1905048]
- 6253: regulation of methionine-tRNA ligase activity [GO_1905018]
- 6254: regulation of microtubule binding [GO_1904526]
- 6255: regulation of microtubule cytoskeleton organization [GO_0070507]
- 6256: regulation of microtubule depolymerization [GO_0031114]
- 6257: regulation of microtubule minus-end binding [GO_1902619]
- 6258: regulation of microtubule nucleation [GO_0010968]
- 6259: regulation of microtubule plus-end binding [GO_1903031]
- 6260: regulation of microtubule polymerization [GO_0031113]
- 6261: regulation of microtubule polymerization or depolymerization [GO_0031110]
- 6262: regulation of microtubule-based movement [GO_0060632]
- 6263: regulation of microtubule-based process [GO_0032886]
- 6264: regulation of microvillus assembly [GO_0032534]
- 6265: regulation of microvillus organization [GO_0032530]
- 6266: regulation of miRNA-mediated gene silencing [GO_0060964]
- 6267: regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905706]
- 6268: regulation of mitochondrial DNA metabolic process [GO_1901858]
- 6269: regulation of mitochondrial DNA replication [GO_0090296]
- 6270: regulation of mitochondrial gene expression [GO_0062125]
- 6271: regulation of mitochondrial mRNA catabolic process [GO_1905637]
- 6272: regulation of mitochondrial RNA catabolic process [GO_0000960]
- 6273: regulation of mitochondrial transcription [GO_1903108]
- 6274: regulation of mitochondrial translation [GO_0070129]
- 6275: regulation of mitochondrial translational elongation [GO_1905082]
- 6276: regulation of mitochondrial translational initiation [GO_0070132]
- 6277: regulation of mitochondrion organization [GO_0010821]
- 6278: regulation of mitotic cell cycle [GO_0007346]
- 6279: regulation of mitotic cell cycle DNA replication [GO_1903463]
- 6280: regulation of mitotic cell cycle, embryonic [GO_0009794]
- 6281: regulation of mitotic chromosome condensation [GO_1903379]
- 6282: regulation of mitotic nuclear division [GO_0007088]
- 6283: regulation of mitotic nuclear envelope disassembly [GO_1905557]
- 6284: regulation of mitotic sister chromatid segregation [GO_0033047]
- 6285: regulation of molecular function [GO_0065009]
- 6286: regulation of mononuclear cell proliferation [GO_0032944]
- 6287: regulation of monooxygenase activity [GO_0032768]
- 6288: regulation of morphogenesis of a branching structure [GO_0060688]
- 6289: regulation of morphogenesis of an epithelium [GO_1905330]
- 6290: regulation of motor neuron apoptotic process [GO_2000671]
- 6291: regulation of mRNA 3'-UTR binding [GO_1903837]
- 6292: regulation of mRNA binding [GO_1902415]
- 6293: regulation of mRNA catabolic process [GO_0061013]
- 6294: regulation of mRNA metabolic process [GO_1903311]
- 6295: regulation of mRNA stability [GO_0043488]
- 6296: regulation of mRNA stability involved in response to oxidative stress [GO_2000815]
- 6297: regulation of mRNA stability involved in response to stress [GO_0010610]
- 6298: regulation of mucus secretion [GO_0070255]
- 6299: regulation of multicellular organism growth [GO_0040014]
- 6300: regulation of multicellular organismal development [GO_2000026]
- 6301: regulation of multicellular organismal process [GO_0051239]
- 6302: regulation of muscle adaptation [GO_0043502]
- 6303: regulation of muscle cell apoptotic process [GO_0010660]
- 6304: regulation of muscle cell differentiation [GO_0051147]
- 6305: regulation of muscle contraction [GO_0006937]
- 6306: regulation of muscle hypertrophy [GO_0014743]
- 6307: regulation of muscle organ development [GO_0048634]
- 6308: regulation of muscle system process [GO_0090257]
- 6309: regulation of muscle tissue development [GO_1901861]
- 6310: regulation of myeloid cell apoptotic process [GO_0033032]
- 6311: regulation of myeloid cell differentiation [GO_0045637]
- 6312: regulation of myeloid leukocyte differentiation [GO_0002761]
- 6313: regulation of myeloid leukocyte mediated immunity [GO_0002886]
- 6314: regulation of myeloid progenitor cell differentiation [GO_1905453]
- 6315: regulation of myoblast differentiation [GO_0045661]
- 6316: regulation of myoblast proliferation [GO_2000291]
- 6317: regulation of myosin light chain kinase activity [GO_0035504]
- 6318: regulation of myotome development [GO_2000290]
- 6319: regulation of myotube differentiation [GO_0010830]
- 6320: regulation of NAD+ ADP-ribosyltransferase activity [GO_1901664]
- 6321: regulation of NAD+ kinase activity [GO_0033670]
- 6322: regulation of negative chemotaxis [GO_0050923]
- 6323: regulation of nervous system development [GO_0051960]
- 6324: regulation of nervous system process [GO_0031644]
- 6325: regulation of netrin-activated signaling pathway [GO_1902841]
- 6326: regulation of neural crest cell differentiation [GO_1905292]
- 6327: regulation of neural crest formation [GO_0090299]
- 6328: regulation of neural precursor cell proliferation [GO_2000177]
- 6329: regulation of neural retina development [GO_0061074]
- 6330: regulation of neuroblast proliferation [GO_1902692]
- 6331: regulation of neurogenesis [GO_0050767]
- 6332: regulation of neuromuscular junction development [GO_1904396]
- 6333: regulation of neuron apoptotic process [GO_0043523]
- 6334: regulation of neuron death [GO_1901214]
- 6335: regulation of neuron differentiation [GO_0045664]
- 6336: regulation of neuron maturation [GO_0014041]
- 6337: regulation of neuron projection development [GO_0010975]
- 6338: regulation of neuronal action potential [GO_0098908]
- 6339: regulation of neurotransmitter levels [GO_0001505]
- 6340: regulation of neurotransmitter receptor activity [GO_0099601]
- 6341: regulation of neurotransmitter secretion [GO_0046928]
- 6342: regulation of neurotransmitter transport [GO_0051588]
- 6343: regulation of neurotransmitter uptake [GO_0051580]
- 6344: regulation of nitric-oxide synthase activity [GO_0050999]
- 6345: regulation of nitrogen compound metabolic process [GO_0051171]
- 6346: regulation of NMDA receptor activity [GO_2000310]
- 6347: regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903995]
- 6348: regulation of norepinephrine secretion [GO_0014061]
- 6349: regulation of norepinephrine uptake [GO_0051621]
- 6350: regulation of nuclear cell cycle DNA replication [GO_0033262]
- 6351: regulation of nuclear division [GO_0051783]
- 6352: regulation of nuclear migration along microtubule [GO_1902838]
- 6353: regulation of nuclease activity [GO_0032069]
- 6354: regulation of nucleic acid-templated transcription [GO_1903506]
- 6355: regulation of nucleobase-containing compound metabolic process [GO_0019219]
- 6356: regulation of nucleobase-containing compound transport [GO_0032239]
- 6357: regulation of nucleocytoplasmic transport [GO_0046822]
- 6358: regulation of nucleoside metabolic process [GO_0009118]
- 6359: regulation of nucleoside transport [GO_0032242]
- 6360: regulation of nucleotide biosynthetic process [GO_0030808]
- 6361: regulation of nucleotide metabolic process [GO_0006140]
- 6362: regulation of nucleus organization [GO_1903353]
- 6363: regulation of olfactory learning [GO_0090328]
- 6364: regulation of oligopeptide transport [GO_0090088]
- 6365: regulation of oocyte development [GO_0060281]
- 6366: regulation of oocyte maturation [GO_1900193]
- 6367: regulation of oogenesis [GO_1905879]
- 6368: regulation of organ growth [GO_0046620]
- 6369: regulation of organelle assembly [GO_1902115]
- 6370: regulation of organelle organization [GO_0033043]
- 6371: regulation of organelle transport along microtubule [GO_1902513]
- 6372: regulation of organic acid transport [GO_0032890]
- 6373: regulation of ossification [GO_0030278]
- 6374: regulation of oviposition [GO_0046662]
- 6375: regulation of oxidative phosphorylation [GO_0002082]
- 6376: regulation of oxidoreductase activity [GO_0051341]
- 6377: regulation of oxygen metabolic process [GO_2000374]
- 6378: regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903406]
- 6379: regulation of pancreatic A cell differentiation [GO_2000226]
- 6380: regulation of peptidase activity [GO_0052547]
- 6381: regulation of peptide hormone secretion [GO_0090276]
- 6382: regulation of peptide secretion [GO_0002791]
- 6383: regulation of peptide transport [GO_0090087]
- 6384: regulation of peptidyl-tyrosine phosphorylation [GO_0050730]
- 6385: regulation of peroxidase activity [GO_2000468]
- 6386: regulation of pharynx morphogenesis [GO_0110041]
- 6387: regulation of phosphatase activity [GO_0010921]
- 6388: regulation of phosphate metabolic process [GO_0019220]
- 6389: regulation of phosphate transmembrane transport [GO_2000185]
- 6390: regulation of phosphate transport [GO_0010966]
- 6391: regulation of phosphatidate phosphatase activity [GO_1903730]
- 6392: regulation of phosphatidylcholine biosynthetic process [GO_2001245]
- 6393: regulation of phosphatidylcholine metabolic process [GO_0150172]
- 6394: regulation of phosphatidylinositol 3-kinase activity [GO_0043551]
- 6395: regulation of phosphatidylinositol biosynthetic process [GO_0010511]
- 6396: regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120138]
- 6397: regulation of phospholipase A2 activity [GO_0032429]
- 6398: regulation of phospholipase activity [GO_0010517]
- 6399: regulation of phospholipase C activity [GO_1900274]
- 6400: regulation of phospholipase D activity [GO_1904005]
- 6401: regulation of phospholipid biosynthetic process [GO_0071071]
- 6402: regulation of phospholipid metabolic process [GO_1903725]
- 6403: regulation of phospholipid scramblase activity [GO_1900161]
- 6404: regulation of phospholipid translocation [GO_0061091]
- 6405: regulation of phospholipid transport [GO_2001138]
- 6406: regulation of phosphoprotein phosphatase activity [GO_0043666]
- 6407: regulation of phosphorus metabolic process [GO_0051174]
- 6408: regulation of phosphorylation [GO_0042325]
- 6409: regulation of photoreceptor cell differentiation [GO_0046532]
- 6410: regulation of pigment cell differentiation [GO_0050932]
- 6411: regulation of pigmentation [GO_0120305]
- 6412: regulation of placenta blood vessel development [GO_0110079]
- 6413: regulation of plasma membrane bounded cell projection assembly [GO_0120032]
- 6414: regulation of plasma membrane bounded cell projection organization [GO_0120035]
- 6415: regulation of plasma membrane organization [GO_1903729]
- 6416: regulation of poly(A)-specific ribonuclease activity [GO_0106246]
- 6417: regulation of polyamine transmembrane transport [GO_1902267]
- 6418: regulation of polynucleotide adenylyltransferase activity [GO_1904245]
- 6419: regulation of polysaccharide biosynthetic process [GO_0032885]
- 6420: regulation of polysaccharide metabolic process [GO_0032881]
- 6421: regulation of polysome binding [GO_1905696]
- 6422: regulation of positive chemotaxis [GO_0050926]
- 6423: regulation of post-embryonic development [GO_0048580]
- 6424: regulation of post-transcriptional gene silencing [GO_0060147]
- 6425: regulation of post-transcriptional gene silencing by RNA [GO_1900368]
- 6426: regulation of postsynapse assembly [GO_0150052]
- 6427: regulation of postsynapse organization [GO_0099175]
- 6428: regulation of postsynaptic membrane potential [GO_0060078]
- 6429: regulation of postsynaptic neurotransmitter receptor activity [GO_0098962]
- 6430: regulation of potassium ion transmembrane transport [GO_1901379]
- 6431: regulation of potassium ion transmembrane transporter activity [GO_1901016]
- 6432: regulation of potassium ion transport [GO_0043266]
- 6433: regulation of presynapse assembly [GO_1905606]
- 6434: regulation of presynapse organization [GO_0099174]
- 6435: regulation of primary metabolic process [GO_0080090]
- 6436: regulation of programmed cell death [GO_0043067]
- 6437: regulation of prostaglandin-E synthase activity [GO_2000361]
- 6438: regulation of proteasomal protein catabolic process [GO_0061136]
- 6439: regulation of protein ADP-ribosylation [GO_0010835]
- 6440: regulation of protein binding [GO_0043393]
- 6441: regulation of protein catabolic process [GO_0042176]
- 6442: regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO_0099576]
- 6443: regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO_0099575]
- 6444: regulation of protein catabolic process at synapse, modulating synaptic transmission [GO_0099574]
- 6445: regulation of protein catabolic process in the vacuole [GO_1904350]
- 6446: regulation of protein deacetylation [GO_0090311]
- 6447: regulation of protein dephosphorylation [GO_0035304]
- 6448: regulation of protein depolymerization [GO_1901879]
- 6449: regulation of protein deubiquitination [GO_0090085]
- 6450: regulation of protein folding [GO_1903332]
- 6451: regulation of protein heterodimerization activity [GO_0043497]
- 6452: regulation of protein homodimerization activity [GO_0043496]
- 6453: regulation of protein K48-linked deubiquitination [GO_1903093]
- 6454: regulation of protein K63-linked deubiquitination [GO_1903004]
- 6455: regulation of protein kinase activity [GO_0045859]
- 6456: regulation of protein kinase C activity [GO_1900019]
- 6457: regulation of protein localization [GO_0032880]
- 6458: regulation of protein localization to cell cortex [GO_1904776]
- 6459: regulation of protein localization to cell leading edge [GO_1905871]
- 6460: regulation of protein localization to cell periphery [GO_1904375]
- 6461: regulation of protein localization to cell-cell junction [GO_0150106]
- 6462: regulation of protein localization to chromatin [GO_1905634]
- 6463: regulation of protein localization to ciliary membrane [GO_1903567]
- 6464: regulation of protein localization to cilium [GO_1903564]
- 6465: regulation of protein localization to membrane [GO_1905475]
- 6466: regulation of protein localization to microtubule [GO_1902816]
- 6467: regulation of protein localization to nucleolus [GO_1904749]
- 6468: regulation of protein localization to nucleus [GO_1900180]
- 6469: regulation of protein localization to plasma membrane [GO_1903076]
- 6470: regulation of protein localization to presynapse [GO_1905384]
- 6471: regulation of protein localization to synapse [GO_1902473]
- 6472: regulation of protein metabolic process [GO_0051246]
- 6473: regulation of protein modification by small protein conjugation or removal [GO_1903320]
- 6474: regulation of protein modification process [GO_0031399]
- 6475: regulation of protein phosphorylation [GO_0001932]
- 6476: regulation of protein polymerization [GO_0032271]
- 6477: regulation of protein secretion [GO_0050708]
- 6478: regulation of protein serine/threonine kinase activity [GO_0071900]
- 6479: regulation of protein sumoylation [GO_0033233]
- 6480: regulation of protein transport [GO_0051223]
- 6481: regulation of protein tyrosine kinase activity [GO_0061097]
- 6482: regulation of protein tyrosine phosphatase activity [GO_1903613]
- 6483: regulation of protein ubiquitination [GO_0031396]
- 6484: regulation of protein-containing complex assembly [GO_0043254]
- 6485: regulation of protein-containing complex disassembly [GO_0043244]
- 6486: regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150073]
- 6487: regulation of proteolysis [GO_0030162]
- 6488: regulation of proteolysis involved in protein catabolic process [GO_1903050]
- 6489: regulation of proton transport [GO_0010155]
- 6490: regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905271]
- 6491: regulation of proton-transporting ATPase activity, rotational mechanism [GO_0010849]
- 6492: regulation of purine nucleotide biosynthetic process [GO_1900371]
- 6493: regulation of purine nucleotide metabolic process [GO_1900542]
- 6494: regulation of Purkinje myocyte action potential [GO_0098906]
- 6495: regulation of pyrimidine nucleotide biosynthetic process [GO_1900397]
- 6496: regulation of pyrroline-5-carboxylate reductase activity [GO_1903167]
- 6497: regulation of pyruvate dehydrogenase activity [GO_1904182]
- 6498: regulation of pyruvate kinase activity [GO_1903302]
- 6499: regulation of reactive oxygen species metabolic process [GO_2000377]
- 6500: regulation of receptor binding [GO_1900120]
- 6501: regulation of receptor-mediated endocytosis [GO_0048259]
- 6502: regulation of release of sequestered calcium ion into cytosol [GO_0051279]
- 6503: regulation of removal of superoxide radicals [GO_2000121]
- 6504: regulation of renal system process [GO_0098801]
- 6505: regulation of reproductive process [GO_2000241]
- 6506: regulation of respiratory gaseous exchange [GO_0043576]
- 6507: regulation of respiratory gaseous exchange by nervous system process [GO_0002087]
- 6508: regulation of respiratory system process [GO_0044065]
- 6509: regulation of response to alcohol [GO_1901419]
- 6510: regulation of response to biotic stimulus [GO_0002831]
- 6511: regulation of response to calcium ion [GO_1905945]
- 6512: regulation of response to cytokine stimulus [GO_0060759]
- 6513: regulation of response to DNA damage stimulus [GO_2001020]
- 6514: regulation of response to drug [GO_2001023]
- 6515: regulation of response to external stimulus [GO_0032101]
- 6516: regulation of response to extracellular stimulus [GO_0032104]
- 6517: regulation of response to nutrient levels [GO_0032107]
- 6518: regulation of response to osmotic stress [GO_0047484]
- 6519: regulation of response to oxidative stress [GO_1902882]
- 6520: regulation of response to reactive oxygen species [GO_1901031]
- 6521: regulation of response to stimulus [GO_0048583]
- 6522: regulation of response to stress [GO_0080134]
- 6523: regulation of response to wounding [GO_1903034]
- 6524: regulation of retina development in camera-type eye [GO_1902866]
- 6525: regulation of retinal cell programmed cell death [GO_0046668]
- 6526: regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905432]
- 6527: regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000298]
- 6528: regulation of rhodopsin mediated signaling pathway [GO_0022400]
- 6529: regulation of ribonuclease activity [GO_0060700]
- 6530: regulation of ribosome biogenesis [GO_0090069]
- 6531: regulation of RNA binding [GO_1905214]
- 6532: regulation of RNA biosynthetic process [GO_2001141]
- 6533: regulation of RNA helicase activity [GO_1902280]
- 6534: regulation of RNA metabolic process [GO_0051252]
- 6535: regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901839]
- 6536: regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903025]
- 6537: regulation of RNA polymerase III activity [GO_1903622]
- 6538: regulation of RNA stability [GO_0043487]
- 6539: regulation of rRNA processing [GO_2000232]
- 6540: regulation of ryanodine-sensitive calcium-release channel activity [GO_0060314]
- 6541: regulation of SA node cell action potential [GO_0098907]
- 6542: regulation of saliva secretion [GO_0046877]
- 6543: regulation of sarcomere organization [GO_0060297]
- 6544: regulation of sclerotome development [GO_0061190]
- 6545: regulation of secondary metabolic process [GO_0043455]
- 6546: regulation of secondary metabolite biosynthetic process [GO_1900376]
- 6547: regulation of secretion [GO_0051046]
- 6548: regulation of secretion by cell [GO_1903530]
- 6549: regulation of secretory granule organization [GO_1904409]
- 6550: regulation of semaphorin-plexin signaling pathway [GO_2001260]
- 6551: regulation of sensory perception [GO_0051931]
- 6552: regulation of sensory perception of bitter taste [GO_1904660]
- 6553: regulation of sensory perception of pain [GO_0051930]
- 6554: regulation of sensory perception of sweet taste [GO_1904656]
- 6555: regulation of sequestering of calcium ion [GO_0051282]
- 6556: regulation of serine C-palmitoyltransferase activity [GO_1904220]
- 6557: regulation of serine-type endopeptidase activity [GO_1900003]
- 6558: regulation of serine-type peptidase activity [GO_1902571]
- 6559: regulation of serotonin biosynthetic process [GO_1905627]
- 6560: regulation of serotonin secretion [GO_0014062]
- 6561: regulation of serotonin uptake [GO_0051611]
- 6562: regulation of signal transduction [GO_0009966]
- 6563: regulation of signaling [GO_0023051]
- 6564: regulation of signaling receptor activity [GO_0010469]
- 6565: regulation of single-stranded telomeric DNA binding [GO_0060380]
- 6566: regulation of sister chromatid segregation [GO_0033045]
- 6567: regulation of skeletal muscle adaptation [GO_0014733]
- 6568: regulation of skeletal muscle cell differentiation [GO_2001014]
- 6569: regulation of skeletal muscle cell proliferation [GO_0014857]
- 6570: regulation of skeletal muscle contraction [GO_0014819]
- 6571: regulation of skeletal muscle contraction by action potential [GO_0100001]
- 6572: regulation of skeletal muscle contraction via regulation of action potential [GO_0014861]
- 6573: regulation of skeletal muscle fiber development [GO_0048742]
- 6574: regulation of skeletal muscle fiber differentiation [GO_1902809]
- 6575: regulation of skeletal muscle hypertrophy [GO_1904204]
- 6576: regulation of skeletal muscle tissue development [GO_0048641]
- 6577: regulation of skeletal muscle tissue growth [GO_0048631]
- 6578: regulation of small GTPase binding [GO_1904475]
- 6579: regulation of small intestine smooth muscle contraction [GO_1904347]
- 6580: regulation of small molecule metabolic process [GO_0062012]
- 6581: regulation of smooth muscle cell apoptotic process [GO_0034391]
- 6582: regulation of smooth muscle cell differentiation [GO_0051150]
- 6583: regulation of smooth muscle cell proliferation [GO_0048660]
- 6584: regulation of smooth muscle contraction [GO_0006940]
- 6585: regulation of smooth muscle hypertrophy [GO_1905147]
- 6586: regulation of smooth muscle tissue development [GO_1905899]
- 6587: regulation of sodium ion transmembrane transport [GO_1902305]
- 6588: regulation of sodium ion transmembrane transporter activity [GO_2000649]
- 6589: regulation of sodium ion transport [GO_0002028]
- 6590: regulation of sodium:proton antiporter activity [GO_0032415]
- 6591: regulation of somatic stem cell division [GO_1904675]
- 6592: regulation of somatostatin secretion [GO_0090273]
- 6593: regulation of somitogenesis [GO_0014807]
- 6594: regulation of stem cell differentiation [GO_2000736]
- 6595: regulation of stem cell division [GO_2000035]
- 6596: regulation of stem cell proliferation [GO_0072091]
- 6597: regulation of steroid biosynthetic process [GO_0050810]
- 6598: regulation of steroid hormone secretion [GO_2000831]
- 6599: regulation of steroid metabolic process [GO_0019218]
- 6600: regulation of sterol transport [GO_0032371]
- 6601: regulation of stomach neuroendocrine cell differentiation [GO_0061105]
- 6602: regulation of store-operated calcium channel activity [GO_1901339]
- 6603: regulation of stress-activated MAPK cascade [GO_0032872]
- 6604: regulation of stress-activated protein kinase signaling cascade [GO_0070302]
- 6605: regulation of striated muscle cell apoptotic process [GO_0010662]
- 6606: regulation of striated muscle cell differentiation [GO_0051153]
- 6607: regulation of striated muscle contraction [GO_0006942]
- 6608: regulation of striated muscle tissue development [GO_0016202]
- 6609: regulation of succinate dehydrogenase activity [GO_1904229]
- 6610: regulation of sulfur metabolic process [GO_0042762]
- 6611: regulation of SUMO transferase activity [GO_1903182]
- 6612: regulation of superoxide dismutase activity [GO_1901668]
- 6613: regulation of superoxide metabolic process [GO_0090322]
- 6614: regulation of supramolecular fiber organization [GO_1902903]
- 6615: regulation of synapse assembly [GO_0051963]
- 6616: regulation of synapse organization [GO_0050807]
- 6617: regulation of synapse organization by posttranscriptional regulation of gene expression [GO_1904739]
- 6618: regulation of synapse pruning [GO_1905806]
- 6619: regulation of synapse structure or activity [GO_0050803]
- 6620: regulation of synaptic transmission, cholinergic [GO_0032222]
- 6621: regulation of synaptic transmission, dopaminergic [GO_0032225]
- 6622: regulation of synaptic transmission, GABAergic [GO_0032228]
- 6623: regulation of synaptic transmission, glutamatergic [GO_0051966]
- 6624: regulation of synaptic transmission, glycinergic [GO_0060092]
- 6625: regulation of syncytium formation by plasma membrane fusion [GO_0060142]
- 6626: regulation of system process [GO_0044057]
- 6627: regulation of tau-protein kinase activity [GO_1902947]
- 6628: regulation of telomerase activity [GO_0051972]
- 6629: regulation of telomeric DNA binding [GO_1904742]
- 6630: regulation of termination of DNA-templated transcription [GO_0031554]
- 6631: regulation of tetrapyrrole biosynthetic process [GO_1901463]
- 6632: regulation of tetrapyrrole catabolic process [GO_1901404]
- 6633: regulation of tetrapyrrole metabolic process [GO_1901401]
- 6634: regulation of thioredoxin peroxidase activity [GO_1903123]
- 6635: regulation of threonine-tRNA ligase activity [GO_1905021]
- 6636: regulation of timing of cell differentiation [GO_0048505]
- 6637: regulation of trans-synaptic signaling [GO_0099177]
- 6638: regulation of transcription by RNA polymerase I [GO_0006356]
- 6639: regulation of transcription by RNA polymerase II [GO_0006357]
- 6640: regulation of transcription by RNA polymerase III [GO_0006359]
- 6641: regulation of transcription regulatory region DNA binding [GO_2000677]
- 6642: regulation of transepithelial transport [GO_0150111]
- 6643: regulation of transferase activity [GO_0051338]
- 6644: regulation of translation [GO_0006417]
- 6645: regulation of translation at postsynapse [GO_0140245]
- 6646: regulation of translation at postsynapse, modulating synaptic transmission [GO_0099578]
- 6647: regulation of translation at presynapse [GO_0140244]
- 6648: regulation of translation at presynapse, modulating synaptic transmission [GO_0099577]
- 6649: regulation of translation at synapse [GO_0140243]
- 6650: regulation of translation at synapse, modulating synaptic transmission [GO_0099547]
- 6651: regulation of translation by machinery localization [GO_0043143]
- 6652: regulation of translation in response to oxidative stress [GO_0043556]
- 6653: regulation of translation in response to stress [GO_0043555]
- 6654: regulation of translational elongation [GO_0006448]
- 6655: regulation of translational fidelity [GO_0006450]
- 6656: regulation of translational initiation [GO_0006446]
- 6657: regulation of translational initiation in response to stress [GO_0043558]
- 6658: regulation of translational termination [GO_0006449]
- 6659: regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090092]
- 6660: regulation of transmembrane transport [GO_0034762]
- 6661: regulation of transmembrane transporter activity [GO_0022898]
- 6662: regulation of transmission of nerve impulse [GO_0051969]
- 6663: regulation of transport [GO_0051049]
- 6664: regulation of transporter activity [GO_0032409]
- 6665: regulation of triglyceride biosynthetic process [GO_0010866]
- 6666: regulation of triglyceride metabolic process [GO_0090207]
- 6667: regulation of tRNA metabolic process [GO_1903326]
- 6668: regulation of tRNA methylation [GO_0110002]
- 6669: regulation of tRNA processing [GO_2000235]
- 6670: regulation of trophectodermal cell proliferation [GO_1904073]
- 6671: regulation of tube lumen cavitation [GO_1903132]
- 6672: regulation of turning behavior involved in mating [GO_0061094]
- 6673: regulation of type B pancreatic cell apoptotic process [GO_2000674]
- 6674: regulation of type B pancreatic cell development [GO_2000074]
- 6675: regulation of type B pancreatic cell proliferation [GO_0061469]
- 6676: regulation of tyrosinase activity [GO_0032771]
- 6677: regulation of tyrosine 3-monooxygenase activity [GO_1903176]
- 6678: regulation of ubiquitin protein ligase activity [GO_1904666]
- 6679: regulation of ubiquitin-dependent protein catabolic process [GO_2000058]
- 6680: regulation of ubiquitin-protein transferase activity [GO_0051438]
- 6681: regulation of ubiquitin-specific protease activity [GO_2000152]
- 6682: regulation of vacuolar transport [GO_1903335]
- 6683: regulation of vacuole organization [GO_0044088]
- 6684: regulation of vascular associated smooth muscle cell apoptotic process [GO_1905459]
- 6685: regulation of vascular associated smooth muscle cell differentiation [GO_1905063]
- 6686: regulation of vascular associated smooth muscle cell proliferation [GO_1904705]
- 6687: regulation of vascular endothelial cell proliferation [GO_1905562]
- 6688: regulation of vasculature development [GO_1901342]
- 6689: regulation of vasculogenesis [GO_2001212]
- 6690: regulation of vesicle fusion [GO_0031338]
- 6691: regulation of vesicle fusion with Golgi apparatus [GO_0106214]
- 6692: regulation of vesicle targeting, to, from or within Golgi [GO_0048209]
- 6693: regulation of vesicle transport along microtubule [GO_1901608]
- 6694: regulation of vesicle-mediated transport [GO_0060627]
- 6695: regulation of vitamin D 24-hydroxylase activity [GO_0010979]
- 6696: regulation of vitamin metabolic process [GO_0030656]
- 6697: regulation of voltage-gated calcium channel activity [GO_1901385]
- 6698: regulation of voltage-gated chloride channel activity [GO_1902941]
- 6699: regulation of voltage-gated sodium channel activity [GO_1905150]
- 6700: regulation of water channel activity [GO_1902427]
- 6701: regulation of Wnt signaling pathway [GO_0030111]
- 6702: regulation of wound healing [GO_0061041]
- 6703: regulation of zinc ion transmembrane transport [GO_0071580]
- 6704: regulation of zinc ion transport [GO_0071579]
- 6705: regulation protein catabolic process at postsynapse [GO_0140252]
- 6706: regulation protein catabolic process at presynapse [GO_0140251]
- 6707: regulation protein catabolic process at synapse [GO_0140250]
- 6708: regulatory region RNA binding [GO_0001069]
- 6709: regulatory RNA binding [GO_0061980]
- 6710: release of sequestered calcium ion into cytosol [GO_0051209]
- 6711: Removal of remaining Flap from the C-strand [GO_0017108]
- 6712: removal of superoxide radicals [GO_0019430]
- 6713: renal filtration [GO_0097205]
- 6714: renal sodium ion transport [GO_0003096]
- 6715: renal system development [GO_0072001]
- 6716: renal system process [GO_0003014]
- 6717: renal tubular secretion [GO_0097254]
- 6718: replacement bone morphogenesis [GO_0061971]
- 6719: reproduction [GO_0000003]
- 6720: reproductive behavior [GO_0019098]
- 6721: reproductive process [GO_0022414]
- 6722: reproductive structure development [GO_0048608]
- 6723: reproductive system development [GO_0061458]
- 6724: respiratory electron transport chain [GO_0022904]
- 6725: respiratory gaseous exchange by respiratory system [GO_0007585]
- 6726: respiratory system development [GO_0060541]
- 6727: respiratory system process [GO_0003016]
- 6728: respiratory tube development [GO_0030323]
- 6729: response to abiotic stimulus [GO_0009628]
- 6730: response to acetylcholine [GO_1905144]
- 6731: response to acid chemical [GO_0001101]
- 6732: response to alcohol [GO_0097305]
- 6733: response to alkaloid [GO_0043279]
- 6734: response to amine [GO_0014075]
- 6735: response to amino acid [GO_0043200]
- 6736: response to ammonium ion [GO_0060359]
- 6737: response to antibiotic [GO_0046677]
- 6738: response to bacterium [GO_0009617]
- 6739: response to bile acid [GO_1903412]
- 6740: response to biotic stimulus [GO_0009607]
- 6741: response to blue light [GO_0009637]
- 6742: response to BMP [GO_0071772]
- 6743: response to caffeine [GO_0031000]
- 6744: response to calcium ion [GO_0051592]
- 6745: response to carbamate [GO_0046681]
- 6746: response to carbohydrate [GO_0009743]
- 6747: response to catecholamine [GO_0071869]
- 6748: response to chemical [GO_0042221]
- 6749: response to cold [GO_0009409]
- 6750: response to cytokine [GO_0034097]
- 6751: response to diuretic [GO_0036270]
- 6752: response to dopamine [GO_1903350]
- 6753: response to endogenous stimulus [GO_0009719]
- 6754: response to external biotic stimulus [GO_0043207]
- 6755: response to external stimulus [GO_0009605]
- 6756: response to extracellular stimulus [GO_0009991]
- 6757: response to farnesol [GO_0097307]
- 6758: response to fibroblast growth factor [GO_0071774]
- 6759: response to fungus [GO_0009620]
- 6760: response to glucagon [GO_0033762]
- 6761: response to glucose [GO_0009749]
- 6762: response to glycoprotein [GO_1904587]
- 6763: response to gravity [GO_0009629]
- 6764: response to growth factor [GO_0070848]
- 6765: response to heat [GO_0009408]
- 6766: response to hexose [GO_0009746]
- 6767: response to hormone [GO_0009725]
- 6768: response to inorganic substance [GO_0010035]
- 6769: response to insecticide [GO_0017085]
- 6770: response to insulin [GO_0032868]
- 6771: response to ketone [GO_1901654]
- 6772: response to light stimulus [GO_0009416]
- 6773: response to lipid [GO_0033993]
- 6774: response to lipopolysaccharide [GO_0032496]
- 6775: response to mechanical stimulus [GO_0009612]
- 6776: response to metal ion [GO_0010038]
- 6777: response to molecule of bacterial origin [GO_0002237]
- 6778: response to molecule of fungal origin [GO_0002238]
- 6779: response to monoamine [GO_0071867]
- 6780: response to monosaccharide [GO_0034284]
- 6781: response to nitrogen compound [GO_1901698]
- 6782: response to norepinephrine [GO_0071873]
- 6783: response to nutrient [GO_0007584]
- 6784: response to nutrient levels [GO_0031667]
- 6785: response to organic cyclic compound [GO_0014070]
- 6786: response to organic substance [GO_0010033]
- 6787: response to organonitrogen compound [GO_0010243]
- 6788: response to osmotic stress [GO_0006970]
- 6789: response to other organism [GO_0051707]
- 6790: response to oxidative stress [GO_0006979]
- 6791: response to oxygen radical [GO_0000305]
- 6792: response to oxygen-containing compound [GO_1901700]
- 6793: response to pain [GO_0048265]
- 6794: response to peptide [GO_1901652]
- 6795: response to peptide hormone [GO_0043434]
- 6796: response to pheromone [GO_0019236]
- 6797: response to purine-containing compound [GO_0014074]
- 6798: response to radiation [GO_0009314]
- 6799: response to reactive oxygen species [GO_0000302]
- 6800: response to salt [GO_1902074]
- 6801: response to serotonin [GO_1904014]
- 6802: response to starvation [GO_0042594]
- 6803: response to steroid hormone [GO_0048545]
- 6804: response to stimulus [GO_0050896]
- 6805: response to stimulus involved in regulation of muscle adaptation [GO_0014874]
- 6806: response to stress [GO_0006950]
- 6807: response to superoxide [GO_0000303]
- 6808: response to temperature stimulus [GO_0009266]
- 6809: response to toxic substance [GO_0009636]
- 6810: response to wounding [GO_0009611]
- 6811: response to xenobiotic stimulus [GO_0009410]
- 6812: response to yeast [GO_0001878]
- 6813: retina development in camera-type eye [GO_0060041]
- 6814: retina layer formation [GO_0010842]
- 6815: retina morphogenesis in camera-type eye [GO_0060042]
- 6816: retina vasculature development in camera-type eye [GO_0061298]
- 6817: retina vasculature morphogenesis in camera-type eye [GO_0061299]
- 6818: retinal binding [GO_0016918]
- 6819: retinal blood vessel morphogenesis [GO_0061304]
- 6820: retinal cell apoptotic process [GO_1990009]
- 6821: retinal cell programmed cell death [GO_0046666]
- 6822: retinal cone cell apoptotic process [GO_0097474]
- 6823: retinal cone cell development [GO_0046549]
- 6824: retinal cone cell differentiation [GO_0042670]
- 6825: retinal rod cell apoptotic process [GO_0097473]
- 6826: retinal rod cell development [GO_0046548]
- 6827: retinal rod cell differentiation [GO_0060221]
- 6828: retinoid binding [GO_0005501]
- 6829: retinoid metabolic process [GO_0001523]
- 6830: retinol binding [GO_0019841]
- 6831: retinol metabolic process [GO_0042572]
- 6832: retrograde trans-synaptic signaling [GO_0098917]
- 6833: retrograde trans-synaptic signaling by lipid [GO_0098920]
- 6834: retrograde trans-synaptic signaling by neuropeptide [GO_0099082]
- 6835: retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO_0099083]
- 6836: Rho GDP-dissociation inhibitor activity [GO_0005094]
- 6837: Rho-dependent protein serine/threonine kinase activity [GO_0072518]
- 6838: rhodopsin mediated signaling pathway [GO_0016056]
- 6839: rhombomere boundary formation [GO_0021654]
- 6840: rhombomere cell migration [GO_0022035]
- 6841: rhombomere development [GO_0021546]
- 6842: rhombomere formation [GO_0021594]
- 6843: rhombomere morphogenesis [GO_0021593]
- 6844: rhythmic behavior [GO_0007622]
- 6845: rhythmic process [GO_0048511]
- 6846: riboflavin kinase activity [GO_0008531]
- 6847: riboflavin reductase (NADPH) activity [GO_0042602]
- 6848: riboflavin transport [GO_0032218]
- 6849: ribonuclease activity [GO_0004540]
- 6850: ribonuclease III activity [GO_0004525]
- 6851: ribonuclease inhibitor activity [GO_0008428]
- 6852: ribonuclease P RNA binding [GO_0033204]
- 6853: ribonucleoprotein complex [GO_1990904]
- 6854: ribonucleoprotein complex assembly [GO_0022618]
- 6855: ribonucleoprotein complex binding [GO_0043021]
- 6856: ribonucleoprotein complex biogenesis [GO_0022613]
- 6857: ribonucleoprotein complex disassembly [GO_0032988]
- 6858: ribonucleoprotein complex subunit organization [GO_0071826]
- 6859: ribonucleoside catabolic process [GO_0042454]
- 6860: ribonucleoside diphosphate metabolic process [GO_0009185]
- 6861: ribonucleoside metabolic process [GO_0009119]
- 6862: ribonucleoside monophosphate biosynthetic process [GO_0009156]
- 6863: ribonucleoside monophosphate metabolic process [GO_0009161]
- 6864: ribonucleoside triphosphate biosynthetic process [GO_0009201]
- 6865: ribonucleoside triphosphate metabolic process [GO_0009199]
- 6866: ribonucleotide binding [GO_0032553]
- 6867: ribonucleotide biosynthetic process [GO_0009260]
- 6868: ribonucleotide metabolic process [GO_0009259]
- 6869: ribose phosphate biosynthetic process [GO_0046390]
- 6870: ribose phosphate diphosphokinase activity [GO_0004749]
- 6871: ribose phosphate metabolic process [GO_0019693]
- 6872: ribosomal large subunit binding [GO_0043023]
- 6873: ribosomal protein S6 kinase activity [GO_0004711]
- 6874: ribosomal small subunit binding [GO_0043024]
- 6875: ribosome [GO_0005840]
- 6876: ribosome assembly [GO_0042255]
- 6877: ribosome binding [GO_0043022]
- 6878: ribosome biogenesis [GO_0042254]
- 6879: ribosome disassembly [GO_0032790]
- 6880: ribosome localization [GO_0033750]
- 6881: ribosylpyrimidine nucleosidase activity [GO_0050263]
- 6882: right horn of sinus venosus development [GO_0061080]
- 6883: right lung development [GO_0060458]
- 6884: right lung morphogenesis [GO_0060461]
- 6885: right ventricular cardiac muscle tissue morphogenesis [GO_0003221]
- 6886: RISC complex binding [GO_1905172]
- 6887: RNA (guanine-N7)-methylation [GO_0036265]
- 6888: RNA 7-methylguanosine cap binding [GO_0000340]
- 6889: RNA adenylyltransferase activity [GO_1990817]
- 6890: RNA biosynthetic process [GO_0032774]
- 6891: RNA cap binding [GO_0000339]
- 6892: RNA catabolic process [GO_0006401]
- 6893: RNA destabilization [GO_0050779]
- 6894: RNA lariat debranching enzyme activator activity [GO_0061632]
- 6895: RNA lariat debranching enzyme activity [GO_0008419]
- 6896: RNA localization [GO_0006403]
- 6897: RNA localization to chromatin [GO_1990280]
- 6898: RNA localization to nucleus [GO_0090685]
- 6899: RNA metabolic process [GO_0016070]
- 6900: RNA methylation [GO_0001510]
- 6901: RNA modification [GO_0009451]
- 6902: RNA phosphodiester bond hydrolysis [GO_0090501]
- 6903: RNA phosphodiester bond hydrolysis, endonucleolytic [GO_0090502]
- 6904: RNA phosphodiester bond hydrolysis, exonucleolytic [GO_0090503]
- 6905: RNA polymerase activity [GO_0097747]
- 6906: RNA polymerase binding [GO_0070063]
- 6907: RNA polymerase core enzyme binding [GO_0043175]
- 6908: RNA polymerase I activity [GO_0001054]
- 6909: RNA polymerase I core binding [GO_0001042]
- 6910: RNA polymerase I general transcription initiation factor activity [GO_0001181]
- 6911: RNA polymerase I transcription regulatory region sequence-specific DNA binding [GO_0001163]
- 6912: RNA polymerase II C-terminal domain binding [GO_0099122]
- 6913: RNA polymerase II C-terminal domain phosphoserine binding [GO_1990269]
- 6914: RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO_0000978]
- 6915: RNA polymerase II complex binding [GO_0000993]
- 6916: RNA polymerase II core promoter sequence-specific DNA binding [GO_0000979]
- 6917: RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO_0008420]
- 6918: RNA polymerase II general transcription initiation factor activity [GO_0016251]
- 6919: RNA polymerase II general transcription initiation factor binding [GO_0001091]
- 6920: RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO_0000977]
- 6921: RNA polymerase II-specific DNA-binding transcription factor binding [GO_0061629]
- 6922: RNA polymerase III core binding [GO_0000994]
- 6923: RNA polymerase III transcribes microbial dsDNA to dsRNA [GO_0001056]
- 6924: RNA processing [GO_0006396]
- 6925: RNA stem-loop binding [GO_0035613]
- 6926: RNA strand annealing activity [GO_0033592]
- 6927: RNA strand-exchange activity [GO_0034057]
- 6928: RNA transmembrane transporter activity [GO_0051033]
- 6929: RNA transport [GO_0050658]
- 6930: RNA uridylyltransferase activity [GO_0050265]
- 6931: RNA-mediated gene silencing [GO_0031047]
- 6932: RNA-mediated post-transcriptional gene silencing [GO_0035194]
- 6933: RNA-templated DNA biosynthetic process [GO_0006278]
- 6934: RNLS:FAD oxidises dh-beta-NAD to NAD+ [GO_0016651]
- 6935: rostrocaudal neural tube patterning [GO_0021903]
- 6936: Roundabout binding [GO_0048495]
- 6937: RPE dimers isomerise RU5P to XY5P [GO_0004750]
- 6938: rRNA binding [GO_0019843]
- 6939: rRNA metabolic process [GO_0016072]
- 6940: rRNA methylation [GO_0031167]
- 6941: rRNA methyltransferase activity [GO_0008649]
- 6942: rRNA modification [GO_0000154]
- 6943: rRNA processing [GO_0006364]
- 6944: RYR tetramers transport Ca2+ from sarcoplasmic reticulum lumen to cytosol [GO_0005219]
- 6945: S-acetyltransferase activity [GO_0016418]
- 6946: S-acyltransferase activity [GO_0016417]
- 6947: S-adenosylmethionine-dependent methyltransferase activity [GO_0008757]
- 6948: S-adenosylmethionine-homocysteine S-methyltransferase activity [GO_0008898]
- 6949: S-methyl-5-thioadenosine phosphorylase activity [GO_0017061]
- 6950: S-nitrosoglutathione reductase activity [GO_0080007]
- 6951: S-succinyltransferase activity [GO_0016751]
- 6952: S100 protein binding [GO_0044548]
- 6953: SA node cell action potential [GO_0086015]
- 6954: SA node cell to atrial cardiac muscle cell communication [GO_0086070]
- 6955: SA node cell to atrial cardiac muscle cell signaling [GO_0086018]
- 6956: saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO_0004754]
- 6957: saccharopine dehydrogenase activity [GO_0004753]
- 6958: saliva secretion [GO_0046541]
- 6959: salivary nucleus development [GO_0021751]
- 6960: salt transmembrane transporter activity [GO_1901702]
- 6961: salty taste receptor activity [GO_0033039]
- 6962: Salvage - Sepiapterin is reduced to BH2 [GO_0004757]
- 6963: SAM domain binding [GO_0032093]
- 6964: SAM50 complex inserts proteins into mitochondrial outer membrane [GO_0032977]
- 6965: sarcomere [GO_0030017]
- 6966: sarcomere organization [GO_0045214]
- 6967: sarcoplasm [GO_0016528]
- 6968: satellite DNA binding [GO_0003696]
- 6969: scaffold protein binding [GO_0097110]
- 6970: scavenger receptor activity [GO_0005044]
- 6971: SCD desaturates ST-CoA to OLE-CoA [GO_0004768]
- 6972: Schwann cell microvillus [GO_0097454]
- 6973: sclerotome development [GO_0061056]
- 6974: SCNN channels transport extracellular Na+ to cytosol [GO_0015280]
- 6975: second-messenger-mediated signaling [GO_0019932]
- 6976: secondary active monocarboxylate transmembrane transporter activity [GO_0015355]
- 6977: secondary active oligopeptide transmembrane transporter activity [GO_0015322]
- 6978: secondary metabolic process [GO_0019748]
- 6979: secondary metabolite biosynthetic process [GO_0044550]
- 6980: secretion [GO_0046903]
- 6981: secretion by cell [GO_0032940]
- 6982: secretion by tissue [GO_0032941]
- 6983: secretory granule [GO_0030141]
- 6984: secretory granule localization [GO_0032252]
- 6985: secretory granule maturation [GO_0061792]
- 6986: secretory granule membrane [GO_0030667]
- 6987: secretory granule organization [GO_0033363]
- 6988: secretory vesicle [GO_0099503]
- 6989: sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate <=> D-erythrose 4-phosphate + D-fructose 6-phosphate [GO_0004801]
- 6990: segmentation [GO_0035282]
- 6991: selenotransferase activity [GO_0016785]
- 6992: semaphorin receptor activity [GO_0017154]
- 6993: semaphorin receptor binding [GO_0030215]
- 6994: semaphorin-plexin signaling pathway [GO_0071526]
- 6995: semaphorin-plexin signaling pathway involved in axon guidance [GO_1902287]
- 6996: semaphorin-plexin signaling pathway involved in neuron projection guidance [GO_1902285]
- 6997: sensory organ development [GO_0007423]
- 6998: sensory organ morphogenesis [GO_0090596]
- 6999: sensory perception [GO_0007600]
- 7000: sensory perception of bitter taste [GO_0050913]
- 7001: sensory perception of chemical stimulus [GO_0007606]
- 7002: sensory perception of cold stimulus [GO_0062035]
- 7003: sensory perception of high humidity [GO_0098510]
- 7004: sensory perception of hot stimulus [GO_0062036]
- 7005: sensory perception of humidity [GO_0098509]
- 7006: sensory perception of light stimulus [GO_0050953]
- 7007: sensory perception of low humidity [GO_0098511]
- 7008: sensory perception of mechanical stimulus [GO_0050954]
- 7009: sensory perception of pain [GO_0019233]
- 7010: sensory perception of salty taste [GO_0050914]
- 7011: sensory perception of smell [GO_0007608]
- 7012: sensory perception of sound [GO_0007605]
- 7013: sensory perception of sour taste [GO_0050915]
- 7014: sensory perception of sweet taste [GO_0050916]
- 7015: sensory perception of taste [GO_0050909]
- 7016: sensory perception of temperature stimulus [GO_0050951]
- 7017: sensory perception of touch [GO_0050975]
- 7018: sensory perception of umami taste [GO_0050917]
- 7019: sensory perception of wind [GO_0071063]
- 7020: sensory system development [GO_0048880]
- 7021: septum transversum development [GO_0003343]
- 7022: sequence-specific DNA binding [GO_0043565]
- 7023: sequence-specific double-stranded DNA binding [GO_1990837]
- 7024: sequence-specific mRNA binding [GO_1990825]
- 7025: sequence-specific single stranded DNA binding [GO_0098847]
- 7026: sequestering of calcium ion [GO_0051208]
- 7027: serine binding [GO_0070905]
- 7028: serine hydrolase activity [GO_0017171]
- 7029: serine racemase activity [GO_0030378]
- 7030: serine transmembrane transporter activity [GO_0022889]
- 7031: serine transport [GO_0032329]
- 7032: serine-pyruvate transaminase activity [GO_0004760]
- 7033: serine-type exopeptidase activity [GO_0070008]
- 7034: serotonin binding [GO_0051378]
- 7035: serotonin biosynthetic process [GO_0042427]
- 7036: serotonin catabolic process [GO_0042429]
- 7037: serotonin metabolic process [GO_0042428]
- 7038: serotonin receptor activity [GO_0099589]
- 7039: serotonin receptor signaling pathway [GO_0007210]
- 7040: serotonin secretion [GO_0001820]
- 7041: serotonin secretion, neurotransmission [GO_0060096]
- 7042: serotonin transport [GO_0006837]
- 7043: serotonin uptake [GO_0051610]
- 7044: serotonin:sodium:chloride symporter activity [GO_0005335]
- 7045: serous membrane development [GO_1904817]
- 7046: SETD8 methylates TP53 [GO_0016278]
- 7047: sevenless binding [GO_0005118]
- 7048: sex determination [GO_0007530]
- 7049: sex differentiation [GO_0007548]
- 7050: sexual reproduction [GO_0019953]
- 7051: SH2 domain binding [GO_0042169]
- 7052: SH3 domain binding [GO_0017124]
- 7053: SHMT1 tetramer cleaves HTMLYS to yield TEABL and Gly [GO_0004372]
- 7054: short-chain carboxylesterase activity [GO_0034338]
- 7055: short-chain fatty acid-CoA ligase activity [GO_0031955]
- 7056: short-term memory [GO_0007614]
- 7057: sialylation [GO_0097503]
- 7058: signal recognition particle binding [GO_0005047]
- 7059: signal release [GO_0023061]
- 7060: signal release from synapse [GO_0099643]
- 7061: signal sequence binding [GO_0005048]
- 7062: signal transduction [GO_0007165]
- 7063: signal transduction involved in regulation of gene expression [GO_0023019]
- 7064: signaling [GO_0023052]
- 7065: signaling adaptor activity [GO_0035591]
- 7066: signaling receptor activator activity [GO_0030546]
- 7067: signaling receptor activity [GO_0038023]
- 7068: signaling receptor binding [GO_0005102]
- 7069: signaling receptor complex adaptor activity [GO_0030159]
- 7070: signaling receptor inhibitor activity [GO_0030547]
- 7071: signaling receptor regulator activity [GO_0030545]
- 7072: single-strand break-containing DNA binding [GO_1990165]
- 7073: single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO_0008310]
- 7074: single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO_0045145]
- 7075: single-stranded DNA binding [GO_0003697]
- 7076: single-stranded DNA endodeoxyribonuclease activity [GO_0000014]
- 7077: single-stranded DNA exodeoxyribonuclease activity [GO_0008297]
- 7078: single-stranded RNA binding [GO_0003727]
- 7079: single-stranded telomeric DNA binding [GO_0043047]
- 7080: single-subunit type RNA polymerase binding [GO_0001050]
- 7081: sinoatrial node cell development [GO_0060931]
- 7082: sinoatrial node cell differentiation [GO_0060921]
- 7083: sinoatrial node development [GO_0003163]
- 7084: sinus venosus development [GO_0003235]
- 7085: sinus venosus formation [GO_0003237]
- 7086: sinus venosus morphogenesis [GO_0003236]
- 7087: siRNA binding [GO_0035197]
- 7088: SIRT3 deacetylates ACCS2, GLUD, IDH2, SOD2 [GO_0034979]
- 7089: sister chromatid segregation [GO_0000819]
- 7090: skeletal muscle adaptation [GO_0043501]
- 7091: skeletal muscle cell differentiation [GO_0035914]
- 7092: skeletal muscle cell proliferation [GO_0014856]
- 7093: skeletal muscle contraction [GO_0003009]
- 7094: skeletal muscle fiber development [GO_0048741]
- 7095: skeletal muscle fiber differentiation [GO_0098528]
- 7096: skeletal muscle hypertrophy [GO_0014734]
- 7097: skeletal muscle myofibril [GO_0098723]
- 7098: skeletal muscle organ development [GO_0060538]
- 7099: skeletal muscle tissue development [GO_0007519]
- 7100: skeletal muscle tissue growth [GO_0048630]
- 7101: skeletal myofibril assembly [GO_0014866]
- 7102: skeletal system development [GO_0001501]
- 7103: skeletal system morphogenesis [GO_0048705]
- 7104: skin development [GO_0043588]
- 7105: skin epidermis development [GO_0098773]
- 7106: skin morphogenesis [GO_0043589]
- 7107: SLC12A1,2 cotransports Na+, K+, 2Cl- from extracellular region to cytosol [GO_0008511]
- 7108: SLC12A3 cotransports Cl-, Na+ from extracellular region to cytosol [GO_0015378]
- 7109: SLC16A1:BSG cotransports monocarboxylates, H+ from extracellular region to cytosol [GO_0008028]
- 7110: SLC1A1,2,3,6,7 cotransport L-Glu,L-Asp,D-Asp,H+,3Na+ from extracellular region to cytosol [GO_0005314]
- 7111: SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix [GO_0015291]
- 7112: SLC25A18,A22 cotransport Glu, H+ from cytosol to mitochondrial matrix [GO_0005280]
- 7113: SLC25A29 transports basic amino acids from cytosol to mitochondrial matrix [GO_0015174]
- 7114: SLC27A1,4,6 transport LCFAs from extracellular region to cytosol [GO_0015245]
- 7115: SLC2A1 tetramer transports Glc from cytosol to Golgi lumen [GO_0005355]
- 7116: SLC2A1,3 transports DeHA from extracellular region to cytosol [GO_0033300]
- 7117: SLC2A2 tetramer transports Fru, Gal, Glc from cytosol to extracellular region [GO_0015149]
- 7118: SLC2A5 transports fructose from extracellular region to cytosol [GO_0005353]
- 7119: SLC35D1 hexamer transports UDP-GlcA, UDP-GlcNAc from cytosol to endoplasmic reticulum lumen [GO_0005461]
- 7120: SLC36A2 cotransports Gly, L-Pro with H+ from extracellular region to cytosol [GO_0015171]
- 7121: SLC46A1 transports FeHM, heme from extracellular region to cytosol [GO_0015232]
- 7122: SLC4A5,7,9 cotransport Na+ with 3HCO3- [GO_0008510]
- 7123: SLC52A1,2,3 transport RIB from extracellular region to cytosol [GO_0032217]
- 7124: SLC5A10 cotransports Na+ with Man, Fru from extracellular region to cytosol [GO_0015370]
- 7125: SLC5A12 cotransports Na+ with LACT, PYR, NCA from extracellular region to cytosol [GO_0005343]
- 7126: SLC8A1,2,3 exchange 3Na+ for Ca2+ [GO_0005432]
- 7127: SLC9B1/C2 exchange Na+ for H+ [GO_0015385]
- 7128: SLCO1B1 transports ALB:(GCCA,TCCA) from extracellular region to cytosol [GO_0015125]
- 7129: SLCO1B1 transports BIL from extracellular region (blood) to cytosol (hepatocyte) [GO_0015347]
- 7130: SLCO1B1 transports T3,T4 from extracellular region to cytosol [GO_0015349]
- 7131: sleep [GO_0030431]
- 7132: SMAD binding [GO_0046332]
- 7133: small conductance calcium-activated potassium channel activity [GO_0016286]
- 7134: small conductance calcium-activated potassium channel inhibitor activity [GO_0140629]
- 7135: small GTPase binding [GO_0031267]
- 7136: small intestine smooth muscle contraction [GO_1990770]
- 7137: small molecule binding [GO_0036094]
- 7138: small molecule biosynthetic process [GO_0044283]
- 7139: small molecule catabolic process [GO_0044282]
- 7140: small molecule metabolic process [GO_0044281]
- 7141: small molecule sensor activity [GO_0140299]
- 7142: small protein activating enzyme binding [GO_0044388]
- 7143: small ribosomal subunit rRNA binding [GO_0070181]
- 7144: small RNA binding translational repressor activity [GO_0140764]
- 7145: smooth muscle adaptation [GO_0014805]
- 7146: smooth muscle cell apoptotic process [GO_0034390]
- 7147: smooth muscle cell differentiation [GO_0051145]
- 7148: smooth muscle cell proliferation [GO_0048659]
- 7149: smooth muscle contractile fiber [GO_0030485]
- 7150: smooth muscle contraction [GO_0006939]
- 7151: smooth muscle hypertrophy [GO_0014895]
- 7152: smooth muscle tissue development [GO_0048745]
- 7153: smoothened binding [GO_0005119]
- 7154: SNAP receptor activity [GO_0005484]
- 7155: snoRNA binding [GO_0030515]
- 7156: snRNA binding [GO_0017069]
- 7157: snRNA Cap hypermethylation [GO_0008173]
- 7158: snRNP binding [GO_0070990]
- 7159: SOCS family protein binding [GO_0097678]
- 7160: SodB gets secreted [GO_0015450]
- 7161: sodium channel activity [GO_0005272]
- 7162: sodium channel inhibitor activity [GO_0019871]
- 7163: sodium channel regulator activity [GO_0017080]
- 7164: sodium ion homeostasis [GO_0055078]
- 7165: sodium ion transmembrane transport [GO_0035725]
- 7166: sodium ion transmembrane transporter activity [GO_0015081]
- 7167: sodium ion transport [GO_0006814]
- 7168: soluble NSF attachment protein activity [GO_0005483]
- 7169: solute:anion antiporter activity [GO_0140323]
- 7170: solute:bicarbonate symporter activity [GO_0140410]
- 7171: solute:cation antiporter activity [GO_0015298]
- 7172: solute:cation symporter activity [GO_0015294]
- 7173: solute:potassium antiporter activity [GO_0022821]
- 7174: solute:proton symporter activity [GO_0015295]
- 7175: somatic stem cell division [GO_0048103]
- 7176: somato-dendritic dopamine secretion [GO_0099123]
- 7177: somatodendritic compartment [GO_0036477]
- 7178: somatostatin binding [GO_0120023]
- 7179: somatostatin receptor activity [GO_0004994]
- 7180: somatostatin receptor signaling pathway [GO_0038169]
- 7181: somatostatin secretion [GO_0070253]
- 7182: somatostatin signaling pathway [GO_0038170]
- 7183: somite development [GO_0061053]
- 7184: somitogenesis [GO_0001756]
- 7185: sour taste receptor activity [GO_0033040]
- 7186: SPAST (spastin) mediates the severing of microtubules at chromosome attachment sites [GO_0008568]
- 7187: spectrin binding [GO_0030507]
- 7188: sperm competition [GO_0046692]
- 7189: sperm storage [GO_0046693]
- 7190: spermidine synthase activity [GO_0004766]
- 7191: spermine synthase activity [GO_0016768]
- 7192: sphinganine + stearyl-CoA => dihydroceramide + CoASH [GO_0050291]
- 7193: sphinganine-1-phosphate aldolase activity [GO_0008117]
- 7194: sphingolipid binding [GO_0046625]
- 7195: sphingolipid delta-4 desaturase activity [GO_0042284]
- 7196: sphingolipid transfer activity [GO_0120016]
- 7197: sphingolipid transporter activity [GO_0046624]
- 7198: sphingomyelin phosphodiesterase activator activity [GO_0016230]
- 7199: Sphingomyelinase is activated by the NGF:p75NTR complex [GO_0004888]
- 7200: sphingosine-1-phosphate phosphatase activity [GO_0042392]
- 7201: spinal cord development [GO_0021510]
- 7202: spinal cord motor neuron differentiation [GO_0021522]
- 7203: spleen development [GO_0048536]
- 7204: SPO11 hydrolyzes DNA forming double-strand breaks [GO_0016888]
- 7205: SPPL2a/b cleaves TNF(1-76) [GO_0042500]
- 7206: SQR oxidizes sulfide to bound persulfide [GO_0070224]
- 7207: SRD5A1 dehydrogenates TEST to DHTEST [GO_0003865]
- 7208: SRD5A3 reduces pPNOL to DCHOL [GO_0016628]
- 7209: ST6GAL1 transfers Neu5Ac to terminal Gal of N-glycans [GO_0003835]
- 7210: starch binding [GO_2001070]
- 7211: STAT family protein binding [GO_0097677]
- 7212: stem cell development [GO_0048864]
- 7213: stem cell differentiation [GO_0048863]
- 7214: stem cell division [GO_0017145]
- 7215: stem cell proliferation [GO_0072089]
- 7216: steroid binding [GO_0005496]
- 7217: steroid biosynthetic process [GO_0006694]
- 7218: steroid catabolic process [GO_0006706]
- 7219: steroid dehydrogenase activity [GO_0016229]
- 7220: steroid dehydrogenase activity, acting on the CH-CH group of donors [GO_0033765]
- 7221: steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO_0033764]
- 7222: steroid hormone binding [GO_1990239]
- 7223: steroid hormone mediated signaling pathway [GO_0043401]
- 7224: steroid hormone secretion [GO_0035929]
- 7225: steroid metabolic process [GO_0008202]
- 7226: sterol binding [GO_0032934]
- 7227: sterol O-acyltransferase activity [GO_0004772]
- 7228: sterol transfer activity [GO_0120015]
- 7229: sterol transport [GO_0015918]
- 7230: STIM1 oligomerizes [GO_0005261]
- 7231: stomach development [GO_0062094]
- 7232: stomach neuroendocrine cell differentiation [GO_0061102]
- 7233: store-operated calcium channel activity [GO_0015279]
- 7234: stress-activated MAPK cascade [GO_0051403]
- 7235: stress-activated protein kinase signaling cascade [GO_0031098]
- 7236: stretch-activated, cation-selective, calcium channel activity [GO_0015275]
- 7237: striated muscle adaptation [GO_0014888]
- 7238: striated muscle cell apoptotic process [GO_0010658]
- 7239: striated muscle cell development [GO_0055002]
- 7240: striated muscle cell differentiation [GO_0051146]
- 7241: striated muscle cell proliferation [GO_0014855]
- 7242: striated muscle contraction [GO_0006941]
- 7243: striated muscle hypertrophy [GO_0014897]
- 7244: striated muscle tissue development [GO_0014706]
- 7245: strictosidine synthase activity [GO_0016844]
- 7246: structural constituent of adult chitin-based cuticle [GO_0008012]
- 7247: structural constituent of chitin-based cuticle [GO_0005214]
- 7248: structural constituent of chitin-based larval cuticle [GO_0008010]
- 7249: structural constituent of chromatin [GO_0030527]
- 7250: structural constituent of cuticle [GO_0042302]
- 7251: structural constituent of cytoskeleton [GO_0005200]
- 7252: structural constituent of egg chorion [GO_0005213]
- 7253: structural constituent of eye lens [GO_0005212]
- 7254: structural constituent of muscle [GO_0008307]
- 7255: structural constituent of peritrophic membrane [GO_0016490]
- 7256: structural constituent of presynaptic active zone [GO_0098882]
- 7257: structural constituent of pupal chitin-based cuticle [GO_0008011]
- 7258: structural constituent of ribosome [GO_0003735]
- 7259: structural constituent of synapse [GO_0098918]
- 7260: structural constituent of vitelline membrane [GO_0008316]
- 7261: structural molecule activity [GO_0005198]
- 7262: substantia propria of cornea development [GO_1903701]
- 7263: succinate dehydrogenase (ubiquinone) activity [GO_0008177]
- 7264: succinate dehydrogenase activity [GO_0000104]
- 7265: succinate transmembrane transport [GO_0071422]
- 7266: succinate transmembrane transporter activity [GO_0015141]
- 7267: succinate transport [GO_0015744]
- 7268: succinate-CoA ligase (ADP-forming) activity [GO_0004775]
- 7269: succinate-CoA ligase (GDP-forming) activity [GO_0004776]
- 7270: succinate-CoA ligase activity [GO_0004774]
- 7271: succinate-semialdehyde dehydrogenase (NAD+) activity [GO_0004777]
- 7272: succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO_0009013]
- 7273: succinyl-CoA:3-oxo-acid CoA-transferase activity [GO_0008260]
- 7274: succinyltransferase activity [GO_0016748]
- 7275: sucrose transmembrane transporter activity [GO_0008515]
- 7276: sucrose transport [GO_0015770]
- 7277: sucrose:cation symporter activity [GO_0009669]
- 7278: sucrose:proton symporter activity [GO_0008506]
- 7279: sugar transmembrane transporter activity [GO_0051119]
- 7280: sugar-phosphatase activity [GO_0050308]
- 7281: sulfate binding [GO_0043199]
- 7282: sulfate ion homeostasis [GO_0055063]
- 7283: Sulfate is exported to the cytosol in exchange for dicarboxylate [GO_0005310]
- 7284: sulfate transmembrane transport [GO_1902358]
- 7285: sulfate transport [GO_0008272]
- 7286: sulfur amino acid transmembrane transporter activity [GO_0000099]
- 7287: sulfur amino acid transport [GO_0000101]
- 7288: sulfur compound binding [GO_1901681]
- 7289: sulfur compound biosynthetic process [GO_0044272]
- 7290: sulfur compound catabolic process [GO_0044273]
- 7291: sulfur compound metabolic process [GO_0006790]
- 7292: sulfur compound transmembrane transporter activity [GO_1901682]
- 7293: sulfur compound transport [GO_0072348]
- 7294: sulfuric ester hydrolase activity [GO_0008484]
- 7295: SUMO activating enzyme activity [GO_0019948]
- 7296: SUMO conjugating enzyme activity [GO_0061656]
- 7297: SUMO ligase activity [GO_0061665]
- 7298: SUMO-specific endopeptidase activity [GO_0070139]
- 7299: superior olivary nucleus development [GO_0021718]
- 7300: superior olivary nucleus formation [GO_0021720]
- 7301: superior olivary nucleus maturation [GO_0021722]
- 7302: superior olivary nucleus morphogenesis [GO_0021719]
- 7303: superior salivary nucleus development [GO_0021753]
- 7304: superior vena cava morphogenesis [GO_0060578]
- 7305: superoxide dismutase activity [GO_0004784]
- 7306: superoxide dismutase copper chaperone activity [GO_0016532]
- 7307: superoxide metabolic process [GO_0006801]
- 7308: supramolecular complex [GO_0099080]
- 7309: supramolecular fiber [GO_0099512]
- 7310: supramolecular fiber organization [GO_0097435]
- 7311: supramolecular polymer [GO_0099081]
- 7312: surfactant homeostasis [GO_0043129]
- 7313: sympathetic ganglion development [GO_0061549]
- 7314: sympathetic nervous system development [GO_0048485]
- 7315: symporter activity [GO_0015293]
- 7316: synapse [GO_0045202]
- 7317: synapse assembly [GO_0007416]
- 7318: synapse organization [GO_0050808]
- 7319: synapse pruning [GO_0098883]
- 7320: synaptic membrane [GO_0097060]
- 7321: synaptic receptor adaptor activity [GO_0030160]
- 7322: synaptic signaling [GO_0099536]
- 7323: synaptic signaling via neuropeptide [GO_0099538]
- 7324: synaptic transmission, cholinergic [GO_0007271]
- 7325: synaptic transmission, dopaminergic [GO_0001963]
- 7326: synaptic transmission, GABAergic [GO_0051932]
- 7327: synaptic transmission, glutamatergic [GO_0035249]
- 7328: synaptic transmission, glycinergic [GO_0060012]
- 7329: syncytial nuclear migration [GO_0035190]
- 7330: syncytium formation [GO_0006949]
- 7331: syncytium formation by plasma membrane fusion [GO_0000768]
- 7332: SYNJ hydrolyze PI(4,5)P2 to PI(4)P [GO_0004439]
- 7333: syntaxin binding [GO_0019905]
- 7334: syntaxin-1 binding [GO_0017075]
- 7335: Synthesis of GABA by GAD2 [GO_0004351]
- 7336: Synthesis of minus strand strong stop DNA (-sssDNA) [GO_0003964]
- 7337: Synthesis of PB1-F2 [GO_0003746]
- 7338: system development [GO_0048731]
- 7339: system process [GO_0003008]
- 7340: SYVN1 ubiquitinates Hh C-terminal fragments [GO_0004842]
- 7341: tachykinin receptor activity [GO_0004995]
- 7342: tachykinin receptor binding [GO_0071861]
- 7343: tachykinin receptor signaling pathway [GO_0007217]
- 7344: taste receptor activity [GO_0008527]
- 7345: tau-protein kinase activity [GO_0050321]
- 7346: taurine transmembrane transporter activity [GO_0005368]
- 7347: taurine transport [GO_0015734]
- 7348: taurine:sodium symporter activity [GO_0005369]
- 7349: taxis [GO_0042330]
- 7350: TBP-class protein binding [GO_0017025]
- 7351: TDO tetramer dioxygenates L-Trp to NFK [GO_0004833]
- 7352: TECR,TECRL dehydrogenate TOD-CoA to ST-CoA [GO_0017099]
- 7353: telomerase inhibitor activity [GO_0010521]
- 7354: telomerase RNA binding [GO_0070034]
- 7355: telomeric DNA binding [GO_0042162]
- 7356: temperature homeostasis [GO_0001659]
- 7357: temperature-gated cation channel activity [GO_0097604]
- 7358: temperature-gated ion channel activity [GO_0097603]
- 7359: tendon development [GO_0035989]
- 7360: tendon formation [GO_0035992]
- 7361: tendon sheath development [GO_0002932]
- 7362: termination of mitochondrial transcription [GO_0006393]
- 7363: terpenoid metabolic process [GO_0006721]
- 7364: TERRA transcription [GO_0003899]
- 7365: testosterone 17-beta-dehydrogenase (NADP+) activity [GO_0047045]
- 7366: testosterone dehydrogenase (NAD+) activity [GO_0047035]
- 7367: testosterone dehydrogenase [NAD(P)] activity [GO_0030283]
- 7368: TET1,2,3 oxidizes 5-methylcytosine to 5-hydroxymethylcytosine [GO_0070579]
- 7369: tetrapyrrole binding [GO_0046906]
- 7370: tetrapyrrole biosynthetic process [GO_0033014]
- 7371: tetrapyrrole catabolic process [GO_0033015]
- 7372: tetrapyrrole metabolic process [GO_0033013]
- 7373: TFIIA-class transcription factor complex binding [GO_0001092]
- 7374: TFIID-class transcription factor complex binding [GO_0001094]
- 7375: TFIIF-class transcription factor complex binding [GO_0001096]
- 7376: The PIDDosome activates CASP2 [GO_0097153]
- 7377: The receptor:G-protein complex binds GTP [GO_0005525]
- 7378: THEM86B hydrolyses PMCHO, PMETAM [GO_0016803]
- 7379: thermoception [GO_0050955]
- 7380: thermosensory behavior [GO_0040040]
- 7381: thermotaxis [GO_0043052]
- 7382: THG1L transfers GMP to 5' end of tRNA(His) [GO_0016779]
- 7383: thiamine pyrophosphate binding [GO_0030976]
- 7384: thiamine transmembrane transport [GO_0071934]
- 7385: thiamine transmembrane transporter activity [GO_0015234]
- 7386: thiamine transport [GO_0015888]
- 7387: thioester transport [GO_1901337]
- 7388: thiol oxidase activity [GO_0016972]
- 7389: thiolester hydrolase activity [GO_0016790]
- 7390: thioredoxin peroxidase activity [GO_0008379]
- 7391: thioredoxin-dependent peroxiredoxin activity [GO_0140824]
- 7392: thiosulfate transmembrane transporter activity [GO_0015117]
- 7393: thiosulfate transport [GO_0015709]
- 7394: threonine + tRNA(Thr) + ATP => Thr-tRNA(Thr) + AMP + pyrophosphate [GO_0004829]
- 7395: threonine aldolase activity [GO_0004793]
- 7396: threonine-type endopeptidase activity [GO_0004298]
- 7397: threonine-type peptidase activity [GO_0070003]
- 7398: thyroid hormone transport [GO_0070327]
- 7399: TIGAR converts D-fructose-2,6-bisphosphate to D-fructose 6-phosphate [GO_0004331]
- 7400: TIR domain binding [GO_0070976]
- 7401: tissue development [GO_0009888]
- 7402: tissue homeostasis [GO_0001894]
- 7403: tissue morphogenesis [GO_0048729]
- 7404: tissue regeneration [GO_0042246]
- 7405: TNFAIP3 in OTUD7B:TNFAIP3:ZRANB1 deubiquitinates K63polyUb-TRAF6 [GO_0061578]
- 7406: Toll binding [GO_0005121]
- 7407: Toll-like receptor binding [GO_0035325]
- 7408: torso binding [GO_0005122]
- 7409: TPR domain binding [GO_0030911]
- 7410: trachea cartilage development [GO_0060534]
- 7411: trachea cartilage morphogenesis [GO_0060535]
- 7412: trachea development [GO_0060438]
- 7413: trachea formation [GO_0060440]
- 7414: trachea gland development [GO_0061153]
- 7415: trachea morphogenesis [GO_0060439]
- 7416: trachea submucosa development [GO_0061152]
- 7417: trans-hexaprenyltranstransferase activity [GO_0000010]
- 7418: trans-synaptic signaling [GO_0099537]
- 7419: trans-synaptic signaling by lipid [GO_0099541]
- 7420: trans-synaptic signaling by lipid, modulating synaptic transmission [GO_0099552]
- 7421: trans-synaptic signaling by neuropeptide [GO_0099540]
- 7422: trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO_0099551]
- 7423: trans-synaptic signaling, modulating synaptic transmission [GO_0099550]
- 7424: trans-synaptic signalling via exosome [GO_0099157]
- 7425: Transamination of MOB to methionine [GO_0008483]
- 7426: transcription by RNA polymerase I [GO_0006360]
- 7427: transcription by RNA polymerase II [GO_0006366]
- 7428: transcription by RNA polymerase III [GO_0006383]
- 7429: transcription cis-regulatory region binding [GO_0000976]
- 7430: transcription coactivator activity [GO_0003713]
- 7431: transcription coactivator binding [GO_0001223]
- 7432: transcription coregulator activity [GO_0003712]
- 7433: transcription coregulator binding [GO_0001221]
- 7434: transcription corepressor activity [GO_0003714]
- 7435: transcription corepressor binding [GO_0001222]
- 7436: transcription elongation factor activity [GO_0003711]
- 7437: transcription factor binding [GO_0008134]
- 7438: transcription regulator activator activity [GO_0140537]
- 7439: transcription regulator activity [GO_0140110]
- 7440: transcription regulator inhibitor activity [GO_0140416]
- 7441: transcription regulatory region nucleic acid binding [GO_0001067]
- 7442: transcription termination site sequence-specific DNA binding [GO_0001147]
- 7443: transepithelial ammonium transport [GO_0070634]
- 7444: transepithelial transport [GO_0070633]
- 7445: Transfer of N-glycan to the protein [GO_0004579]
- 7446: Transfer of SUMO1 from E1 to UBE2I (UBC9) [GO_0019789]
- 7447: transferase activity, transferring nitrogenous groups [GO_0016769]
- 7448: transferase activity, transferring one-carbon groups [GO_0016741]
- 7449: transferase activity, transferring phosphorus-containing groups [GO_0016772]
- 7450: transferase activity, transferring sulphur-containing groups [GO_0016782]
- 7451: transferase complex [GO_1990234]
- 7452: transferase complex, transferring phosphorus-containing groups [GO_0061695]
- 7453: transforming growth factor beta binding [GO_0050431]
- 7454: transforming growth factor beta receptor activity [GO_0005024]
- 7455: transforming growth factor beta receptor activity, type I [GO_0005025]
- 7456: transforming growth factor beta receptor binding [GO_0005160]
- 7457: transition metal ion binding [GO_0046914]
- 7458: transition metal ion transmembrane transporter activity [GO_0046915]
- 7459: transition metal ion transport [GO_0000041]
- 7460: transketolase activity [GO_0004802]
- 7461: transketolase or transaldolase activity [GO_0016744]
- 7462: translation [GO_0006412]
- 7463: translation activator activity [GO_0008494]
- 7464: translation at postsynapse [GO_0140242]
- 7465: translation at presynapse [GO_0140236]
- 7466: translation at presynapse, modulating chemical synaptic transmission [GO_0140237]
- 7467: translation at synapse [GO_0140241]
- 7468: translation factor activity, RNA binding [GO_0008135]
- 7469: translation initiation factor binding [GO_0031369]
- 7470: translation initiation ternary complex [GO_0044207]
- 7471: translation regulator activity [GO_0045182]
- 7472: translation regulator activity, nucleic acid binding [GO_0090079]
- 7473: translation release factor activity [GO_0003747]
- 7474: translation release factor activity, codon specific [GO_0016149]
- 7475: translation repressor activity [GO_0030371]
- 7476: translation termination factor activity [GO_0008079]
- 7477: translational elongation [GO_0006414]
- 7478: translational initiation [GO_0006413]
- 7479: translational termination [GO_0006415]
- 7480: transmembrane ascorbate ferrireductase activity [GO_0140571]
- 7481: transmembrane collagen trimer [GO_0030936]
- 7482: transmembrane monodehydroascorbate reductase activity [GO_0140575]
- 7483: transmembrane protein dislocase activity [GO_0140567]
- 7484: transmembrane receptor protein phosphatase activity [GO_0019198]
- 7485: transmembrane receptor protein serine/threonine kinase binding [GO_0070696]
- 7486: transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0007178]
- 7487: transmembrane receptor protein tyrosine kinase activator activity [GO_0030297]
- 7488: transmembrane receptor protein tyrosine kinase adaptor activity [GO_0005068]
- 7489: transmembrane receptor protein tyrosine kinase inhibitor activity [GO_0030293]
- 7490: transmembrane receptor protein tyrosine kinase signaling pathway [GO_0007169]
- 7491: transmembrane receptor protein tyrosine phosphatase activity [GO_0005001]
- 7492: transmembrane transport [GO_0055085]
- 7493: transmembrane transporter binding [GO_0044325]
- 7494: transmembrane transporter complex [GO_1902495]
- 7495: transmembrane-ephrin receptor activity [GO_0005005]
- 7496: transmission of nerve impulse [GO_0019226]
- 7497: transmitter-gated channel activity [GO_0022835]
- 7498: transmitter-gated ion channel activity [GO_0022824]
- 7499: transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO_1904315]
- 7500: transport [GO_0006810]
- 7501: transport along microtubule [GO_0010970]
- 7502: transport vesicle [GO_0030133]
- 7503: transport vesicle membrane [GO_0030658]
- 7504: transporter activity [GO_0005215]
- 7505: transporter complex [GO_1990351]
- 7506: trehalase activity [GO_0015927]
- 7507: trehalose transmembrane transporter activity [GO_0015574]
- 7508: trehalose transport [GO_0015771]
- 7509: trehalose-phosphatase activity [GO_0004805]
- 7510: TRIAP1:PRELID1, PRELID3A transports PA from the outer to the inner mitochondrial membrane [GO_0005319]
- 7511: tricarboxylate secondary active transmembrane transporter activity [GO_0005371]
- 7512: tricarboxylic acid transmembrane transport [GO_0035674]
- 7513: tricarboxylic acid transmembrane transporter activity [GO_0015142]
- 7514: tricarboxylic acid transport [GO_0006842]
- 7515: trigeminal ganglion development [GO_0061551]
- 7516: trigeminal ganglion formation [GO_0061561]
- 7517: trigeminal ganglion maturation [GO_0061557]
- 7518: trigeminal ganglion morphogenesis [GO_0061556]
- 7519: trigeminal nerve development [GO_0021559]
- 7520: trigeminal nerve formation [GO_0021638]
- 7521: trigeminal nerve maturation [GO_0021635]
- 7522: trigeminal nerve morphogenesis [GO_0021636]
- 7523: triglyceride biosynthetic process [GO_0019432]
- 7524: triglyceride metabolic process [GO_0006641]
- 7525: Trimmed spike protein binds to calnexin [GO_0051082]
- 7526: Trimming of N-ter extended precursor fragments by cytosolic aminopeptidases [GO_0004177]
- 7527: tripeptidyl-peptidase activity [GO_0008240]
- 7528: trivalent inorganic anion homeostasis [GO_0072506]
- 7529: tRNA (adenine) methyltransferase activity [GO_0016426]
- 7530: tRNA (guanine) methyltransferase activity [GO_0016423]
- 7531: tRNA (guanine-N7)-methylation [GO_0106004]
- 7532: tRNA 2'-phosphotransferase activity [GO_0000215]
- 7533: tRNA binding [GO_0000049]
- 7534: tRNA ligase activator activity [GO_0140733]
- 7535: tRNA m6t6A37 methyltransferase activity [GO_0089715]
- 7536: tRNA metabolic process [GO_0006399]
- 7537: tRNA methylation [GO_0030488]
- 7538: tRNA modification [GO_0006400]
- 7539: tRNA processing [GO_0008033]
- 7540: tRNA threonylcarbamoyladenosine metabolic process [GO_0070525]
- 7541: trophectodermal cell differentiation [GO_0001829]
- 7542: trophectodermal cell proliferation [GO_0001834]
- 7543: trophectodermal cellular morphogenesis [GO_0001831]
- 7544: tropomyosin binding [GO_0005523]
- 7545: TSTA3 dimer epimerises GDP-DHDMan to GDP-KDGal [GO_0016853]
- 7546: tube development [GO_0035295]
- 7547: tube formation [GO_0035148]
- 7548: tube lumen cavitation [GO_0060605]
- 7549: tube morphogenesis [GO_0035239]
- 7550: tubulin binding [GO_0015631]
- 7551: tubulin N-acetyltransferase activity [GO_0019799]
- 7552: tumor necrosis factor receptor binding [GO_0005164]
- 7553: tumor necrosis factor receptor superfamily binding [GO_0032813]
- 7554: turning behavior [GO_0035178]
- 7555: turning behavior involved in mating [GO_0034607]
- 7556: TUSC3 transports Mg2+ from extracellular region to cytosol [GO_0015095]
- 7557: TXNRD2 catalyzes the reduction of TXN2 by NADPH [GO_0004791]
- 7558: type B pancreatic cell apoptotic process [GO_0097050]
- 7559: type B pancreatic cell development [GO_0003323]
- 7560: type B pancreatic cell differentiation [GO_0003309]
- 7561: type B pancreatic cell maturation [GO_0072560]
- 7562: type B pancreatic cell proliferation [GO_0044342]
- 7563: type I transforming growth factor beta receptor binding [GO_0034713]
- 7564: tyramine receptor activity [GO_0008226]
- 7565: tyramine secretion [GO_0061545]
- 7566: tyramine secretion, neurotransmission [GO_0061546]
- 7567: tyrosinase activity [GO_0004503]
- 7568: tyrosine 3-monooxygenase activator activity [GO_0036470]
- 7569: tyrosine 3-monooxygenase activity [GO_0004511]
- 7570: TYW1:FMN:4Fe-4S transforms 1-methylguanosine yielding yW-187 (4-demethylwyosine) at nucleotide 37 of tRNA(Phe) [GO_0016829]
- 7571: U1 snRNA binding [GO_0030619]
- 7572: U2 snRNA binding [GO_0030620]
- 7573: U2 snRNP binding [GO_1990447]
- 7574: U4 snRNA binding [GO_0030621]
- 7575: U5 snRNA binding [GO_0030623]
- 7576: U6 snRNA binding [GO_0017070]
- 7577: Ub-Cys625-UBA6 adenylates ubiquitin in the cytosol [GO_0004839]
- 7578: ubiquinone binding [GO_0048039]
- 7579: ubiquitin activating enzyme binding [GO_0033134]
- 7580: ubiquitin binding [GO_0043130]
- 7581: ubiquitin conjugating enzyme activity [GO_0061631]
- 7582: ubiquitin conjugating enzyme binding [GO_0031624]
- 7583: ubiquitin ligase activator activity [GO_1990757]
- 7584: ubiquitin ligase-substrate adaptor activity [GO_1990756]
- 7585: ubiquitin protein ligase binding [GO_0031625]
- 7586: ubiquitin-dependent protein binding [GO_0140036]
- 7587: ubiquitin-dependent protein catabolic process [GO_0006511]
- 7588: ubiquitin-like modifier activating enzyme activity [GO_0008641]
- 7589: ubiquitin-like protein binding [GO_0032182]
- 7590: ubiquitin-like protein conjugating enzyme activity [GO_0061650]
- 7591: ubiquitin-like protein conjugating enzyme binding [GO_0044390]
- 7592: ubiquitin-like protein ligase activity [GO_0061659]
- 7593: ubiquitin-like protein ligase binding [GO_0044389]
- 7594: ubiquitin-like protein peptidase activity [GO_0019783]
- 7595: ubiquitin-like protein transferase activity [GO_0019787]
- 7596: ubiquitin-like protein-specific endopeptidase activity [GO_0070137]
- 7597: ubiquitin-protein transferase activator activity [GO_0097027]
- 7598: ubiquitin-protein transferase regulator activity [GO_0055106]
- 7599: ubiquitin-specific protease binding [GO_1990381]
- 7600: ubiquitination-like modification-dependent protein binding [GO_0140035]
- 7601: UCKL1 phosphorylates urindine, cytidine [GO_0004849]
- 7602: UDP phosphatase activity [GO_0045134]
- 7603: UDP-galactose transmembrane transport [GO_0072334]
- 7604: UDP-galactose transmembrane transporter activity [GO_0005459]
- 7605: UDP-galactosyltransferase activity [GO_0035250]
- 7606: UDP-glucose is oxidised to UDP-glucuronate [GO_0003979]
- 7607: UDP-glucose transmembrane transport [GO_0015786]
- 7608: UDP-glucose transmembrane transporter activity [GO_0005460]
- 7609: UDP-glucosyltransferase activity [GO_0035251]
- 7610: UDP-glucuronic acid transmembrane transport [GO_0015787]
- 7611: UDP-N-acetylgalactosamine transmembrane transport [GO_0015789]
- 7612: UDP-N-acetylgalactosamine transmembrane transporter activity [GO_0005463]
- 7613: UDP-N-acetylglucosamine 4-epimerase activity [GO_0003974]
- 7614: UDP-N-acetylglucosamine transmembrane transport [GO_1990569]
- 7615: UDP-N-acetylglucosamine transmembrane transporter activity [GO_0005462]
- 7616: UDP-sugar diphosphatase activity [GO_0008768]
- 7617: UDP-xylose transmembrane transport [GO_0015790]
- 7618: UDP-xylose transmembrane transporter activity [GO_0005464]
- 7619: UFM1 ligase activity [GO_0061666]
- 7620: UFM1 transferase activity [GO_0071568]
- 7621: UMP biosynthetic process [GO_0006222]
- 7622: UMP kinase activity [GO_0033862]
- 7623: UMP metabolic process [GO_0046049]
- 7624: uniporter activity [GO_0015292]
- 7625: Unwinding of DNA for the nascent HIV-1 transcript: Second Transition [GO_0043138]
- 7626: uracil + (deoxy)ribose 1-phosphate <=> (deoxy)uridine + orthophosphate [UPP] [GO_0004850]
- 7627: uracil binding [GO_0002058]
- 7628: urate oxidase activity [GO_0004846]
- 7629: uridylate kinase activity [GO_0009041]
- 7630: uridylyltransferase activity [GO_0070569]
- 7631: UROD decarboxylates URO3 to COPRO3 [GO_0004853]
- 7632: urogenital system development [GO_0001655]
- 7633: UROS transforms HMB to URO3 [GO_0004852]
- 7634: USP1 autocleavage [GO_0008233]
- 7635: USP9X deubiquitinates Ub-SNCA [GO_0008234]
- 7636: uterine epithelium development [GO_0035847]
- 7637: uterine gland development [GO_1903709]
- 7638: uterine wall growth [GO_0042702]
- 7639: uterus development [GO_0060065]
- 7640: uterus morphogenesis [GO_0061038]
- 7641: UTP-monosaccharide-1-phosphate uridylyltransferase activity [GO_0051748]
- 7642: UTP:glucose-1-phosphate uridylyltransferase activity [GO_0003983]
- 7643: UTP:glucose-1-phosphate uridylyltransferase regulator activity [GO_0043763]
- 7644: vacuolar amino acid transmembrane transport [GO_0034487]
- 7645: vacuolar calcium ion homeostasis [GO_0007036]
- 7646: vacuolar localization [GO_1990849]
- 7647: vacuolar lumen [GO_0005775]
- 7648: vacuolar membrane [GO_0005774]
- 7649: vacuolar transmembrane transport [GO_0034486]
- 7650: vacuolar transport [GO_0007034]
- 7651: vacuole [GO_0005773]
- 7652: vacuole fission [GO_0140572]
- 7653: vacuole fusion [GO_0097576]
- 7654: vacuole inheritance [GO_0000011]
- 7655: vacuole organization [GO_0007033]
- 7656: valine + tRNA(Val) + ATP => Val-tRNA(Val) + AMP + pyrophosphate [GO_0004832]
- 7657: vascular associated smooth muscle cell apoptotic process [GO_1905288]
- 7658: vascular associated smooth muscle cell development [GO_0097084]
- 7659: vascular associated smooth muscle cell differentiation [GO_0035886]
- 7660: vascular associated smooth muscle cell proliferation [GO_1990874]
- 7661: vascular cord development [GO_0072360]
- 7662: vascular endothelial cell proliferation [GO_0101023]
- 7663: vascular endothelial growth factor binding [GO_0038085]
- 7664: vascular endothelial growth factor receptor 2 binding [GO_0043184]
- 7665: vascular endothelial growth factor receptor binding [GO_0005172]
- 7666: vasculature development [GO_0001944]
- 7667: vasculogenesis [GO_0001570]
- 7668: vasculogenesis involved in coronary vascular morphogenesis [GO_0060979]
- 7669: vasopressin receptor activity [GO_0005000]
- 7670: VDAC1 transports PYR from cytosol to mitochondrial intermembrane space [GO_0008308]
- 7671: venous blood vessel development [GO_0060841]
- 7672: venous blood vessel morphogenesis [GO_0048845]
- 7673: venous endothelial cell differentiation [GO_0060843]
- 7674: ventral spinal cord development [GO_0021517]
- 7675: ventral spinal cord interneuron differentiation [GO_0021514]
- 7676: ventricular cardiac muscle tissue development [GO_0003229]
- 7677: ventricular cardiac muscle tissue morphogenesis [GO_0055010]
- 7678: ventricular septum development [GO_0003281]
- 7679: ventricular septum morphogenesis [GO_0060412]
- 7680: very-low-density lipoprotein particle binding [GO_0034189]
- 7681: very-low-density lipoprotein particle receptor activity [GO_0030229]
- 7682: vesicle [GO_0031982]
- 7683: vesicle budding from membrane [GO_0006900]
- 7684: vesicle cytoskeletal trafficking [GO_0099518]
- 7685: vesicle fusion [GO_0006906]
- 7686: vesicle fusion to plasma membrane [GO_0099500]
- 7687: vesicle fusion with Golgi apparatus [GO_0048280]
- 7688: vesicle fusion with vacuole [GO_0051469]
- 7689: vesicle localization [GO_0051648]
- 7690: vesicle membrane [GO_0012506]
- 7691: vesicle organization [GO_0016050]
- 7692: vesicle targeting [GO_0006903]
- 7693: vesicle targeting, to, from or within Golgi [GO_0048199]
- 7694: vesicle targeting, trans-Golgi to periciliary membrane compartment [GO_0097712]
- 7695: vesicle transport along actin filament [GO_0030050]
- 7696: vesicle transport along microtubule [GO_0047496]
- 7697: vesicle-mediated intercellular transport [GO_0110077]
- 7698: vesicle-mediated transport [GO_0016192]
- 7699: vesicle-mediated transport in synapse [GO_0099003]
- 7700: vesicle-mediated transport to the plasma membrane [GO_0098876]
- 7701: Vesicular inhibitory amino acid transport [GO_0015495]
- 7702: Viral UL47:UL48 Proteins Bind HCMV Tegumented Virion to Host Microtuble and Dynein complexs [GO_0008017]
- 7703: virion binding [GO_0046790]
- 7704: visceral peritoneum development [GO_1904818]
- 7705: visceral serous pericardium development [GO_0061032]
- 7706: visual behavior [GO_0007632]
- 7707: visual perception [GO_0007601]
- 7708: visual perception involved in equilibrioception [GO_0051356]
- 7709: visual system development [GO_0150063]
- 7710: vitamin B6 binding [GO_0070279]
- 7711: vitamin B6 biosynthetic process [GO_0042819]
- 7712: vitamin B6 metabolic process [GO_0042816]
- 7713: vitamin binding [GO_0019842]
- 7714: vitamin biosynthetic process [GO_0009110]
- 7715: vitamin D 24-hydroxylase activity [GO_0070576]
- 7716: vitamin metabolic process [GO_0006766]
- 7717: vitamin transmembrane transport [GO_0035461]
- 7718: vitamin transmembrane transporter activity [GO_0090482]
- 7719: vitamin transport [GO_0051180]
- 7720: vitellogenin receptor activity [GO_0008196]
- 7721: voltage-gated channel activity [GO_0022832]
- 7722: voltage-gated chloride channel activity [GO_0005247]
- 7723: voltage-gated ion channel activity [GO_0005244]
- 7724: voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO_1905030]
- 7725: voltage-gated potassium channel activity [GO_0005249]
- 7726: voltage-gated sodium channel activity [GO_0005248]
- 7727: volume-sensitive chloride channel activity [GO_0072320]
- 7728: VRAC heteromer transports I-, Cl- from cytosol to extracellular region [GO_0005225]
- 7729: walking behavior [GO_0090659]
- 7730: water transmembrane transporter activity [GO_0005372]
- 7731: water transport [GO_0006833]
- 7732: water-soluble vitamin biosynthetic process [GO_0042364]
- 7733: water-soluble vitamin metabolic process [GO_0006767]
- 7734: wide pore channel activity [GO_0022829]
- 7735: Wnt receptor activity [GO_0042813]
- 7736: Wnt signaling pathway [GO_0016055]
- 7737: Wnt-protein binding [GO_0017147]
- 7738: wound healing [GO_0042060]
- 7739: WW domain binding [GO_0050699]
- 7740: X11-like protein binding [GO_0042988]
- 7741: xenobiotic transmembrane transporter activity [GO_0042910]
- 7742: xenobiotic transport [GO_0042908]
- 7743: XMP + L-Glutamine + ATP + H2O => GMP + L-Glutamate + AMP + pyrophosphate [GO_0003922]
- 7744: XYLB phosphorylates D-xylulose [GO_0004856]
- 7745: Y-form DNA binding [GO_0000403]
- 7746: zinc efflux transmembrane transporter activity [GO_0022883]
- 7747: zinc ion binding [GO_0008270]
- 7748: zinc ion sensor activity [GO_0106219]
- 7749: zinc ion transmembrane transport [GO_0071577]
- 7750: zinc ion transport [GO_0006829]
- 7751: ZIP7 mediates zinc efflux from the endoplasmic reticulum [GO_0005385]
- 7752: zygote asymmetric cell division [GO_0010070]
- 7753: zymogen granule [GO_0042588]
- 7754: zymogen granule membrane [GO_0042589]
1 - ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose [GO_0004135]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerVFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004135",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004135",
"label": "((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose"
},
"description": [
"Catalysis of the hydrolysis of (1->6)-alpha-D-glucosidic branch linkages in glycogen phosphorylase limit dextrin. Limit dextrin is the highly branched core that remains after exhaustive treatment of glycogen with glycogen phosphorylase. It is formed because these enzymes cannot hydrolyze the (1->6) glycosidic linkages present."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0090599",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0090599",
"label": "alpha-glucosidase activity"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "amylo-1,6-glucosidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "dextrin-1,6-glucosidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
2 - (2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK) [GO_0004001]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK) in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004001",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004001",
"label": "(2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK)"
},
"description": [
"Catalysis of the reaction: ATP + adenosine = ADP + AMP."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0019206",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0019206",
"label": "nucleoside kinase activity"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016773",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016773",
"label": "phosphotransferase activity, alcohol group as acceptor"
}
],
"relationships": [
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/BFO_0000050",
"label": "is part of",
"type": "part_of"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0006167",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0006167",
"label": "AMP biosynthetic process"
}
}
],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "adenosine 5-phosphotransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "ATP:adenosine 5'-phosphotransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
3 - (d)ADP + ADP <=> (d)AMP + ATP (AK1) [GO_0004017]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (d)ADP + ADP <=> (d)AMP + ATP (AK1) in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004017",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004017",
"label": "(d)ADP + ADP <=> (d)AMP + ATP (AK1)"
},
"description": [
"Catalysis of the reaction: ATP + AMP = 2 ADP."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0050145",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0050145",
"label": "(d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1)"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "myokinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
4 - (d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1) [GO_0050145]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1) in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0050145",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0050145",
"label": "(d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1)"
},
"description": [
"Catalysis of the reaction: ATP + nucleoside monophosphate = ADP + nucleoside diphosphate."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016776",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016776",
"label": "phosphotransferase activity, phosphate group as acceptor"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0019205",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0019205",
"label": "nucleobase-containing compound kinase activity"
}
],
"relationships": [
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/BFO_0000050",
"label": "is part of",
"type": "part_of"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0046940",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0046940",
"label": "nucleoside monophosphate phosphorylation"
}
}
],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_related_synonym",
"label": "nucleotide kinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_exact_synonym",
"label": "nucleoside-phosphate kinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "NMP-kinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
5 - (d)GMP + ATP <=> (d)GDP + ADP (GUK1) [GO_0004385]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (d)GMP + ATP <=> (d)GDP + ADP (GUK1) in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004385",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004385",
"label": "(d)GMP + ATP <=> (d)GDP + ADP (GUK1)"
},
"description": [
"Catalysis of the reaction: ATP + GMP = ADP + GDP."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0050145",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0050145",
"label": "(d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1)"
}
],
"relationships": [
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/BFO_0000050",
"label": "is part of",
"type": "part_of"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0046037",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0046037",
"label": "GMP metabolic process"
}
},
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/BFO_0000050",
"label": "is part of",
"type": "part_of"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0046710",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0046710",
"label": "GDP metabolic process"
}
}
],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "membrane-associated guanylate kinase",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
6 - (d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3) [GO_0004550]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3) in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004550",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004550",
"label": "(d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3)"
},
"description": [
"Catalysis of the reaction: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016776",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016776",
"label": "phosphotransferase activity, phosphate group as acceptor"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0019205",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0019205",
"label": "nucleobase-containing compound kinase activity"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "nucleoside-diphosphate kinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "nucleotide phosphate kinase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
7 - (S)-2-hydroxy-acid oxidase activity [GO_0003973]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen (S)-2-hydroxy-acid oxidase activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0003973",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0003973",
"label": "(S)-2-hydroxy-acid oxidase activity"
},
"description": [
"Catalysis of the reaction: (S)-2-hydroxy-acid + O2 = 2-oxo acid + hydrogen peroxide."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016899",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016899",
"label": "oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_related_synonym",
"label": "glycolate oxidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "medium-chain-(S)-2-hydroxy-acid oxidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "L-2-hydroxy acid oxidase",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "L-alpha-hydroxy acid oxidase",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "hydroxyacid oxidase A",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "very-long-chain-(S)-2-hydroxy-acid oxidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "hydroxy-acid oxidase B activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
8 - 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] [GO_0004144]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004144",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004144",
"label": "1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2]"
},
"description": [
"Catalysis of the reaction: acyl-CoA + 1,2-diacylglycerol = CoA + triacylglycerol."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016411",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016411",
"label": "2-MAG and DAG are transacylated to TAG by PNPLA2/3"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_related_synonym",
"label": "diacylglycerol acyltransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
9 - 1,4-alpha-glucan branching enzyme activity [GO_0003844]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1,4-alpha-glucan branching enzyme activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0003844",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0003844",
"label": "1,4-alpha-glucan branching enzyme activity"
},
"description": [
"Catalysis of the transfer of a segment of a (1->4)-alpha-D-glucan chain to a primary hydroxyl group in a similar glucan chain."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016758",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016758",
"label": "hexosyltransferase activity"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-alpha-D-(1,4-alpha-D-glucano)-transferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_exact_synonym",
"label": "1,4-glucan-6-(1,4-glucano)-transferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "amylo-(1,4 to 1,6)transglucosidase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
10 - 1,4-alpha-oligoglucan phosphorylase activity [GO_0004645]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1,4-alpha-oligoglucan phosphorylase activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004645",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004645",
"label": "1,4-alpha-oligoglucan phosphorylase activity"
},
"description": [
"Catalysis of the reaction: 1,4-alpha-D-glucosyl(n) + phosphate = 1,4-alpha-D-glucosyl(n-1) + alpha-D-glucose 1-phosphate. The name should be qualified in each instance by adding the name of the natural substrate, e.g. maltodextrin phosphorylase, starch phosphorylase, glycogen phosphorylase."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016758",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016758",
"label": "hexosyltransferase activity"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "muscle phosphorylase",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
11 - 1-acyl LPE is acylated to PE by LPEAT [GO_0003841]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-acyl LPE is acylated to PE by LPEAT in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0003841",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0003841",
"label": "1-acyl LPE is acylated to PE by LPEAT"
},
"description": [
"Catalysis of the reaction: acyl-CoA + 1-acyl-sn-glycerol-3-phosphate = CoA + 1,2-diacyl-sn-glycerol-3-phosphate."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0042171",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0042171",
"label": "lysophosphatidic acid acyltransferase activity"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016411",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016411",
"label": "2-MAG and DAG are transacylated to TAG by PNPLA2/3"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "1-acyl-sn-glycerol-3-phosphate acyltransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_exact_synonym",
"label": "lysophosphatidate acyltransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_related_synonym",
"label": "acyl-CoA:1-acyl-sn-glycerol-3-phosphate 2-O-acyltransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
12 - 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C [GO_0004622]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0004622",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004622",
"label": "1-acyl LPE is hydrolyzed to GPETA by PLA2G4C"
},
"description": [
"Catalysis of the reaction: 2-lysophosphatidylcholine + H2O = glycerophosphocholine + a carboxylate."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0052689",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0052689",
"label": "CES1trimer hydrolyses ACEI pro-drugs to ACEIs"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0004620",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004620",
"label": "DDHD1,2 hydrolyse PA"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_related_synonym",
"label": "lecitholipase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
13 - 1-acylglycerophosphocholine O-acyltransferase activity [GO_0047184]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-acylglycerophosphocholine O-acyltransferase activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0047184",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0047184",
"label": "1-acylglycerophosphocholine O-acyltransferase activity"
},
"description": [
"Catalysis of the reaction: 1-acyl-sn-glycero-3-phosphocholine + acyl-CoA = phosphatidylcholine + CoA."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0008374",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0008374",
"label": "HHAT palmitoylates Hh N-terminal fragment"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_related_synonym",
"label": "acyl coenzyme A-monoacylphosphatidylcholine acyltransferase activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
14 - 1-phosphatidylinositol 4-kinase activator activity [GO_0098744]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-phosphatidylinositol 4-kinase activator activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0098744",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0098744",
"label": "1-phosphatidylinositol 4-kinase activator activity"
},
"description": [
"Binds to and increases the activity of 1-phosphatidylinositol 4-kinase."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0140677",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0140677",
"label": "molecular function activator activity"
},
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0019207",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0019207",
"label": "kinase regulator activity"
}
],
"relationships": [
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/RO_0002211",
"label": "regulates",
"type": "regulates"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0004430",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0004430",
"label": "PI is phosphorylated to PI4P by PI4KB at the Golgi membrane"
}
}
],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [],
"def_pubs": [
{
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
]
}
15 - 1-phosphatidylinositol binding [GO_0005545]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-phosphatidylinositol binding in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0005545",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0005545",
"label": "1-phosphatidylinositol binding"
},
"description": [
"Binding to a phosphatidylinositol, a glycophospholipid with its sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0035091",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0035091",
"label": "phosphatidylinositol binding"
}
],
"relationships": [],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [],
"def_pubs": [
{
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
]
}
16 - 1-phosphatidylinositol-3-kinase regulator activity [GO_0046935]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-phosphatidylinositol-3-kinase regulator activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0046935",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0046935",
"label": "1-phosphatidylinositol-3-kinase regulator activity"
},
"description": [
"Modulates the activity of the enzyme 1-phosphatidylinositol-3-kinase activity."
],
"comment": [
"See also the molecular function term '1-phosphatidylinositol-3-kinase activity ; GO:0016303'."
]
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0035014",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0035014",
"label": "phosphatidylinositol 3-kinase regulator activity"
}
],
"relationships": [
{
"relation": {
"iri": "http://purl.obolibrary.org/obo/RO_0002211",
"label": "regulates",
"type": "regulates"
},
"object": {
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016303",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016303",
"label": "PI3K-containing complexes phosphorylate PIP2 to PIP3"
}
}
],
"xrefs": [],
"anatomy_channel_image": [],
"pub_syn": [
{
"synonym": {
"scope": "has_exact_synonym",
"label": "1-phosphatidylinositol 3-kinase regulator activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
},
{
"synonym": {
"scope": "has_narrow_synonym",
"label": "phosphatidylinositol 3-kinase, class I, regulator activity",
"type": ""
},
"pub": {
"core": {
"symbol": "",
"iri": "http://flybase.org/reports/Unattributed",
"types": [
"Entity",
"Individual",
"pub"
],
"short_form": "Unattributed",
"label": ""
},
"FlyBase": "",
"PubMed": "",
"DOI": ""
}
}
],
"def_pubs": []
}
17 - 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO_0016309]
Note
This page displays the raw VFB json record for this term. Please use the link below to open the term inside the Virtual Fly Brain viewerOpen 1-phosphatidylinositol-5-phosphate 4-kinase activity in VFB
VFB Term Json
{
"term": {
"core": {
"iri": "http://purl.obolibrary.org/obo/GO_0016309",
"symbol": "",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016309",
"label": "1-phosphatidylinositol-5-phosphate 4-kinase activity"
},
"description": [
"Catalysis of the reaction: ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate."
],
"comment": []
},
"query": "Get JSON for Class",
"version": "44725ae",
"parents": [
{
"symbol": "",
"iri": "http://purl.obolibrary.org/obo/GO_0016307",
"types": [
"Entity",
"Class"
],
"short_form": "GO_0016307",
"label": "phosphatidylinositol phosphate kinase activity"
}
],
"relationships": [],
"xrefs": [],